{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-105","AGE":37.84738,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-01 09:53:10","TRTEDTM":"2021-02-28 21:53:10","EOSDY":731,"EOSDT":"2021-02-28","STRATA1":"B","STRATA2":"S1","BMRKR1":11.10167,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-105","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-02-28 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-105","AGE":37.84738,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-01 09:53:10","TRTEDTM":"2021-02-28 21:53:10","EOSDY":731,"EOSDT":"2021-02-28","STRATA1":"B","STRATA2":"S1","BMRKR1":11.10167,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-105","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-105","AGE":37.84738,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-01 09:53:10","TRTEDTM":"2021-02-28 21:53:10","EOSDY":731,"EOSDT":"2021-02-28","STRATA1":"B","STRATA2":"S1","BMRKR1":11.10167,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-105","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-105","AGE":37.84738,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-01 09:53:10","TRTEDTM":"2021-02-28 21:53:10","EOSDY":731,"EOSDT":"2021-02-28","STRATA1":"B","STRATA2":"S1","BMRKR1":11.10167,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-105","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-105","AGE":37.84738,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-01 09:53:10","TRTEDTM":"2021-02-28 21:53:10","EOSDY":731,"EOSDT":"2021-02-28","STRATA1":"B","STRATA2":"S1","BMRKR1":11.10167,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-105","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-03-01 09:53:10","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-105","AGE":37.84738,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-01 09:53:10","TRTEDTM":"2021-02-28 21:53:10","EOSDY":731,"EOSDT":"2021-02-28","STRATA1":"B","STRATA2":"S1","BMRKR1":11.10167,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-105","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.19788,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-13 09:53:10","ADY":73}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-105","AGE":37.84738,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-01 09:53:10","TRTEDTM":"2021-02-28 21:53:10","EOSDY":731,"EOSDT":"2021-02-28","STRATA1":"B","STRATA2":"S1","BMRKR1":11.10167,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-105","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.00777,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-03-04 09:53:10","ADY":3}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-105","AGE":37.84738,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-01 09:53:10","TRTEDTM":"2021-02-28 21:53:10","EOSDY":731,"EOSDT":"2021-02-28","STRATA1":"B","STRATA2":"S1","BMRKR1":11.10167,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-105","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":13.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-05-31 17:25:57","ADY":92}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-105","AGE":37.84738,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-01 09:53:10","TRTEDTM":"2021-02-28 21:53:10","EOSDY":731,"EOSDT":"2021-02-28","STRATA1":"B","STRATA2":"S1","BMRKR1":11.10167,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-105","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":20,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-07-18 02:26:34","ADY":140}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-171","AGE":29.75131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-12 12:18:31","TRTEDTM":"2022-12-13 00:18:31","EOSDY":731,"EOSDT":"2022-12-13","STRATA1":"A","STRATA2":"S2","BMRKR1":7.01712,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-171","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-12-13 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-171","AGE":29.75131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-12 12:18:31","TRTEDTM":"2022-12-13 00:18:31","EOSDY":731,"EOSDT":"2022-12-13","STRATA1":"A","STRATA2":"S2","BMRKR1":7.01712,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-171","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-171","AGE":29.75131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-12 12:18:31","TRTEDTM":"2022-12-13 00:18:31","EOSDY":731,"EOSDT":"2022-12-13","STRATA1":"A","STRATA2":"S2","BMRKR1":7.01712,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-171","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-171","AGE":29.75131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-12 12:18:31","TRTEDTM":"2022-12-13 00:18:31","EOSDY":731,"EOSDT":"2022-12-13","STRATA1":"A","STRATA2":"S2","BMRKR1":7.01712,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-171","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-171","AGE":29.75131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-12 12:18:31","TRTEDTM":"2022-12-13 00:18:31","EOSDY":731,"EOSDT":"2022-12-13","STRATA1":"A","STRATA2":"S2","BMRKR1":7.01712,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-171","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-12-14 12:18:31","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-171","AGE":29.75131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-12 12:18:31","TRTEDTM":"2022-12-13 00:18:31","EOSDY":731,"EOSDT":"2022-12-13","STRATA1":"A","STRATA2":"S2","BMRKR1":7.01712,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-171","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.17212,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-02-13 12:18:31","ADY":63}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-171","AGE":29.75131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-12 12:18:31","TRTEDTM":"2022-12-13 00:18:31","EOSDY":731,"EOSDT":"2022-12-13","STRATA1":"A","STRATA2":"S2","BMRKR1":7.01712,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-171","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.64517,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-08-05 12:18:31","ADY":236}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-171","AGE":29.75131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-12 12:18:31","TRTEDTM":"2022-12-13 00:18:31","EOSDY":731,"EOSDT":"2022-12-13","STRATA1":"A","STRATA2":"S2","BMRKR1":7.01712,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-171","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":100.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-11-14 00:10:59","ADY":703}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-171","AGE":29.75131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-12 12:18:31","TRTEDTM":"2022-12-13 00:18:31","EOSDY":731,"EOSDT":"2022-12-13","STRATA1":"A","STRATA2":"S2","BMRKR1":7.01712,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-171","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":90,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-09-02 14:48:22","ADY":630}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-177","AGE":38.93351,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-31 18:46:20","TRTEDTM":"2021-08-31 06:46:20","EOSDY":731,"EOSDT":"2021-08-31","STRATA1":"C","STRATA2":"S1","BMRKR1":9.37806,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-177","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-08-31 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-177","AGE":38.93351,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-31 18:46:20","TRTEDTM":"2021-08-31 06:46:20","EOSDY":731,"EOSDT":"2021-08-31","STRATA1":"C","STRATA2":"S1","BMRKR1":9.37806,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-177","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":9}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-177","AGE":38.93351,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-31 18:46:20","TRTEDTM":"2021-08-31 06:46:20","EOSDY":731,"EOSDT":"2021-08-31","STRATA1":"C","STRATA2":"S1","BMRKR1":9.37806,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-177","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-177","AGE":38.93351,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-31 18:46:20","TRTEDTM":"2021-08-31 06:46:20","EOSDY":731,"EOSDT":"2021-08-31","STRATA1":"C","STRATA2":"S1","BMRKR1":9.37806,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-177","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-177","AGE":38.93351,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-31 18:46:20","TRTEDTM":"2021-08-31 06:46:20","EOSDY":731,"EOSDT":"2021-08-31","STRATA1":"C","STRATA2":"S1","BMRKR1":9.37806,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-177","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.10888,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-10-10 18:46:20","ADY":40}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-177","AGE":38.93351,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-31 18:46:20","TRTEDTM":"2021-08-31 06:46:20","EOSDY":731,"EOSDT":"2021-08-31","STRATA1":"C","STRATA2":"S1","BMRKR1":9.37806,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-177","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.38622,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-01-20 18:46:20","ADY":142}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-177","AGE":38.93351,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-31 18:46:20","TRTEDTM":"2021-08-31 06:46:20","EOSDY":731,"EOSDT":"2021-08-31","STRATA1":"C","STRATA2":"S1","BMRKR1":9.37806,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-177","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.1764,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-04 18:46:20","ADY":65}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-177","AGE":38.93351,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-31 18:46:20","TRTEDTM":"2021-08-31 06:46:20","EOSDY":731,"EOSDT":"2021-08-31","STRATA1":"C","STRATA2":"S1","BMRKR1":9.37806,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-177","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":31.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-04-06 16:51:23","ADY":220}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-177","AGE":38.93351,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-31 18:46:20","TRTEDTM":"2021-08-31 06:46:20","EOSDY":731,"EOSDT":"2021-08-31","STRATA1":"C","STRATA2":"S1","BMRKR1":9.37806,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-177","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":35,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-05-01 14:42:44","ADY":245}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-23","AGE":41.33079,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-07 07:32:49","TRTEDTM":"2021-09-06 19:32:49","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S2","BMRKR1":6.84753,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-23","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-09-06 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-23","AGE":41.33079,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-07 07:32:49","TRTEDTM":"2021-09-06 19:32:49","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S2","BMRKR1":6.84753,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-23","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-23","AGE":41.33079,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-07 07:32:49","TRTEDTM":"2021-09-06 19:32:49","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S2","BMRKR1":6.84753,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-23","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-23","AGE":41.33079,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-07 07:32:49","TRTEDTM":"2021-09-06 19:32:49","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S2","BMRKR1":6.84753,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-23","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-23","AGE":41.33079,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-07 07:32:49","TRTEDTM":"2021-09-06 19:32:49","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S2","BMRKR1":6.84753,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-23","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-09-07 07:32:49","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-23","AGE":41.33079,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-07 07:32:49","TRTEDTM":"2021-09-06 19:32:49","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S2","BMRKR1":6.84753,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-23","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.21289,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-24 07:32:49","ADY":78}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-23","AGE":41.33079,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-07 07:32:49","TRTEDTM":"2021-09-06 19:32:49","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S2","BMRKR1":6.84753,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-23","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-09-07 07:32:49","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-23","AGE":41.33079,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-07 07:32:49","TRTEDTM":"2021-09-06 19:32:49","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S2","BMRKR1":6.84753,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-23","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":56.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-10-03 10:09:03","ADY":393}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-23","AGE":41.33079,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-07 07:32:49","TRTEDTM":"2021-09-06 19:32:49","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S2","BMRKR1":6.84753,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-23","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":57,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-10-09 06:24:19","ADY":399}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-59","AGE":26.69895,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-22 23:54:46","TRTEDTM":"2022-03-23 11:54:46","EOSDY":731,"EOSDT":"2022-03-23","STRATA1":"C","STRATA2":"S1","BMRKR1":3.80602,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-59","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-03-23 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-59","AGE":26.69895,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-22 23:54:46","TRTEDTM":"2022-03-23 11:54:46","EOSDY":731,"EOSDT":"2022-03-23","STRATA1":"C","STRATA2":"S1","BMRKR1":3.80602,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-59","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-59","AGE":26.69895,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-22 23:54:46","TRTEDTM":"2022-03-23 11:54:46","EOSDY":731,"EOSDT":"2022-03-23","STRATA1":"C","STRATA2":"S1","BMRKR1":3.80602,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-59","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-59","AGE":26.69895,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-22 23:54:46","TRTEDTM":"2022-03-23 11:54:46","EOSDY":731,"EOSDT":"2022-03-23","STRATA1":"C","STRATA2":"S1","BMRKR1":3.80602,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-59","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-59","AGE":26.69895,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-22 23:54:46","TRTEDTM":"2022-03-23 11:54:46","EOSDY":731,"EOSDT":"2022-03-23","STRATA1":"C","STRATA2":"S1","BMRKR1":3.80602,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-59","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-03-24 23:54:46","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-59","AGE":26.69895,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-22 23:54:46","TRTEDTM":"2022-03-23 11:54:46","EOSDY":731,"EOSDT":"2022-03-23","STRATA1":"C","STRATA2":"S1","BMRKR1":3.80602,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-59","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-03-24 23:54:46","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-59","AGE":26.69895,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-22 23:54:46","TRTEDTM":"2022-03-23 11:54:46","EOSDY":731,"EOSDT":"2022-03-23","STRATA1":"C","STRATA2":"S1","BMRKR1":3.80602,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-59","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-03-24 23:54:46","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-59","AGE":26.69895,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-22 23:54:46","TRTEDTM":"2022-03-23 11:54:46","EOSDY":731,"EOSDT":"2022-03-23","STRATA1":"C","STRATA2":"S1","BMRKR1":3.80602,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-59","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":9.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-05-28 22:59:47","ADY":68}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-59","AGE":26.69895,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-22 23:54:46","TRTEDTM":"2022-03-23 11:54:46","EOSDY":731,"EOSDT":"2022-03-23","STRATA1":"C","STRATA2":"S1","BMRKR1":3.80602,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-59","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":3.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-04-14 00:33:18","ADY":24}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-9","AGE":34.52635,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-09 14:39:09","TRTEDTM":"2022-04-10 02:39:09","EOSDY":731,"EOSDT":"2022-04-10","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80594,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-9","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-04-10 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-9","AGE":34.52635,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-09 14:39:09","TRTEDTM":"2022-04-10 02:39:09","EOSDY":731,"EOSDT":"2022-04-10","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80594,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-9","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-9","AGE":34.52635,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-09 14:39:09","TRTEDTM":"2022-04-10 02:39:09","EOSDY":731,"EOSDT":"2022-04-10","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80594,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-9","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-9","AGE":34.52635,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-09 14:39:09","TRTEDTM":"2022-04-10 02:39:09","EOSDY":731,"EOSDT":"2022-04-10","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80594,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-9","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-9","AGE":34.52635,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-09 14:39:09","TRTEDTM":"2022-04-10 02:39:09","EOSDY":731,"EOSDT":"2022-04-10","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80594,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-9","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.62366,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-11-23 14:39:09","ADY":228}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-9","AGE":34.52635,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-09 14:39:09","TRTEDTM":"2022-04-10 02:39:09","EOSDY":731,"EOSDT":"2022-04-10","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80594,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-9","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2022-04-11 14:39:09","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-9","AGE":34.52635,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-09 14:39:09","TRTEDTM":"2022-04-10 02:39:09","EOSDY":731,"EOSDT":"2022-04-10","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80594,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-9","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-04-11 14:39:09","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-9","AGE":34.52635,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-09 14:39:09","TRTEDTM":"2022-04-10 02:39:09","EOSDY":731,"EOSDT":"2022-04-10","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80594,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-9","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-04-09 14:39:09","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-1","SUBJID":"id-9","AGE":34.52635,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-09 14:39:09","TRTEDTM":"2022-04-10 02:39:09","EOSDY":731,"EOSDT":"2022-04-10","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80594,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-1-id-9","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":59.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-05-30 01:32:16","ADY":417}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-11","SUBJID":"id-8","AGE":29.42386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 02:02:07","TRTEDTM":"2022-06-17 14:02:07","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"C","STRATA2":"S1","BMRKR1":5.48013,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-11-id-8","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-06-17 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-11","SUBJID":"id-8","AGE":29.42386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 02:02:07","TRTEDTM":"2022-06-17 14:02:07","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"C","STRATA2":"S1","BMRKR1":5.48013,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-11-id-8","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-11","SUBJID":"id-8","AGE":29.42386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 02:02:07","TRTEDTM":"2022-06-17 14:02:07","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"C","STRATA2":"S1","BMRKR1":5.48013,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-11-id-8","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-11","SUBJID":"id-8","AGE":29.42386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 02:02:07","TRTEDTM":"2022-06-17 14:02:07","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"C","STRATA2":"S1","BMRKR1":5.48013,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-11-id-8","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-11","SUBJID":"id-8","AGE":29.42386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 02:02:07","TRTEDTM":"2022-06-17 14:02:07","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"C","STRATA2":"S1","BMRKR1":5.48013,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-11-id-8","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.78585,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-04-01 02:02:07","ADY":288}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-11","SUBJID":"id-8","AGE":29.42386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 02:02:07","TRTEDTM":"2022-06-17 14:02:07","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"C","STRATA2":"S1","BMRKR1":5.48013,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-11-id-8","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-06-18 02:02:07","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-11","SUBJID":"id-8","AGE":29.42386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 02:02:07","TRTEDTM":"2022-06-17 14:02:07","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"C","STRATA2":"S1","BMRKR1":5.48013,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-11-id-8","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.0557,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-07-08 02:02:07","ADY":21}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-11","SUBJID":"id-8","AGE":29.42386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 02:02:07","TRTEDTM":"2022-06-17 14:02:07","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"C","STRATA2":"S1","BMRKR1":5.48013,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-11-id-8","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":37.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-03-07 04:45:57","ADY":264}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-11","SUBJID":"id-8","AGE":29.42386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 02:02:07","TRTEDTM":"2022-06-17 14:02:07","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"C","STRATA2":"S1","BMRKR1":5.48013,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-11-id-8","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":24.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-12-05 10:43:34","ADY":172}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-120","AGE":47.18494,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-07 01:42:29","TRTEDTM":"2021-04-06 13:42:29","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":4.01102,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-120","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-04-06 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-120","AGE":47.18494,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-07 01:42:29","TRTEDTM":"2021-04-06 13:42:29","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":4.01102,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-120","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-120","AGE":47.18494,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-07 01:42:29","TRTEDTM":"2021-04-06 13:42:29","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":4.01102,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-120","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-120","AGE":47.18494,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-07 01:42:29","TRTEDTM":"2021-04-06 13:42:29","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":4.01102,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-120","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-120","AGE":47.18494,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-07 01:42:29","TRTEDTM":"2021-04-06 13:42:29","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":4.01102,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-120","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-04-07 01:42:29","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-120","AGE":47.18494,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-07 01:42:29","TRTEDTM":"2021-04-06 13:42:29","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":4.01102,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-120","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.32161,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-03 01:42:29","ADY":118}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-120","AGE":47.18494,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-07 01:42:29","TRTEDTM":"2021-04-06 13:42:29","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":4.01102,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-120","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.04278,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-04-23 01:42:29","ADY":16}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-120","AGE":47.18494,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-07 01:42:29","TRTEDTM":"2021-04-06 13:42:29","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":4.01102,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-120","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":24.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-09-22 16:34:22","ADY":169}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-120","AGE":47.18494,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-07 01:42:29","TRTEDTM":"2021-04-06 13:42:29","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":4.01102,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-120","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":15.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-07-24 20:16:47","ADY":109}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-42","AGE":32.41375,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-03 19:47:31","TRTEDTM":"2022-08-04 07:47:31","EOSDY":731,"EOSDT":"2022-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":5.09991,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-42","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-08-04 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-42","AGE":32.41375,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-03 19:47:31","TRTEDTM":"2022-08-04 07:47:31","EOSDY":731,"EOSDT":"2022-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":5.09991,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-42","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-42","AGE":32.41375,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-03 19:47:31","TRTEDTM":"2022-08-04 07:47:31","EOSDY":731,"EOSDT":"2022-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":5.09991,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-42","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-42","AGE":32.41375,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-03 19:47:31","TRTEDTM":"2022-08-04 07:47:31","EOSDY":731,"EOSDT":"2022-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":5.09991,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-42","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-42","AGE":32.41375,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-03 19:47:31","TRTEDTM":"2022-08-04 07:47:31","EOSDY":731,"EOSDT":"2022-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":5.09991,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-42","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.07125,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-30 19:47:31","ADY":27}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-42","AGE":32.41375,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-03 19:47:31","TRTEDTM":"2022-08-04 07:47:31","EOSDY":731,"EOSDT":"2022-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":5.09991,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-42","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.07996,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-02 19:47:31","ADY":30}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-42","AGE":32.41375,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-03 19:47:31","TRTEDTM":"2022-08-04 07:47:31","EOSDY":731,"EOSDT":"2022-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":5.09991,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-42","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.01948,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-11 19:47:31","ADY":8}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-42","AGE":32.41375,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-03 19:47:31","TRTEDTM":"2022-08-04 07:47:31","EOSDY":731,"EOSDT":"2022-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":5.09991,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-42","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":94.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-05-24 00:52:54","ADY":660}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-12","SUBJID":"id-42","AGE":32.41375,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-03 19:47:31","TRTEDTM":"2022-08-04 07:47:31","EOSDY":731,"EOSDT":"2022-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":5.09991,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-12-id-42","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":44.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-06-10 13:44:53","ADY":312}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-101","AGE":36.08913,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-07-24 21:50:04","TRTEDTM":"2022-07-25 09:50:04","EOSDY":731,"EOSDT":"2022-07-25","STRATA1":"A","STRATA2":"S2","BMRKR1":1.79765,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-101","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-07-25 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-101","AGE":36.08913,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-07-24 21:50:04","TRTEDTM":"2022-07-25 09:50:04","EOSDY":731,"EOSDT":"2022-07-25","STRATA1":"A","STRATA2":"S2","BMRKR1":1.79765,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-101","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-101","AGE":36.08913,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-07-24 21:50:04","TRTEDTM":"2022-07-25 09:50:04","EOSDY":731,"EOSDT":"2022-07-25","STRATA1":"A","STRATA2":"S2","BMRKR1":1.79765,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-101","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-101","AGE":36.08913,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-07-24 21:50:04","TRTEDTM":"2022-07-25 09:50:04","EOSDY":731,"EOSDT":"2022-07-25","STRATA1":"A","STRATA2":"S2","BMRKR1":1.79765,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-101","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":9}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-101","AGE":36.08913,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-07-24 21:50:04","TRTEDTM":"2022-07-25 09:50:04","EOSDY":731,"EOSDT":"2022-07-25","STRATA1":"A","STRATA2":"S2","BMRKR1":1.79765,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-101","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-07-26 21:50:04","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-101","AGE":36.08913,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-07-24 21:50:04","TRTEDTM":"2022-07-25 09:50:04","EOSDY":731,"EOSDT":"2022-07-25","STRATA1":"A","STRATA2":"S2","BMRKR1":1.79765,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-101","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-07-26 21:50:04","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-101","AGE":36.08913,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-07-24 21:50:04","TRTEDTM":"2022-07-25 09:50:04","EOSDY":731,"EOSDT":"2022-07-25","STRATA1":"A","STRATA2":"S2","BMRKR1":1.79765,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-101","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.10424,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-01 21:50:04","ADY":39}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-101","AGE":36.08913,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-07-24 21:50:04","TRTEDTM":"2022-07-25 09:50:04","EOSDY":731,"EOSDT":"2022-07-25","STRATA1":"A","STRATA2":"S2","BMRKR1":1.79765,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-101","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-07-24 21:50:04","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-101","AGE":36.08913,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-07-24 21:50:04","TRTEDTM":"2022-07-25 09:50:04","EOSDY":731,"EOSDT":"2022-07-25","STRATA1":"A","STRATA2":"S2","BMRKR1":1.79765,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-101","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":77.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-01-14 09:05:25","ADY":540}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-36","AGE":29.13114,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-18 16:58:33","TRTEDTM":"2022-10-19 04:58:33","EOSDY":731,"EOSDT":"2022-10-19","STRATA1":"B","STRATA2":"S1","BMRKR1":10.70442,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-36","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-10-19 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-36","AGE":29.13114,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-18 16:58:33","TRTEDTM":"2022-10-19 04:58:33","EOSDY":731,"EOSDT":"2022-10-19","STRATA1":"B","STRATA2":"S1","BMRKR1":10.70442,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-36","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-36","AGE":29.13114,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-18 16:58:33","TRTEDTM":"2022-10-19 04:58:33","EOSDY":731,"EOSDT":"2022-10-19","STRATA1":"B","STRATA2":"S1","BMRKR1":10.70442,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-36","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-36","AGE":29.13114,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-18 16:58:33","TRTEDTM":"2022-10-19 04:58:33","EOSDY":731,"EOSDT":"2022-10-19","STRATA1":"B","STRATA2":"S1","BMRKR1":10.70442,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-36","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-36","AGE":29.13114,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-18 16:58:33","TRTEDTM":"2022-10-19 04:58:33","EOSDY":731,"EOSDT":"2022-10-19","STRATA1":"B","STRATA2":"S1","BMRKR1":10.70442,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-36","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-10-20 16:58:33","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-36","AGE":29.13114,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-18 16:58:33","TRTEDTM":"2022-10-19 04:58:33","EOSDY":731,"EOSDT":"2022-10-19","STRATA1":"B","STRATA2":"S1","BMRKR1":10.70442,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-36","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.26139,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-22 16:58:33","ADY":96}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-36","AGE":29.13114,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-18 16:58:33","TRTEDTM":"2022-10-19 04:58:33","EOSDY":731,"EOSDT":"2022-10-19","STRATA1":"B","STRATA2":"S1","BMRKR1":10.70442,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-36","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.11723,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-11-30 16:58:33","ADY":43}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-36","AGE":29.13114,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-18 16:58:33","TRTEDTM":"2022-10-19 04:58:33","EOSDY":731,"EOSDT":"2022-10-19","STRATA1":"B","STRATA2":"S1","BMRKR1":10.70442,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-36","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":34.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-06-16 12:32:28","ADY":242}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-36","AGE":29.13114,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-18 16:58:33","TRTEDTM":"2022-10-19 04:58:33","EOSDY":731,"EOSDT":"2022-10-19","STRATA1":"B","STRATA2":"S1","BMRKR1":10.70442,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-36","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":38.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-07-11 22:56:32","ADY":267}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-65","AGE":36.31569,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-30 11:27:16","TRTEDTM":"2022-08-30 23:27:16","EOSDY":731,"EOSDT":"2022-08-30","STRATA1":"A","STRATA2":"S2","BMRKR1":8.76531,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-65","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-08-30 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-65","AGE":36.31569,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-30 11:27:16","TRTEDTM":"2022-08-30 23:27:16","EOSDY":731,"EOSDT":"2022-08-30","STRATA1":"A","STRATA2":"S2","BMRKR1":8.76531,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-65","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-65","AGE":36.31569,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-30 11:27:16","TRTEDTM":"2022-08-30 23:27:16","EOSDY":731,"EOSDT":"2022-08-30","STRATA1":"A","STRATA2":"S2","BMRKR1":8.76531,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-65","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-65","AGE":36.31569,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-30 11:27:16","TRTEDTM":"2022-08-30 23:27:16","EOSDY":731,"EOSDT":"2022-08-30","STRATA1":"A","STRATA2":"S2","BMRKR1":8.76531,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-65","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-65","AGE":36.31569,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-30 11:27:16","TRTEDTM":"2022-08-30 23:27:16","EOSDY":731,"EOSDT":"2022-08-30","STRATA1":"A","STRATA2":"S2","BMRKR1":8.76531,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-65","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-08-31 11:27:16","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-65","AGE":36.31569,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-30 11:27:16","TRTEDTM":"2022-08-30 23:27:16","EOSDY":731,"EOSDT":"2022-08-30","STRATA1":"A","STRATA2":"S2","BMRKR1":8.76531,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-65","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.22533,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-11-21 11:27:16","ADY":83}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-65","AGE":36.31569,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-30 11:27:16","TRTEDTM":"2022-08-30 23:27:16","EOSDY":731,"EOSDT":"2022-08-30","STRATA1":"A","STRATA2":"S2","BMRKR1":8.76531,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-65","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.61305,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-04-11 11:27:16","ADY":224}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-65","AGE":36.31569,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-30 11:27:16","TRTEDTM":"2022-08-30 23:27:16","EOSDY":731,"EOSDT":"2022-08-30","STRATA1":"A","STRATA2":"S2","BMRKR1":8.76531,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-65","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":95.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-06-26 01:41:30","ADY":666}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-13","SUBJID":"id-65","AGE":36.31569,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-30 11:27:16","TRTEDTM":"2022-08-30 23:27:16","EOSDY":731,"EOSDT":"2022-08-30","STRATA1":"A","STRATA2":"S2","BMRKR1":8.76531,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-13-id-65","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":4.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-10-01 03:31:05","ADY":33}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-15","SUBJID":"id-134","AGE":50.78693,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-04 11:51:36","TRTEDTM":"2022-09-04 23:51:36","EOSDY":731,"EOSDT":"2022-09-04","STRATA1":"A","STRATA2":"S1","BMRKR1":7.40518,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-15-id-134","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-09-04 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-15","SUBJID":"id-134","AGE":50.78693,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-04 11:51:36","TRTEDTM":"2022-09-04 23:51:36","EOSDY":731,"EOSDT":"2022-09-04","STRATA1":"A","STRATA2":"S1","BMRKR1":7.40518,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-15-id-134","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-15","SUBJID":"id-134","AGE":50.78693,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-04 11:51:36","TRTEDTM":"2022-09-04 23:51:36","EOSDY":731,"EOSDT":"2022-09-04","STRATA1":"A","STRATA2":"S1","BMRKR1":7.40518,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-15-id-134","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-15","SUBJID":"id-134","AGE":50.78693,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-04 11:51:36","TRTEDTM":"2022-09-04 23:51:36","EOSDY":731,"EOSDT":"2022-09-04","STRATA1":"A","STRATA2":"S1","BMRKR1":7.40518,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-15-id-134","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-15","SUBJID":"id-134","AGE":50.78693,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-04 11:51:36","TRTEDTM":"2022-09-04 23:51:36","EOSDY":731,"EOSDT":"2022-09-04","STRATA1":"A","STRATA2":"S1","BMRKR1":7.40518,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-15-id-134","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.24854,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-12-04 11:51:36","ADY":91}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-15","SUBJID":"id-134","AGE":50.78693,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-04 11:51:36","TRTEDTM":"2022-09-04 23:51:36","EOSDY":731,"EOSDT":"2022-09-04","STRATA1":"A","STRATA2":"S1","BMRKR1":7.40518,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-15-id-134","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.01522,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-10 11:51:36","ADY":6}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-15","SUBJID":"id-134","AGE":50.78693,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-04 11:51:36","TRTEDTM":"2022-09-04 23:51:36","EOSDY":731,"EOSDT":"2022-09-04","STRATA1":"A","STRATA2":"S1","BMRKR1":7.40518,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-15-id-134","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.40615,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-31 11:51:36","ADY":149}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-15","SUBJID":"id-134","AGE":50.78693,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-04 11:51:36","TRTEDTM":"2022-09-04 23:51:36","EOSDY":731,"EOSDT":"2022-09-04","STRATA1":"A","STRATA2":"S1","BMRKR1":7.40518,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-15-id-134","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":38,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-05-27 17:27:36","ADY":266}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-15","SUBJID":"id-134","AGE":50.78693,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-04 11:51:36","TRTEDTM":"2022-09-04 23:51:36","EOSDY":731,"EOSDT":"2022-09-04","STRATA1":"A","STRATA2":"S1","BMRKR1":7.40518,"BMRKR2":"HIGH","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-15-id-134","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":61.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-11-10 17:02:08","ADY":433}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-17","SUBJID":"id-50","AGE":48.27756,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-07-10 23:20:07","TRTEDTM":"2022-07-11 11:20:07","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"A","STRATA2":"S2","BMRKR1":5.50458,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-17-id-50","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-07-11 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-17","SUBJID":"id-50","AGE":48.27756,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-07-10 23:20:07","TRTEDTM":"2022-07-11 11:20:07","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"A","STRATA2":"S2","BMRKR1":5.50458,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-17-id-50","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-17","SUBJID":"id-50","AGE":48.27756,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-07-10 23:20:07","TRTEDTM":"2022-07-11 11:20:07","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"A","STRATA2":"S2","BMRKR1":5.50458,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-17-id-50","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-17","SUBJID":"id-50","AGE":48.27756,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-07-10 23:20:07","TRTEDTM":"2022-07-11 11:20:07","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"A","STRATA2":"S2","BMRKR1":5.50458,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-17-id-50","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-17","SUBJID":"id-50","AGE":48.27756,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-07-10 23:20:07","TRTEDTM":"2022-07-11 11:20:07","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"A","STRATA2":"S2","BMRKR1":5.50458,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-17-id-50","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-07-12 23:20:07","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-17","SUBJID":"id-50","AGE":48.27756,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-07-10 23:20:07","TRTEDTM":"2022-07-11 11:20:07","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"A","STRATA2":"S2","BMRKR1":5.50458,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-17-id-50","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.19413,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-19 23:20:07","ADY":71}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-17","SUBJID":"id-50","AGE":48.27756,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-07-10 23:20:07","TRTEDTM":"2022-07-11 11:20:07","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"A","STRATA2":"S2","BMRKR1":5.50458,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-17-id-50","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2022-07-12 23:20:07","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-17","SUBJID":"id-50","AGE":48.27756,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-07-10 23:20:07","TRTEDTM":"2022-07-11 11:20:07","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"A","STRATA2":"S2","BMRKR1":5.50458,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-17-id-50","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":33.28571,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-02-27 09:35:36","ADY":233}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-17","SUBJID":"id-50","AGE":48.27756,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-07-10 23:20:07","TRTEDTM":"2022-07-11 11:20:07","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"A","STRATA2":"S2","BMRKR1":5.50458,"BMRKR2":"LOW","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-17-id-50","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":50,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-06-24 04:18:12","ADY":350}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-19","SUBJID":"id-141","AGE":37.17052,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-25 11:24:31","TRTEDTM":"2022-01-24 23:24:31","EOSDY":731,"EOSDT":"2022-01-24","STRATA1":"A","STRATA2":"S2","BMRKR1":3.80941,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-19-id-141","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-01-24 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-19","SUBJID":"id-141","AGE":37.17052,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-25 11:24:31","TRTEDTM":"2022-01-24 23:24:31","EOSDY":731,"EOSDT":"2022-01-24","STRATA1":"A","STRATA2":"S2","BMRKR1":3.80941,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-19-id-141","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-19","SUBJID":"id-141","AGE":37.17052,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-25 11:24:31","TRTEDTM":"2022-01-24 23:24:31","EOSDY":731,"EOSDT":"2022-01-24","STRATA1":"A","STRATA2":"S2","BMRKR1":3.80941,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-19-id-141","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-19","SUBJID":"id-141","AGE":37.17052,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-25 11:24:31","TRTEDTM":"2022-01-24 23:24:31","EOSDY":731,"EOSDT":"2022-01-24","STRATA1":"A","STRATA2":"S2","BMRKR1":3.80941,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-19-id-141","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-19","SUBJID":"id-141","AGE":37.17052,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-25 11:24:31","TRTEDTM":"2022-01-24 23:24:31","EOSDY":731,"EOSDT":"2022-01-24","STRATA1":"A","STRATA2":"S2","BMRKR1":3.80941,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-19-id-141","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.03063,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-02-06 11:24:31","ADY":12}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-19","SUBJID":"id-141","AGE":37.17052,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-25 11:24:31","TRTEDTM":"2022-01-24 23:24:31","EOSDY":731,"EOSDT":"2022-01-24","STRATA1":"A","STRATA2":"S2","BMRKR1":3.80941,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-19-id-141","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.04697,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-02-12 11:24:31","ADY":18}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-19","SUBJID":"id-141","AGE":37.17052,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-25 11:24:31","TRTEDTM":"2022-01-24 23:24:31","EOSDY":731,"EOSDT":"2022-01-24","STRATA1":"A","STRATA2":"S2","BMRKR1":3.80941,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-19-id-141","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.14566,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-03-19 11:24:31","ADY":54}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-19","SUBJID":"id-141","AGE":37.17052,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-25 11:24:31","TRTEDTM":"2022-01-24 23:24:31","EOSDY":731,"EOSDT":"2022-01-24","STRATA1":"A","STRATA2":"S2","BMRKR1":3.80941,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-19-id-141","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":33.14286,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2020-09-12 12:41:32","ADY":232}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-19","SUBJID":"id-141","AGE":37.17052,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-25 11:24:31","TRTEDTM":"2022-01-24 23:24:31","EOSDY":731,"EOSDT":"2022-01-24","STRATA1":"A","STRATA2":"S2","BMRKR1":3.80941,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-19-id-141","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":84.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-09-05 00:48:48","ADY":590}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-3","SUBJID":"id-13","AGE":28.62693,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-27 23:49:47","TRTEDTM":"2021-07-27 11:49:47","EOSDY":731,"EOSDT":"2021-07-27","STRATA1":"C","STRATA2":"S1","BMRKR1":5.55444,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-3-id-13","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-07-27 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-3","SUBJID":"id-13","AGE":28.62693,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-27 23:49:47","TRTEDTM":"2021-07-27 11:49:47","EOSDY":731,"EOSDT":"2021-07-27","STRATA1":"C","STRATA2":"S1","BMRKR1":5.55444,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-3-id-13","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-3","SUBJID":"id-13","AGE":28.62693,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-27 23:49:47","TRTEDTM":"2021-07-27 11:49:47","EOSDY":731,"EOSDT":"2021-07-27","STRATA1":"C","STRATA2":"S1","BMRKR1":5.55444,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-3-id-13","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-3","SUBJID":"id-13","AGE":28.62693,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-27 23:49:47","TRTEDTM":"2021-07-27 11:49:47","EOSDY":731,"EOSDT":"2021-07-27","STRATA1":"C","STRATA2":"S1","BMRKR1":5.55444,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-3-id-13","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-3","SUBJID":"id-13","AGE":28.62693,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-27 23:49:47","TRTEDTM":"2021-07-27 11:49:47","EOSDY":731,"EOSDT":"2021-07-27","STRATA1":"C","STRATA2":"S1","BMRKR1":5.55444,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-3-id-13","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.68398,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-02 23:49:47","ADY":250}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-3","SUBJID":"id-13","AGE":28.62693,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-27 23:49:47","TRTEDTM":"2021-07-27 11:49:47","EOSDY":731,"EOSDT":"2021-07-27","STRATA1":"C","STRATA2":"S1","BMRKR1":5.55444,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-3-id-13","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.55302,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-02-14 23:49:47","ADY":202}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-3","SUBJID":"id-13","AGE":28.62693,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-27 23:49:47","TRTEDTM":"2021-07-27 11:49:47","EOSDY":731,"EOSDT":"2021-07-27","STRATA1":"C","STRATA2":"S1","BMRKR1":5.55444,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-3-id-13","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.0529,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-16 23:49:47","ADY":20}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-3","SUBJID":"id-13","AGE":28.62693,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-27 23:49:47","TRTEDTM":"2021-07-27 11:49:47","EOSDY":731,"EOSDT":"2021-07-27","STRATA1":"C","STRATA2":"S1","BMRKR1":5.55444,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-3-id-13","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":69.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-11-22 02:52:45","ADY":485}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-3","SUBJID":"id-13","AGE":28.62693,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-27 23:49:47","TRTEDTM":"2021-07-27 11:49:47","EOSDY":731,"EOSDT":"2021-07-27","STRATA1":"C","STRATA2":"S1","BMRKR1":5.55444,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-3-id-13","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":9.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-09-29 05:28:44","ADY":65}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-8","SUBJID":"id-93","AGE":35.42985,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-03-27 00:17:36","TRTEDTM":"2022-03-27 12:17:36","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.49814,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-8-id-93","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-03-27 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-8","SUBJID":"id-93","AGE":35.42985,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-03-27 00:17:36","TRTEDTM":"2022-03-27 12:17:36","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.49814,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-8-id-93","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-8","SUBJID":"id-93","AGE":35.42985,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-03-27 00:17:36","TRTEDTM":"2022-03-27 12:17:36","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.49814,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-8-id-93","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-8","SUBJID":"id-93","AGE":35.42985,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-03-27 00:17:36","TRTEDTM":"2022-03-27 12:17:36","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.49814,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-8-id-93","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-8","SUBJID":"id-93","AGE":35.42985,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-03-27 00:17:36","TRTEDTM":"2022-03-27 12:17:36","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.49814,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-8-id-93","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.00508,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-03-29 00:17:36","ADY":2}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-8","SUBJID":"id-93","AGE":35.42985,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-03-27 00:17:36","TRTEDTM":"2022-03-27 12:17:36","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.49814,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-8-id-93","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.02591,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-06 00:17:36","ADY":10}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-8","SUBJID":"id-93","AGE":35.42985,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-03-27 00:17:36","TRTEDTM":"2022-03-27 12:17:36","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.49814,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-8-id-93","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.25353,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-06-28 00:17:36","ADY":93}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-8","SUBJID":"id-93","AGE":35.42985,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-03-27 00:17:36","TRTEDTM":"2022-03-27 12:17:36","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.49814,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-8-id-93","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":71.28571,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-08-07 09:31:45","ADY":499}
{"STUDYID":"AB12345","COUNTRY":"BRA","SITEID":"BRA-8","SUBJID":"id-93","AGE":35.42985,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-03-27 00:17:36","TRTEDTM":"2022-03-27 12:17:36","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.49814,"BMRKR2":"MEDIUM","REGION1":"South America","SAFFL":"Y","USUBJID":"AB12345-BRA-8-id-93","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":77.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-09-22 02:00:58","ADY":545}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-1","SUBJID":"id-104","AGE":36.17335,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-11-24 18:50:36","TRTEDTM":"2022-11-25 06:50:36","EOSDY":731,"EOSDT":"2022-11-25","STRATA1":"B","STRATA2":"S1","BMRKR1":2.22913,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-1-id-104","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-11-25 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-1","SUBJID":"id-104","AGE":36.17335,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-11-24 18:50:36","TRTEDTM":"2022-11-25 06:50:36","EOSDY":731,"EOSDT":"2022-11-25","STRATA1":"B","STRATA2":"S1","BMRKR1":2.22913,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-1-id-104","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-1","SUBJID":"id-104","AGE":36.17335,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-11-24 18:50:36","TRTEDTM":"2022-11-25 06:50:36","EOSDY":731,"EOSDT":"2022-11-25","STRATA1":"B","STRATA2":"S1","BMRKR1":2.22913,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-1-id-104","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-1","SUBJID":"id-104","AGE":36.17335,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-11-24 18:50:36","TRTEDTM":"2022-11-25 06:50:36","EOSDY":731,"EOSDT":"2022-11-25","STRATA1":"B","STRATA2":"S1","BMRKR1":2.22913,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-1-id-104","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-1","SUBJID":"id-104","AGE":36.17335,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-11-24 18:50:36","TRTEDTM":"2022-11-25 06:50:36","EOSDY":731,"EOSDT":"2022-11-25","STRATA1":"B","STRATA2":"S1","BMRKR1":2.22913,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-1-id-104","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-11-26 18:50:36","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-1","SUBJID":"id-104","AGE":36.17335,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-11-24 18:50:36","TRTEDTM":"2022-11-25 06:50:36","EOSDY":731,"EOSDT":"2022-11-25","STRATA1":"B","STRATA2":"S1","BMRKR1":2.22913,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-1-id-104","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.06659,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-12-19 18:50:36","ADY":25}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-1","SUBJID":"id-104","AGE":36.17335,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-11-24 18:50:36","TRTEDTM":"2022-11-25 06:50:36","EOSDY":731,"EOSDT":"2022-11-25","STRATA1":"B","STRATA2":"S1","BMRKR1":2.22913,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-1-id-104","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.24652,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-02-23 18:50:36","ADY":91}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-1","SUBJID":"id-104","AGE":36.17335,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-11-24 18:50:36","TRTEDTM":"2022-11-25 06:50:36","EOSDY":731,"EOSDT":"2022-11-25","STRATA1":"B","STRATA2":"S1","BMRKR1":2.22913,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-1-id-104","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":56.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-12-24 02:10:41","ADY":396}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-1","SUBJID":"id-104","AGE":36.17335,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-11-24 18:50:36","TRTEDTM":"2022-11-25 06:50:36","EOSDY":731,"EOSDT":"2022-11-25","STRATA1":"B","STRATA2":"S1","BMRKR1":2.22913,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-1-id-104","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":0,"AVAL":40.85714,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-09-05 20:25:49","ADY":286}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-12","SUBJID":"id-139","AGE":26.91924,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-06 11:13:24","TRTEDTM":"2022-08-06 23:13:24","EOSDY":731,"EOSDT":"2022-08-06","STRATA1":"C","STRATA2":"S2","BMRKR1":8.03101,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-12-id-139","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-08-06 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-12","SUBJID":"id-139","AGE":26.91924,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-06 11:13:24","TRTEDTM":"2022-08-06 23:13:24","EOSDY":731,"EOSDT":"2022-08-06","STRATA1":"C","STRATA2":"S2","BMRKR1":8.03101,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-12-id-139","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-12","SUBJID":"id-139","AGE":26.91924,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-06 11:13:24","TRTEDTM":"2022-08-06 23:13:24","EOSDY":731,"EOSDT":"2022-08-06","STRATA1":"C","STRATA2":"S2","BMRKR1":8.03101,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-12-id-139","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-12","SUBJID":"id-139","AGE":26.91924,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-06 11:13:24","TRTEDTM":"2022-08-06 23:13:24","EOSDY":731,"EOSDT":"2022-08-06","STRATA1":"C","STRATA2":"S2","BMRKR1":8.03101,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-12-id-139","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-12","SUBJID":"id-139","AGE":26.91924,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-06 11:13:24","TRTEDTM":"2022-08-06 23:13:24","EOSDY":731,"EOSDT":"2022-08-06","STRATA1":"C","STRATA2":"S2","BMRKR1":8.03101,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-12-id-139","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-08-07 11:13:24","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-12","SUBJID":"id-139","AGE":26.91924,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-06 11:13:24","TRTEDTM":"2022-08-06 23:13:24","EOSDY":731,"EOSDT":"2022-08-06","STRATA1":"C","STRATA2":"S2","BMRKR1":8.03101,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-12-id-139","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.15795,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-03 11:13:24","ADY":58}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-12","SUBJID":"id-139","AGE":26.91924,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-06 11:13:24","TRTEDTM":"2022-08-06 23:13:24","EOSDY":731,"EOSDT":"2022-08-06","STRATA1":"C","STRATA2":"S2","BMRKR1":8.03101,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-12-id-139","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.22496,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-28 11:13:24","ADY":83}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-12","SUBJID":"id-139","AGE":26.91924,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-06 11:13:24","TRTEDTM":"2022-08-06 23:13:24","EOSDY":731,"EOSDT":"2022-08-06","STRATA1":"C","STRATA2":"S2","BMRKR1":8.03101,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-12-id-139","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":84,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-03-16 20:27:13","ADY":588}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-12","SUBJID":"id-139","AGE":26.91924,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-08-06 11:13:24","TRTEDTM":"2022-08-06 23:13:24","EOSDY":731,"EOSDT":"2022-08-06","STRATA1":"C","STRATA2":"S2","BMRKR1":8.03101,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-12-id-139","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":0,"AVAL":9.71429,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2020-10-12 19:15:44","ADY":68}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-14","SUBJID":"id-121","AGE":36.99048,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-04-06 01:03:13","TRTEDTM":"2022-04-06 13:03:13","EOSDY":731,"EOSDT":"2022-04-06","STRATA1":"B","STRATA2":"S1","BMRKR1":4.15571,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-14-id-121","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-04-06 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-14","SUBJID":"id-121","AGE":36.99048,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-04-06 01:03:13","TRTEDTM":"2022-04-06 13:03:13","EOSDY":731,"EOSDT":"2022-04-06","STRATA1":"B","STRATA2":"S1","BMRKR1":4.15571,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-14-id-121","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-14","SUBJID":"id-121","AGE":36.99048,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-04-06 01:03:13","TRTEDTM":"2022-04-06 13:03:13","EOSDY":731,"EOSDT":"2022-04-06","STRATA1":"B","STRATA2":"S1","BMRKR1":4.15571,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-14-id-121","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-14","SUBJID":"id-121","AGE":36.99048,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-04-06 01:03:13","TRTEDTM":"2022-04-06 13:03:13","EOSDY":731,"EOSDT":"2022-04-06","STRATA1":"B","STRATA2":"S1","BMRKR1":4.15571,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-14-id-121","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":11}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-14","SUBJID":"id-121","AGE":36.99048,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-04-06 01:03:13","TRTEDTM":"2022-04-06 13:03:13","EOSDY":731,"EOSDT":"2022-04-06","STRATA1":"B","STRATA2":"S1","BMRKR1":4.15571,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-14-id-121","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-04-07 01:03:13","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-14","SUBJID":"id-121","AGE":36.99048,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-04-06 01:03:13","TRTEDTM":"2022-04-06 13:03:13","EOSDY":731,"EOSDT":"2022-04-06","STRATA1":"B","STRATA2":"S1","BMRKR1":4.15571,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-14-id-121","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.37103,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-20 01:03:13","ADY":136}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-14","SUBJID":"id-121","AGE":36.99048,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-04-06 01:03:13","TRTEDTM":"2022-04-06 13:03:13","EOSDY":731,"EOSDT":"2022-04-06","STRATA1":"B","STRATA2":"S1","BMRKR1":4.15571,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-14-id-121","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.12838,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-05-23 01:03:13","ADY":47}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-14","SUBJID":"id-121","AGE":36.99048,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-04-06 01:03:13","TRTEDTM":"2022-04-06 13:03:13","EOSDY":731,"EOSDT":"2022-04-06","STRATA1":"B","STRATA2":"S1","BMRKR1":4.15571,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-14-id-121","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":45.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-02-16 05:23:04","ADY":317}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-14","SUBJID":"id-121","AGE":36.99048,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-04-06 01:03:13","TRTEDTM":"2022-04-06 13:03:13","EOSDY":731,"EOSDT":"2022-04-06","STRATA1":"B","STRATA2":"S1","BMRKR1":4.15571,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-14-id-121","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":0,"AVAL":71.57143,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-08-19 17:26:46","ADY":501}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-17","SUBJID":"id-18","AGE":23.92453,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2021-01-31 09:56:15","TRTEDTM":"2023-01-31 21:56:15","EOSDY":731,"EOSDT":"2023-01-31","STRATA1":"C","STRATA2":"S2","BMRKR1":3.72193,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-17-id-18","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2023-01-31 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-17","SUBJID":"id-18","AGE":23.92453,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2021-01-31 09:56:15","TRTEDTM":"2023-01-31 21:56:15","EOSDY":731,"EOSDT":"2023-01-31","STRATA1":"C","STRATA2":"S2","BMRKR1":3.72193,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-17-id-18","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-17","SUBJID":"id-18","AGE":23.92453,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2021-01-31 09:56:15","TRTEDTM":"2023-01-31 21:56:15","EOSDY":731,"EOSDT":"2023-01-31","STRATA1":"C","STRATA2":"S2","BMRKR1":3.72193,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-17-id-18","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-17","SUBJID":"id-18","AGE":23.92453,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2021-01-31 09:56:15","TRTEDTM":"2023-01-31 21:56:15","EOSDY":731,"EOSDT":"2023-01-31","STRATA1":"C","STRATA2":"S2","BMRKR1":3.72193,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-17-id-18","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-17","SUBJID":"id-18","AGE":23.92453,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2021-01-31 09:56:15","TRTEDTM":"2023-01-31 21:56:15","EOSDY":731,"EOSDT":"2023-01-31","STRATA1":"C","STRATA2":"S2","BMRKR1":3.72193,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-17-id-18","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2023-02-01 09:56:15","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-17","SUBJID":"id-18","AGE":23.92453,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2021-01-31 09:56:15","TRTEDTM":"2023-01-31 21:56:15","EOSDY":731,"EOSDT":"2023-01-31","STRATA1":"C","STRATA2":"S2","BMRKR1":3.72193,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-17-id-18","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.0301,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-02-11 09:56:15","ADY":11}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-17","SUBJID":"id-18","AGE":23.92453,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2021-01-31 09:56:15","TRTEDTM":"2023-01-31 21:56:15","EOSDY":731,"EOSDT":"2023-01-31","STRATA1":"C","STRATA2":"S2","BMRKR1":3.72193,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-17-id-18","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.03212,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-02-12 09:56:15","ADY":12}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-17","SUBJID":"id-18","AGE":23.92453,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2021-01-31 09:56:15","TRTEDTM":"2023-01-31 21:56:15","EOSDY":731,"EOSDT":"2023-01-31","STRATA1":"C","STRATA2":"S2","BMRKR1":3.72193,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-17-id-18","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":85.57143,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2022-09-21 06:21:47","ADY":599}
{"STUDYID":"AB12345","COUNTRY":"CAN","SITEID":"CAN-17","SUBJID":"id-18","AGE":23.92453,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2021-01-31 09:56:15","TRTEDTM":"2023-01-31 21:56:15","EOSDY":731,"EOSDT":"2023-01-31","STRATA1":"C","STRATA2":"S2","BMRKR1":3.72193,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-CAN-17-id-18","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":0,"AVAL":98.57143,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2022-12-21 19:27:54","ADY":690}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-1","AGE":36.94418,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-05-04 08:54:28","TRTEDTM":"2022-05-04 20:54:28","EOSDY":731,"EOSDT":"2022-05-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.80298,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-1","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-05-04 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-1","AGE":36.94418,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-05-04 08:54:28","TRTEDTM":"2022-05-04 20:54:28","EOSDY":731,"EOSDT":"2022-05-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.80298,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-1","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-1","AGE":36.94418,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-05-04 08:54:28","TRTEDTM":"2022-05-04 20:54:28","EOSDY":731,"EOSDT":"2022-05-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.80298,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-1","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-1","AGE":36.94418,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-05-04 08:54:28","TRTEDTM":"2022-05-04 20:54:28","EOSDY":731,"EOSDT":"2022-05-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.80298,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-1","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-1","AGE":36.94418,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-05-04 08:54:28","TRTEDTM":"2022-05-04 20:54:28","EOSDY":731,"EOSDT":"2022-05-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.80298,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-1","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2022-05-05 08:54:28","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-1","AGE":36.94418,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-05-04 08:54:28","TRTEDTM":"2022-05-04 20:54:28","EOSDY":731,"EOSDT":"2022-05-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.80298,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-1","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-05-05 08:54:28","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-1","AGE":36.94418,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-05-04 08:54:28","TRTEDTM":"2022-05-04 20:54:28","EOSDY":731,"EOSDT":"2022-05-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.80298,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-1","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.34402,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-07 08:54:28","ADY":126}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-1","AGE":36.94418,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-05-04 08:54:28","TRTEDTM":"2022-05-04 20:54:28","EOSDY":731,"EOSDT":"2022-05-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.80298,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-1","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":19.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-09-19 11:54:17","ADY":139}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-1","AGE":36.94418,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-05-04 08:54:28","TRTEDTM":"2022-05-04 20:54:28","EOSDY":731,"EOSDT":"2022-05-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.80298,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-1","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":16.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-24 10:31:31","ADY":113}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-103","AGE":29.39329,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","TRTSDTM":"2020-11-08 18:39:38","TRTEDTM":"2022-11-09 06:39:38","EOSDY":731,"EOSDT":"2022-11-09","STRATA1":"B","STRATA2":"S2","BMRKR1":4.93211,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-103","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-11-09 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-103","AGE":29.39329,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","TRTSDTM":"2020-11-08 18:39:38","TRTEDTM":"2022-11-09 06:39:38","EOSDY":731,"EOSDT":"2022-11-09","STRATA1":"B","STRATA2":"S2","BMRKR1":4.93211,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-103","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-103","AGE":29.39329,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","TRTSDTM":"2020-11-08 18:39:38","TRTEDTM":"2022-11-09 06:39:38","EOSDY":731,"EOSDT":"2022-11-09","STRATA1":"B","STRATA2":"S2","BMRKR1":4.93211,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-103","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-103","AGE":29.39329,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","TRTSDTM":"2020-11-08 18:39:38","TRTEDTM":"2022-11-09 06:39:38","EOSDY":731,"EOSDT":"2022-11-09","STRATA1":"B","STRATA2":"S2","BMRKR1":4.93211,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-103","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-103","AGE":29.39329,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","TRTSDTM":"2020-11-08 18:39:38","TRTEDTM":"2022-11-09 06:39:38","EOSDY":731,"EOSDT":"2022-11-09","STRATA1":"B","STRATA2":"S2","BMRKR1":4.93211,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-103","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.15462,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-04 18:39:38","ADY":57}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-103","AGE":29.39329,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","TRTSDTM":"2020-11-08 18:39:38","TRTEDTM":"2022-11-09 06:39:38","EOSDY":731,"EOSDT":"2022-11-09","STRATA1":"B","STRATA2":"S2","BMRKR1":4.93211,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-103","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.62365,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-06-24 18:39:38","ADY":228}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-103","AGE":29.39329,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","TRTSDTM":"2020-11-08 18:39:38","TRTEDTM":"2022-11-09 06:39:38","EOSDY":731,"EOSDT":"2022-11-09","STRATA1":"B","STRATA2":"S2","BMRKR1":4.93211,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-103","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.20263,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-22 18:39:38","ADY":75}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-103","AGE":29.39329,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","TRTSDTM":"2020-11-08 18:39:38","TRTEDTM":"2022-11-09 06:39:38","EOSDY":731,"EOSDT":"2022-11-09","STRATA1":"B","STRATA2":"S2","BMRKR1":4.93211,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-103","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":86.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-07-06 04:04:10","ADY":606}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-103","AGE":29.39329,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","TRTSDTM":"2020-11-08 18:39:38","TRTEDTM":"2022-11-09 06:39:38","EOSDY":731,"EOSDT":"2022-11-09","STRATA1":"B","STRATA2":"S2","BMRKR1":4.93211,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-103","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":54,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-11-20 23:06:36","ADY":378}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-115","AGE":48.04644,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-28 16:23:06","TRTEDTM":"2021-08-28 04:23:06","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"B","STRATA2":"S1","BMRKR1":3.38308,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-115","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-08-28 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-115","AGE":48.04644,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-28 16:23:06","TRTEDTM":"2021-08-28 04:23:06","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"B","STRATA2":"S1","BMRKR1":3.38308,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-115","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-115","AGE":48.04644,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-28 16:23:06","TRTEDTM":"2021-08-28 04:23:06","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"B","STRATA2":"S1","BMRKR1":3.38308,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-115","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-115","AGE":48.04644,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-28 16:23:06","TRTEDTM":"2021-08-28 04:23:06","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"B","STRATA2":"S1","BMRKR1":3.38308,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-115","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-115","AGE":48.04644,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-28 16:23:06","TRTEDTM":"2021-08-28 04:23:06","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"B","STRATA2":"S1","BMRKR1":3.38308,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-115","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.09658,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-10-03 16:23:06","ADY":36}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-115","AGE":48.04644,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-28 16:23:06","TRTEDTM":"2021-08-28 04:23:06","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"B","STRATA2":"S1","BMRKR1":3.38308,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-115","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.18066,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-02 16:23:06","ADY":66}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-115","AGE":48.04644,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-28 16:23:06","TRTEDTM":"2021-08-28 04:23:06","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"B","STRATA2":"S1","BMRKR1":3.38308,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-115","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.36008,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-01-07 16:23:06","ADY":132}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-115","AGE":48.04644,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-28 16:23:06","TRTEDTM":"2021-08-28 04:23:06","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"B","STRATA2":"S1","BMRKR1":3.38308,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-115","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":66,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-12-01 04:35:05","ADY":462}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-115","AGE":48.04644,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-28 16:23:06","TRTEDTM":"2021-08-28 04:23:06","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"B","STRATA2":"S1","BMRKR1":3.38308,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-115","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":4.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-09-28 07:59:06","ADY":32}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-116","AGE":26.85474,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-08 12:05:19","TRTEDTM":"2021-05-08 00:05:19","EOSDY":731,"EOSDT":"2021-05-08","STRATA1":"A","STRATA2":"S2","BMRKR1":12.07038,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-116","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-05-08 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-116","AGE":26.85474,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-08 12:05:19","TRTEDTM":"2021-05-08 00:05:19","EOSDY":731,"EOSDT":"2021-05-08","STRATA1":"A","STRATA2":"S2","BMRKR1":12.07038,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-116","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-116","AGE":26.85474,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-08 12:05:19","TRTEDTM":"2021-05-08 00:05:19","EOSDY":731,"EOSDT":"2021-05-08","STRATA1":"A","STRATA2":"S2","BMRKR1":12.07038,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-116","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-116","AGE":26.85474,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-08 12:05:19","TRTEDTM":"2021-05-08 00:05:19","EOSDY":731,"EOSDT":"2021-05-08","STRATA1":"A","STRATA2":"S2","BMRKR1":12.07038,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-116","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-116","AGE":26.85474,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-08 12:05:19","TRTEDTM":"2021-05-08 00:05:19","EOSDY":731,"EOSDT":"2021-05-08","STRATA1":"A","STRATA2":"S2","BMRKR1":12.07038,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-116","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.04217,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-24 12:05:19","ADY":16}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-116","AGE":26.85474,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-08 12:05:19","TRTEDTM":"2021-05-08 00:05:19","EOSDY":731,"EOSDT":"2021-05-08","STRATA1":"A","STRATA2":"S2","BMRKR1":12.07038,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-116","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.66115,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-01-05 12:05:19","ADY":242}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-116","AGE":26.85474,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-08 12:05:19","TRTEDTM":"2021-05-08 00:05:19","EOSDY":731,"EOSDT":"2021-05-08","STRATA1":"A","STRATA2":"S2","BMRKR1":12.07038,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-116","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.08151,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-06-07 12:05:19","ADY":30}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-116","AGE":26.85474,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-08 12:05:19","TRTEDTM":"2021-05-08 00:05:19","EOSDY":731,"EOSDT":"2021-05-08","STRATA1":"A","STRATA2":"S2","BMRKR1":12.07038,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-116","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":32.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-12-18 06:47:46","ADY":225}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-116","AGE":26.85474,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-08 12:05:19","TRTEDTM":"2021-05-08 00:05:19","EOSDY":731,"EOSDT":"2021-05-08","STRATA1":"A","STRATA2":"S2","BMRKR1":12.07038,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-116","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":30.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-12-06 08:45:08","ADY":213}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-118","AGE":25.09857,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-04 15:16:11","TRTEDTM":"2023-01-05 03:16:11","EOSDY":731,"EOSDT":"2023-01-05","STRATA1":"B","STRATA2":"S2","BMRKR1":10.7801,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-118","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2023-01-05 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-118","AGE":25.09857,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-04 15:16:11","TRTEDTM":"2023-01-05 03:16:11","EOSDY":731,"EOSDT":"2023-01-05","STRATA1":"B","STRATA2":"S2","BMRKR1":10.7801,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-118","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-118","AGE":25.09857,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-04 15:16:11","TRTEDTM":"2023-01-05 03:16:11","EOSDY":731,"EOSDT":"2023-01-05","STRATA1":"B","STRATA2":"S2","BMRKR1":10.7801,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-118","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-118","AGE":25.09857,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-04 15:16:11","TRTEDTM":"2023-01-05 03:16:11","EOSDY":731,"EOSDT":"2023-01-05","STRATA1":"B","STRATA2":"S2","BMRKR1":10.7801,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-118","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-118","AGE":25.09857,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-04 15:16:11","TRTEDTM":"2023-01-05 03:16:11","EOSDY":731,"EOSDT":"2023-01-05","STRATA1":"B","STRATA2":"S2","BMRKR1":10.7801,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-118","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.47108,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-06-26 15:16:11","ADY":173}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-118","AGE":25.09857,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-04 15:16:11","TRTEDTM":"2023-01-05 03:16:11","EOSDY":731,"EOSDT":"2023-01-05","STRATA1":"B","STRATA2":"S2","BMRKR1":10.7801,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-118","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2023-01-06 15:16:11","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-118","AGE":25.09857,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-04 15:16:11","TRTEDTM":"2023-01-05 03:16:11","EOSDY":731,"EOSDT":"2023-01-05","STRATA1":"B","STRATA2":"S2","BMRKR1":10.7801,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-118","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.19254,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-03-16 15:16:11","ADY":71}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-118","AGE":25.09857,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-04 15:16:11","TRTEDTM":"2023-01-05 03:16:11","EOSDY":731,"EOSDT":"2023-01-05","STRATA1":"B","STRATA2":"S2","BMRKR1":10.7801,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-118","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":1.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-01-11 01:02:43","ADY":8}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-118","AGE":25.09857,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-04 15:16:11","TRTEDTM":"2023-01-05 03:16:11","EOSDY":731,"EOSDT":"2023-01-05","STRATA1":"B","STRATA2":"S2","BMRKR1":10.7801,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-118","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":36.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-09-18 16:52:18","ADY":258}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-122","AGE":37.44088,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-08-21 11:36:57","TRTEDTM":"2021-08-20 23:36:57","EOSDY":731,"EOSDT":"2021-08-20","STRATA1":"C","STRATA2":"S2","BMRKR1":8.22579,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-122","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-08-20 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-122","AGE":37.44088,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-08-21 11:36:57","TRTEDTM":"2021-08-20 23:36:57","EOSDY":731,"EOSDT":"2021-08-20","STRATA1":"C","STRATA2":"S2","BMRKR1":8.22579,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-122","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-122","AGE":37.44088,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-08-21 11:36:57","TRTEDTM":"2021-08-20 23:36:57","EOSDY":731,"EOSDT":"2021-08-20","STRATA1":"C","STRATA2":"S2","BMRKR1":8.22579,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-122","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-122","AGE":37.44088,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-08-21 11:36:57","TRTEDTM":"2021-08-20 23:36:57","EOSDY":731,"EOSDT":"2021-08-20","STRATA1":"C","STRATA2":"S2","BMRKR1":8.22579,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-122","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-122","AGE":37.44088,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-08-21 11:36:57","TRTEDTM":"2021-08-20 23:36:57","EOSDY":731,"EOSDT":"2021-08-20","STRATA1":"C","STRATA2":"S2","BMRKR1":8.22579,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-122","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.13746,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-10-11 11:36:57","ADY":51}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-122","AGE":37.44088,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-08-21 11:36:57","TRTEDTM":"2021-08-20 23:36:57","EOSDY":731,"EOSDT":"2021-08-20","STRATA1":"C","STRATA2":"S2","BMRKR1":8.22579,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-122","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.23538,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-15 11:36:57","ADY":86}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-122","AGE":37.44088,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-08-21 11:36:57","TRTEDTM":"2021-08-20 23:36:57","EOSDY":731,"EOSDT":"2021-08-20","STRATA1":"C","STRATA2":"S2","BMRKR1":8.22579,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-122","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-08-21 11:36:57","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-122","AGE":37.44088,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-08-21 11:36:57","TRTEDTM":"2021-08-20 23:36:57","EOSDY":731,"EOSDT":"2021-08-20","STRATA1":"C","STRATA2":"S2","BMRKR1":8.22579,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-122","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":57.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-09-25 02:05:25","ADY":402}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-122","AGE":37.44088,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-08-21 11:36:57","TRTEDTM":"2021-08-20 23:36:57","EOSDY":731,"EOSDT":"2021-08-20","STRATA1":"C","STRATA2":"S2","BMRKR1":8.22579,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-122","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":51.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-13 10:45:06","ADY":359}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-123","AGE":32.33763,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-22 13:03:49","TRTEDTM":"2022-04-23 01:03:49","EOSDY":731,"EOSDT":"2022-04-23","STRATA1":"B","STRATA2":"S2","BMRKR1":2.9845,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-123","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-04-23 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-123","AGE":32.33763,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-22 13:03:49","TRTEDTM":"2022-04-23 01:03:49","EOSDY":731,"EOSDT":"2022-04-23","STRATA1":"B","STRATA2":"S2","BMRKR1":2.9845,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-123","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":9}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-123","AGE":32.33763,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-22 13:03:49","TRTEDTM":"2022-04-23 01:03:49","EOSDY":731,"EOSDT":"2022-04-23","STRATA1":"B","STRATA2":"S2","BMRKR1":2.9845,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-123","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-123","AGE":32.33763,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-22 13:03:49","TRTEDTM":"2022-04-23 01:03:49","EOSDY":731,"EOSDT":"2022-04-23","STRATA1":"B","STRATA2":"S2","BMRKR1":2.9845,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-123","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-123","AGE":32.33763,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-22 13:03:49","TRTEDTM":"2022-04-23 01:03:49","EOSDY":731,"EOSDT":"2022-04-23","STRATA1":"B","STRATA2":"S2","BMRKR1":2.9845,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-123","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.06563,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-05-16 13:03:49","ADY":24}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-123","AGE":32.33763,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-22 13:03:49","TRTEDTM":"2022-04-23 01:03:49","EOSDY":731,"EOSDT":"2022-04-23","STRATA1":"B","STRATA2":"S2","BMRKR1":2.9845,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-123","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.00244,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-23 13:03:49","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-123","AGE":32.33763,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-22 13:03:49","TRTEDTM":"2022-04-23 01:03:49","EOSDY":731,"EOSDT":"2022-04-23","STRATA1":"B","STRATA2":"S2","BMRKR1":2.9845,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-123","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.01935,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-30 13:03:49","ADY":8}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-123","AGE":32.33763,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-22 13:03:49","TRTEDTM":"2022-04-23 01:03:49","EOSDY":731,"EOSDT":"2022-04-23","STRATA1":"B","STRATA2":"S2","BMRKR1":2.9845,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-123","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-04-22 13:03:49","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-123","AGE":32.33763,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-22 13:03:49","TRTEDTM":"2022-04-23 01:03:49","EOSDY":731,"EOSDT":"2022-04-23","STRATA1":"B","STRATA2":"S2","BMRKR1":2.9845,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-123","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":27.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-10-30 01:21:00","ADY":192}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-129","AGE":26.66218,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"MULTIPLE","TRTSDTM":"2021-01-19 18:54:16","TRTEDTM":"2023-01-20 06:54:16","EOSDY":731,"EOSDT":"2023-01-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.15748,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-129","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2023-01-20 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-129","AGE":26.66218,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"MULTIPLE","TRTSDTM":"2021-01-19 18:54:16","TRTEDTM":"2023-01-20 06:54:16","EOSDY":731,"EOSDT":"2023-01-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.15748,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-129","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-129","AGE":26.66218,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"MULTIPLE","TRTSDTM":"2021-01-19 18:54:16","TRTEDTM":"2023-01-20 06:54:16","EOSDY":731,"EOSDT":"2023-01-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.15748,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-129","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-129","AGE":26.66218,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"MULTIPLE","TRTSDTM":"2021-01-19 18:54:16","TRTEDTM":"2023-01-20 06:54:16","EOSDY":731,"EOSDT":"2023-01-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.15748,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-129","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-129","AGE":26.66218,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"MULTIPLE","TRTSDTM":"2021-01-19 18:54:16","TRTEDTM":"2023-01-20 06:54:16","EOSDY":731,"EOSDT":"2023-01-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.15748,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-129","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.5746,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-08-17 18:54:16","ADY":210}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-129","AGE":26.66218,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"MULTIPLE","TRTSDTM":"2021-01-19 18:54:16","TRTEDTM":"2023-01-20 06:54:16","EOSDY":731,"EOSDT":"2023-01-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.15748,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-129","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2023-01-21 18:54:16","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-129","AGE":26.66218,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"MULTIPLE","TRTSDTM":"2021-01-19 18:54:16","TRTEDTM":"2023-01-20 06:54:16","EOSDY":731,"EOSDT":"2023-01-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.15748,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-129","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.24664,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-04-20 18:54:16","ADY":91}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-129","AGE":26.66218,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"MULTIPLE","TRTSDTM":"2021-01-19 18:54:16","TRTEDTM":"2023-01-20 06:54:16","EOSDY":731,"EOSDT":"2023-01-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.15748,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-129","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":68.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-05-11 11:23:41","ADY":478}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-129","AGE":26.66218,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"MULTIPLE","TRTSDTM":"2021-01-19 18:54:16","TRTEDTM":"2023-01-20 06:54:16","EOSDY":731,"EOSDT":"2023-01-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.15748,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-129","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2021-01-19 18:54:16","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-132","AGE":39.75369,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-20 11:38:32","TRTEDTM":"2022-12-20 23:38:32","EOSDY":731,"EOSDT":"2022-12-20","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80483,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-132","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-12-20 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-132","AGE":39.75369,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-20 11:38:32","TRTEDTM":"2022-12-20 23:38:32","EOSDY":731,"EOSDT":"2022-12-20","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80483,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-132","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-132","AGE":39.75369,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-20 11:38:32","TRTEDTM":"2022-12-20 23:38:32","EOSDY":731,"EOSDT":"2022-12-20","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80483,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-132","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-132","AGE":39.75369,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-20 11:38:32","TRTEDTM":"2022-12-20 23:38:32","EOSDY":731,"EOSDT":"2022-12-20","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80483,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-132","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-132","AGE":39.75369,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-20 11:38:32","TRTEDTM":"2022-12-20 23:38:32","EOSDY":731,"EOSDT":"2022-12-20","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80483,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-132","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.03039,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-01 11:38:32","ADY":12}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-132","AGE":39.75369,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-20 11:38:32","TRTEDTM":"2022-12-20 23:38:32","EOSDY":731,"EOSDT":"2022-12-20","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80483,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-132","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-12-21 11:38:32","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-132","AGE":39.75369,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-20 11:38:32","TRTEDTM":"2022-12-20 23:38:32","EOSDY":731,"EOSDT":"2022-12-20","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80483,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-132","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.03026,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-01 11:38:32","ADY":12}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-132","AGE":39.75369,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-20 11:38:32","TRTEDTM":"2022-12-20 23:38:32","EOSDY":731,"EOSDT":"2022-12-20","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80483,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-132","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":78.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-06-22 18:37:39","ADY":550}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-132","AGE":39.75369,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-20 11:38:32","TRTEDTM":"2022-12-20 23:38:32","EOSDY":731,"EOSDT":"2022-12-20","STRATA1":"A","STRATA2":"S1","BMRKR1":7.80483,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-132","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":69,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-04-16 10:05:55","ADY":483}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-133","AGE":33.35915,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-24 12:44:00","TRTEDTM":"2021-06-24 00:44:00","EOSDY":731,"EOSDT":"2021-06-24","STRATA1":"A","STRATA2":"S2","BMRKR1":4.46567,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-133","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-06-24 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-133","AGE":33.35915,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-24 12:44:00","TRTEDTM":"2021-06-24 00:44:00","EOSDY":731,"EOSDT":"2021-06-24","STRATA1":"A","STRATA2":"S2","BMRKR1":4.46567,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-133","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-133","AGE":33.35915,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-24 12:44:00","TRTEDTM":"2021-06-24 00:44:00","EOSDY":731,"EOSDT":"2021-06-24","STRATA1":"A","STRATA2":"S2","BMRKR1":4.46567,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-133","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-133","AGE":33.35915,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-24 12:44:00","TRTEDTM":"2021-06-24 00:44:00","EOSDY":731,"EOSDT":"2021-06-24","STRATA1":"A","STRATA2":"S2","BMRKR1":4.46567,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-133","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":8}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-133","AGE":33.35915,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-24 12:44:00","TRTEDTM":"2021-06-24 00:44:00","EOSDY":731,"EOSDT":"2021-06-24","STRATA1":"A","STRATA2":"S2","BMRKR1":4.46567,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-133","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.19412,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-03 12:44:00","ADY":71}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-133","AGE":33.35915,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-24 12:44:00","TRTEDTM":"2021-06-24 00:44:00","EOSDY":731,"EOSDT":"2021-06-24","STRATA1":"A","STRATA2":"S2","BMRKR1":4.46567,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-133","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.16338,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-23 12:44:00","ADY":60}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-133","AGE":33.35915,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-24 12:44:00","TRTEDTM":"2021-06-24 00:44:00","EOSDY":731,"EOSDT":"2021-06-24","STRATA1":"A","STRATA2":"S2","BMRKR1":4.46567,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-133","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.12396,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-09 12:44:00","ADY":46}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-133","AGE":33.35915,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-24 12:44:00","TRTEDTM":"2021-06-24 00:44:00","EOSDY":731,"EOSDT":"2021-06-24","STRATA1":"A","STRATA2":"S2","BMRKR1":4.46567,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-133","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":40,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-03-29 09:11:57","ADY":280}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-133","AGE":33.35915,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-24 12:44:00","TRTEDTM":"2021-06-24 00:44:00","EOSDY":731,"EOSDT":"2021-06-24","STRATA1":"A","STRATA2":"S2","BMRKR1":4.46567,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-133","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":97.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-05-07 23:32:13","ADY":684}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-144","AGE":32.63316,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-29 10:51:46","TRTEDTM":"2022-03-29 22:51:46","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.79224,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-144","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-03-29 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-144","AGE":32.63316,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-29 10:51:46","TRTEDTM":"2022-03-29 22:51:46","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.79224,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-144","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-144","AGE":32.63316,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-29 10:51:46","TRTEDTM":"2022-03-29 22:51:46","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.79224,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-144","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-144","AGE":32.63316,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-29 10:51:46","TRTEDTM":"2022-03-29 22:51:46","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.79224,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-144","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-144","AGE":32.63316,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-29 10:51:46","TRTEDTM":"2022-03-29 22:51:46","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.79224,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-144","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.4054,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-25 10:51:46","ADY":149}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-144","AGE":32.63316,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-29 10:51:46","TRTEDTM":"2022-03-29 22:51:46","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.79224,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-144","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2022-03-30 10:51:46","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-144","AGE":32.63316,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-29 10:51:46","TRTEDTM":"2022-03-29 22:51:46","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.79224,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-144","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-03-30 10:51:46","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-144","AGE":32.63316,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-29 10:51:46","TRTEDTM":"2022-03-29 22:51:46","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.79224,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-144","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":104.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-03-27 22:10:58","ADY":729}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-144","AGE":32.63316,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-29 10:51:46","TRTEDTM":"2022-03-29 22:51:46","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.79224,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-144","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":49.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-03-10 19:44:32","ADY":347}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-146","AGE":40.84589,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 22:31:40","TRTEDTM":"2022-06-18 10:31:40","EOSDY":731,"EOSDT":"2022-06-18","STRATA1":"B","STRATA2":"S1","BMRKR1":5.0774,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-146","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-06-18 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-146","AGE":40.84589,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 22:31:40","TRTEDTM":"2022-06-18 10:31:40","EOSDY":731,"EOSDT":"2022-06-18","STRATA1":"B","STRATA2":"S1","BMRKR1":5.0774,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-146","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-146","AGE":40.84589,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 22:31:40","TRTEDTM":"2022-06-18 10:31:40","EOSDY":731,"EOSDT":"2022-06-18","STRATA1":"B","STRATA2":"S1","BMRKR1":5.0774,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-146","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-146","AGE":40.84589,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 22:31:40","TRTEDTM":"2022-06-18 10:31:40","EOSDY":731,"EOSDT":"2022-06-18","STRATA1":"B","STRATA2":"S1","BMRKR1":5.0774,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-146","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-146","AGE":40.84589,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 22:31:40","TRTEDTM":"2022-06-18 10:31:40","EOSDY":731,"EOSDT":"2022-06-18","STRATA1":"B","STRATA2":"S1","BMRKR1":5.0774,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-146","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.14489,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-09 22:31:40","ADY":53}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-146","AGE":40.84589,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 22:31:40","TRTEDTM":"2022-06-18 10:31:40","EOSDY":731,"EOSDT":"2022-06-18","STRATA1":"B","STRATA2":"S1","BMRKR1":5.0774,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-146","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.37969,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-11-03 22:31:40","ADY":139}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-146","AGE":40.84589,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 22:31:40","TRTEDTM":"2022-06-18 10:31:40","EOSDY":731,"EOSDT":"2022-06-18","STRATA1":"B","STRATA2":"S1","BMRKR1":5.0774,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-146","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.0635,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-07-11 22:31:40","ADY":24}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-146","AGE":40.84589,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 22:31:40","TRTEDTM":"2022-06-18 10:31:40","EOSDY":731,"EOSDT":"2022-06-18","STRATA1":"B","STRATA2":"S1","BMRKR1":5.0774,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-146","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":24,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-12-01 08:56:03","ADY":168}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-146","AGE":40.84589,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-17 22:31:40","TRTEDTM":"2022-06-18 10:31:40","EOSDY":731,"EOSDT":"2022-06-18","STRATA1":"B","STRATA2":"S1","BMRKR1":5.0774,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-146","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":13.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-09-21 01:04:18","ADY":97}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-147","AGE":31.34158,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-14 16:32:36","TRTEDTM":"2022-05-15 04:32:36","EOSDY":731,"EOSDT":"2022-05-15","STRATA1":"B","STRATA2":"S1","BMRKR1":2.99274,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-147","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-05-15 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-147","AGE":31.34158,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-14 16:32:36","TRTEDTM":"2022-05-15 04:32:36","EOSDY":731,"EOSDT":"2022-05-15","STRATA1":"B","STRATA2":"S1","BMRKR1":2.99274,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-147","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-147","AGE":31.34158,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-14 16:32:36","TRTEDTM":"2022-05-15 04:32:36","EOSDY":731,"EOSDT":"2022-05-15","STRATA1":"B","STRATA2":"S1","BMRKR1":2.99274,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-147","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-147","AGE":31.34158,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-14 16:32:36","TRTEDTM":"2022-05-15 04:32:36","EOSDY":731,"EOSDT":"2022-05-15","STRATA1":"B","STRATA2":"S1","BMRKR1":2.99274,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-147","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-147","AGE":31.34158,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-14 16:32:36","TRTEDTM":"2022-05-15 04:32:36","EOSDY":731,"EOSDT":"2022-05-15","STRATA1":"B","STRATA2":"S1","BMRKR1":2.99274,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-147","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.41965,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-15 16:32:36","ADY":154}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-147","AGE":31.34158,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-14 16:32:36","TRTEDTM":"2022-05-15 04:32:36","EOSDY":731,"EOSDT":"2022-05-15","STRATA1":"B","STRATA2":"S1","BMRKR1":2.99274,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-147","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-05-16 16:32:36","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-147","AGE":31.34158,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-14 16:32:36","TRTEDTM":"2022-05-15 04:32:36","EOSDY":731,"EOSDT":"2022-05-15","STRATA1":"B","STRATA2":"S1","BMRKR1":2.99274,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-147","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.04595,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-05-31 16:32:36","ADY":17}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-147","AGE":31.34158,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-14 16:32:36","TRTEDTM":"2022-05-15 04:32:36","EOSDY":731,"EOSDT":"2022-05-15","STRATA1":"B","STRATA2":"S1","BMRKR1":2.99274,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-147","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":79.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-11-19 07:12:26","ADY":555}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-147","AGE":31.34158,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-14 16:32:36","TRTEDTM":"2022-05-15 04:32:36","EOSDY":731,"EOSDT":"2022-05-15","STRATA1":"B","STRATA2":"S1","BMRKR1":2.99274,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-147","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-05-14 16:32:36","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-149","AGE":32.57801,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-24 19:50:42","TRTEDTM":"2021-09-24 07:50:42","EOSDY":731,"EOSDT":"2021-09-24","STRATA1":"C","STRATA2":"S1","BMRKR1":8.26944,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-149","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-09-24 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-149","AGE":32.57801,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-24 19:50:42","TRTEDTM":"2021-09-24 07:50:42","EOSDY":731,"EOSDT":"2021-09-24","STRATA1":"C","STRATA2":"S1","BMRKR1":8.26944,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-149","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-149","AGE":32.57801,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-24 19:50:42","TRTEDTM":"2021-09-24 07:50:42","EOSDY":731,"EOSDT":"2021-09-24","STRATA1":"C","STRATA2":"S1","BMRKR1":8.26944,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-149","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-149","AGE":32.57801,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-24 19:50:42","TRTEDTM":"2021-09-24 07:50:42","EOSDY":731,"EOSDT":"2021-09-24","STRATA1":"C","STRATA2":"S1","BMRKR1":8.26944,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-149","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-149","AGE":32.57801,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-24 19:50:42","TRTEDTM":"2021-09-24 07:50:42","EOSDY":731,"EOSDT":"2021-09-24","STRATA1":"C","STRATA2":"S1","BMRKR1":8.26944,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-149","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-09-25 19:50:42","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-149","AGE":32.57801,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-24 19:50:42","TRTEDTM":"2021-09-24 07:50:42","EOSDY":731,"EOSDT":"2021-09-24","STRATA1":"C","STRATA2":"S1","BMRKR1":8.26944,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-149","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.07609,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-10-22 19:50:42","ADY":28}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-149","AGE":32.57801,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-24 19:50:42","TRTEDTM":"2021-09-24 07:50:42","EOSDY":731,"EOSDT":"2021-09-24","STRATA1":"C","STRATA2":"S1","BMRKR1":8.26944,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-149","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-09-25 19:50:42","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-149","AGE":32.57801,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-24 19:50:42","TRTEDTM":"2021-09-24 07:50:42","EOSDY":731,"EOSDT":"2021-09-24","STRATA1":"C","STRATA2":"S1","BMRKR1":8.26944,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-149","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":45,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-03 17:26:14","ADY":315}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-149","AGE":32.57801,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-24 19:50:42","TRTEDTM":"2021-09-24 07:50:42","EOSDY":731,"EOSDT":"2021-09-24","STRATA1":"C","STRATA2":"S1","BMRKR1":8.26944,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-149","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":74.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-02-24 06:43:09","ADY":520}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-154","AGE":29.59203,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-21 22:44:02","TRTEDTM":"2021-04-21 10:44:02","EOSDY":731,"EOSDT":"2021-04-21","STRATA1":"B","STRATA2":"S2","BMRKR1":12.79945,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-154","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-04-21 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-154","AGE":29.59203,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-21 22:44:02","TRTEDTM":"2021-04-21 10:44:02","EOSDY":731,"EOSDT":"2021-04-21","STRATA1":"B","STRATA2":"S2","BMRKR1":12.79945,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-154","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-154","AGE":29.59203,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-21 22:44:02","TRTEDTM":"2021-04-21 10:44:02","EOSDY":731,"EOSDT":"2021-04-21","STRATA1":"B","STRATA2":"S2","BMRKR1":12.79945,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-154","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-154","AGE":29.59203,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-21 22:44:02","TRTEDTM":"2021-04-21 10:44:02","EOSDY":731,"EOSDT":"2021-04-21","STRATA1":"B","STRATA2":"S2","BMRKR1":12.79945,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-154","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-154","AGE":29.59203,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-21 22:44:02","TRTEDTM":"2021-04-21 10:44:02","EOSDY":731,"EOSDT":"2021-04-21","STRATA1":"B","STRATA2":"S2","BMRKR1":12.79945,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-154","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.03501,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-04 22:44:02","ADY":13}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-154","AGE":29.59203,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-21 22:44:02","TRTEDTM":"2021-04-21 10:44:02","EOSDY":731,"EOSDT":"2021-04-21","STRATA1":"B","STRATA2":"S2","BMRKR1":12.79945,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-154","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.16426,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-06-20 22:44:02","ADY":60}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-154","AGE":29.59203,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-21 22:44:02","TRTEDTM":"2021-04-21 10:44:02","EOSDY":731,"EOSDT":"2021-04-21","STRATA1":"B","STRATA2":"S2","BMRKR1":12.79945,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-154","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.25736,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-25 22:44:02","ADY":95}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-154","AGE":29.59203,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-21 22:44:02","TRTEDTM":"2021-04-21 10:44:02","EOSDY":731,"EOSDT":"2021-04-21","STRATA1":"B","STRATA2":"S2","BMRKR1":12.79945,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-154","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":67.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-05 20:19:37","ADY":473}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-154","AGE":29.59203,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-21 22:44:02","TRTEDTM":"2021-04-21 10:44:02","EOSDY":731,"EOSDT":"2021-04-21","STRATA1":"B","STRATA2":"S2","BMRKR1":12.79945,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-154","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-04-21 22:44:02","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-156","AGE":36.39787,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-06 02:44:04","TRTEDTM":"2022-09-06 14:44:04","EOSDY":731,"EOSDT":"2022-09-06","STRATA1":"C","STRATA2":"S1","BMRKR1":12.05006,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-156","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-09-06 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-156","AGE":36.39787,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-06 02:44:04","TRTEDTM":"2022-09-06 14:44:04","EOSDY":731,"EOSDT":"2022-09-06","STRATA1":"C","STRATA2":"S1","BMRKR1":12.05006,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-156","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-156","AGE":36.39787,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-06 02:44:04","TRTEDTM":"2022-09-06 14:44:04","EOSDY":731,"EOSDT":"2022-09-06","STRATA1":"C","STRATA2":"S1","BMRKR1":12.05006,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-156","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-156","AGE":36.39787,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-06 02:44:04","TRTEDTM":"2022-09-06 14:44:04","EOSDY":731,"EOSDT":"2022-09-06","STRATA1":"C","STRATA2":"S1","BMRKR1":12.05006,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-156","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-156","AGE":36.39787,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-06 02:44:04","TRTEDTM":"2022-09-06 14:44:04","EOSDY":731,"EOSDT":"2022-09-06","STRATA1":"C","STRATA2":"S1","BMRKR1":12.05006,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-156","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.01845,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-13 02:44:04","ADY":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-156","AGE":36.39787,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-06 02:44:04","TRTEDTM":"2022-09-06 14:44:04","EOSDY":731,"EOSDT":"2022-09-06","STRATA1":"C","STRATA2":"S1","BMRKR1":12.05006,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-156","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.07633,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-04 02:44:04","ADY":28}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-156","AGE":36.39787,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-06 02:44:04","TRTEDTM":"2022-09-06 14:44:04","EOSDY":731,"EOSDT":"2022-09-06","STRATA1":"C","STRATA2":"S1","BMRKR1":12.05006,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-156","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.00884,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-10 02:44:04","ADY":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-156","AGE":36.39787,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-06 02:44:04","TRTEDTM":"2022-09-06 14:44:04","EOSDY":731,"EOSDT":"2022-09-06","STRATA1":"C","STRATA2":"S1","BMRKR1":12.05006,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-156","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":56.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-10-06 16:31:18","ADY":396}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-156","AGE":36.39787,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-06 02:44:04","TRTEDTM":"2022-09-06 14:44:04","EOSDY":731,"EOSDT":"2022-09-06","STRATA1":"C","STRATA2":"S1","BMRKR1":12.05006,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-156","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":45.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-07-20 10:11:53","ADY":318}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-16","AGE":44.12233,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-31 20:12:15","TRTEDTM":"2021-05-31 08:12:15","EOSDY":731,"EOSDT":"2021-05-31","STRATA1":"C","STRATA2":"S2","BMRKR1":5.03643,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-16","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-05-31 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-16","AGE":44.12233,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-31 20:12:15","TRTEDTM":"2021-05-31 08:12:15","EOSDY":731,"EOSDT":"2021-05-31","STRATA1":"C","STRATA2":"S2","BMRKR1":5.03643,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-16","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-16","AGE":44.12233,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-31 20:12:15","TRTEDTM":"2021-05-31 08:12:15","EOSDY":731,"EOSDT":"2021-05-31","STRATA1":"C","STRATA2":"S2","BMRKR1":5.03643,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-16","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-16","AGE":44.12233,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-31 20:12:15","TRTEDTM":"2021-05-31 08:12:15","EOSDY":731,"EOSDT":"2021-05-31","STRATA1":"C","STRATA2":"S2","BMRKR1":5.03643,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-16","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-16","AGE":44.12233,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-31 20:12:15","TRTEDTM":"2021-05-31 08:12:15","EOSDY":731,"EOSDT":"2021-05-31","STRATA1":"C","STRATA2":"S2","BMRKR1":5.03643,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-16","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.27725,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-10 20:12:15","ADY":102}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-16","AGE":44.12233,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-31 20:12:15","TRTEDTM":"2021-05-31 08:12:15","EOSDY":731,"EOSDT":"2021-05-31","STRATA1":"C","STRATA2":"S2","BMRKR1":5.03643,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-16","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.13207,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-19 20:12:15","ADY":49}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-16","AGE":44.12233,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-31 20:12:15","TRTEDTM":"2021-05-31 08:12:15","EOSDY":731,"EOSDT":"2021-05-31","STRATA1":"C","STRATA2":"S2","BMRKR1":5.03643,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-16","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.04007,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-06-15 20:12:15","ADY":15}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-16","AGE":44.12233,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-31 20:12:15","TRTEDTM":"2021-05-31 08:12:15","EOSDY":731,"EOSDT":"2021-05-31","STRATA1":"C","STRATA2":"S2","BMRKR1":5.03643,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-16","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":74.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-11-03 19:06:43","ADY":523}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-16","AGE":44.12233,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-31 20:12:15","TRTEDTM":"2021-05-31 08:12:15","EOSDY":731,"EOSDT":"2021-05-31","STRATA1":"C","STRATA2":"S2","BMRKR1":5.03643,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-16","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":13.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-09-01 05:06:53","ADY":94}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-160","AGE":48.16553,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-02 15:20:15","TRTEDTM":"2021-11-02 03:20:15","EOSDY":731,"EOSDT":"2021-11-02","STRATA1":"A","STRATA2":"S1","BMRKR1":3.05847,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-160","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-11-02 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-160","AGE":48.16553,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-02 15:20:15","TRTEDTM":"2021-11-02 03:20:15","EOSDY":731,"EOSDT":"2021-11-02","STRATA1":"A","STRATA2":"S1","BMRKR1":3.05847,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-160","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-160","AGE":48.16553,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-02 15:20:15","TRTEDTM":"2021-11-02 03:20:15","EOSDY":731,"EOSDT":"2021-11-02","STRATA1":"A","STRATA2":"S1","BMRKR1":3.05847,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-160","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-160","AGE":48.16553,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-02 15:20:15","TRTEDTM":"2021-11-02 03:20:15","EOSDY":731,"EOSDT":"2021-11-02","STRATA1":"A","STRATA2":"S1","BMRKR1":3.05847,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-160","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":10}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-160","AGE":48.16553,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-02 15:20:15","TRTEDTM":"2021-11-02 03:20:15","EOSDY":731,"EOSDT":"2021-11-02","STRATA1":"A","STRATA2":"S1","BMRKR1":3.05847,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-160","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.07643,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-30 15:20:15","ADY":28}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-160","AGE":48.16553,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-02 15:20:15","TRTEDTM":"2021-11-02 03:20:15","EOSDY":731,"EOSDT":"2021-11-02","STRATA1":"A","STRATA2":"S1","BMRKR1":3.05847,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-160","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.33534,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-03-04 15:20:15","ADY":123}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-160","AGE":48.16553,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-02 15:20:15","TRTEDTM":"2021-11-02 03:20:15","EOSDY":731,"EOSDT":"2021-11-02","STRATA1":"A","STRATA2":"S1","BMRKR1":3.05847,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-160","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.15719,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-30 15:20:15","ADY":58}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-160","AGE":48.16553,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-02 15:20:15","TRTEDTM":"2021-11-02 03:20:15","EOSDY":731,"EOSDT":"2021-11-02","STRATA1":"A","STRATA2":"S1","BMRKR1":3.05847,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-160","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":44.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-09-08 08:55:50","ADY":312}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-160","AGE":48.16553,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-02 15:20:15","TRTEDTM":"2021-11-02 03:20:15","EOSDY":731,"EOSDT":"2021-11-02","STRATA1":"A","STRATA2":"S1","BMRKR1":3.05847,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-160","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-11-07 16:34:15","ADY":6}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-170","AGE":28.58525,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-08-27 04:21:00","TRTEDTM":"2022-08-27 16:21:00","EOSDY":731,"EOSDT":"2022-08-27","STRATA1":"C","STRATA2":"S2","BMRKR1":5.67981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-170","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-08-27 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-170","AGE":28.58525,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-08-27 04:21:00","TRTEDTM":"2022-08-27 16:21:00","EOSDY":731,"EOSDT":"2022-08-27","STRATA1":"C","STRATA2":"S2","BMRKR1":5.67981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-170","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-170","AGE":28.58525,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-08-27 04:21:00","TRTEDTM":"2022-08-27 16:21:00","EOSDY":731,"EOSDT":"2022-08-27","STRATA1":"C","STRATA2":"S2","BMRKR1":5.67981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-170","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-170","AGE":28.58525,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-08-27 04:21:00","TRTEDTM":"2022-08-27 16:21:00","EOSDY":731,"EOSDT":"2022-08-27","STRATA1":"C","STRATA2":"S2","BMRKR1":5.67981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-170","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-170","AGE":28.58525,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-08-27 04:21:00","TRTEDTM":"2022-08-27 16:21:00","EOSDY":731,"EOSDT":"2022-08-27","STRATA1":"C","STRATA2":"S2","BMRKR1":5.67981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-170","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2022-08-28 04:21:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-170","AGE":28.58525,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-08-27 04:21:00","TRTEDTM":"2022-08-27 16:21:00","EOSDY":731,"EOSDT":"2022-08-27","STRATA1":"C","STRATA2":"S2","BMRKR1":5.67981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-170","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2022-08-28 04:21:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-170","AGE":28.58525,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-08-27 04:21:00","TRTEDTM":"2022-08-27 16:21:00","EOSDY":731,"EOSDT":"2022-08-27","STRATA1":"C","STRATA2":"S2","BMRKR1":5.67981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-170","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.02834,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-07 04:21:00","ADY":11}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-170","AGE":28.58525,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-08-27 04:21:00","TRTEDTM":"2022-08-27 16:21:00","EOSDY":731,"EOSDT":"2022-08-27","STRATA1":"C","STRATA2":"S2","BMRKR1":5.67981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-170","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":90.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-05-23 17:43:36","ADY":635}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-170","AGE":28.58525,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-08-27 04:21:00","TRTEDTM":"2022-08-27 16:21:00","EOSDY":731,"EOSDT":"2022-08-27","STRATA1":"C","STRATA2":"S2","BMRKR1":5.67981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-170","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-08-27 04:21:00","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-181","AGE":32.0102,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-09-28 11:07:20","TRTEDTM":"2021-09-27 23:07:20","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"B","STRATA2":"S1","BMRKR1":6.56235,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-181","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-09-27 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-181","AGE":32.0102,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-09-28 11:07:20","TRTEDTM":"2021-09-27 23:07:20","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"B","STRATA2":"S1","BMRKR1":6.56235,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-181","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-181","AGE":32.0102,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-09-28 11:07:20","TRTEDTM":"2021-09-27 23:07:20","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"B","STRATA2":"S1","BMRKR1":6.56235,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-181","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-181","AGE":32.0102,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-09-28 11:07:20","TRTEDTM":"2021-09-27 23:07:20","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"B","STRATA2":"S1","BMRKR1":6.56235,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-181","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-181","AGE":32.0102,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-09-28 11:07:20","TRTEDTM":"2021-09-27 23:07:20","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"B","STRATA2":"S1","BMRKR1":6.56235,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-181","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.18112,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-04 11:07:20","ADY":67}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-181","AGE":32.0102,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-09-28 11:07:20","TRTEDTM":"2021-09-27 23:07:20","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"B","STRATA2":"S1","BMRKR1":6.56235,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-181","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.24434,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-27 11:07:20","ADY":90}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-181","AGE":32.0102,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-09-28 11:07:20","TRTEDTM":"2021-09-27 23:07:20","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"B","STRATA2":"S1","BMRKR1":6.56235,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-181","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-09-28 11:07:20","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-181","AGE":32.0102,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-09-28 11:07:20","TRTEDTM":"2021-09-27 23:07:20","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"B","STRATA2":"S1","BMRKR1":6.56235,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-181","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-09-28 11:07:20","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-181","AGE":32.0102,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-09-28 11:07:20","TRTEDTM":"2021-09-27 23:07:20","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"B","STRATA2":"S1","BMRKR1":6.56235,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-181","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":68.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-01-20 02:35:42","ADY":481}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-199","AGE":29.32248,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-01-21 21:49:24","TRTEDTM":"2022-01-21 09:49:24","EOSDY":731,"EOSDT":"2022-01-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.14841,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-199","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-01-21 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-199","AGE":29.32248,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-01-21 21:49:24","TRTEDTM":"2022-01-21 09:49:24","EOSDY":731,"EOSDT":"2022-01-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.14841,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-199","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-199","AGE":29.32248,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-01-21 21:49:24","TRTEDTM":"2022-01-21 09:49:24","EOSDY":731,"EOSDT":"2022-01-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.14841,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-199","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-199","AGE":29.32248,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-01-21 21:49:24","TRTEDTM":"2022-01-21 09:49:24","EOSDY":731,"EOSDT":"2022-01-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.14841,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-199","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-199","AGE":29.32248,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-01-21 21:49:24","TRTEDTM":"2022-01-21 09:49:24","EOSDY":731,"EOSDT":"2022-01-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.14841,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-199","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.57958,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-20 21:49:24","ADY":212}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-199","AGE":29.32248,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-01-21 21:49:24","TRTEDTM":"2022-01-21 09:49:24","EOSDY":731,"EOSDT":"2022-01-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.14841,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-199","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.02187,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-01-29 21:49:24","ADY":8}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-199","AGE":29.32248,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-01-21 21:49:24","TRTEDTM":"2022-01-21 09:49:24","EOSDY":731,"EOSDT":"2022-01-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.14841,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-199","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.06147,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-02-13 21:49:24","ADY":23}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-199","AGE":29.32248,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-01-21 21:49:24","TRTEDTM":"2022-01-21 09:49:24","EOSDY":731,"EOSDT":"2022-01-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.14841,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-199","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":5.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-02-26 09:35:12","ADY":37}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-199","AGE":29.32248,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-01-21 21:49:24","TRTEDTM":"2022-01-21 09:49:24","EOSDY":731,"EOSDT":"2022-01-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.14841,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-199","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":61.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-03-23 23:37:59","ADY":428}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-27","AGE":43.0576,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-05-17 17:35:19","TRTEDTM":"2022-05-18 05:35:19","EOSDY":731,"EOSDT":"2022-05-18","STRATA1":"A","STRATA2":"S1","BMRKR1":2.87215,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-27","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-05-18 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-27","AGE":43.0576,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-05-17 17:35:19","TRTEDTM":"2022-05-18 05:35:19","EOSDY":731,"EOSDT":"2022-05-18","STRATA1":"A","STRATA2":"S1","BMRKR1":2.87215,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-27","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-27","AGE":43.0576,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-05-17 17:35:19","TRTEDTM":"2022-05-18 05:35:19","EOSDY":731,"EOSDT":"2022-05-18","STRATA1":"A","STRATA2":"S1","BMRKR1":2.87215,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-27","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-27","AGE":43.0576,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-05-17 17:35:19","TRTEDTM":"2022-05-18 05:35:19","EOSDY":731,"EOSDT":"2022-05-18","STRATA1":"A","STRATA2":"S1","BMRKR1":2.87215,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-27","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-27","AGE":43.0576,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-05-17 17:35:19","TRTEDTM":"2022-05-18 05:35:19","EOSDY":731,"EOSDT":"2022-05-18","STRATA1":"A","STRATA2":"S1","BMRKR1":2.87215,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-27","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-05-19 17:35:19","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-27","AGE":43.0576,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-05-17 17:35:19","TRTEDTM":"2022-05-18 05:35:19","EOSDY":731,"EOSDT":"2022-05-18","STRATA1":"A","STRATA2":"S1","BMRKR1":2.87215,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-27","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.41163,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-15 17:35:19","ADY":151}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-27","AGE":43.0576,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-05-17 17:35:19","TRTEDTM":"2022-05-18 05:35:19","EOSDY":731,"EOSDT":"2022-05-18","STRATA1":"A","STRATA2":"S1","BMRKR1":2.87215,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-27","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2022-05-19 17:35:19","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-27","AGE":43.0576,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-05-17 17:35:19","TRTEDTM":"2022-05-18 05:35:19","EOSDY":731,"EOSDT":"2022-05-18","STRATA1":"A","STRATA2":"S1","BMRKR1":2.87215,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-27","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":51.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-05-12 18:48:55","ADY":361}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-27","AGE":43.0576,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-05-17 17:35:19","TRTEDTM":"2022-05-18 05:35:19","EOSDY":731,"EOSDT":"2022-05-18","STRATA1":"A","STRATA2":"S1","BMRKR1":2.87215,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-27","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":104.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-05-18 05:07:39","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-31","AGE":38.09817,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-06-28 00:21:53","TRTEDTM":"2021-06-27 12:21:53","EOSDY":731,"EOSDT":"2021-06-27","STRATA1":"B","STRATA2":"S1","BMRKR1":1.66702,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-31","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-06-27 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-31","AGE":38.09817,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-06-28 00:21:53","TRTEDTM":"2021-06-27 12:21:53","EOSDY":731,"EOSDT":"2021-06-27","STRATA1":"B","STRATA2":"S1","BMRKR1":1.66702,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-31","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-31","AGE":38.09817,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-06-28 00:21:53","TRTEDTM":"2021-06-27 12:21:53","EOSDY":731,"EOSDT":"2021-06-27","STRATA1":"B","STRATA2":"S1","BMRKR1":1.66702,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-31","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-31","AGE":38.09817,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-06-28 00:21:53","TRTEDTM":"2021-06-27 12:21:53","EOSDY":731,"EOSDT":"2021-06-27","STRATA1":"B","STRATA2":"S1","BMRKR1":1.66702,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-31","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-31","AGE":38.09817,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-06-28 00:21:53","TRTEDTM":"2021-06-27 12:21:53","EOSDY":731,"EOSDT":"2021-06-27","STRATA1":"B","STRATA2":"S1","BMRKR1":1.66702,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-31","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-06-28 00:21:53","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-31","AGE":38.09817,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-06-28 00:21:53","TRTEDTM":"2021-06-27 12:21:53","EOSDY":731,"EOSDT":"2021-06-27","STRATA1":"B","STRATA2":"S1","BMRKR1":1.66702,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-31","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-06-28 00:21:53","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-31","AGE":38.09817,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-06-28 00:21:53","TRTEDTM":"2021-06-27 12:21:53","EOSDY":731,"EOSDT":"2021-06-27","STRATA1":"B","STRATA2":"S1","BMRKR1":1.66702,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-31","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.02802,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-09 00:21:53","ADY":11}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-31","AGE":38.09817,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-06-28 00:21:53","TRTEDTM":"2021-06-27 12:21:53","EOSDY":731,"EOSDT":"2021-06-27","STRATA1":"B","STRATA2":"S1","BMRKR1":1.66702,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-31","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":52.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-06-28 22:37:06","ADY":367}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-31","AGE":38.09817,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-06-28 00:21:53","TRTEDTM":"2021-06-27 12:21:53","EOSDY":731,"EOSDT":"2021-06-27","STRATA1":"B","STRATA2":"S1","BMRKR1":1.66702,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-31","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-06-28 00:21:53","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-33","AGE":47.68788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-03-25 09:30:52","TRTEDTM":"2022-03-25 21:30:52","EOSDY":731,"EOSDT":"2022-03-25","STRATA1":"C","STRATA2":"S2","BMRKR1":3.80259,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-33","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-03-25 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-33","AGE":47.68788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-03-25 09:30:52","TRTEDTM":"2022-03-25 21:30:52","EOSDY":731,"EOSDT":"2022-03-25","STRATA1":"C","STRATA2":"S2","BMRKR1":3.80259,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-33","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-33","AGE":47.68788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-03-25 09:30:52","TRTEDTM":"2022-03-25 21:30:52","EOSDY":731,"EOSDT":"2022-03-25","STRATA1":"C","STRATA2":"S2","BMRKR1":3.80259,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-33","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-33","AGE":47.68788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-03-25 09:30:52","TRTEDTM":"2022-03-25 21:30:52","EOSDY":731,"EOSDT":"2022-03-25","STRATA1":"C","STRATA2":"S2","BMRKR1":3.80259,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-33","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-33","AGE":47.68788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-03-25 09:30:52","TRTEDTM":"2022-03-25 21:30:52","EOSDY":731,"EOSDT":"2022-03-25","STRATA1":"C","STRATA2":"S2","BMRKR1":3.80259,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-33","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.18768,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-06-02 09:30:52","ADY":69}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-33","AGE":47.68788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-03-25 09:30:52","TRTEDTM":"2022-03-25 21:30:52","EOSDY":731,"EOSDT":"2022-03-25","STRATA1":"C","STRATA2":"S2","BMRKR1":3.80259,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-33","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.02279,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-03 09:30:52","ADY":9}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-33","AGE":47.68788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-03-25 09:30:52","TRTEDTM":"2022-03-25 21:30:52","EOSDY":731,"EOSDT":"2022-03-25","STRATA1":"C","STRATA2":"S2","BMRKR1":3.80259,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-33","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-03-26 09:30:52","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-33","AGE":47.68788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-03-25 09:30:52","TRTEDTM":"2022-03-25 21:30:52","EOSDY":731,"EOSDT":"2022-03-25","STRATA1":"C","STRATA2":"S2","BMRKR1":3.80259,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-33","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":35.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-11-25 21:54:28","ADY":246}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-33","AGE":47.68788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-03-25 09:30:52","TRTEDTM":"2022-03-25 21:30:52","EOSDY":731,"EOSDT":"2022-03-25","STRATA1":"C","STRATA2":"S2","BMRKR1":3.80259,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-33","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":40.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-12-31 12:38:48","ADY":282}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-40","AGE":40.35818,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-03-22 09:38:20","TRTEDTM":"2022-03-22 21:38:20","EOSDY":731,"EOSDT":"2022-03-22","STRATA1":"B","STRATA2":"S2","BMRKR1":2.49102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-40","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-03-22 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-40","AGE":40.35818,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-03-22 09:38:20","TRTEDTM":"2022-03-22 21:38:20","EOSDY":731,"EOSDT":"2022-03-22","STRATA1":"B","STRATA2":"S2","BMRKR1":2.49102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-40","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-40","AGE":40.35818,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-03-22 09:38:20","TRTEDTM":"2022-03-22 21:38:20","EOSDY":731,"EOSDT":"2022-03-22","STRATA1":"B","STRATA2":"S2","BMRKR1":2.49102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-40","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-40","AGE":40.35818,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-03-22 09:38:20","TRTEDTM":"2022-03-22 21:38:20","EOSDY":731,"EOSDT":"2022-03-22","STRATA1":"B","STRATA2":"S2","BMRKR1":2.49102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-40","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":11}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-40","AGE":40.35818,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-03-22 09:38:20","TRTEDTM":"2022-03-22 21:38:20","EOSDY":731,"EOSDT":"2022-03-22","STRATA1":"B","STRATA2":"S2","BMRKR1":2.49102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-40","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-03-23 09:38:20","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-40","AGE":40.35818,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-03-22 09:38:20","TRTEDTM":"2022-03-22 21:38:20","EOSDY":731,"EOSDT":"2022-03-22","STRATA1":"B","STRATA2":"S2","BMRKR1":2.49102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-40","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.11072,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-05-02 09:38:20","ADY":41}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-40","AGE":40.35818,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-03-22 09:38:20","TRTEDTM":"2022-03-22 21:38:20","EOSDY":731,"EOSDT":"2022-03-22","STRATA1":"B","STRATA2":"S2","BMRKR1":2.49102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-40","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.03283,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-03 09:38:20","ADY":12}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-40","AGE":40.35818,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-03-22 09:38:20","TRTEDTM":"2022-03-22 21:38:20","EOSDY":731,"EOSDT":"2022-03-22","STRATA1":"B","STRATA2":"S2","BMRKR1":2.49102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-40","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":61.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-05-26 14:28:43","ADY":431}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-40","AGE":40.35818,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-03-22 09:38:20","TRTEDTM":"2022-03-22 21:38:20","EOSDY":731,"EOSDT":"2022-03-22","STRATA1":"B","STRATA2":"S2","BMRKR1":2.49102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-40","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-03-22 09:38:20","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-47","AGE":29.16539,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-15 12:42:50","TRTEDTM":"2022-05-16 00:42:50","EOSDY":731,"EOSDT":"2022-05-16","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57136,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-47","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-05-16 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-47","AGE":29.16539,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-15 12:42:50","TRTEDTM":"2022-05-16 00:42:50","EOSDY":731,"EOSDT":"2022-05-16","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57136,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-47","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-47","AGE":29.16539,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-15 12:42:50","TRTEDTM":"2022-05-16 00:42:50","EOSDY":731,"EOSDT":"2022-05-16","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57136,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-47","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-47","AGE":29.16539,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-15 12:42:50","TRTEDTM":"2022-05-16 00:42:50","EOSDY":731,"EOSDT":"2022-05-16","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57136,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-47","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-47","AGE":29.16539,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-15 12:42:50","TRTEDTM":"2022-05-16 00:42:50","EOSDY":731,"EOSDT":"2022-05-16","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57136,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-47","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.40414,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-10 12:42:50","ADY":148}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-47","AGE":29.16539,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-15 12:42:50","TRTEDTM":"2022-05-16 00:42:50","EOSDY":731,"EOSDT":"2022-05-16","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57136,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-47","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-05-17 12:42:50","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-47","AGE":29.16539,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-15 12:42:50","TRTEDTM":"2022-05-16 00:42:50","EOSDY":731,"EOSDT":"2022-05-16","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57136,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-47","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-05-17 12:42:50","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-47","AGE":29.16539,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-15 12:42:50","TRTEDTM":"2022-05-16 00:42:50","EOSDY":731,"EOSDT":"2022-05-16","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57136,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-47","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":52.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-05-16 17:30:04","ADY":367}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-47","AGE":29.16539,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-05-15 12:42:50","TRTEDTM":"2022-05-16 00:42:50","EOSDY":731,"EOSDT":"2022-05-16","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57136,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-47","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":68.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-09-03 05:50:32","ADY":477}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-53","AGE":34.77283,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-22 20:08:34","TRTEDTM":"2022-11-23 08:08:34","EOSDY":731,"EOSDT":"2022-11-23","STRATA1":"C","STRATA2":"S2","BMRKR1":10.81987,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-53","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-11-23 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-53","AGE":34.77283,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-22 20:08:34","TRTEDTM":"2022-11-23 08:08:34","EOSDY":731,"EOSDT":"2022-11-23","STRATA1":"C","STRATA2":"S2","BMRKR1":10.81987,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-53","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-53","AGE":34.77283,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-22 20:08:34","TRTEDTM":"2022-11-23 08:08:34","EOSDY":731,"EOSDT":"2022-11-23","STRATA1":"C","STRATA2":"S2","BMRKR1":10.81987,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-53","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-53","AGE":34.77283,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-22 20:08:34","TRTEDTM":"2022-11-23 08:08:34","EOSDY":731,"EOSDT":"2022-11-23","STRATA1":"C","STRATA2":"S2","BMRKR1":10.81987,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-53","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-53","AGE":34.77283,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-22 20:08:34","TRTEDTM":"2022-11-23 08:08:34","EOSDY":731,"EOSDT":"2022-11-23","STRATA1":"C","STRATA2":"S2","BMRKR1":10.81987,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-53","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.00259,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-11-23 20:08:34","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-53","AGE":34.77283,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-22 20:08:34","TRTEDTM":"2022-11-23 08:08:34","EOSDY":731,"EOSDT":"2022-11-23","STRATA1":"C","STRATA2":"S2","BMRKR1":10.81987,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-53","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.6019,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-06-30 20:08:34","ADY":220}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-53","AGE":34.77283,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-22 20:08:34","TRTEDTM":"2022-11-23 08:08:34","EOSDY":731,"EOSDT":"2022-11-23","STRATA1":"C","STRATA2":"S2","BMRKR1":10.81987,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-53","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.12473,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-07 20:08:34","ADY":46}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-53","AGE":34.77283,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-22 20:08:34","TRTEDTM":"2022-11-23 08:08:34","EOSDY":731,"EOSDT":"2022-11-23","STRATA1":"C","STRATA2":"S2","BMRKR1":10.81987,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-53","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":68.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-03-16 12:29:37","ADY":480}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-53","AGE":34.77283,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-22 20:08:34","TRTEDTM":"2022-11-23 08:08:34","EOSDY":731,"EOSDT":"2022-11-23","STRATA1":"C","STRATA2":"S2","BMRKR1":10.81987,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-53","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":48.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-10-29 06:06:05","ADY":342}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-55","AGE":30.83574,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2021-02-15 19:33:48","TRTEDTM":"2023-02-16 07:33:48","EOSDY":731,"EOSDT":"2023-02-16","STRATA1":"C","STRATA2":"S2","BMRKR1":1.49385,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-55","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2023-02-16 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-55","AGE":30.83574,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2021-02-15 19:33:48","TRTEDTM":"2023-02-16 07:33:48","EOSDY":731,"EOSDT":"2023-02-16","STRATA1":"C","STRATA2":"S2","BMRKR1":1.49385,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-55","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-55","AGE":30.83574,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2021-02-15 19:33:48","TRTEDTM":"2023-02-16 07:33:48","EOSDY":731,"EOSDT":"2023-02-16","STRATA1":"C","STRATA2":"S2","BMRKR1":1.49385,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-55","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-55","AGE":30.83574,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2021-02-15 19:33:48","TRTEDTM":"2023-02-16 07:33:48","EOSDY":731,"EOSDT":"2023-02-16","STRATA1":"C","STRATA2":"S2","BMRKR1":1.49385,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-55","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":9}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-55","AGE":30.83574,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2021-02-15 19:33:48","TRTEDTM":"2023-02-16 07:33:48","EOSDY":731,"EOSDT":"2023-02-16","STRATA1":"C","STRATA2":"S2","BMRKR1":1.49385,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-55","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.12742,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-04-03 19:33:48","ADY":47}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-55","AGE":30.83574,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2021-02-15 19:33:48","TRTEDTM":"2023-02-16 07:33:48","EOSDY":731,"EOSDT":"2023-02-16","STRATA1":"C","STRATA2":"S2","BMRKR1":1.49385,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-55","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.11725,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-03-30 19:33:48","ADY":43}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-55","AGE":30.83574,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2021-02-15 19:33:48","TRTEDTM":"2023-02-16 07:33:48","EOSDY":731,"EOSDT":"2023-02-16","STRATA1":"C","STRATA2":"S2","BMRKR1":1.49385,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-55","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.02321,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-02-24 19:33:48","ADY":9}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-55","AGE":30.83574,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2021-02-15 19:33:48","TRTEDTM":"2023-02-16 07:33:48","EOSDY":731,"EOSDT":"2023-02-16","STRATA1":"C","STRATA2":"S2","BMRKR1":1.49385,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-55","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":100.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2023-01-21 09:19:14","ADY":706}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-55","AGE":30.83574,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2021-02-15 19:33:48","TRTEDTM":"2023-02-16 07:33:48","EOSDY":731,"EOSDT":"2023-02-16","STRATA1":"C","STRATA2":"S2","BMRKR1":1.49385,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-55","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":16.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-06-11 10:41:17","ADY":117}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-62","AGE":49.62581,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-05 18:05:36","TRTEDTM":"2021-03-05 06:05:36","EOSDY":731,"EOSDT":"2021-03-05","STRATA1":"B","STRATA2":"S2","BMRKR1":2.1702,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-62","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-03-05 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-62","AGE":49.62581,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-05 18:05:36","TRTEDTM":"2021-03-05 06:05:36","EOSDY":731,"EOSDT":"2021-03-05","STRATA1":"B","STRATA2":"S2","BMRKR1":2.1702,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-62","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-62","AGE":49.62581,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-05 18:05:36","TRTEDTM":"2021-03-05 06:05:36","EOSDY":731,"EOSDT":"2021-03-05","STRATA1":"B","STRATA2":"S2","BMRKR1":2.1702,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-62","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-62","AGE":49.62581,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-05 18:05:36","TRTEDTM":"2021-03-05 06:05:36","EOSDY":731,"EOSDT":"2021-03-05","STRATA1":"B","STRATA2":"S2","BMRKR1":2.1702,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-62","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-62","AGE":49.62581,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-05 18:05:36","TRTEDTM":"2021-03-05 06:05:36","EOSDY":731,"EOSDT":"2021-03-05","STRATA1":"B","STRATA2":"S2","BMRKR1":2.1702,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-62","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.19994,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-18 18:05:36","ADY":74}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-62","AGE":49.62581,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-05 18:05:36","TRTEDTM":"2021-03-05 06:05:36","EOSDY":731,"EOSDT":"2021-03-05","STRATA1":"B","STRATA2":"S2","BMRKR1":2.1702,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-62","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.2169,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-24 18:05:36","ADY":80}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-62","AGE":49.62581,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-05 18:05:36","TRTEDTM":"2021-03-05 06:05:36","EOSDY":731,"EOSDT":"2021-03-05","STRATA1":"B","STRATA2":"S2","BMRKR1":2.1702,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-62","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.13064,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-04-22 18:05:36","ADY":48}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-62","AGE":49.62581,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-05 18:05:36","TRTEDTM":"2021-03-05 06:05:36","EOSDY":731,"EOSDT":"2021-03-05","STRATA1":"B","STRATA2":"S2","BMRKR1":2.1702,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-62","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":15,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-06-17 19:06:04","ADY":105}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-62","AGE":49.62581,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-05 18:05:36","TRTEDTM":"2021-03-05 06:05:36","EOSDY":731,"EOSDT":"2021-03-05","STRATA1":"B","STRATA2":"S2","BMRKR1":2.1702,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-62","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":14,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-06-10 09:51:20","ADY":98}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-63","AGE":27.8548,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-12 19:29:10","TRTEDTM":"2022-03-13 07:29:10","EOSDY":731,"EOSDT":"2022-03-13","STRATA1":"C","STRATA2":"S1","BMRKR1":2.95779,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-63","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-03-13 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-63","AGE":27.8548,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-12 19:29:10","TRTEDTM":"2022-03-13 07:29:10","EOSDY":731,"EOSDT":"2022-03-13","STRATA1":"C","STRATA2":"S1","BMRKR1":2.95779,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-63","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-63","AGE":27.8548,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-12 19:29:10","TRTEDTM":"2022-03-13 07:29:10","EOSDY":731,"EOSDT":"2022-03-13","STRATA1":"C","STRATA2":"S1","BMRKR1":2.95779,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-63","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-63","AGE":27.8548,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-12 19:29:10","TRTEDTM":"2022-03-13 07:29:10","EOSDY":731,"EOSDT":"2022-03-13","STRATA1":"C","STRATA2":"S1","BMRKR1":2.95779,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-63","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":9}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-63","AGE":27.8548,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-12 19:29:10","TRTEDTM":"2022-03-13 07:29:10","EOSDY":731,"EOSDT":"2022-03-13","STRATA1":"C","STRATA2":"S1","BMRKR1":2.95779,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-63","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.05318,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-01 19:29:10","ADY":20}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-63","AGE":27.8548,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-12 19:29:10","TRTEDTM":"2022-03-13 07:29:10","EOSDY":731,"EOSDT":"2022-03-13","STRATA1":"C","STRATA2":"S1","BMRKR1":2.95779,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-63","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.10011,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-18 19:29:10","ADY":37}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-63","AGE":27.8548,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-12 19:29:10","TRTEDTM":"2022-03-13 07:29:10","EOSDY":731,"EOSDT":"2022-03-13","STRATA1":"C","STRATA2":"S1","BMRKR1":2.95779,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-63","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.03137,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-03-24 19:29:10","ADY":12}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-63","AGE":27.8548,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-12 19:29:10","TRTEDTM":"2022-03-13 07:29:10","EOSDY":731,"EOSDT":"2022-03-13","STRATA1":"C","STRATA2":"S1","BMRKR1":2.95779,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-63","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":72,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-07-28 03:10:06","ADY":504}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-63","AGE":27.8548,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-12 19:29:10","TRTEDTM":"2022-03-13 07:29:10","EOSDY":731,"EOSDT":"2022-03-13","STRATA1":"C","STRATA2":"S1","BMRKR1":2.95779,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-63","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":4.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-04-14 08:55:55","ADY":34}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-73","AGE":28.60293,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-08 00:11:41","TRTEDTM":"2022-09-08 12:11:41","EOSDY":731,"EOSDT":"2022-09-08","STRATA1":"C","STRATA2":"S1","BMRKR1":10.33912,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-73","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-09-08 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-73","AGE":28.60293,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-08 00:11:41","TRTEDTM":"2022-09-08 12:11:41","EOSDY":731,"EOSDT":"2022-09-08","STRATA1":"C","STRATA2":"S1","BMRKR1":10.33912,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-73","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-73","AGE":28.60293,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-08 00:11:41","TRTEDTM":"2022-09-08 12:11:41","EOSDY":731,"EOSDT":"2022-09-08","STRATA1":"C","STRATA2":"S1","BMRKR1":10.33912,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-73","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-73","AGE":28.60293,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-08 00:11:41","TRTEDTM":"2022-09-08 12:11:41","EOSDY":731,"EOSDT":"2022-09-08","STRATA1":"C","STRATA2":"S1","BMRKR1":10.33912,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-73","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-73","AGE":28.60293,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-08 00:11:41","TRTEDTM":"2022-09-08 12:11:41","EOSDY":731,"EOSDT":"2022-09-08","STRATA1":"C","STRATA2":"S1","BMRKR1":10.33912,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-73","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.09129,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-12 00:11:41","ADY":34}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-73","AGE":28.60293,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-08 00:11:41","TRTEDTM":"2022-09-08 12:11:41","EOSDY":731,"EOSDT":"2022-09-08","STRATA1":"C","STRATA2":"S1","BMRKR1":10.33912,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-73","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.40664,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-02-04 00:11:41","ADY":149}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-73","AGE":28.60293,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-08 00:11:41","TRTEDTM":"2022-09-08 12:11:41","EOSDY":731,"EOSDT":"2022-09-08","STRATA1":"C","STRATA2":"S1","BMRKR1":10.33912,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-73","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.04534,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-25 00:11:41","ADY":17}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-73","AGE":28.60293,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-08 00:11:41","TRTEDTM":"2022-09-08 12:11:41","EOSDY":731,"EOSDT":"2022-09-08","STRATA1":"C","STRATA2":"S1","BMRKR1":10.33912,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-73","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":71.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-01-18 20:45:49","ADY":498}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-73","AGE":28.60293,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-08 00:11:41","TRTEDTM":"2022-09-08 12:11:41","EOSDY":731,"EOSDT":"2022-09-08","STRATA1":"C","STRATA2":"S1","BMRKR1":10.33912,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-73","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":11.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-11-26 13:22:22","ADY":80}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-75","AGE":42.3135,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-11-04 04:42:16","TRTEDTM":"2022-11-04 16:42:16","EOSDY":731,"EOSDT":"2022-11-04","STRATA1":"B","STRATA2":"S1","BMRKR1":9.98965,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-75","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-11-04 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-75","AGE":42.3135,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-11-04 04:42:16","TRTEDTM":"2022-11-04 16:42:16","EOSDY":731,"EOSDT":"2022-11-04","STRATA1":"B","STRATA2":"S1","BMRKR1":9.98965,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-75","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-75","AGE":42.3135,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-11-04 04:42:16","TRTEDTM":"2022-11-04 16:42:16","EOSDY":731,"EOSDT":"2022-11-04","STRATA1":"B","STRATA2":"S1","BMRKR1":9.98965,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-75","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-75","AGE":42.3135,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-11-04 04:42:16","TRTEDTM":"2022-11-04 16:42:16","EOSDY":731,"EOSDT":"2022-11-04","STRATA1":"B","STRATA2":"S1","BMRKR1":9.98965,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-75","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-75","AGE":42.3135,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-11-04 04:42:16","TRTEDTM":"2022-11-04 16:42:16","EOSDY":731,"EOSDT":"2022-11-04","STRATA1":"B","STRATA2":"S1","BMRKR1":9.98965,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-75","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.00616,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-11-07 04:42:16","ADY":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-75","AGE":42.3135,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-11-04 04:42:16","TRTEDTM":"2022-11-04 16:42:16","EOSDY":731,"EOSDT":"2022-11-04","STRATA1":"B","STRATA2":"S1","BMRKR1":9.98965,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-75","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.5615,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-05-29 04:42:16","ADY":206}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-75","AGE":42.3135,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-11-04 04:42:16","TRTEDTM":"2022-11-04 16:42:16","EOSDY":731,"EOSDT":"2022-11-04","STRATA1":"B","STRATA2":"S1","BMRKR1":9.98965,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-75","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2022-11-05 04:42:16","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-75","AGE":42.3135,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-11-04 04:42:16","TRTEDTM":"2022-11-04 16:42:16","EOSDY":731,"EOSDT":"2022-11-04","STRATA1":"B","STRATA2":"S1","BMRKR1":9.98965,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-75","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":42.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-08-27 20:50:02","ADY":297}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-75","AGE":42.3135,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-11-04 04:42:16","TRTEDTM":"2022-11-04 16:42:16","EOSDY":731,"EOSDT":"2022-11-04","STRATA1":"B","STRATA2":"S1","BMRKR1":9.98965,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-75","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":62.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-01-12 23:16:04","ADY":435}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-84","AGE":29.18577,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-21 04:19:56","TRTEDTM":"2021-05-20 16:19:56","EOSDY":731,"EOSDT":"2021-05-20","STRATA1":"B","STRATA2":"S1","BMRKR1":6.99994,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-84","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-05-20 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-84","AGE":29.18577,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-21 04:19:56","TRTEDTM":"2021-05-20 16:19:56","EOSDY":731,"EOSDT":"2021-05-20","STRATA1":"B","STRATA2":"S1","BMRKR1":6.99994,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-84","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-84","AGE":29.18577,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-21 04:19:56","TRTEDTM":"2021-05-20 16:19:56","EOSDY":731,"EOSDT":"2021-05-20","STRATA1":"B","STRATA2":"S1","BMRKR1":6.99994,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-84","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-84","AGE":29.18577,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-21 04:19:56","TRTEDTM":"2021-05-20 16:19:56","EOSDY":731,"EOSDT":"2021-05-20","STRATA1":"B","STRATA2":"S1","BMRKR1":6.99994,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-84","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-84","AGE":29.18577,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-21 04:19:56","TRTEDTM":"2021-05-20 16:19:56","EOSDY":731,"EOSDT":"2021-05-20","STRATA1":"B","STRATA2":"S1","BMRKR1":6.99994,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-84","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.28613,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-03 04:19:56","ADY":105}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-84","AGE":29.18577,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-21 04:19:56","TRTEDTM":"2021-05-20 16:19:56","EOSDY":731,"EOSDT":"2021-05-20","STRATA1":"B","STRATA2":"S1","BMRKR1":6.99994,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-84","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-05-21 04:19:56","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-84","AGE":29.18577,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-21 04:19:56","TRTEDTM":"2021-05-20 16:19:56","EOSDY":731,"EOSDT":"2021-05-20","STRATA1":"B","STRATA2":"S1","BMRKR1":6.99994,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-84","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-05-21 04:19:56","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-84","AGE":29.18577,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-21 04:19:56","TRTEDTM":"2021-05-20 16:19:56","EOSDY":731,"EOSDT":"2021-05-20","STRATA1":"B","STRATA2":"S1","BMRKR1":6.99994,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-84","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":41.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-03-03 07:11:11","ADY":288}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-1","SUBJID":"id-84","AGE":29.18577,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-21 04:19:56","TRTEDTM":"2021-05-20 16:19:56","EOSDY":731,"EOSDT":"2021-05-20","STRATA1":"B","STRATA2":"S1","BMRKR1":6.99994,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-1-id-84","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-05-21 04:19:56","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-102","AGE":33.51395,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-28 08:09:03","TRTEDTM":"2023-01-28 20:09:03","EOSDY":731,"EOSDT":"2023-01-28","STRATA1":"A","STRATA2":"S1","BMRKR1":8.67213,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-102","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2023-01-28 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-102","AGE":33.51395,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-28 08:09:03","TRTEDTM":"2023-01-28 20:09:03","EOSDY":731,"EOSDT":"2023-01-28","STRATA1":"A","STRATA2":"S1","BMRKR1":8.67213,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-102","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-102","AGE":33.51395,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-28 08:09:03","TRTEDTM":"2023-01-28 20:09:03","EOSDY":731,"EOSDT":"2023-01-28","STRATA1":"A","STRATA2":"S1","BMRKR1":8.67213,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-102","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-102","AGE":33.51395,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-28 08:09:03","TRTEDTM":"2023-01-28 20:09:03","EOSDY":731,"EOSDT":"2023-01-28","STRATA1":"A","STRATA2":"S1","BMRKR1":8.67213,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-102","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-102","AGE":33.51395,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-28 08:09:03","TRTEDTM":"2023-01-28 20:09:03","EOSDY":731,"EOSDT":"2023-01-28","STRATA1":"A","STRATA2":"S1","BMRKR1":8.67213,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-102","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.09963,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-03-06 08:09:03","ADY":37}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-102","AGE":33.51395,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-28 08:09:03","TRTEDTM":"2023-01-28 20:09:03","EOSDY":731,"EOSDT":"2023-01-28","STRATA1":"A","STRATA2":"S1","BMRKR1":8.67213,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-102","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.44056,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-07-08 08:09:03","ADY":161}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-102","AGE":33.51395,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-28 08:09:03","TRTEDTM":"2023-01-28 20:09:03","EOSDY":731,"EOSDT":"2023-01-28","STRATA1":"A","STRATA2":"S1","BMRKR1":8.67213,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-102","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.25548,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-05-02 08:09:03","ADY":94}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-102","AGE":33.51395,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-28 08:09:03","TRTEDTM":"2023-01-28 20:09:03","EOSDY":731,"EOSDT":"2023-01-28","STRATA1":"A","STRATA2":"S1","BMRKR1":8.67213,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-102","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2021-01-28 08:09:03","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-102","AGE":33.51395,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-28 08:09:03","TRTEDTM":"2023-01-28 20:09:03","EOSDY":731,"EOSDT":"2023-01-28","STRATA1":"A","STRATA2":"S1","BMRKR1":8.67213,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-102","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":13.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-04-30 08:17:09","ADY":93}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-107","AGE":34.80676,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-19 14:33:35","TRTEDTM":"2021-11-19 02:33:35","EOSDY":731,"EOSDT":"2021-11-19","STRATA1":"C","STRATA2":"S1","BMRKR1":7.89394,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-107","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-11-19 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-107","AGE":34.80676,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-19 14:33:35","TRTEDTM":"2021-11-19 02:33:35","EOSDY":731,"EOSDT":"2021-11-19","STRATA1":"C","STRATA2":"S1","BMRKR1":7.89394,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-107","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-107","AGE":34.80676,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-19 14:33:35","TRTEDTM":"2021-11-19 02:33:35","EOSDY":731,"EOSDT":"2021-11-19","STRATA1":"C","STRATA2":"S1","BMRKR1":7.89394,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-107","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-107","AGE":34.80676,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-19 14:33:35","TRTEDTM":"2021-11-19 02:33:35","EOSDY":731,"EOSDT":"2021-11-19","STRATA1":"C","STRATA2":"S1","BMRKR1":7.89394,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-107","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-107","AGE":34.80676,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-19 14:33:35","TRTEDTM":"2021-11-19 02:33:35","EOSDY":731,"EOSDT":"2021-11-19","STRATA1":"C","STRATA2":"S1","BMRKR1":7.89394,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-107","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-11-20 14:33:35","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-107","AGE":34.80676,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-19 14:33:35","TRTEDTM":"2021-11-19 02:33:35","EOSDY":731,"EOSDT":"2021-11-19","STRATA1":"C","STRATA2":"S1","BMRKR1":7.89394,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-107","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.39002,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-10 14:33:35","ADY":143}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-107","AGE":34.80676,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-19 14:33:35","TRTEDTM":"2021-11-19 02:33:35","EOSDY":731,"EOSDT":"2021-11-19","STRATA1":"C","STRATA2":"S1","BMRKR1":7.89394,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-107","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.26901,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-02-26 14:33:35","ADY":99}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-107","AGE":34.80676,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-19 14:33:35","TRTEDTM":"2021-11-19 02:33:35","EOSDY":731,"EOSDT":"2021-11-19","STRATA1":"C","STRATA2":"S1","BMRKR1":7.89394,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-107","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":37.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-05 17:29:44","ADY":261}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-107","AGE":34.80676,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-19 14:33:35","TRTEDTM":"2021-11-19 02:33:35","EOSDY":731,"EOSDT":"2021-11-19","STRATA1":"C","STRATA2":"S1","BMRKR1":7.89394,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-107","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":23.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-05-02 09:53:17","ADY":166}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-12","AGE":41.77541,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-18 15:19:06","TRTEDTM":"2021-10-18 03:19:06","EOSDY":731,"EOSDT":"2021-10-18","STRATA1":"B","STRATA2":"S2","BMRKR1":8.61174,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-12","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-10-18 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-12","AGE":41.77541,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-18 15:19:06","TRTEDTM":"2021-10-18 03:19:06","EOSDY":731,"EOSDT":"2021-10-18","STRATA1":"B","STRATA2":"S2","BMRKR1":8.61174,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-12","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-12","AGE":41.77541,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-18 15:19:06","TRTEDTM":"2021-10-18 03:19:06","EOSDY":731,"EOSDT":"2021-10-18","STRATA1":"B","STRATA2":"S2","BMRKR1":8.61174,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-12","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-12","AGE":41.77541,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-18 15:19:06","TRTEDTM":"2021-10-18 03:19:06","EOSDY":731,"EOSDT":"2021-10-18","STRATA1":"B","STRATA2":"S2","BMRKR1":8.61174,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-12","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-12","AGE":41.77541,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-18 15:19:06","TRTEDTM":"2021-10-18 03:19:06","EOSDY":731,"EOSDT":"2021-10-18","STRATA1":"B","STRATA2":"S2","BMRKR1":8.61174,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-12","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-10-19 15:19:06","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-12","AGE":41.77541,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-18 15:19:06","TRTEDTM":"2021-10-18 03:19:06","EOSDY":731,"EOSDT":"2021-10-18","STRATA1":"B","STRATA2":"S2","BMRKR1":8.61174,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-12","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.06616,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-12 15:19:06","ADY":25}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-12","AGE":41.77541,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-18 15:19:06","TRTEDTM":"2021-10-18 03:19:06","EOSDY":731,"EOSDT":"2021-10-18","STRATA1":"B","STRATA2":"S2","BMRKR1":8.61174,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-12","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.13423,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-07 15:19:06","ADY":50}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-12","AGE":41.77541,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-18 15:19:06","TRTEDTM":"2021-10-18 03:19:06","EOSDY":731,"EOSDT":"2021-10-18","STRATA1":"B","STRATA2":"S2","BMRKR1":8.61174,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-12","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":40.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-07-29 07:24:34","ADY":286}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-12","AGE":41.77541,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-18 15:19:06","TRTEDTM":"2021-10-18 03:19:06","EOSDY":731,"EOSDT":"2021-10-18","STRATA1":"B","STRATA2":"S2","BMRKR1":8.61174,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-12","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":73.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-03-12 03:33:44","ADY":512}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-158","AGE":28.35207,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-16 19:48:46","TRTEDTM":"2021-06-16 07:48:46","EOSDY":731,"EOSDT":"2021-06-16","STRATA1":"B","STRATA2":"S2","BMRKR1":6.91271,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-158","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-06-16 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-158","AGE":28.35207,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-16 19:48:46","TRTEDTM":"2021-06-16 07:48:46","EOSDY":731,"EOSDT":"2021-06-16","STRATA1":"B","STRATA2":"S2","BMRKR1":6.91271,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-158","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-158","AGE":28.35207,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-16 19:48:46","TRTEDTM":"2021-06-16 07:48:46","EOSDY":731,"EOSDT":"2021-06-16","STRATA1":"B","STRATA2":"S2","BMRKR1":6.91271,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-158","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-158","AGE":28.35207,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-16 19:48:46","TRTEDTM":"2021-06-16 07:48:46","EOSDY":731,"EOSDT":"2021-06-16","STRATA1":"B","STRATA2":"S2","BMRKR1":6.91271,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-158","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-158","AGE":28.35207,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-16 19:48:46","TRTEDTM":"2021-06-16 07:48:46","EOSDY":731,"EOSDT":"2021-06-16","STRATA1":"B","STRATA2":"S2","BMRKR1":6.91271,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-158","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-06-17 19:48:46","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-158","AGE":28.35207,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-16 19:48:46","TRTEDTM":"2021-06-16 07:48:46","EOSDY":731,"EOSDT":"2021-06-16","STRATA1":"B","STRATA2":"S2","BMRKR1":6.91271,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-158","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.16295,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-15 19:48:46","ADY":60}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-158","AGE":28.35207,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-16 19:48:46","TRTEDTM":"2021-06-16 07:48:46","EOSDY":731,"EOSDT":"2021-06-16","STRATA1":"B","STRATA2":"S2","BMRKR1":6.91271,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-158","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.09353,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-21 19:48:46","ADY":35}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-158","AGE":28.35207,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-16 19:48:46","TRTEDTM":"2021-06-16 07:48:46","EOSDY":731,"EOSDT":"2021-06-16","STRATA1":"B","STRATA2":"S2","BMRKR1":6.91271,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-158","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":8.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-08-11 02:35:23","ADY":57}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-158","AGE":28.35207,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-16 19:48:46","TRTEDTM":"2021-06-16 07:48:46","EOSDY":731,"EOSDT":"2021-06-16","STRATA1":"B","STRATA2":"S2","BMRKR1":6.91271,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-158","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":82.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-01-15 02:59:30","ADY":580}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-161","AGE":31.66064,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-29 02:54:03","TRTEDTM":"2021-06-28 14:54:03","EOSDY":731,"EOSDT":"2021-06-28","STRATA1":"C","STRATA2":"S1","BMRKR1":4.05839,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-161","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-06-28 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-161","AGE":31.66064,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-29 02:54:03","TRTEDTM":"2021-06-28 14:54:03","EOSDY":731,"EOSDT":"2021-06-28","STRATA1":"C","STRATA2":"S1","BMRKR1":4.05839,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-161","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-161","AGE":31.66064,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-29 02:54:03","TRTEDTM":"2021-06-28 14:54:03","EOSDY":731,"EOSDT":"2021-06-28","STRATA1":"C","STRATA2":"S1","BMRKR1":4.05839,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-161","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-161","AGE":31.66064,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-29 02:54:03","TRTEDTM":"2021-06-28 14:54:03","EOSDY":731,"EOSDT":"2021-06-28","STRATA1":"C","STRATA2":"S1","BMRKR1":4.05839,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-161","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-161","AGE":31.66064,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-29 02:54:03","TRTEDTM":"2021-06-28 14:54:03","EOSDY":731,"EOSDT":"2021-06-28","STRATA1":"C","STRATA2":"S1","BMRKR1":4.05839,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-161","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.03005,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-10 02:54:03","ADY":11}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-161","AGE":31.66064,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-29 02:54:03","TRTEDTM":"2021-06-28 14:54:03","EOSDY":731,"EOSDT":"2021-06-28","STRATA1":"C","STRATA2":"S1","BMRKR1":4.05839,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-161","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.00275,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-01 02:54:03","ADY":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-161","AGE":31.66064,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-29 02:54:03","TRTEDTM":"2021-06-28 14:54:03","EOSDY":731,"EOSDT":"2021-06-28","STRATA1":"C","STRATA2":"S1","BMRKR1":4.05839,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-161","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.10075,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-05 02:54:03","ADY":37}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-161","AGE":31.66064,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-29 02:54:03","TRTEDTM":"2021-06-28 14:54:03","EOSDY":731,"EOSDT":"2021-06-28","STRATA1":"C","STRATA2":"S1","BMRKR1":4.05839,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-161","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":50.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-06-14 09:17:29","ADY":352}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-161","AGE":31.66064,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-29 02:54:03","TRTEDTM":"2021-06-28 14:54:03","EOSDY":731,"EOSDT":"2021-06-28","STRATA1":"C","STRATA2":"S1","BMRKR1":4.05839,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-161","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":25.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-12-23 04:12:13","ADY":178}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-167","AGE":38.46115,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-28 20:37:14","TRTEDTM":"2021-08-28 08:37:14","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"C","STRATA2":"S1","BMRKR1":2.15301,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-167","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-08-28 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-167","AGE":38.46115,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-28 20:37:14","TRTEDTM":"2021-08-28 08:37:14","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"C","STRATA2":"S1","BMRKR1":2.15301,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-167","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-167","AGE":38.46115,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-28 20:37:14","TRTEDTM":"2021-08-28 08:37:14","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"C","STRATA2":"S1","BMRKR1":2.15301,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-167","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-167","AGE":38.46115,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-28 20:37:14","TRTEDTM":"2021-08-28 08:37:14","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"C","STRATA2":"S1","BMRKR1":2.15301,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-167","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-167","AGE":38.46115,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-28 20:37:14","TRTEDTM":"2021-08-28 08:37:14","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"C","STRATA2":"S1","BMRKR1":2.15301,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-167","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.05033,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-16 20:37:14","ADY":19}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-167","AGE":38.46115,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-28 20:37:14","TRTEDTM":"2021-08-28 08:37:14","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"C","STRATA2":"S1","BMRKR1":2.15301,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-167","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.03446,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-10 20:37:14","ADY":13}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-167","AGE":38.46115,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-28 20:37:14","TRTEDTM":"2021-08-28 08:37:14","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"C","STRATA2":"S1","BMRKR1":2.15301,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-167","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-08-29 20:37:14","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-167","AGE":38.46115,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-28 20:37:14","TRTEDTM":"2021-08-28 08:37:14","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"C","STRATA2":"S1","BMRKR1":2.15301,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-167","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":87.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-04-29 14:19:52","ADY":611}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-167","AGE":38.46115,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-08-28 20:37:14","TRTEDTM":"2021-08-28 08:37:14","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"C","STRATA2":"S1","BMRKR1":2.15301,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-167","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":71.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-01-06 17:58:28","ADY":498}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-174","AGE":44.86719,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-04-28 04:03:49","TRTEDTM":"2021-04-27 16:03:49","EOSDY":731,"EOSDT":"2021-04-27","STRATA1":"A","STRATA2":"S2","BMRKR1":4.30304,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-174","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-04-27 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-174","AGE":44.86719,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-04-28 04:03:49","TRTEDTM":"2021-04-27 16:03:49","EOSDY":731,"EOSDT":"2021-04-27","STRATA1":"A","STRATA2":"S2","BMRKR1":4.30304,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-174","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-174","AGE":44.86719,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-04-28 04:03:49","TRTEDTM":"2021-04-27 16:03:49","EOSDY":731,"EOSDT":"2021-04-27","STRATA1":"A","STRATA2":"S2","BMRKR1":4.30304,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-174","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-174","AGE":44.86719,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-04-28 04:03:49","TRTEDTM":"2021-04-27 16:03:49","EOSDY":731,"EOSDT":"2021-04-27","STRATA1":"A","STRATA2":"S2","BMRKR1":4.30304,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-174","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-174","AGE":44.86719,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-04-28 04:03:49","TRTEDTM":"2021-04-27 16:03:49","EOSDY":731,"EOSDT":"2021-04-27","STRATA1":"A","STRATA2":"S2","BMRKR1":4.30304,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-174","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.03353,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-11 04:03:49","ADY":13}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-174","AGE":44.86719,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-04-28 04:03:49","TRTEDTM":"2021-04-27 16:03:49","EOSDY":731,"EOSDT":"2021-04-27","STRATA1":"A","STRATA2":"S2","BMRKR1":4.30304,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-174","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-04-28 04:03:49","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-174","AGE":44.86719,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-04-28 04:03:49","TRTEDTM":"2021-04-27 16:03:49","EOSDY":731,"EOSDT":"2021-04-27","STRATA1":"A","STRATA2":"S2","BMRKR1":4.30304,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-174","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.07757,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-27 04:03:49","ADY":29}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-174","AGE":44.86719,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-04-28 04:03:49","TRTEDTM":"2021-04-27 16:03:49","EOSDY":731,"EOSDT":"2021-04-27","STRATA1":"A","STRATA2":"S2","BMRKR1":4.30304,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-174","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-04-28 04:03:49","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-174","AGE":44.86719,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-04-28 04:03:49","TRTEDTM":"2021-04-27 16:03:49","EOSDY":731,"EOSDT":"2021-04-27","STRATA1":"A","STRATA2":"S2","BMRKR1":4.30304,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-174","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":42.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-02-19 00:52:11","ADY":298}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-175","AGE":38.29802,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-11-03 18:20:42","TRTEDTM":"2021-11-03 06:20:42","EOSDY":731,"EOSDT":"2021-11-03","STRATA1":"B","STRATA2":"S1","BMRKR1":11.35195,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-175","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-11-03 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-175","AGE":38.29802,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-11-03 18:20:42","TRTEDTM":"2021-11-03 06:20:42","EOSDY":731,"EOSDT":"2021-11-03","STRATA1":"B","STRATA2":"S1","BMRKR1":11.35195,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-175","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-175","AGE":38.29802,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-11-03 18:20:42","TRTEDTM":"2021-11-03 06:20:42","EOSDY":731,"EOSDT":"2021-11-03","STRATA1":"B","STRATA2":"S1","BMRKR1":11.35195,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-175","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-175","AGE":38.29802,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-11-03 18:20:42","TRTEDTM":"2021-11-03 06:20:42","EOSDY":731,"EOSDT":"2021-11-03","STRATA1":"B","STRATA2":"S1","BMRKR1":11.35195,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-175","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-175","AGE":38.29802,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-11-03 18:20:42","TRTEDTM":"2021-11-03 06:20:42","EOSDY":731,"EOSDT":"2021-11-03","STRATA1":"B","STRATA2":"S1","BMRKR1":11.35195,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-175","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-11-04 18:20:42","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-175","AGE":38.29802,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-11-03 18:20:42","TRTEDTM":"2021-11-03 06:20:42","EOSDY":731,"EOSDT":"2021-11-03","STRATA1":"B","STRATA2":"S1","BMRKR1":11.35195,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-175","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":1.17198,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-05 18:20:42","ADY":429}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-175","AGE":38.29802,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-11-03 18:20:42","TRTEDTM":"2021-11-03 06:20:42","EOSDY":731,"EOSDT":"2021-11-03","STRATA1":"B","STRATA2":"S1","BMRKR1":11.35195,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-175","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.0614,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-26 18:20:42","ADY":23}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-175","AGE":38.29802,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-11-03 18:20:42","TRTEDTM":"2021-11-03 06:20:42","EOSDY":731,"EOSDT":"2021-11-03","STRATA1":"B","STRATA2":"S1","BMRKR1":11.35195,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-175","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":87,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-07-03 06:34:17","ADY":609}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-175","AGE":38.29802,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-11-03 18:20:42","TRTEDTM":"2021-11-03 06:20:42","EOSDY":731,"EOSDT":"2021-11-03","STRATA1":"B","STRATA2":"S1","BMRKR1":11.35195,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-175","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":1.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-11-13 01:46:21","ADY":11}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-186","AGE":41.6954,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-20 00:12:53","TRTEDTM":"2022-01-19 12:12:53","EOSDY":731,"EOSDT":"2022-01-19","STRATA1":"C","STRATA2":"S1","BMRKR1":4.25304,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-186","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-01-19 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-186","AGE":41.6954,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-20 00:12:53","TRTEDTM":"2022-01-19 12:12:53","EOSDY":731,"EOSDT":"2022-01-19","STRATA1":"C","STRATA2":"S1","BMRKR1":4.25304,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-186","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-186","AGE":41.6954,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-20 00:12:53","TRTEDTM":"2022-01-19 12:12:53","EOSDY":731,"EOSDT":"2022-01-19","STRATA1":"C","STRATA2":"S1","BMRKR1":4.25304,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-186","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-186","AGE":41.6954,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-20 00:12:53","TRTEDTM":"2022-01-19 12:12:53","EOSDY":731,"EOSDT":"2022-01-19","STRATA1":"C","STRATA2":"S1","BMRKR1":4.25304,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-186","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-186","AGE":41.6954,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-20 00:12:53","TRTEDTM":"2022-01-19 12:12:53","EOSDY":731,"EOSDT":"2022-01-19","STRATA1":"C","STRATA2":"S1","BMRKR1":4.25304,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-186","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.12487,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-03-06 00:12:53","ADY":46}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-186","AGE":41.6954,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-20 00:12:53","TRTEDTM":"2022-01-19 12:12:53","EOSDY":731,"EOSDT":"2022-01-19","STRATA1":"C","STRATA2":"S1","BMRKR1":4.25304,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-186","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2022-01-20 00:12:53","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-186","AGE":41.6954,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-20 00:12:53","TRTEDTM":"2022-01-19 12:12:53","EOSDY":731,"EOSDT":"2022-01-19","STRATA1":"C","STRATA2":"S1","BMRKR1":4.25304,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-186","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-01-20 00:12:53","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-186","AGE":41.6954,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-20 00:12:53","TRTEDTM":"2022-01-19 12:12:53","EOSDY":731,"EOSDT":"2022-01-19","STRATA1":"C","STRATA2":"S1","BMRKR1":4.25304,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-186","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":19,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-05-31 16:27:53","ADY":133}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-186","AGE":41.6954,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-01-20 00:12:53","TRTEDTM":"2022-01-19 12:12:53","EOSDY":731,"EOSDT":"2022-01-19","STRATA1":"C","STRATA2":"S1","BMRKR1":4.25304,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-186","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":93.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-11-06 20:05:32","ADY":657}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-192","AGE":40.85488,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-13 09:44:24","TRTEDTM":"2021-03-12 21:44:24","EOSDY":731,"EOSDT":"2021-03-12","STRATA1":"A","STRATA2":"S1","BMRKR1":8.92734,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-192","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-03-12 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-192","AGE":40.85488,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-13 09:44:24","TRTEDTM":"2021-03-12 21:44:24","EOSDY":731,"EOSDT":"2021-03-12","STRATA1":"A","STRATA2":"S1","BMRKR1":8.92734,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-192","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-192","AGE":40.85488,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-13 09:44:24","TRTEDTM":"2021-03-12 21:44:24","EOSDY":731,"EOSDT":"2021-03-12","STRATA1":"A","STRATA2":"S1","BMRKR1":8.92734,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-192","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-192","AGE":40.85488,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-13 09:44:24","TRTEDTM":"2021-03-12 21:44:24","EOSDY":731,"EOSDT":"2021-03-12","STRATA1":"A","STRATA2":"S1","BMRKR1":8.92734,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-192","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-192","AGE":40.85488,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-13 09:44:24","TRTEDTM":"2021-03-12 21:44:24","EOSDY":731,"EOSDT":"2021-03-12","STRATA1":"A","STRATA2":"S1","BMRKR1":8.92734,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-192","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.41379,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-12 09:44:24","ADY":152}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-192","AGE":40.85488,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-13 09:44:24","TRTEDTM":"2021-03-12 21:44:24","EOSDY":731,"EOSDT":"2021-03-12","STRATA1":"A","STRATA2":"S1","BMRKR1":8.92734,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-192","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.21175,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-30 09:44:24","ADY":78}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-192","AGE":40.85488,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-13 09:44:24","TRTEDTM":"2021-03-12 21:44:24","EOSDY":731,"EOSDT":"2021-03-12","STRATA1":"A","STRATA2":"S1","BMRKR1":8.92734,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-192","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.21627,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-31 09:44:24","ADY":79}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-192","AGE":40.85488,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-13 09:44:24","TRTEDTM":"2021-03-12 21:44:24","EOSDY":731,"EOSDT":"2021-03-12","STRATA1":"A","STRATA2":"S1","BMRKR1":8.92734,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-192","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":88.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-11-19 18:01:16","ADY":618}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-192","AGE":40.85488,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-13 09:44:24","TRTEDTM":"2021-03-12 21:44:24","EOSDY":731,"EOSDT":"2021-03-12","STRATA1":"A","STRATA2":"S1","BMRKR1":8.92734,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-192","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":82.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-10-11 21:46:55","ADY":579}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-195","AGE":25.41226,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-14 05:48:12","TRTEDTM":"2022-07-14 17:48:12","EOSDY":731,"EOSDT":"2022-07-14","STRATA1":"B","STRATA2":"S2","BMRKR1":7.1536,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-195","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-07-14 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-195","AGE":25.41226,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-14 05:48:12","TRTEDTM":"2022-07-14 17:48:12","EOSDY":731,"EOSDT":"2022-07-14","STRATA1":"B","STRATA2":"S2","BMRKR1":7.1536,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-195","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-195","AGE":25.41226,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-14 05:48:12","TRTEDTM":"2022-07-14 17:48:12","EOSDY":731,"EOSDT":"2022-07-14","STRATA1":"B","STRATA2":"S2","BMRKR1":7.1536,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-195","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-195","AGE":25.41226,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-14 05:48:12","TRTEDTM":"2022-07-14 17:48:12","EOSDY":731,"EOSDT":"2022-07-14","STRATA1":"B","STRATA2":"S2","BMRKR1":7.1536,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-195","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-195","AGE":25.41226,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-14 05:48:12","TRTEDTM":"2022-07-14 17:48:12","EOSDY":731,"EOSDT":"2022-07-14","STRATA1":"B","STRATA2":"S2","BMRKR1":7.1536,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-195","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.14599,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-06 05:48:12","ADY":54}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-195","AGE":25.41226,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-14 05:48:12","TRTEDTM":"2022-07-14 17:48:12","EOSDY":731,"EOSDT":"2022-07-14","STRATA1":"B","STRATA2":"S2","BMRKR1":7.1536,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-195","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.07474,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-11 05:48:12","ADY":28}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-195","AGE":25.41226,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-14 05:48:12","TRTEDTM":"2022-07-14 17:48:12","EOSDY":731,"EOSDT":"2022-07-14","STRATA1":"B","STRATA2":"S2","BMRKR1":7.1536,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-195","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.17094,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-15 05:48:12","ADY":63}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-195","AGE":25.41226,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-14 05:48:12","TRTEDTM":"2022-07-14 17:48:12","EOSDY":731,"EOSDT":"2022-07-14","STRATA1":"B","STRATA2":"S2","BMRKR1":7.1536,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-195","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":93.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-04-26 11:18:39","ADY":652}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-195","AGE":25.41226,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-14 05:48:12","TRTEDTM":"2022-07-14 17:48:12","EOSDY":731,"EOSDT":"2022-07-14","STRATA1":"B","STRATA2":"S2","BMRKR1":7.1536,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-195","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":58,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-08-23 01:05:23","ADY":406}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-2","AGE":39.82057,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-07 04:41:42","TRTEDTM":"2021-07-06 16:41:42","EOSDY":731,"EOSDT":"2021-07-06","STRATA1":"A","STRATA2":"S2","BMRKR1":8.60416,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-2","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-07-06 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-2","AGE":39.82057,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-07 04:41:42","TRTEDTM":"2021-07-06 16:41:42","EOSDY":731,"EOSDT":"2021-07-06","STRATA1":"A","STRATA2":"S2","BMRKR1":8.60416,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-2","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-2","AGE":39.82057,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-07 04:41:42","TRTEDTM":"2021-07-06 16:41:42","EOSDY":731,"EOSDT":"2021-07-06","STRATA1":"A","STRATA2":"S2","BMRKR1":8.60416,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-2","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-2","AGE":39.82057,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-07 04:41:42","TRTEDTM":"2021-07-06 16:41:42","EOSDY":731,"EOSDT":"2021-07-06","STRATA1":"A","STRATA2":"S2","BMRKR1":8.60416,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-2","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-2","AGE":39.82057,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-07 04:41:42","TRTEDTM":"2021-07-06 16:41:42","EOSDY":731,"EOSDT":"2021-07-06","STRATA1":"A","STRATA2":"S2","BMRKR1":8.60416,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-2","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.00018,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-08 04:41:42","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-2","AGE":39.82057,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-07 04:41:42","TRTEDTM":"2021-07-06 16:41:42","EOSDY":731,"EOSDT":"2021-07-06","STRATA1":"A","STRATA2":"S2","BMRKR1":8.60416,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-2","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.60588,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-02-14 04:41:42","ADY":222}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-2","AGE":39.82057,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-07 04:41:42","TRTEDTM":"2021-07-06 16:41:42","EOSDY":731,"EOSDT":"2021-07-06","STRATA1":"A","STRATA2":"S2","BMRKR1":8.60416,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-2","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.03295,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-20 04:41:42","ADY":13}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-2","AGE":39.82057,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-07 04:41:42","TRTEDTM":"2021-07-06 16:41:42","EOSDY":731,"EOSDT":"2021-07-06","STRATA1":"A","STRATA2":"S2","BMRKR1":8.60416,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-2","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-07-07 04:41:42","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-2","AGE":39.82057,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-07 04:41:42","TRTEDTM":"2021-07-06 16:41:42","EOSDY":731,"EOSDT":"2021-07-06","STRATA1":"A","STRATA2":"S2","BMRKR1":8.60416,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-2","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":54.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-07-20 23:14:36","ADY":380}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-22","AGE":27.16924,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-07 22:37:23","TRTEDTM":"2021-10-07 10:37:23","EOSDY":731,"EOSDT":"2021-10-07","STRATA1":"B","STRATA2":"S1","BMRKR1":11.98596,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-22","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-10-07 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-22","AGE":27.16924,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-07 22:37:23","TRTEDTM":"2021-10-07 10:37:23","EOSDY":731,"EOSDT":"2021-10-07","STRATA1":"B","STRATA2":"S1","BMRKR1":11.98596,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-22","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-22","AGE":27.16924,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-07 22:37:23","TRTEDTM":"2021-10-07 10:37:23","EOSDY":731,"EOSDT":"2021-10-07","STRATA1":"B","STRATA2":"S1","BMRKR1":11.98596,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-22","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-22","AGE":27.16924,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-07 22:37:23","TRTEDTM":"2021-10-07 10:37:23","EOSDY":731,"EOSDT":"2021-10-07","STRATA1":"B","STRATA2":"S1","BMRKR1":11.98596,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-22","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-22","AGE":27.16924,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-07 22:37:23","TRTEDTM":"2021-10-07 10:37:23","EOSDY":731,"EOSDT":"2021-10-07","STRATA1":"B","STRATA2":"S1","BMRKR1":11.98596,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-22","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-10-08 22:37:23","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-22","AGE":27.16924,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-07 22:37:23","TRTEDTM":"2021-10-07 10:37:23","EOSDY":731,"EOSDT":"2021-10-07","STRATA1":"B","STRATA2":"S1","BMRKR1":11.98596,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-22","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.10073,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-13 22:37:23","ADY":37}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-22","AGE":27.16924,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-07 22:37:23","TRTEDTM":"2021-10-07 10:37:23","EOSDY":731,"EOSDT":"2021-10-07","STRATA1":"B","STRATA2":"S1","BMRKR1":11.98596,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-22","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-10-08 22:37:23","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-22","AGE":27.16924,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-07 22:37:23","TRTEDTM":"2021-10-07 10:37:23","EOSDY":731,"EOSDT":"2021-10-07","STRATA1":"B","STRATA2":"S1","BMRKR1":11.98596,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-22","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":96.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-08-12 13:32:12","ADY":676}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-22","AGE":27.16924,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-07 22:37:23","TRTEDTM":"2021-10-07 10:37:23","EOSDY":731,"EOSDT":"2021-10-07","STRATA1":"B","STRATA2":"S1","BMRKR1":11.98596,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-22","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":38,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-06-28 05:41:18","ADY":266}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-28","AGE":32.81032,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-28 17:56:25","TRTEDTM":"2021-08-28 05:56:25","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"A","STRATA2":"S2","BMRKR1":2.30963,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-28","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-08-28 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-28","AGE":32.81032,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-28 17:56:25","TRTEDTM":"2021-08-28 05:56:25","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"A","STRATA2":"S2","BMRKR1":2.30963,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-28","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-28","AGE":32.81032,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-28 17:56:25","TRTEDTM":"2021-08-28 05:56:25","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"A","STRATA2":"S2","BMRKR1":2.30963,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-28","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-28","AGE":32.81032,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-28 17:56:25","TRTEDTM":"2021-08-28 05:56:25","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"A","STRATA2":"S2","BMRKR1":2.30963,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-28","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-28","AGE":32.81032,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-28 17:56:25","TRTEDTM":"2021-08-28 05:56:25","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"A","STRATA2":"S2","BMRKR1":2.30963,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-28","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-08-29 17:56:25","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-28","AGE":32.81032,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-28 17:56:25","TRTEDTM":"2021-08-28 05:56:25","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"A","STRATA2":"S2","BMRKR1":2.30963,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-28","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-08-29 17:56:25","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-28","AGE":32.81032,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-28 17:56:25","TRTEDTM":"2021-08-28 05:56:25","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"A","STRATA2":"S2","BMRKR1":2.30963,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-28","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-08-29 17:56:25","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-28","AGE":32.81032,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-28 17:56:25","TRTEDTM":"2021-08-28 05:56:25","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"A","STRATA2":"S2","BMRKR1":2.30963,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-28","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":62.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-11-08 06:18:57","ADY":439}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-28","AGE":32.81032,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-28 17:56:25","TRTEDTM":"2021-08-28 05:56:25","EOSDY":731,"EOSDT":"2021-08-28","STRATA1":"A","STRATA2":"S2","BMRKR1":2.30963,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-28","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-08-28 17:56:25","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-48","AGE":39.53027,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-19 16:45:39","TRTEDTM":"2021-06-19 04:45:39","EOSDY":731,"EOSDT":"2021-06-19","STRATA1":"A","STRATA2":"S2","BMRKR1":11.98062,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-48","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-06-19 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-48","AGE":39.53027,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-19 16:45:39","TRTEDTM":"2021-06-19 04:45:39","EOSDY":731,"EOSDT":"2021-06-19","STRATA1":"A","STRATA2":"S2","BMRKR1":11.98062,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-48","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-48","AGE":39.53027,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-19 16:45:39","TRTEDTM":"2021-06-19 04:45:39","EOSDY":731,"EOSDT":"2021-06-19","STRATA1":"A","STRATA2":"S2","BMRKR1":11.98062,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-48","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-48","AGE":39.53027,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-19 16:45:39","TRTEDTM":"2021-06-19 04:45:39","EOSDY":731,"EOSDT":"2021-06-19","STRATA1":"A","STRATA2":"S2","BMRKR1":11.98062,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-48","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-48","AGE":39.53027,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-19 16:45:39","TRTEDTM":"2021-06-19 04:45:39","EOSDY":731,"EOSDT":"2021-06-19","STRATA1":"A","STRATA2":"S2","BMRKR1":11.98062,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-48","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-06-20 16:45:39","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-48","AGE":39.53027,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-19 16:45:39","TRTEDTM":"2021-06-19 04:45:39","EOSDY":731,"EOSDT":"2021-06-19","STRATA1":"A","STRATA2":"S2","BMRKR1":11.98062,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-48","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.0726,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-16 16:45:39","ADY":27}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-48","AGE":39.53027,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-19 16:45:39","TRTEDTM":"2021-06-19 04:45:39","EOSDY":731,"EOSDT":"2021-06-19","STRATA1":"A","STRATA2":"S2","BMRKR1":11.98062,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-48","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":1.14834,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-12 16:45:39","ADY":420}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-48","AGE":39.53027,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-19 16:45:39","TRTEDTM":"2021-06-19 04:45:39","EOSDY":731,"EOSDT":"2021-06-19","STRATA1":"A","STRATA2":"S2","BMRKR1":11.98062,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-48","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":99.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-05-16 21:37:01","ADY":698}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-48","AGE":39.53027,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-19 16:45:39","TRTEDTM":"2021-06-19 04:45:39","EOSDY":731,"EOSDT":"2021-06-19","STRATA1":"A","STRATA2":"S2","BMRKR1":11.98062,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-48","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-06-19 16:45:39","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-5","AGE":33.16138,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-11-23 23:05:49","TRTEDTM":"2022-11-24 11:05:49","EOSDY":731,"EOSDT":"2022-11-24","STRATA1":"B","STRATA2":"S1","BMRKR1":4.9743,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-5","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-11-24 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-5","AGE":33.16138,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-11-23 23:05:49","TRTEDTM":"2022-11-24 11:05:49","EOSDY":731,"EOSDT":"2022-11-24","STRATA1":"B","STRATA2":"S1","BMRKR1":4.9743,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-5","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-5","AGE":33.16138,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-11-23 23:05:49","TRTEDTM":"2022-11-24 11:05:49","EOSDY":731,"EOSDT":"2022-11-24","STRATA1":"B","STRATA2":"S1","BMRKR1":4.9743,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-5","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-5","AGE":33.16138,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-11-23 23:05:49","TRTEDTM":"2022-11-24 11:05:49","EOSDY":731,"EOSDT":"2022-11-24","STRATA1":"B","STRATA2":"S1","BMRKR1":4.9743,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-5","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-5","AGE":33.16138,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-11-23 23:05:49","TRTEDTM":"2022-11-24 11:05:49","EOSDY":731,"EOSDT":"2022-11-24","STRATA1":"B","STRATA2":"S1","BMRKR1":4.9743,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-5","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.10471,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-01 23:05:49","ADY":39}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-5","AGE":33.16138,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-11-23 23:05:49","TRTEDTM":"2022-11-24 11:05:49","EOSDY":731,"EOSDT":"2022-11-24","STRATA1":"B","STRATA2":"S1","BMRKR1":4.9743,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-5","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.41356,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-04-24 23:05:49","ADY":152}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-5","AGE":33.16138,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-11-23 23:05:49","TRTEDTM":"2022-11-24 11:05:49","EOSDY":731,"EOSDT":"2022-11-24","STRATA1":"B","STRATA2":"S1","BMRKR1":4.9743,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-5","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.23617,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-02-18 23:05:49","ADY":87}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-5","AGE":33.16138,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-11-23 23:05:49","TRTEDTM":"2022-11-24 11:05:49","EOSDY":731,"EOSDT":"2022-11-24","STRATA1":"B","STRATA2":"S1","BMRKR1":4.9743,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-5","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-11-23 23:05:49","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-5","AGE":33.16138,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-11-23 23:05:49","TRTEDTM":"2022-11-24 11:05:49","EOSDY":731,"EOSDT":"2022-11-24","STRATA1":"B","STRATA2":"S1","BMRKR1":4.9743,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-5","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-11-23 23:05:49","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-56","AGE":29.7235,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-11 03:15:21","TRTEDTM":"2021-03-10 15:15:21","EOSDY":731,"EOSDT":"2021-03-10","STRATA1":"A","STRATA2":"S2","BMRKR1":7.17632,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-56","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-03-10 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-56","AGE":29.7235,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-11 03:15:21","TRTEDTM":"2021-03-10 15:15:21","EOSDY":731,"EOSDT":"2021-03-10","STRATA1":"A","STRATA2":"S2","BMRKR1":7.17632,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-56","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":9}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-56","AGE":29.7235,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-11 03:15:21","TRTEDTM":"2021-03-10 15:15:21","EOSDY":731,"EOSDT":"2021-03-10","STRATA1":"A","STRATA2":"S2","BMRKR1":7.17632,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-56","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-56","AGE":29.7235,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-11 03:15:21","TRTEDTM":"2021-03-10 15:15:21","EOSDY":731,"EOSDT":"2021-03-10","STRATA1":"A","STRATA2":"S2","BMRKR1":7.17632,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-56","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-56","AGE":29.7235,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-11 03:15:21","TRTEDTM":"2021-03-10 15:15:21","EOSDY":731,"EOSDT":"2021-03-10","STRATA1":"A","STRATA2":"S2","BMRKR1":7.17632,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-56","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.8663,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-01-22 03:15:21","ADY":317}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-56","AGE":29.7235,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-11 03:15:21","TRTEDTM":"2021-03-10 15:15:21","EOSDY":731,"EOSDT":"2021-03-10","STRATA1":"A","STRATA2":"S2","BMRKR1":7.17632,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-56","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.55964,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-10-02 03:15:21","ADY":205}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-56","AGE":29.7235,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-11 03:15:21","TRTEDTM":"2021-03-10 15:15:21","EOSDY":731,"EOSDT":"2021-03-10","STRATA1":"A","STRATA2":"S2","BMRKR1":7.17632,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-56","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.03648,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-03-25 03:15:21","ADY":14}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-56","AGE":29.7235,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-11 03:15:21","TRTEDTM":"2021-03-10 15:15:21","EOSDY":731,"EOSDT":"2021-03-10","STRATA1":"A","STRATA2":"S2","BMRKR1":7.17632,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-56","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":86.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-11-06 13:38:04","ADY":607}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-56","AGE":29.7235,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-11 03:15:21","TRTEDTM":"2021-03-10 15:15:21","EOSDY":731,"EOSDT":"2021-03-10","STRATA1":"A","STRATA2":"S2","BMRKR1":7.17632,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-56","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":9.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-05-17 10:20:00","ADY":68}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-57","AGE":32.22841,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-11-07 22:21:51","TRTEDTM":"2021-11-07 10:21:51","EOSDY":731,"EOSDT":"2021-11-07","STRATA1":"A","STRATA2":"S1","BMRKR1":3.86722,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-57","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-11-07 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-57","AGE":32.22841,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-11-07 22:21:51","TRTEDTM":"2021-11-07 10:21:51","EOSDY":731,"EOSDT":"2021-11-07","STRATA1":"A","STRATA2":"S1","BMRKR1":3.86722,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-57","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-57","AGE":32.22841,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-11-07 22:21:51","TRTEDTM":"2021-11-07 10:21:51","EOSDY":731,"EOSDT":"2021-11-07","STRATA1":"A","STRATA2":"S1","BMRKR1":3.86722,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-57","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-57","AGE":32.22841,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-11-07 22:21:51","TRTEDTM":"2021-11-07 10:21:51","EOSDY":731,"EOSDT":"2021-11-07","STRATA1":"A","STRATA2":"S1","BMRKR1":3.86722,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-57","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-57","AGE":32.22841,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-11-07 22:21:51","TRTEDTM":"2021-11-07 10:21:51","EOSDY":731,"EOSDT":"2021-11-07","STRATA1":"A","STRATA2":"S1","BMRKR1":3.86722,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-57","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.01002,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-11 22:21:51","ADY":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-57","AGE":32.22841,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-11-07 22:21:51","TRTEDTM":"2021-11-07 10:21:51","EOSDY":731,"EOSDT":"2021-11-07","STRATA1":"A","STRATA2":"S1","BMRKR1":3.86722,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-57","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.28659,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-02-20 22:21:51","ADY":105}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-57","AGE":32.22841,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-11-07 22:21:51","TRTEDTM":"2021-11-07 10:21:51","EOSDY":731,"EOSDT":"2021-11-07","STRATA1":"A","STRATA2":"S1","BMRKR1":3.86722,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-57","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.01424,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-13 22:21:51","ADY":6}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-57","AGE":32.22841,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-11-07 22:21:51","TRTEDTM":"2021-11-07 10:21:51","EOSDY":731,"EOSDT":"2021-11-07","STRATA1":"A","STRATA2":"S1","BMRKR1":3.86722,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-57","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":31,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-06-10 01:15:06","ADY":217}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-57","AGE":32.22841,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-11-07 22:21:51","TRTEDTM":"2021-11-07 10:21:51","EOSDY":731,"EOSDT":"2021-11-07","STRATA1":"A","STRATA2":"S1","BMRKR1":3.86722,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-57","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":6,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-12-18 19:18:53","ADY":42}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-66","AGE":36.25836,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-08 14:50:33","TRTEDTM":"2021-09-08 02:50:33","EOSDY":731,"EOSDT":"2021-09-08","STRATA1":"C","STRATA2":"S2","BMRKR1":7.12627,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-66","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-09-08 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-66","AGE":36.25836,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-08 14:50:33","TRTEDTM":"2021-09-08 02:50:33","EOSDY":731,"EOSDT":"2021-09-08","STRATA1":"C","STRATA2":"S2","BMRKR1":7.12627,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-66","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-66","AGE":36.25836,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-08 14:50:33","TRTEDTM":"2021-09-08 02:50:33","EOSDY":731,"EOSDT":"2021-09-08","STRATA1":"C","STRATA2":"S2","BMRKR1":7.12627,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-66","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-66","AGE":36.25836,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-08 14:50:33","TRTEDTM":"2021-09-08 02:50:33","EOSDY":731,"EOSDT":"2021-09-08","STRATA1":"C","STRATA2":"S2","BMRKR1":7.12627,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-66","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-66","AGE":36.25836,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-08 14:50:33","TRTEDTM":"2021-09-08 02:50:33","EOSDY":731,"EOSDT":"2021-09-08","STRATA1":"C","STRATA2":"S2","BMRKR1":7.12627,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-66","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.01685,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-15 14:50:33","ADY":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-66","AGE":36.25836,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-08 14:50:33","TRTEDTM":"2021-09-08 02:50:33","EOSDY":731,"EOSDT":"2021-09-08","STRATA1":"C","STRATA2":"S2","BMRKR1":7.12627,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-66","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.01311,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-13 14:50:33","ADY":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-66","AGE":36.25836,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-08 14:50:33","TRTEDTM":"2021-09-08 02:50:33","EOSDY":731,"EOSDT":"2021-09-08","STRATA1":"C","STRATA2":"S2","BMRKR1":7.12627,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-66","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.3871,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-01-28 14:50:33","ADY":142}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-66","AGE":36.25836,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-08 14:50:33","TRTEDTM":"2021-09-08 02:50:33","EOSDY":731,"EOSDT":"2021-09-08","STRATA1":"C","STRATA2":"S2","BMRKR1":7.12627,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-66","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":36,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-05-16 05:26:36","ADY":252}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-66","AGE":36.25836,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-08 14:50:33","TRTEDTM":"2021-09-08 02:50:33","EOSDY":731,"EOSDT":"2021-09-08","STRATA1":"C","STRATA2":"S2","BMRKR1":7.12627,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-66","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-09-08 14:50:33","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-67","AGE":26.1047,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-02-26 02:12:55","TRTEDTM":"2022-02-25 14:12:55","EOSDY":731,"EOSDT":"2022-02-25","STRATA1":"C","STRATA2":"S2","BMRKR1":7.10821,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-67","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-02-25 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-67","AGE":26.1047,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-02-26 02:12:55","TRTEDTM":"2022-02-25 14:12:55","EOSDY":731,"EOSDT":"2022-02-25","STRATA1":"C","STRATA2":"S2","BMRKR1":7.10821,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-67","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-67","AGE":26.1047,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-02-26 02:12:55","TRTEDTM":"2022-02-25 14:12:55","EOSDY":731,"EOSDT":"2022-02-25","STRATA1":"C","STRATA2":"S2","BMRKR1":7.10821,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-67","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-67","AGE":26.1047,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-02-26 02:12:55","TRTEDTM":"2022-02-25 14:12:55","EOSDY":731,"EOSDT":"2022-02-25","STRATA1":"C","STRATA2":"S2","BMRKR1":7.10821,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-67","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-67","AGE":26.1047,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-02-26 02:12:55","TRTEDTM":"2022-02-25 14:12:55","EOSDY":731,"EOSDT":"2022-02-25","STRATA1":"C","STRATA2":"S2","BMRKR1":7.10821,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-67","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-02-26 02:12:55","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-67","AGE":26.1047,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-02-26 02:12:55","TRTEDTM":"2022-02-25 14:12:55","EOSDY":731,"EOSDT":"2022-02-25","STRATA1":"C","STRATA2":"S2","BMRKR1":7.10821,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-67","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.1481,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-21 02:12:55","ADY":55}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-67","AGE":26.1047,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-02-26 02:12:55","TRTEDTM":"2022-02-25 14:12:55","EOSDY":731,"EOSDT":"2022-02-25","STRATA1":"C","STRATA2":"S2","BMRKR1":7.10821,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-67","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.55036,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-15 02:12:55","ADY":202}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-67","AGE":26.1047,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-02-26 02:12:55","TRTEDTM":"2022-02-25 14:12:55","EOSDY":731,"EOSDT":"2022-02-25","STRATA1":"C","STRATA2":"S2","BMRKR1":7.10821,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-67","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-02-26 02:12:55","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-67","AGE":26.1047,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-02-26 02:12:55","TRTEDTM":"2022-02-25 14:12:55","EOSDY":731,"EOSDT":"2022-02-25","STRATA1":"C","STRATA2":"S2","BMRKR1":7.10821,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-67","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":9.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-05-01 13:28:40","ADY":66}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-71","AGE":40.37375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-11-01 01:27:23","TRTEDTM":"2021-10-31 13:27:23","EOSDY":731,"EOSDT":"2021-10-31","STRATA1":"B","STRATA2":"S1","BMRKR1":7.58423,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-71","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-10-31 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-71","AGE":40.37375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-11-01 01:27:23","TRTEDTM":"2021-10-31 13:27:23","EOSDY":731,"EOSDT":"2021-10-31","STRATA1":"B","STRATA2":"S1","BMRKR1":7.58423,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-71","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-71","AGE":40.37375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-11-01 01:27:23","TRTEDTM":"2021-10-31 13:27:23","EOSDY":731,"EOSDT":"2021-10-31","STRATA1":"B","STRATA2":"S1","BMRKR1":7.58423,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-71","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-71","AGE":40.37375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-11-01 01:27:23","TRTEDTM":"2021-10-31 13:27:23","EOSDY":731,"EOSDT":"2021-10-31","STRATA1":"B","STRATA2":"S1","BMRKR1":7.58423,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-71","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-71","AGE":40.37375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-11-01 01:27:23","TRTEDTM":"2021-10-31 13:27:23","EOSDY":731,"EOSDT":"2021-10-31","STRATA1":"B","STRATA2":"S1","BMRKR1":7.58423,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-71","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-11-01 01:27:23","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-71","AGE":40.37375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-11-01 01:27:23","TRTEDTM":"2021-10-31 13:27:23","EOSDY":731,"EOSDT":"2021-10-31","STRATA1":"B","STRATA2":"S1","BMRKR1":7.58423,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-71","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-11-01 01:27:23","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-71","AGE":40.37375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-11-01 01:27:23","TRTEDTM":"2021-10-31 13:27:23","EOSDY":731,"EOSDT":"2021-10-31","STRATA1":"B","STRATA2":"S1","BMRKR1":7.58423,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-71","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.07516,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-29 01:27:23","ADY":28}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-71","AGE":40.37375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-11-01 01:27:23","TRTEDTM":"2021-10-31 13:27:23","EOSDY":731,"EOSDT":"2021-10-31","STRATA1":"B","STRATA2":"S1","BMRKR1":7.58423,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-71","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":41.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-19 21:01:08","ADY":293}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-71","AGE":40.37375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-11-01 01:27:23","TRTEDTM":"2021-10-31 13:27:23","EOSDY":731,"EOSDT":"2021-10-31","STRATA1":"B","STRATA2":"S1","BMRKR1":7.58423,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-71","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":100.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-10-02 12:08:31","ADY":702}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-74","AGE":42.6761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-08 01:54:50","TRTEDTM":"2021-03-07 13:54:50","EOSDY":731,"EOSDT":"2021-03-07","STRATA1":"C","STRATA2":"S2","BMRKR1":3.74741,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-74","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-03-07 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-74","AGE":42.6761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-08 01:54:50","TRTEDTM":"2021-03-07 13:54:50","EOSDY":731,"EOSDT":"2021-03-07","STRATA1":"C","STRATA2":"S2","BMRKR1":3.74741,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-74","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-74","AGE":42.6761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-08 01:54:50","TRTEDTM":"2021-03-07 13:54:50","EOSDY":731,"EOSDT":"2021-03-07","STRATA1":"C","STRATA2":"S2","BMRKR1":3.74741,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-74","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-74","AGE":42.6761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-08 01:54:50","TRTEDTM":"2021-03-07 13:54:50","EOSDY":731,"EOSDT":"2021-03-07","STRATA1":"C","STRATA2":"S2","BMRKR1":3.74741,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-74","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":10}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-74","AGE":42.6761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-08 01:54:50","TRTEDTM":"2021-03-07 13:54:50","EOSDY":731,"EOSDT":"2021-03-07","STRATA1":"C","STRATA2":"S2","BMRKR1":3.74741,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-74","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.28757,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-06-22 01:54:50","ADY":106}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-74","AGE":42.6761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-08 01:54:50","TRTEDTM":"2021-03-07 13:54:50","EOSDY":731,"EOSDT":"2021-03-07","STRATA1":"C","STRATA2":"S2","BMRKR1":3.74741,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-74","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.10663,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-04-16 01:54:50","ADY":39}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-74","AGE":42.6761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-08 01:54:50","TRTEDTM":"2021-03-07 13:54:50","EOSDY":731,"EOSDT":"2021-03-07","STRATA1":"C","STRATA2":"S2","BMRKR1":3.74741,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-74","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.15734,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-05 01:54:50","ADY":58}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-74","AGE":42.6761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-08 01:54:50","TRTEDTM":"2021-03-07 13:54:50","EOSDY":731,"EOSDT":"2021-03-07","STRATA1":"C","STRATA2":"S2","BMRKR1":3.74741,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-74","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":18.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-07-17 17:36:25","ADY":132}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-74","AGE":42.6761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-08 01:54:50","TRTEDTM":"2021-03-07 13:54:50","EOSDY":731,"EOSDT":"2021-03-07","STRATA1":"C","STRATA2":"S2","BMRKR1":3.74741,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-74","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":100.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-02-09 22:37:12","ADY":705}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-78","AGE":46.68965,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-30 10:09:19","TRTEDTM":"2021-05-29 22:09:19","EOSDY":731,"EOSDT":"2021-05-29","STRATA1":"B","STRATA2":"S2","BMRKR1":3.38983,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-78","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-05-29 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-78","AGE":46.68965,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-30 10:09:19","TRTEDTM":"2021-05-29 22:09:19","EOSDY":731,"EOSDT":"2021-05-29","STRATA1":"B","STRATA2":"S2","BMRKR1":3.38983,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-78","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-78","AGE":46.68965,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-30 10:09:19","TRTEDTM":"2021-05-29 22:09:19","EOSDY":731,"EOSDT":"2021-05-29","STRATA1":"B","STRATA2":"S2","BMRKR1":3.38983,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-78","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-78","AGE":46.68965,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-30 10:09:19","TRTEDTM":"2021-05-29 22:09:19","EOSDY":731,"EOSDT":"2021-05-29","STRATA1":"B","STRATA2":"S2","BMRKR1":3.38983,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-78","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-78","AGE":46.68965,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-30 10:09:19","TRTEDTM":"2021-05-29 22:09:19","EOSDY":731,"EOSDT":"2021-05-29","STRATA1":"B","STRATA2":"S2","BMRKR1":3.38983,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-78","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.70754,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-02-13 10:09:19","ADY":259}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-78","AGE":46.68965,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-30 10:09:19","TRTEDTM":"2021-05-29 22:09:19","EOSDY":731,"EOSDT":"2021-05-29","STRATA1":"B","STRATA2":"S2","BMRKR1":3.38983,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-78","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-05-30 10:09:19","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-78","AGE":46.68965,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-30 10:09:19","TRTEDTM":"2021-05-29 22:09:19","EOSDY":731,"EOSDT":"2021-05-29","STRATA1":"B","STRATA2":"S2","BMRKR1":3.38983,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-78","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-05-30 10:09:19","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-78","AGE":46.68965,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-30 10:09:19","TRTEDTM":"2021-05-29 22:09:19","EOSDY":731,"EOSDT":"2021-05-29","STRATA1":"B","STRATA2":"S2","BMRKR1":3.38983,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-78","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":19,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-10-09 06:48:04","ADY":133}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-78","AGE":46.68965,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-30 10:09:19","TRTEDTM":"2021-05-29 22:09:19","EOSDY":731,"EOSDT":"2021-05-29","STRATA1":"B","STRATA2":"S2","BMRKR1":3.38983,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-78","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":5.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-07-05 13:07:49","ADY":37}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-81","AGE":30.90637,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-03 00:20:58","TRTEDTM":"2021-07-02 12:20:58","EOSDY":731,"EOSDT":"2021-07-02","STRATA1":"C","STRATA2":"S2","BMRKR1":4.18969,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-81","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-07-02 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-81","AGE":30.90637,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-03 00:20:58","TRTEDTM":"2021-07-02 12:20:58","EOSDY":731,"EOSDT":"2021-07-02","STRATA1":"C","STRATA2":"S2","BMRKR1":4.18969,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-81","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-81","AGE":30.90637,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-03 00:20:58","TRTEDTM":"2021-07-02 12:20:58","EOSDY":731,"EOSDT":"2021-07-02","STRATA1":"C","STRATA2":"S2","BMRKR1":4.18969,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-81","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-81","AGE":30.90637,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-03 00:20:58","TRTEDTM":"2021-07-02 12:20:58","EOSDY":731,"EOSDT":"2021-07-02","STRATA1":"C","STRATA2":"S2","BMRKR1":4.18969,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-81","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-81","AGE":30.90637,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-03 00:20:58","TRTEDTM":"2021-07-02 12:20:58","EOSDY":731,"EOSDT":"2021-07-02","STRATA1":"C","STRATA2":"S2","BMRKR1":4.18969,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-81","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.43924,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-11 00:20:58","ADY":161}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-81","AGE":30.90637,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-03 00:20:58","TRTEDTM":"2021-07-02 12:20:58","EOSDY":731,"EOSDT":"2021-07-02","STRATA1":"C","STRATA2":"S2","BMRKR1":4.18969,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-81","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.16277,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-01 00:20:58","ADY":60}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-81","AGE":30.90637,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-03 00:20:58","TRTEDTM":"2021-07-02 12:20:58","EOSDY":731,"EOSDT":"2021-07-02","STRATA1":"C","STRATA2":"S2","BMRKR1":4.18969,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-81","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.08148,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-02 00:20:58","ADY":30}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-81","AGE":30.90637,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-03 00:20:58","TRTEDTM":"2021-07-02 12:20:58","EOSDY":731,"EOSDT":"2021-07-02","STRATA1":"C","STRATA2":"S2","BMRKR1":4.18969,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-81","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":8.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-08-30 14:48:06","ADY":59}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-81","AGE":30.90637,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-03 00:20:58","TRTEDTM":"2021-07-02 12:20:58","EOSDY":731,"EOSDT":"2021-07-02","STRATA1":"C","STRATA2":"S2","BMRKR1":4.18969,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-81","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":59.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-24 08:49:29","ADY":419}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-86","AGE":46.86112,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-07-21 12:41:41","TRTEDTM":"2021-07-21 00:41:41","EOSDY":731,"EOSDT":"2021-07-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.70213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-86","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-07-21 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-86","AGE":46.86112,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-07-21 12:41:41","TRTEDTM":"2021-07-21 00:41:41","EOSDY":731,"EOSDT":"2021-07-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.70213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-86","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-86","AGE":46.86112,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-07-21 12:41:41","TRTEDTM":"2021-07-21 00:41:41","EOSDY":731,"EOSDT":"2021-07-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.70213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-86","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":8}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-86","AGE":46.86112,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-07-21 12:41:41","TRTEDTM":"2021-07-21 00:41:41","EOSDY":731,"EOSDT":"2021-07-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.70213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-86","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-86","AGE":46.86112,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-07-21 12:41:41","TRTEDTM":"2021-07-21 00:41:41","EOSDY":731,"EOSDT":"2021-07-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.70213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-86","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-07-22 12:41:41","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-86","AGE":46.86112,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-07-21 12:41:41","TRTEDTM":"2021-07-21 00:41:41","EOSDY":731,"EOSDT":"2021-07-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.70213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-86","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.07661,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-18 12:41:41","ADY":28}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-86","AGE":46.86112,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-07-21 12:41:41","TRTEDTM":"2021-07-21 00:41:41","EOSDY":731,"EOSDT":"2021-07-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.70213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-86","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.2658,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-10-27 12:41:41","ADY":98}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-86","AGE":46.86112,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-07-21 12:41:41","TRTEDTM":"2021-07-21 00:41:41","EOSDY":731,"EOSDT":"2021-07-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.70213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-86","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":52,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-07-18 19:41:36","ADY":364}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-86","AGE":46.86112,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-07-21 12:41:41","TRTEDTM":"2021-07-21 00:41:41","EOSDY":731,"EOSDT":"2021-07-21","STRATA1":"A","STRATA2":"S1","BMRKR1":3.70213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-86","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":90.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-04-14 06:06:36","ADY":634}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-88","AGE":29.5911,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-31 22:26:39","TRTEDTM":"2023-01-01 10:26:39","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"B","STRATA2":"S2","BMRKR1":3.35737,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-88","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2023-01-01 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-88","AGE":29.5911,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-31 22:26:39","TRTEDTM":"2023-01-01 10:26:39","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"B","STRATA2":"S2","BMRKR1":3.35737,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-88","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-88","AGE":29.5911,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-31 22:26:39","TRTEDTM":"2023-01-01 10:26:39","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"B","STRATA2":"S2","BMRKR1":3.35737,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-88","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-88","AGE":29.5911,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-31 22:26:39","TRTEDTM":"2023-01-01 10:26:39","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"B","STRATA2":"S2","BMRKR1":3.35737,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-88","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-88","AGE":29.5911,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-31 22:26:39","TRTEDTM":"2023-01-01 10:26:39","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"B","STRATA2":"S2","BMRKR1":3.35737,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-88","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.31604,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-04-26 22:26:39","ADY":116}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-88","AGE":29.5911,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-31 22:26:39","TRTEDTM":"2023-01-01 10:26:39","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"B","STRATA2":"S2","BMRKR1":3.35737,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-88","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.02058,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-08 22:26:39","ADY":8}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-88","AGE":29.5911,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-31 22:26:39","TRTEDTM":"2023-01-01 10:26:39","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"B","STRATA2":"S2","BMRKR1":3.35737,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-88","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":1.28763,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2022-04-16 22:26:39","ADY":471}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-88","AGE":29.5911,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-31 22:26:39","TRTEDTM":"2023-01-01 10:26:39","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"B","STRATA2":"S2","BMRKR1":3.35737,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-88","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":67,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-04-13 20:14:00","ADY":469}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-88","AGE":29.5911,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-31 22:26:39","TRTEDTM":"2023-01-01 10:26:39","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"B","STRATA2":"S2","BMRKR1":3.35737,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-88","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":3.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-01-21 00:27:23","ADY":22}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-89","AGE":35.38027,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-18 01:49:46","TRTEDTM":"2022-07-18 13:49:46","EOSDY":731,"EOSDT":"2022-07-18","STRATA1":"B","STRATA2":"S2","BMRKR1":5.102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-89","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-07-18 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-89","AGE":35.38027,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-18 01:49:46","TRTEDTM":"2022-07-18 13:49:46","EOSDY":731,"EOSDT":"2022-07-18","STRATA1":"B","STRATA2":"S2","BMRKR1":5.102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-89","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-89","AGE":35.38027,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-18 01:49:46","TRTEDTM":"2022-07-18 13:49:46","EOSDY":731,"EOSDT":"2022-07-18","STRATA1":"B","STRATA2":"S2","BMRKR1":5.102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-89","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-89","AGE":35.38027,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-18 01:49:46","TRTEDTM":"2022-07-18 13:49:46","EOSDY":731,"EOSDT":"2022-07-18","STRATA1":"B","STRATA2":"S2","BMRKR1":5.102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-89","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":8}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-89","AGE":35.38027,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-18 01:49:46","TRTEDTM":"2022-07-18 13:49:46","EOSDY":731,"EOSDT":"2022-07-18","STRATA1":"B","STRATA2":"S2","BMRKR1":5.102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-89","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.04847,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-05 01:49:46","ADY":18}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-89","AGE":35.38027,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-18 01:49:46","TRTEDTM":"2022-07-18 13:49:46","EOSDY":731,"EOSDT":"2022-07-18","STRATA1":"B","STRATA2":"S2","BMRKR1":5.102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-89","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.17994,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-22 01:49:46","ADY":66}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-89","AGE":35.38027,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-18 01:49:46","TRTEDTM":"2022-07-18 13:49:46","EOSDY":731,"EOSDT":"2022-07-18","STRATA1":"B","STRATA2":"S2","BMRKR1":5.102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-89","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.15815,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-14 01:49:46","ADY":58}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-89","AGE":35.38027,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-18 01:49:46","TRTEDTM":"2022-07-18 13:49:46","EOSDY":731,"EOSDT":"2022-07-18","STRATA1":"B","STRATA2":"S2","BMRKR1":5.102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-89","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":38.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-04-10 20:41:11","ADY":267}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-89","AGE":35.38027,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-07-18 01:49:46","TRTEDTM":"2022-07-18 13:49:46","EOSDY":731,"EOSDT":"2022-07-18","STRATA1":"B","STRATA2":"S2","BMRKR1":5.102,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-89","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":92.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-04-24 01:34:52","ADY":646}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-90","AGE":40.80629,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-29 00:31:14","TRTEDTM":"2023-01-29 12:31:14","EOSDY":731,"EOSDT":"2023-01-29","STRATA1":"B","STRATA2":"S1","BMRKR1":0.44595,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-90","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2023-01-29 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-90","AGE":40.80629,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-29 00:31:14","TRTEDTM":"2023-01-29 12:31:14","EOSDY":731,"EOSDT":"2023-01-29","STRATA1":"B","STRATA2":"S1","BMRKR1":0.44595,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-90","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-90","AGE":40.80629,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-29 00:31:14","TRTEDTM":"2023-01-29 12:31:14","EOSDY":731,"EOSDT":"2023-01-29","STRATA1":"B","STRATA2":"S1","BMRKR1":0.44595,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-90","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-90","AGE":40.80629,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-29 00:31:14","TRTEDTM":"2023-01-29 12:31:14","EOSDY":731,"EOSDT":"2023-01-29","STRATA1":"B","STRATA2":"S1","BMRKR1":0.44595,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-90","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-90","AGE":40.80629,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-29 00:31:14","TRTEDTM":"2023-01-29 12:31:14","EOSDY":731,"EOSDT":"2023-01-29","STRATA1":"B","STRATA2":"S1","BMRKR1":0.44595,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-90","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2023-01-30 00:31:14","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-90","AGE":40.80629,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-29 00:31:14","TRTEDTM":"2023-01-29 12:31:14","EOSDY":731,"EOSDT":"2023-01-29","STRATA1":"B","STRATA2":"S1","BMRKR1":0.44595,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-90","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.2042,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-04-14 00:31:14","ADY":75}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-90","AGE":40.80629,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-29 00:31:14","TRTEDTM":"2023-01-29 12:31:14","EOSDY":731,"EOSDT":"2023-01-29","STRATA1":"B","STRATA2":"S1","BMRKR1":0.44595,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-90","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.96854,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2022-01-18 00:31:14","ADY":354}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-90","AGE":40.80629,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-29 00:31:14","TRTEDTM":"2023-01-29 12:31:14","EOSDY":731,"EOSDT":"2023-01-29","STRATA1":"B","STRATA2":"S1","BMRKR1":0.44595,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-90","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2021-01-29 00:31:14","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-90","AGE":40.80629,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-29 00:31:14","TRTEDTM":"2023-01-29 12:31:14","EOSDY":731,"EOSDT":"2023-01-29","STRATA1":"B","STRATA2":"S1","BMRKR1":0.44595,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-90","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":62.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-04-08 05:26:46","ADY":435}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-91","AGE":58.34614,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 09:22:49","TRTEDTM":"2022-08-09 21:22:49","EOSDY":731,"EOSDT":"2022-08-09","STRATA1":"C","STRATA2":"S1","BMRKR1":5.28516,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-91","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-08-09 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-91","AGE":58.34614,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 09:22:49","TRTEDTM":"2022-08-09 21:22:49","EOSDY":731,"EOSDT":"2022-08-09","STRATA1":"C","STRATA2":"S1","BMRKR1":5.28516,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-91","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-91","AGE":58.34614,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 09:22:49","TRTEDTM":"2022-08-09 21:22:49","EOSDY":731,"EOSDT":"2022-08-09","STRATA1":"C","STRATA2":"S1","BMRKR1":5.28516,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-91","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":8}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-91","AGE":58.34614,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 09:22:49","TRTEDTM":"2022-08-09 21:22:49","EOSDY":731,"EOSDT":"2022-08-09","STRATA1":"C","STRATA2":"S1","BMRKR1":5.28516,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-91","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":13}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-91","AGE":58.34614,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 09:22:49","TRTEDTM":"2022-08-09 21:22:49","EOSDY":731,"EOSDT":"2022-08-09","STRATA1":"C","STRATA2":"S1","BMRKR1":5.28516,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-91","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.03505,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-22 09:22:49","ADY":13}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-91","AGE":58.34614,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 09:22:49","TRTEDTM":"2022-08-09 21:22:49","EOSDY":731,"EOSDT":"2022-08-09","STRATA1":"C","STRATA2":"S1","BMRKR1":5.28516,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-91","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.28528,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-11-22 09:22:49","ADY":105}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-91","AGE":58.34614,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 09:22:49","TRTEDTM":"2022-08-09 21:22:49","EOSDY":731,"EOSDT":"2022-08-09","STRATA1":"C","STRATA2":"S1","BMRKR1":5.28516,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-91","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.15403,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-05 09:22:49","ADY":57}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-91","AGE":58.34614,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 09:22:49","TRTEDTM":"2022-08-09 21:22:49","EOSDY":731,"EOSDT":"2022-08-09","STRATA1":"C","STRATA2":"S1","BMRKR1":5.28516,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-91","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":49.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-07-19 06:52:29","ADY":345}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-91","AGE":58.34614,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 09:22:49","TRTEDTM":"2022-08-09 21:22:49","EOSDY":731,"EOSDT":"2022-08-09","STRATA1":"C","STRATA2":"S1","BMRKR1":5.28516,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-91","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":81.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-02-27 21:59:55","ADY":568}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-92","AGE":29.3565,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-06-22 11:41:37","TRTEDTM":"2021-06-21 23:41:37","EOSDY":731,"EOSDT":"2021-06-21","STRATA1":"C","STRATA2":"S1","BMRKR1":10.82166,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-92","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-06-21 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-92","AGE":29.3565,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-06-22 11:41:37","TRTEDTM":"2021-06-21 23:41:37","EOSDY":731,"EOSDT":"2021-06-21","STRATA1":"C","STRATA2":"S1","BMRKR1":10.82166,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-92","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-92","AGE":29.3565,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-06-22 11:41:37","TRTEDTM":"2021-06-21 23:41:37","EOSDY":731,"EOSDT":"2021-06-21","STRATA1":"C","STRATA2":"S1","BMRKR1":10.82166,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-92","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-92","AGE":29.3565,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-06-22 11:41:37","TRTEDTM":"2021-06-21 23:41:37","EOSDY":731,"EOSDT":"2021-06-21","STRATA1":"C","STRATA2":"S1","BMRKR1":10.82166,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-92","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":9}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-92","AGE":29.3565,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-06-22 11:41:37","TRTEDTM":"2021-06-21 23:41:37","EOSDY":731,"EOSDT":"2021-06-21","STRATA1":"C","STRATA2":"S1","BMRKR1":10.82166,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-92","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-06-22 11:41:37","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-92","AGE":29.3565,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-06-22 11:41:37","TRTEDTM":"2021-06-21 23:41:37","EOSDY":731,"EOSDT":"2021-06-21","STRATA1":"C","STRATA2":"S1","BMRKR1":10.82166,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-92","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.04269,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-08 11:41:37","ADY":16}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-92","AGE":29.3565,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-06-22 11:41:37","TRTEDTM":"2021-06-21 23:41:37","EOSDY":731,"EOSDT":"2021-06-21","STRATA1":"C","STRATA2":"S1","BMRKR1":10.82166,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-92","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.04424,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-09 11:41:37","ADY":17}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-92","AGE":29.3565,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-06-22 11:41:37","TRTEDTM":"2021-06-21 23:41:37","EOSDY":731,"EOSDT":"2021-06-21","STRATA1":"C","STRATA2":"S1","BMRKR1":10.82166,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-92","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":78.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-12-21 18:05:23","ADY":549}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-92","AGE":29.3565,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-06-22 11:41:37","TRTEDTM":"2021-06-21 23:41:37","EOSDY":731,"EOSDT":"2021-06-21","STRATA1":"C","STRATA2":"S1","BMRKR1":10.82166,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-92","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-06-22 11:41:37","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-97","AGE":32.01975,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-22 19:28:47","TRTEDTM":"2021-05-22 07:28:47","EOSDY":731,"EOSDT":"2021-05-22","STRATA1":"A","STRATA2":"S1","BMRKR1":4.65423,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-97","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-05-22 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-97","AGE":32.01975,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-22 19:28:47","TRTEDTM":"2021-05-22 07:28:47","EOSDY":731,"EOSDT":"2021-05-22","STRATA1":"A","STRATA2":"S1","BMRKR1":4.65423,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-97","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-97","AGE":32.01975,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-22 19:28:47","TRTEDTM":"2021-05-22 07:28:47","EOSDY":731,"EOSDT":"2021-05-22","STRATA1":"A","STRATA2":"S1","BMRKR1":4.65423,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-97","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-97","AGE":32.01975,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-22 19:28:47","TRTEDTM":"2021-05-22 07:28:47","EOSDY":731,"EOSDT":"2021-05-22","STRATA1":"A","STRATA2":"S1","BMRKR1":4.65423,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-97","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-97","AGE":32.01975,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-22 19:28:47","TRTEDTM":"2021-05-22 07:28:47","EOSDY":731,"EOSDT":"2021-05-22","STRATA1":"A","STRATA2":"S1","BMRKR1":4.65423,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-97","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-05-23 19:28:47","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-97","AGE":32.01975,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-22 19:28:47","TRTEDTM":"2021-05-22 07:28:47","EOSDY":731,"EOSDT":"2021-05-22","STRATA1":"A","STRATA2":"S1","BMRKR1":4.65423,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-97","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-05-23 19:28:47","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-97","AGE":32.01975,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-22 19:28:47","TRTEDTM":"2021-05-22 07:28:47","EOSDY":731,"EOSDT":"2021-05-22","STRATA1":"A","STRATA2":"S1","BMRKR1":4.65423,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-97","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.43603,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-10-29 19:28:47","ADY":160}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-97","AGE":32.01975,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-22 19:28:47","TRTEDTM":"2021-05-22 07:28:47","EOSDY":731,"EOSDT":"2021-05-22","STRATA1":"A","STRATA2":"S1","BMRKR1":4.65423,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-97","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":59.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-07-13 09:45:58","ADY":419}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-97","AGE":32.01975,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-05-22 19:28:47","TRTEDTM":"2021-05-22 07:28:47","EOSDY":731,"EOSDT":"2021-05-22","STRATA1":"A","STRATA2":"S1","BMRKR1":4.65423,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-97","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":32.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-01-02 00:19:18","ADY":226}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-98","AGE":38.0291,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-18 01:09:16","TRTEDTM":"2021-10-17 13:09:16","EOSDY":731,"EOSDT":"2021-10-17","STRATA1":"C","STRATA2":"S2","BMRKR1":5.56433,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-98","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-10-17 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-98","AGE":38.0291,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-18 01:09:16","TRTEDTM":"2021-10-17 13:09:16","EOSDY":731,"EOSDT":"2021-10-17","STRATA1":"C","STRATA2":"S2","BMRKR1":5.56433,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-98","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-98","AGE":38.0291,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-18 01:09:16","TRTEDTM":"2021-10-17 13:09:16","EOSDY":731,"EOSDT":"2021-10-17","STRATA1":"C","STRATA2":"S2","BMRKR1":5.56433,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-98","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-98","AGE":38.0291,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-18 01:09:16","TRTEDTM":"2021-10-17 13:09:16","EOSDY":731,"EOSDT":"2021-10-17","STRATA1":"C","STRATA2":"S2","BMRKR1":5.56433,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-98","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-98","AGE":38.0291,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-18 01:09:16","TRTEDTM":"2021-10-17 13:09:16","EOSDY":731,"EOSDT":"2021-10-17","STRATA1":"C","STRATA2":"S2","BMRKR1":5.56433,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-98","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-10-18 01:09:16","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-98","AGE":38.0291,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-18 01:09:16","TRTEDTM":"2021-10-17 13:09:16","EOSDY":731,"EOSDT":"2021-10-17","STRATA1":"C","STRATA2":"S2","BMRKR1":5.56433,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-98","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-10-18 01:09:16","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-98","AGE":38.0291,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-18 01:09:16","TRTEDTM":"2021-10-17 13:09:16","EOSDY":731,"EOSDT":"2021-10-17","STRATA1":"C","STRATA2":"S2","BMRKR1":5.56433,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-98","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.68083,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-06-23 01:09:16","ADY":249}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-98","AGE":38.0291,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-18 01:09:16","TRTEDTM":"2021-10-17 13:09:16","EOSDY":731,"EOSDT":"2021-10-17","STRATA1":"C","STRATA2":"S2","BMRKR1":5.56433,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-98","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":49.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-09-28 23:37:42","ADY":347}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-11","SUBJID":"id-98","AGE":38.0291,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-18 01:09:16","TRTEDTM":"2021-10-17 13:09:16","EOSDY":731,"EOSDT":"2021-10-17","STRATA1":"C","STRATA2":"S2","BMRKR1":5.56433,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-11-id-98","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":79.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-04-25 18:43:17","ADY":556}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-54","AGE":32.79913,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 22:32:06","TRTEDTM":"2022-08-10 10:32:06","EOSDY":731,"EOSDT":"2022-08-10","STRATA1":"B","STRATA2":"S2","BMRKR1":3.42467,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-54","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-08-10 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-54","AGE":32.79913,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 22:32:06","TRTEDTM":"2022-08-10 10:32:06","EOSDY":731,"EOSDT":"2022-08-10","STRATA1":"B","STRATA2":"S2","BMRKR1":3.42467,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-54","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-54","AGE":32.79913,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 22:32:06","TRTEDTM":"2022-08-10 10:32:06","EOSDY":731,"EOSDT":"2022-08-10","STRATA1":"B","STRATA2":"S2","BMRKR1":3.42467,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-54","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-54","AGE":32.79913,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 22:32:06","TRTEDTM":"2022-08-10 10:32:06","EOSDY":731,"EOSDT":"2022-08-10","STRATA1":"B","STRATA2":"S2","BMRKR1":3.42467,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-54","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-54","AGE":32.79913,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 22:32:06","TRTEDTM":"2022-08-10 10:32:06","EOSDY":731,"EOSDT":"2022-08-10","STRATA1":"B","STRATA2":"S2","BMRKR1":3.42467,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-54","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.85311,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-06-17 22:32:06","ADY":312}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-54","AGE":32.79913,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 22:32:06","TRTEDTM":"2022-08-10 10:32:06","EOSDY":731,"EOSDT":"2022-08-10","STRATA1":"B","STRATA2":"S2","BMRKR1":3.42467,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-54","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.26504,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-11-14 22:32:06","ADY":97}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-54","AGE":32.79913,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 22:32:06","TRTEDTM":"2022-08-10 10:32:06","EOSDY":731,"EOSDT":"2022-08-10","STRATA1":"B","STRATA2":"S2","BMRKR1":3.42467,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-54","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.16278,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-08 22:32:06","ADY":60}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-54","AGE":32.79913,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 22:32:06","TRTEDTM":"2022-08-10 10:32:06","EOSDY":731,"EOSDT":"2022-08-10","STRATA1":"B","STRATA2":"S2","BMRKR1":3.42467,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-54","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":49.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-07-23 05:22:02","ADY":349}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-54","AGE":32.79913,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-09 22:32:06","TRTEDTM":"2022-08-10 10:32:06","EOSDY":731,"EOSDT":"2022-08-10","STRATA1":"B","STRATA2":"S2","BMRKR1":3.42467,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-54","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":51.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-08-05 06:51:29","ADY":362}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-69","AGE":54.91049,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-09-16 05:18:15","TRTEDTM":"2022-09-16 17:18:15","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":8.32446,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-69","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-09-16 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-69","AGE":54.91049,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-09-16 05:18:15","TRTEDTM":"2022-09-16 17:18:15","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":8.32446,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-69","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-69","AGE":54.91049,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-09-16 05:18:15","TRTEDTM":"2022-09-16 17:18:15","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":8.32446,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-69","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-69","AGE":54.91049,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-09-16 05:18:15","TRTEDTM":"2022-09-16 17:18:15","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":8.32446,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-69","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-69","AGE":54.91049,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-09-16 05:18:15","TRTEDTM":"2022-09-16 17:18:15","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":8.32446,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-69","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.0162,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-22 05:18:15","ADY":6}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-69","AGE":54.91049,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-09-16 05:18:15","TRTEDTM":"2022-09-16 17:18:15","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":8.32446,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-69","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":1.53846,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2022-04-01 05:18:15","ADY":562}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-69","AGE":54.91049,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-09-16 05:18:15","TRTEDTM":"2022-09-16 17:18:15","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":8.32446,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-69","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.22918,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-12-09 05:18:15","ADY":84}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-69","AGE":54.91049,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-09-16 05:18:15","TRTEDTM":"2022-09-16 17:18:15","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":8.32446,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-69","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":19,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-01-26 21:39:47","ADY":133}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-12","SUBJID":"id-69","AGE":54.91049,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-09-16 05:18:15","TRTEDTM":"2022-09-16 17:18:15","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":8.32446,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-12-id-69","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":41.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-07-04 19:17:44","ADY":292}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-13","SUBJID":"id-168","AGE":30.8761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-23 19:40:55","TRTEDTM":"2021-06-23 07:40:55","EOSDY":731,"EOSDT":"2021-06-23","STRATA1":"B","STRATA2":"S2","BMRKR1":6.69001,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-13-id-168","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-06-23 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-13","SUBJID":"id-168","AGE":30.8761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-23 19:40:55","TRTEDTM":"2021-06-23 07:40:55","EOSDY":731,"EOSDT":"2021-06-23","STRATA1":"B","STRATA2":"S2","BMRKR1":6.69001,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-13-id-168","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-13","SUBJID":"id-168","AGE":30.8761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-23 19:40:55","TRTEDTM":"2021-06-23 07:40:55","EOSDY":731,"EOSDT":"2021-06-23","STRATA1":"B","STRATA2":"S2","BMRKR1":6.69001,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-13-id-168","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-13","SUBJID":"id-168","AGE":30.8761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-23 19:40:55","TRTEDTM":"2021-06-23 07:40:55","EOSDY":731,"EOSDT":"2021-06-23","STRATA1":"B","STRATA2":"S2","BMRKR1":6.69001,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-13-id-168","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-13","SUBJID":"id-168","AGE":30.8761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-23 19:40:55","TRTEDTM":"2021-06-23 07:40:55","EOSDY":731,"EOSDT":"2021-06-23","STRATA1":"B","STRATA2":"S2","BMRKR1":6.69001,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-13-id-168","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.13948,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-13 19:40:55","ADY":51}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-13","SUBJID":"id-168","AGE":30.8761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-23 19:40:55","TRTEDTM":"2021-06-23 07:40:55","EOSDY":731,"EOSDT":"2021-06-23","STRATA1":"B","STRATA2":"S2","BMRKR1":6.69001,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-13-id-168","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-06-24 19:40:55","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-13","SUBJID":"id-168","AGE":30.8761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-23 19:40:55","TRTEDTM":"2021-06-23 07:40:55","EOSDY":731,"EOSDT":"2021-06-23","STRATA1":"B","STRATA2":"S2","BMRKR1":6.69001,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-13-id-168","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-06-24 19:40:55","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-13","SUBJID":"id-168","AGE":30.8761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-23 19:40:55","TRTEDTM":"2021-06-23 07:40:55","EOSDY":731,"EOSDT":"2021-06-23","STRATA1":"B","STRATA2":"S2","BMRKR1":6.69001,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-13-id-168","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":82.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-01-22 11:17:39","ADY":580}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-13","SUBJID":"id-168","AGE":30.8761,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-23 19:40:55","TRTEDTM":"2021-06-23 07:40:55","EOSDY":731,"EOSDT":"2021-06-23","STRATA1":"B","STRATA2":"S2","BMRKR1":6.69001,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-13-id-168","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":102.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-06-11 00:49:34","ADY":720}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-197","AGE":37.89201,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-02-24 02:21:49","TRTEDTM":"2021-02-23 14:21:49","EOSDY":731,"EOSDT":"2021-02-23","STRATA1":"B","STRATA2":"S1","BMRKR1":2.04505,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-197","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-02-23 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-197","AGE":37.89201,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-02-24 02:21:49","TRTEDTM":"2021-02-23 14:21:49","EOSDY":731,"EOSDT":"2021-02-23","STRATA1":"B","STRATA2":"S1","BMRKR1":2.04505,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-197","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-197","AGE":37.89201,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-02-24 02:21:49","TRTEDTM":"2021-02-23 14:21:49","EOSDY":731,"EOSDT":"2021-02-23","STRATA1":"B","STRATA2":"S1","BMRKR1":2.04505,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-197","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-197","AGE":37.89201,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-02-24 02:21:49","TRTEDTM":"2021-02-23 14:21:49","EOSDY":731,"EOSDT":"2021-02-23","STRATA1":"B","STRATA2":"S1","BMRKR1":2.04505,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-197","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-197","AGE":37.89201,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-02-24 02:21:49","TRTEDTM":"2021-02-23 14:21:49","EOSDY":731,"EOSDT":"2021-02-23","STRATA1":"B","STRATA2":"S1","BMRKR1":2.04505,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-197","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.55201,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-14 02:21:49","ADY":202}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-197","AGE":37.89201,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-02-24 02:21:49","TRTEDTM":"2021-02-23 14:21:49","EOSDY":731,"EOSDT":"2021-02-23","STRATA1":"B","STRATA2":"S1","BMRKR1":2.04505,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-197","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.4749,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-17 02:21:49","ADY":174}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-197","AGE":37.89201,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-02-24 02:21:49","TRTEDTM":"2021-02-23 14:21:49","EOSDY":731,"EOSDT":"2021-02-23","STRATA1":"B","STRATA2":"S1","BMRKR1":2.04505,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-197","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":1.95054,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-02-06 02:21:49","ADY":713}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-197","AGE":37.89201,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-02-24 02:21:49","TRTEDTM":"2021-02-23 14:21:49","EOSDY":731,"EOSDT":"2021-02-23","STRATA1":"B","STRATA2":"S1","BMRKR1":2.04505,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-197","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":97,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-01-02 21:04:11","ADY":679}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-197","AGE":37.89201,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2019-02-24 02:21:49","TRTEDTM":"2021-02-23 14:21:49","EOSDY":731,"EOSDT":"2021-02-23","STRATA1":"B","STRATA2":"S1","BMRKR1":2.04505,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-197","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":33.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-10-17 10:51:11","ADY":236}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-34","AGE":37.96305,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-16 02:17:12","TRTEDTM":"2022-09-16 14:17:12","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.11114,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-34","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-09-16 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-34","AGE":37.96305,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-16 02:17:12","TRTEDTM":"2022-09-16 14:17:12","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.11114,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-34","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-34","AGE":37.96305,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-16 02:17:12","TRTEDTM":"2022-09-16 14:17:12","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.11114,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-34","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-34","AGE":37.96305,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-16 02:17:12","TRTEDTM":"2022-09-16 14:17:12","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.11114,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-34","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-34","AGE":37.96305,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-16 02:17:12","TRTEDTM":"2022-09-16 14:17:12","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.11114,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-34","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.0477,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-04 02:17:12","ADY":18}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-34","AGE":37.96305,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-16 02:17:12","TRTEDTM":"2022-09-16 14:17:12","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.11114,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-34","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-09-17 02:17:12","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-34","AGE":37.96305,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-16 02:17:12","TRTEDTM":"2022-09-16 14:17:12","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.11114,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-34","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.21963,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-12-06 02:17:12","ADY":81}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-34","AGE":37.96305,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-16 02:17:12","TRTEDTM":"2022-09-16 14:17:12","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.11114,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-34","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":7.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-11-09 23:53:54","ADY":55}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-14","SUBJID":"id-34","AGE":37.96305,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-16 02:17:12","TRTEDTM":"2022-09-16 14:17:12","EOSDY":731,"EOSDT":"2022-09-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.11114,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-14-id-34","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":33.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-05-05 12:02:22","ADY":232}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-108","AGE":28.56485,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-12-11 14:43:16","TRTEDTM":"2021-12-11 02:43:16","EOSDY":731,"EOSDT":"2021-12-11","STRATA1":"B","STRATA2":"S1","BMRKR1":2.94583,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-108","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-12-11 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-108","AGE":28.56485,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-12-11 14:43:16","TRTEDTM":"2021-12-11 02:43:16","EOSDY":731,"EOSDT":"2021-12-11","STRATA1":"B","STRATA2":"S1","BMRKR1":2.94583,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-108","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-108","AGE":28.56485,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-12-11 14:43:16","TRTEDTM":"2021-12-11 02:43:16","EOSDY":731,"EOSDT":"2021-12-11","STRATA1":"B","STRATA2":"S1","BMRKR1":2.94583,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-108","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-108","AGE":28.56485,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-12-11 14:43:16","TRTEDTM":"2021-12-11 02:43:16","EOSDY":731,"EOSDT":"2021-12-11","STRATA1":"B","STRATA2":"S1","BMRKR1":2.94583,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-108","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-108","AGE":28.56485,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-12-11 14:43:16","TRTEDTM":"2021-12-11 02:43:16","EOSDY":731,"EOSDT":"2021-12-11","STRATA1":"B","STRATA2":"S1","BMRKR1":2.94583,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-108","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.51752,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-06-18 14:43:16","ADY":190}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-108","AGE":28.56485,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-12-11 14:43:16","TRTEDTM":"2021-12-11 02:43:16","EOSDY":731,"EOSDT":"2021-12-11","STRATA1":"B","STRATA2":"S1","BMRKR1":2.94583,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-108","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.03311,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-24 14:43:16","ADY":13}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-108","AGE":28.56485,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-12-11 14:43:16","TRTEDTM":"2021-12-11 02:43:16","EOSDY":731,"EOSDT":"2021-12-11","STRATA1":"B","STRATA2":"S1","BMRKR1":2.94583,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-108","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.19478,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-02-21 14:43:16","ADY":72}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-108","AGE":28.56485,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-12-11 14:43:16","TRTEDTM":"2021-12-11 02:43:16","EOSDY":731,"EOSDT":"2021-12-11","STRATA1":"B","STRATA2":"S1","BMRKR1":2.94583,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-108","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":29,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-06-30 13:50:05","ADY":203}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-108","AGE":28.56485,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-12-11 14:43:16","TRTEDTM":"2021-12-11 02:43:16","EOSDY":731,"EOSDT":"2021-12-11","STRATA1":"B","STRATA2":"S1","BMRKR1":2.94583,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-108","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":95.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-10-07 22:46:05","ADY":667}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-153","AGE":44.13218,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-22 01:09:30","TRTEDTM":"2021-10-21 13:09:30","EOSDY":731,"EOSDT":"2021-10-21","STRATA1":"C","STRATA2":"S1","BMRKR1":3.15282,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-153","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-10-21 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-153","AGE":44.13218,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-22 01:09:30","TRTEDTM":"2021-10-21 13:09:30","EOSDY":731,"EOSDT":"2021-10-21","STRATA1":"C","STRATA2":"S1","BMRKR1":3.15282,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-153","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-153","AGE":44.13218,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-22 01:09:30","TRTEDTM":"2021-10-21 13:09:30","EOSDY":731,"EOSDT":"2021-10-21","STRATA1":"C","STRATA2":"S1","BMRKR1":3.15282,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-153","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-153","AGE":44.13218,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-22 01:09:30","TRTEDTM":"2021-10-21 13:09:30","EOSDY":731,"EOSDT":"2021-10-21","STRATA1":"C","STRATA2":"S1","BMRKR1":3.15282,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-153","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-153","AGE":44.13218,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-22 01:09:30","TRTEDTM":"2021-10-21 13:09:30","EOSDY":731,"EOSDT":"2021-10-21","STRATA1":"C","STRATA2":"S1","BMRKR1":3.15282,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-153","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.0334,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-04 01:09:30","ADY":13}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-153","AGE":44.13218,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-22 01:09:30","TRTEDTM":"2021-10-21 13:09:30","EOSDY":731,"EOSDT":"2021-10-21","STRATA1":"C","STRATA2":"S1","BMRKR1":3.15282,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-153","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.35056,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-02-28 01:09:30","ADY":129}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-153","AGE":44.13218,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-22 01:09:30","TRTEDTM":"2021-10-21 13:09:30","EOSDY":731,"EOSDT":"2021-10-21","STRATA1":"C","STRATA2":"S1","BMRKR1":3.15282,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-153","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.5276,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-05-02 01:09:30","ADY":193}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-153","AGE":44.13218,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-22 01:09:30","TRTEDTM":"2021-10-21 13:09:30","EOSDY":731,"EOSDT":"2021-10-21","STRATA1":"C","STRATA2":"S1","BMRKR1":3.15282,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-153","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":37.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-07-07 12:21:58","ADY":260}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-153","AGE":44.13218,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-10-22 01:09:30","TRTEDTM":"2021-10-21 13:09:30","EOSDY":731,"EOSDT":"2021-10-21","STRATA1":"C","STRATA2":"S1","BMRKR1":3.15282,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-153","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":47.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-09-15 21:03:00","ADY":330}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-64","AGE":37.88952,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-06-25 20:37:57","TRTEDTM":"2022-06-26 08:37:57","EOSDY":731,"EOSDT":"2022-06-26","STRATA1":"B","STRATA2":"S2","BMRKR1":8.37814,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-64","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-06-26 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-64","AGE":37.88952,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-06-25 20:37:57","TRTEDTM":"2022-06-26 08:37:57","EOSDY":731,"EOSDT":"2022-06-26","STRATA1":"B","STRATA2":"S2","BMRKR1":8.37814,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-64","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-64","AGE":37.88952,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-06-25 20:37:57","TRTEDTM":"2022-06-26 08:37:57","EOSDY":731,"EOSDT":"2022-06-26","STRATA1":"B","STRATA2":"S2","BMRKR1":8.37814,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-64","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-64","AGE":37.88952,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-06-25 20:37:57","TRTEDTM":"2022-06-26 08:37:57","EOSDY":731,"EOSDT":"2022-06-26","STRATA1":"B","STRATA2":"S2","BMRKR1":8.37814,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-64","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-64","AGE":37.88952,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-06-25 20:37:57","TRTEDTM":"2022-06-26 08:37:57","EOSDY":731,"EOSDT":"2022-06-26","STRATA1":"B","STRATA2":"S2","BMRKR1":8.37814,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-64","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.23573,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-20 20:37:57","ADY":87}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-64","AGE":37.88952,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-06-25 20:37:57","TRTEDTM":"2022-06-26 08:37:57","EOSDY":731,"EOSDT":"2022-06-26","STRATA1":"B","STRATA2":"S2","BMRKR1":8.37814,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-64","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.19639,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-05 20:37:57","ADY":72}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-64","AGE":37.88952,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-06-25 20:37:57","TRTEDTM":"2022-06-26 08:37:57","EOSDY":731,"EOSDT":"2022-06-26","STRATA1":"B","STRATA2":"S2","BMRKR1":8.37814,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-64","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.57081,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-20 20:37:57","ADY":209}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-64","AGE":37.88952,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-06-25 20:37:57","TRTEDTM":"2022-06-26 08:37:57","EOSDY":731,"EOSDT":"2022-06-26","STRATA1":"B","STRATA2":"S2","BMRKR1":8.37814,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-64","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":96.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-04-30 03:43:01","ADY":675}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-15","SUBJID":"id-64","AGE":37.88952,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-06-25 20:37:57","TRTEDTM":"2022-06-26 08:37:57","EOSDY":731,"EOSDT":"2022-06-26","STRATA1":"B","STRATA2":"S2","BMRKR1":8.37814,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-15-id-64","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":41,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-04-07 06:27:11","ADY":287}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-16","SUBJID":"id-159","AGE":39.95922,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-05 20:51:52","TRTEDTM":"2021-10-05 08:51:52","EOSDY":731,"EOSDT":"2021-10-05","STRATA1":"B","STRATA2":"S1","BMRKR1":13.73524,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-16-id-159","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-10-05 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-16","SUBJID":"id-159","AGE":39.95922,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-05 20:51:52","TRTEDTM":"2021-10-05 08:51:52","EOSDY":731,"EOSDT":"2021-10-05","STRATA1":"B","STRATA2":"S1","BMRKR1":13.73524,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-16-id-159","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-16","SUBJID":"id-159","AGE":39.95922,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-05 20:51:52","TRTEDTM":"2021-10-05 08:51:52","EOSDY":731,"EOSDT":"2021-10-05","STRATA1":"B","STRATA2":"S1","BMRKR1":13.73524,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-16-id-159","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-16","SUBJID":"id-159","AGE":39.95922,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-05 20:51:52","TRTEDTM":"2021-10-05 08:51:52","EOSDY":731,"EOSDT":"2021-10-05","STRATA1":"B","STRATA2":"S1","BMRKR1":13.73524,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-16-id-159","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-16","SUBJID":"id-159","AGE":39.95922,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-05 20:51:52","TRTEDTM":"2021-10-05 08:51:52","EOSDY":731,"EOSDT":"2021-10-05","STRATA1":"B","STRATA2":"S1","BMRKR1":13.73524,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-16-id-159","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.53998,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-20 20:51:52","ADY":198}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-16","SUBJID":"id-159","AGE":39.95922,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-05 20:51:52","TRTEDTM":"2021-10-05 08:51:52","EOSDY":731,"EOSDT":"2021-10-05","STRATA1":"B","STRATA2":"S1","BMRKR1":13.73524,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-16-id-159","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.59109,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-05-08 20:51:52","ADY":216}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-16","SUBJID":"id-159","AGE":39.95922,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-05 20:51:52","TRTEDTM":"2021-10-05 08:51:52","EOSDY":731,"EOSDT":"2021-10-05","STRATA1":"B","STRATA2":"S1","BMRKR1":13.73524,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-16-id-159","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-10-06 20:51:52","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-16","SUBJID":"id-159","AGE":39.95922,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-05 20:51:52","TRTEDTM":"2021-10-05 08:51:52","EOSDY":731,"EOSDT":"2021-10-05","STRATA1":"B","STRATA2":"S1","BMRKR1":13.73524,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-16-id-159","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-10-05 20:51:52","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-16","SUBJID":"id-159","AGE":39.95922,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-05 20:51:52","TRTEDTM":"2021-10-05 08:51:52","EOSDY":731,"EOSDT":"2021-10-05","STRATA1":"B","STRATA2":"S1","BMRKR1":13.73524,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-16-id-159","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":103.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-09-30 21:44:23","ADY":727}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-126","AGE":34.49327,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-05 22:03:45","TRTEDTM":"2021-05-05 10:03:45","EOSDY":731,"EOSDT":"2021-05-05","STRATA1":"B","STRATA2":"S1","BMRKR1":6.69981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-126","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-05-05 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-126","AGE":34.49327,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-05 22:03:45","TRTEDTM":"2021-05-05 10:03:45","EOSDY":731,"EOSDT":"2021-05-05","STRATA1":"B","STRATA2":"S1","BMRKR1":6.69981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-126","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-126","AGE":34.49327,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-05 22:03:45","TRTEDTM":"2021-05-05 10:03:45","EOSDY":731,"EOSDT":"2021-05-05","STRATA1":"B","STRATA2":"S1","BMRKR1":6.69981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-126","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-126","AGE":34.49327,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-05 22:03:45","TRTEDTM":"2021-05-05 10:03:45","EOSDY":731,"EOSDT":"2021-05-05","STRATA1":"B","STRATA2":"S1","BMRKR1":6.69981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-126","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-126","AGE":34.49327,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-05 22:03:45","TRTEDTM":"2021-05-05 10:03:45","EOSDY":731,"EOSDT":"2021-05-05","STRATA1":"B","STRATA2":"S1","BMRKR1":6.69981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-126","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.27612,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-14 22:03:45","ADY":101}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-126","AGE":34.49327,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-05 22:03:45","TRTEDTM":"2021-05-05 10:03:45","EOSDY":731,"EOSDT":"2021-05-05","STRATA1":"B","STRATA2":"S1","BMRKR1":6.69981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-126","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.81625,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-02-28 22:03:45","ADY":299}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-126","AGE":34.49327,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-05 22:03:45","TRTEDTM":"2021-05-05 10:03:45","EOSDY":731,"EOSDT":"2021-05-05","STRATA1":"B","STRATA2":"S1","BMRKR1":6.69981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-126","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.01029,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-09 22:03:45","ADY":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-126","AGE":34.49327,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-05 22:03:45","TRTEDTM":"2021-05-05 10:03:45","EOSDY":731,"EOSDT":"2021-05-05","STRATA1":"B","STRATA2":"S1","BMRKR1":6.69981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-126","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":17.14286,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2019-09-01 19:00:25","ADY":120}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-126","AGE":34.49327,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-05-05 22:03:45","TRTEDTM":"2021-05-05 10:03:45","EOSDY":731,"EOSDT":"2021-05-05","STRATA1":"B","STRATA2":"S1","BMRKR1":6.69981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-126","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-05-05 22:03:45","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-14","AGE":35.04106,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-09 11:03:43","TRTEDTM":"2022-02-08 23:03:43","EOSDY":731,"EOSDT":"2022-02-08","STRATA1":"B","STRATA2":"S2","BMRKR1":2.94539,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-14","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-02-08 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-14","AGE":35.04106,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-09 11:03:43","TRTEDTM":"2022-02-08 23:03:43","EOSDY":731,"EOSDT":"2022-02-08","STRATA1":"B","STRATA2":"S2","BMRKR1":2.94539,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-14","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-14","AGE":35.04106,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-09 11:03:43","TRTEDTM":"2022-02-08 23:03:43","EOSDY":731,"EOSDT":"2022-02-08","STRATA1":"B","STRATA2":"S2","BMRKR1":2.94539,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-14","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-14","AGE":35.04106,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-09 11:03:43","TRTEDTM":"2022-02-08 23:03:43","EOSDY":731,"EOSDT":"2022-02-08","STRATA1":"B","STRATA2":"S2","BMRKR1":2.94539,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-14","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-14","AGE":35.04106,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-09 11:03:43","TRTEDTM":"2022-02-08 23:03:43","EOSDY":731,"EOSDT":"2022-02-08","STRATA1":"B","STRATA2":"S2","BMRKR1":2.94539,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-14","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.09126,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-03-14 11:03:43","ADY":34}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-14","AGE":35.04106,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-09 11:03:43","TRTEDTM":"2022-02-08 23:03:43","EOSDY":731,"EOSDT":"2022-02-08","STRATA1":"B","STRATA2":"S2","BMRKR1":2.94539,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-14","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.21184,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-27 11:03:43","ADY":78}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-14","AGE":35.04106,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-09 11:03:43","TRTEDTM":"2022-02-08 23:03:43","EOSDY":731,"EOSDT":"2022-02-08","STRATA1":"B","STRATA2":"S2","BMRKR1":2.94539,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-14","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.11393,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-03-22 11:03:43","ADY":42}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-14","AGE":35.04106,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-09 11:03:43","TRTEDTM":"2022-02-08 23:03:43","EOSDY":731,"EOSDT":"2022-02-08","STRATA1":"B","STRATA2":"S2","BMRKR1":2.94539,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-14","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":56.85714,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-03-12 00:12:38","ADY":398}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-14","AGE":35.04106,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-09 11:03:43","TRTEDTM":"2022-02-08 23:03:43","EOSDY":731,"EOSDT":"2022-02-08","STRATA1":"B","STRATA2":"S2","BMRKR1":2.94539,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-14","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":62.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-04-23 10:28:50","ADY":440}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-19","AGE":34.09081,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-19 14:45:21","TRTEDTM":"2021-07-19 02:45:21","EOSDY":731,"EOSDT":"2021-07-19","STRATA1":"A","STRATA2":"S1","BMRKR1":3.37762,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-19","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-07-19 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-19","AGE":34.09081,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-19 14:45:21","TRTEDTM":"2021-07-19 02:45:21","EOSDY":731,"EOSDT":"2021-07-19","STRATA1":"A","STRATA2":"S1","BMRKR1":3.37762,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-19","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-19","AGE":34.09081,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-19 14:45:21","TRTEDTM":"2021-07-19 02:45:21","EOSDY":731,"EOSDT":"2021-07-19","STRATA1":"A","STRATA2":"S1","BMRKR1":3.37762,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-19","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-19","AGE":34.09081,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-19 14:45:21","TRTEDTM":"2021-07-19 02:45:21","EOSDY":731,"EOSDT":"2021-07-19","STRATA1":"A","STRATA2":"S1","BMRKR1":3.37762,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-19","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-19","AGE":34.09081,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-19 14:45:21","TRTEDTM":"2021-07-19 02:45:21","EOSDY":731,"EOSDT":"2021-07-19","STRATA1":"A","STRATA2":"S1","BMRKR1":3.37762,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-19","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-07-20 14:45:21","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-19","AGE":34.09081,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-19 14:45:21","TRTEDTM":"2021-07-19 02:45:21","EOSDY":731,"EOSDT":"2021-07-19","STRATA1":"A","STRATA2":"S1","BMRKR1":3.37762,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-19","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.4095,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-16 14:45:21","ADY":150}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-19","AGE":34.09081,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-19 14:45:21","TRTEDTM":"2021-07-19 02:45:21","EOSDY":731,"EOSDT":"2021-07-19","STRATA1":"A","STRATA2":"S1","BMRKR1":3.37762,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-19","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.14522,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-11 14:45:21","ADY":54}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-19","AGE":34.09081,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-19 14:45:21","TRTEDTM":"2021-07-19 02:45:21","EOSDY":731,"EOSDT":"2021-07-19","STRATA1":"A","STRATA2":"S1","BMRKR1":3.37762,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-19","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":51.57143,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2020-07-13 23:15:44","ADY":361}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-19","AGE":34.09081,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-19 14:45:21","TRTEDTM":"2021-07-19 02:45:21","EOSDY":731,"EOSDT":"2021-07-19","STRATA1":"A","STRATA2":"S1","BMRKR1":3.37762,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-19","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":22.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-12-24 00:16:43","ADY":159}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-60","AGE":30.20853,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-12 05:57:15","TRTEDTM":"2021-10-11 17:57:15","EOSDY":731,"EOSDT":"2021-10-11","STRATA1":"A","STRATA2":"S2","BMRKR1":3.43405,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-60","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-10-11 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-60","AGE":30.20853,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-12 05:57:15","TRTEDTM":"2021-10-11 17:57:15","EOSDY":731,"EOSDT":"2021-10-11","STRATA1":"A","STRATA2":"S2","BMRKR1":3.43405,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-60","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-60","AGE":30.20853,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-12 05:57:15","TRTEDTM":"2021-10-11 17:57:15","EOSDY":731,"EOSDT":"2021-10-11","STRATA1":"A","STRATA2":"S2","BMRKR1":3.43405,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-60","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-60","AGE":30.20853,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-12 05:57:15","TRTEDTM":"2021-10-11 17:57:15","EOSDY":731,"EOSDT":"2021-10-11","STRATA1":"A","STRATA2":"S2","BMRKR1":3.43405,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-60","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-60","AGE":30.20853,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-12 05:57:15","TRTEDTM":"2021-10-11 17:57:15","EOSDY":731,"EOSDT":"2021-10-11","STRATA1":"A","STRATA2":"S2","BMRKR1":3.43405,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-60","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.13148,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-30 05:57:15","ADY":49}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-60","AGE":30.20853,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-12 05:57:15","TRTEDTM":"2021-10-11 17:57:15","EOSDY":731,"EOSDT":"2021-10-11","STRATA1":"A","STRATA2":"S2","BMRKR1":3.43405,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-60","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.65173,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-06-07 05:57:15","ADY":239}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-60","AGE":30.20853,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-12 05:57:15","TRTEDTM":"2021-10-11 17:57:15","EOSDY":731,"EOSDT":"2021-10-11","STRATA1":"A","STRATA2":"S2","BMRKR1":3.43405,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-60","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.60504,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-05-20 05:57:15","ADY":221}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-60","AGE":30.20853,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-12 05:57:15","TRTEDTM":"2021-10-11 17:57:15","EOSDY":731,"EOSDT":"2021-10-11","STRATA1":"A","STRATA2":"S2","BMRKR1":3.43405,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-60","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":100.42857,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-09-13 00:14:23","ADY":703}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-17","SUBJID":"id-60","AGE":30.20853,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-10-12 05:57:15","TRTEDTM":"2021-10-11 17:57:15","EOSDY":731,"EOSDT":"2021-10-11","STRATA1":"A","STRATA2":"S2","BMRKR1":3.43405,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-17-id-60","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":21.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-03-07 06:22:59","ADY":148}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-11","AGE":28.20947,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-26 17:13:59","TRTEDTM":"2022-03-27 05:13:59","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.91375,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-11","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-03-27 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-11","AGE":28.20947,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-26 17:13:59","TRTEDTM":"2022-03-27 05:13:59","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.91375,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-11","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-11","AGE":28.20947,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-26 17:13:59","TRTEDTM":"2022-03-27 05:13:59","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.91375,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-11","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-11","AGE":28.20947,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-26 17:13:59","TRTEDTM":"2022-03-27 05:13:59","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.91375,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-11","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-11","AGE":28.20947,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-26 17:13:59","TRTEDTM":"2022-03-27 05:13:59","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.91375,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-11","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.05246,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-15 17:13:59","ADY":20}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-11","AGE":28.20947,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-26 17:13:59","TRTEDTM":"2022-03-27 05:13:59","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.91375,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-11","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.04275,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-11 17:13:59","ADY":16}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-11","AGE":28.20947,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-26 17:13:59","TRTEDTM":"2022-03-27 05:13:59","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.91375,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-11","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.33723,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-07-28 17:13:59","ADY":124}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-11","AGE":28.20947,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-26 17:13:59","TRTEDTM":"2022-03-27 05:13:59","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.91375,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-11","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":60.85714,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-05-25 02:39:19","ADY":426}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-11","AGE":28.20947,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-03-26 17:13:59","TRTEDTM":"2022-03-27 05:13:59","EOSDY":731,"EOSDT":"2022-03-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.91375,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-11","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-03-26 17:13:59","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-119","AGE":45.8134,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-04 21:27:50","TRTEDTM":"2021-07-04 09:27:50","EOSDY":731,"EOSDT":"2021-07-04","STRATA1":"B","STRATA2":"S2","BMRKR1":10.19336,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-119","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-07-04 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-119","AGE":45.8134,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-04 21:27:50","TRTEDTM":"2021-07-04 09:27:50","EOSDY":731,"EOSDT":"2021-07-04","STRATA1":"B","STRATA2":"S2","BMRKR1":10.19336,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-119","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-119","AGE":45.8134,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-04 21:27:50","TRTEDTM":"2021-07-04 09:27:50","EOSDY":731,"EOSDT":"2021-07-04","STRATA1":"B","STRATA2":"S2","BMRKR1":10.19336,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-119","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-119","AGE":45.8134,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-04 21:27:50","TRTEDTM":"2021-07-04 09:27:50","EOSDY":731,"EOSDT":"2021-07-04","STRATA1":"B","STRATA2":"S2","BMRKR1":10.19336,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-119","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-119","AGE":45.8134,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-04 21:27:50","TRTEDTM":"2021-07-04 09:27:50","EOSDY":731,"EOSDT":"2021-07-04","STRATA1":"B","STRATA2":"S2","BMRKR1":10.19336,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-119","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.35852,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-12 21:27:50","ADY":131}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-119","AGE":45.8134,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-04 21:27:50","TRTEDTM":"2021-07-04 09:27:50","EOSDY":731,"EOSDT":"2021-07-04","STRATA1":"B","STRATA2":"S2","BMRKR1":10.19336,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-119","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.18584,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-10 21:27:50","ADY":68}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-119","AGE":45.8134,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-04 21:27:50","TRTEDTM":"2021-07-04 09:27:50","EOSDY":731,"EOSDT":"2021-07-04","STRATA1":"B","STRATA2":"S2","BMRKR1":10.19336,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-119","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.06223,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-27 21:27:50","ADY":23}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-119","AGE":45.8134,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-04 21:27:50","TRTEDTM":"2021-07-04 09:27:50","EOSDY":731,"EOSDT":"2021-07-04","STRATA1":"B","STRATA2":"S2","BMRKR1":10.19336,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-119","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":92,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-04-07 14:40:06","ADY":644}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-18","SUBJID":"id-119","AGE":45.8134,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-07-04 21:27:50","TRTEDTM":"2021-07-04 09:27:50","EOSDY":731,"EOSDT":"2021-07-04","STRATA1":"B","STRATA2":"S2","BMRKR1":10.19336,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-18-id-119","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":43,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-04-29 15:11:28","ADY":301}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-143","AGE":35.56549,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-16 10:00:28","TRTEDTM":"2023-01-16 22:00:28","EOSDY":731,"EOSDT":"2023-01-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.96339,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-143","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2023-01-16 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-143","AGE":35.56549,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-16 10:00:28","TRTEDTM":"2023-01-16 22:00:28","EOSDY":731,"EOSDT":"2023-01-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.96339,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-143","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-143","AGE":35.56549,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-16 10:00:28","TRTEDTM":"2023-01-16 22:00:28","EOSDY":731,"EOSDT":"2023-01-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.96339,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-143","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-143","AGE":35.56549,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-16 10:00:28","TRTEDTM":"2023-01-16 22:00:28","EOSDY":731,"EOSDT":"2023-01-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.96339,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-143","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":8}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-143","AGE":35.56549,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-16 10:00:28","TRTEDTM":"2023-01-16 22:00:28","EOSDY":731,"EOSDT":"2023-01-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.96339,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-143","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2023-01-17 10:00:28","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-143","AGE":35.56549,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-16 10:00:28","TRTEDTM":"2023-01-16 22:00:28","EOSDY":731,"EOSDT":"2023-01-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.96339,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-143","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.04778,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-02-03 10:00:28","ADY":18}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-143","AGE":35.56549,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-16 10:00:28","TRTEDTM":"2023-01-16 22:00:28","EOSDY":731,"EOSDT":"2023-01-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.96339,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-143","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.01725,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-23 10:00:28","ADY":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-143","AGE":35.56549,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-16 10:00:28","TRTEDTM":"2023-01-16 22:00:28","EOSDY":731,"EOSDT":"2023-01-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.96339,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-143","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":68.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-05-09 22:08:42","ADY":479}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-143","AGE":35.56549,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-16 10:00:28","TRTEDTM":"2023-01-16 22:00:28","EOSDY":731,"EOSDT":"2023-01-16","STRATA1":"A","STRATA2":"S2","BMRKR1":3.96339,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-143","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":34,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-09-10 22:14:09","ADY":238}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-182","AGE":33.94379,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-08-14 01:09:47","TRTEDTM":"2022-08-14 13:09:47","EOSDY":731,"EOSDT":"2022-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":4.83152,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-182","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-08-14 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-182","AGE":33.94379,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-08-14 01:09:47","TRTEDTM":"2022-08-14 13:09:47","EOSDY":731,"EOSDT":"2022-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":4.83152,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-182","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-182","AGE":33.94379,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-08-14 01:09:47","TRTEDTM":"2022-08-14 13:09:47","EOSDY":731,"EOSDT":"2022-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":4.83152,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-182","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-182","AGE":33.94379,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-08-14 01:09:47","TRTEDTM":"2022-08-14 13:09:47","EOSDY":731,"EOSDT":"2022-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":4.83152,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-182","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-182","AGE":33.94379,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-08-14 01:09:47","TRTEDTM":"2022-08-14 13:09:47","EOSDY":731,"EOSDT":"2022-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":4.83152,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-182","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2022-08-15 01:09:47","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-182","AGE":33.94379,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-08-14 01:09:47","TRTEDTM":"2022-08-14 13:09:47","EOSDY":731,"EOSDT":"2022-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":4.83152,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-182","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2022-08-15 01:09:47","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-182","AGE":33.94379,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-08-14 01:09:47","TRTEDTM":"2022-08-14 13:09:47","EOSDY":731,"EOSDT":"2022-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":4.83152,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-182","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.03264,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-26 01:09:47","ADY":12}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-182","AGE":33.94379,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-08-14 01:09:47","TRTEDTM":"2022-08-14 13:09:47","EOSDY":731,"EOSDT":"2022-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":4.83152,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-182","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":6.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-09-27 21:14:31","ADY":45}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-182","AGE":33.94379,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-08-14 01:09:47","TRTEDTM":"2022-08-14 13:09:47","EOSDY":731,"EOSDT":"2022-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":4.83152,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-182","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-08-14 01:09:47","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-24","AGE":35.43131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-08-20 06:27:34","TRTEDTM":"2022-08-20 18:27:34","EOSDY":731,"EOSDT":"2022-08-20","STRATA1":"A","STRATA2":"S1","BMRKR1":1.01519,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-24","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-08-20 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-24","AGE":35.43131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-08-20 06:27:34","TRTEDTM":"2022-08-20 18:27:34","EOSDY":731,"EOSDT":"2022-08-20","STRATA1":"A","STRATA2":"S1","BMRKR1":1.01519,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-24","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-24","AGE":35.43131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-08-20 06:27:34","TRTEDTM":"2022-08-20 18:27:34","EOSDY":731,"EOSDT":"2022-08-20","STRATA1":"A","STRATA2":"S1","BMRKR1":1.01519,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-24","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-24","AGE":35.43131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-08-20 06:27:34","TRTEDTM":"2022-08-20 18:27:34","EOSDY":731,"EOSDT":"2022-08-20","STRATA1":"A","STRATA2":"S1","BMRKR1":1.01519,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-24","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-24","AGE":35.43131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-08-20 06:27:34","TRTEDTM":"2022-08-20 18:27:34","EOSDY":731,"EOSDT":"2022-08-20","STRATA1":"A","STRATA2":"S1","BMRKR1":1.01519,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-24","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.33984,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-12-23 06:27:34","ADY":125}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-24","AGE":35.43131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-08-20 06:27:34","TRTEDTM":"2022-08-20 18:27:34","EOSDY":731,"EOSDT":"2022-08-20","STRATA1":"A","STRATA2":"S1","BMRKR1":1.01519,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-24","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.88398,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-07-09 06:27:34","ADY":323}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-24","AGE":35.43131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-08-20 06:27:34","TRTEDTM":"2022-08-20 18:27:34","EOSDY":731,"EOSDT":"2022-08-20","STRATA1":"A","STRATA2":"S1","BMRKR1":1.01519,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-24","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.03438,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-02 06:27:34","ADY":13}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-24","AGE":35.43131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-08-20 06:27:34","TRTEDTM":"2022-08-20 18:27:34","EOSDY":731,"EOSDT":"2022-08-20","STRATA1":"A","STRATA2":"S1","BMRKR1":1.01519,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-24","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":78.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-02-17 15:12:27","ADY":547}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-24","AGE":35.43131,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-08-20 06:27:34","TRTEDTM":"2022-08-20 18:27:34","EOSDY":731,"EOSDT":"2022-08-20","STRATA1":"A","STRATA2":"S1","BMRKR1":1.01519,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-24","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":88.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-04-30 17:29:00","ADY":619}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-26","AGE":39.77552,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-02 12:07:13","TRTEDTM":"2021-04-02 00:07:13","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S2","BMRKR1":12.2981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-26","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-04-02 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-26","AGE":39.77552,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-02 12:07:13","TRTEDTM":"2021-04-02 00:07:13","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S2","BMRKR1":12.2981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-26","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-26","AGE":39.77552,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-02 12:07:13","TRTEDTM":"2021-04-02 00:07:13","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S2","BMRKR1":12.2981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-26","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-26","AGE":39.77552,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-02 12:07:13","TRTEDTM":"2021-04-02 00:07:13","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S2","BMRKR1":12.2981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-26","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":8}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-26","AGE":39.77552,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-02 12:07:13","TRTEDTM":"2021-04-02 00:07:13","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S2","BMRKR1":12.2981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-26","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-04-03 12:07:13","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-26","AGE":39.77552,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-02 12:07:13","TRTEDTM":"2021-04-02 00:07:13","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S2","BMRKR1":12.2981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-26","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.43532,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-09 12:07:13","ADY":160}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-26","AGE":39.77552,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-02 12:07:13","TRTEDTM":"2021-04-02 00:07:13","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S2","BMRKR1":12.2981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-26","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.06888,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-04-28 12:07:13","ADY":26}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-26","AGE":39.77552,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-02 12:07:13","TRTEDTM":"2021-04-02 00:07:13","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S2","BMRKR1":12.2981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-26","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":92.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-01-06 21:38:18","ADY":646}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-26","AGE":39.77552,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-02 12:07:13","TRTEDTM":"2021-04-02 00:07:13","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S2","BMRKR1":12.2981,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-26","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":28,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-10-14 10:18:18","ADY":196}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-38","AGE":46.55401,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-14 19:55:06","TRTEDTM":"2021-08-14 07:55:06","EOSDY":731,"EOSDT":"2021-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":6.8468,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-38","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-08-14 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-38","AGE":46.55401,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-14 19:55:06","TRTEDTM":"2021-08-14 07:55:06","EOSDY":731,"EOSDT":"2021-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":6.8468,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-38","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-38","AGE":46.55401,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-14 19:55:06","TRTEDTM":"2021-08-14 07:55:06","EOSDY":731,"EOSDT":"2021-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":6.8468,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-38","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-38","AGE":46.55401,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-14 19:55:06","TRTEDTM":"2021-08-14 07:55:06","EOSDY":731,"EOSDT":"2021-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":6.8468,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-38","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-38","AGE":46.55401,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-14 19:55:06","TRTEDTM":"2021-08-14 07:55:06","EOSDY":731,"EOSDT":"2021-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":6.8468,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-38","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.01272,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-19 19:55:06","ADY":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-38","AGE":46.55401,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-14 19:55:06","TRTEDTM":"2021-08-14 07:55:06","EOSDY":731,"EOSDT":"2021-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":6.8468,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-38","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.14977,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-10-08 19:55:06","ADY":55}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-38","AGE":46.55401,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-14 19:55:06","TRTEDTM":"2021-08-14 07:55:06","EOSDY":731,"EOSDT":"2021-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":6.8468,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-38","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.30157,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-03 19:55:06","ADY":111}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-38","AGE":46.55401,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-14 19:55:06","TRTEDTM":"2021-08-14 07:55:06","EOSDY":731,"EOSDT":"2021-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":6.8468,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-38","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":97.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-06-27 02:47:24","ADY":684}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-2","SUBJID":"id-38","AGE":46.55401,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-14 19:55:06","TRTEDTM":"2021-08-14 07:55:06","EOSDY":731,"EOSDT":"2021-08-14","STRATA1":"A","STRATA2":"S2","BMRKR1":6.8468,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-2-id-38","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":47.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-07-08 06:16:21","ADY":330}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-128","AGE":36.12988,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-01-01 09:05:27","TRTEDTM":"2023-01-01 21:05:27","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"C","STRATA2":"S1","BMRKR1":7.67723,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-128","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2023-01-01 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-128","AGE":36.12988,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-01-01 09:05:27","TRTEDTM":"2023-01-01 21:05:27","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"C","STRATA2":"S1","BMRKR1":7.67723,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-128","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-128","AGE":36.12988,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-01-01 09:05:27","TRTEDTM":"2023-01-01 21:05:27","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"C","STRATA2":"S1","BMRKR1":7.67723,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-128","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-128","AGE":36.12988,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-01-01 09:05:27","TRTEDTM":"2023-01-01 21:05:27","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"C","STRATA2":"S1","BMRKR1":7.67723,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-128","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-128","AGE":36.12988,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-01-01 09:05:27","TRTEDTM":"2023-01-01 21:05:27","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"C","STRATA2":"S1","BMRKR1":7.67723,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-128","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.0372,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-15 09:05:27","ADY":14}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-128","AGE":36.12988,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-01-01 09:05:27","TRTEDTM":"2023-01-01 21:05:27","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"C","STRATA2":"S1","BMRKR1":7.67723,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-128","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.00709,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-04 09:05:27","ADY":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-128","AGE":36.12988,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-01-01 09:05:27","TRTEDTM":"2023-01-01 21:05:27","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"C","STRATA2":"S1","BMRKR1":7.67723,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-128","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.42551,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-06-06 09:05:27","ADY":156}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-128","AGE":36.12988,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-01-01 09:05:27","TRTEDTM":"2023-01-01 21:05:27","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"C","STRATA2":"S1","BMRKR1":7.67723,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-128","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":90.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-09-27 01:03:44","ADY":635}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-128","AGE":36.12988,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-01-01 09:05:27","TRTEDTM":"2023-01-01 21:05:27","EOSDY":731,"EOSDT":"2023-01-01","STRATA1":"C","STRATA2":"S1","BMRKR1":7.67723,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-128","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":69.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-05-04 09:52:33","ADY":489}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-51","AGE":28.28669,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-03 10:11:21","TRTEDTM":"2022-11-03 22:11:21","EOSDY":731,"EOSDT":"2022-11-03","STRATA1":"C","STRATA2":"S1","BMRKR1":11.11593,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-51","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-11-03 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-51","AGE":28.28669,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-03 10:11:21","TRTEDTM":"2022-11-03 22:11:21","EOSDY":731,"EOSDT":"2022-11-03","STRATA1":"C","STRATA2":"S1","BMRKR1":11.11593,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-51","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-51","AGE":28.28669,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-03 10:11:21","TRTEDTM":"2022-11-03 22:11:21","EOSDY":731,"EOSDT":"2022-11-03","STRATA1":"C","STRATA2":"S1","BMRKR1":11.11593,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-51","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-51","AGE":28.28669,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-03 10:11:21","TRTEDTM":"2022-11-03 22:11:21","EOSDY":731,"EOSDT":"2022-11-03","STRATA1":"C","STRATA2":"S1","BMRKR1":11.11593,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-51","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-51","AGE":28.28669,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-03 10:11:21","TRTEDTM":"2022-11-03 22:11:21","EOSDY":731,"EOSDT":"2022-11-03","STRATA1":"C","STRATA2":"S1","BMRKR1":11.11593,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-51","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.2446,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-02-01 10:11:21","ADY":90}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-51","AGE":28.28669,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-03 10:11:21","TRTEDTM":"2022-11-03 22:11:21","EOSDY":731,"EOSDT":"2022-11-03","STRATA1":"C","STRATA2":"S1","BMRKR1":11.11593,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-51","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-11-04 10:11:21","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-51","AGE":28.28669,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-03 10:11:21","TRTEDTM":"2022-11-03 22:11:21","EOSDY":731,"EOSDT":"2022-11-03","STRATA1":"C","STRATA2":"S1","BMRKR1":11.11593,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-51","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.06392,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-11-27 10:11:21","ADY":24}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-51","AGE":28.28669,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-03 10:11:21","TRTEDTM":"2022-11-03 22:11:21","EOSDY":731,"EOSDT":"2022-11-03","STRATA1":"C","STRATA2":"S1","BMRKR1":11.11593,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-51","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":52.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-11-07 07:37:42","ADY":370}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-3","SUBJID":"id-51","AGE":28.28669,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-03 10:11:21","TRTEDTM":"2022-11-03 22:11:21","EOSDY":731,"EOSDT":"2022-11-03","STRATA1":"C","STRATA2":"S1","BMRKR1":11.11593,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-3-id-51","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-11-03 10:11:21","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-10","AGE":36.86857,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-04 14:47:05","TRTEDTM":"2021-06-04 02:47:05","EOSDY":731,"EOSDT":"2021-06-04","STRATA1":"A","STRATA2":"S1","BMRKR1":6.91868,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-10","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-06-04 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-10","AGE":36.86857,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-04 14:47:05","TRTEDTM":"2021-06-04 02:47:05","EOSDY":731,"EOSDT":"2021-06-04","STRATA1":"A","STRATA2":"S1","BMRKR1":6.91868,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-10","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-10","AGE":36.86857,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-04 14:47:05","TRTEDTM":"2021-06-04 02:47:05","EOSDY":731,"EOSDT":"2021-06-04","STRATA1":"A","STRATA2":"S1","BMRKR1":6.91868,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-10","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-10","AGE":36.86857,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-04 14:47:05","TRTEDTM":"2021-06-04 02:47:05","EOSDY":731,"EOSDT":"2021-06-04","STRATA1":"A","STRATA2":"S1","BMRKR1":6.91868,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-10","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-10","AGE":36.86857,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-04 14:47:05","TRTEDTM":"2021-06-04 02:47:05","EOSDY":731,"EOSDT":"2021-06-04","STRATA1":"A","STRATA2":"S1","BMRKR1":6.91868,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-10","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.12366,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-20 14:47:05","ADY":46}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-10","AGE":36.86857,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-04 14:47:05","TRTEDTM":"2021-06-04 02:47:05","EOSDY":731,"EOSDT":"2021-06-04","STRATA1":"A","STRATA2":"S1","BMRKR1":6.91868,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-10","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.82927,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-02 14:47:05","ADY":303}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-10","AGE":36.86857,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-04 14:47:05","TRTEDTM":"2021-06-04 02:47:05","EOSDY":731,"EOSDT":"2021-06-04","STRATA1":"A","STRATA2":"S1","BMRKR1":6.91868,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-10","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-06-05 14:47:05","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-10","AGE":36.86857,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-04 14:47:05","TRTEDTM":"2021-06-04 02:47:05","EOSDY":731,"EOSDT":"2021-06-04","STRATA1":"A","STRATA2":"S1","BMRKR1":6.91868,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-10","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":83.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-01-06 22:22:29","ADY":583}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-10","AGE":36.86857,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-04 14:47:05","TRTEDTM":"2021-06-04 02:47:05","EOSDY":731,"EOSDT":"2021-06-04","STRATA1":"A","STRATA2":"S1","BMRKR1":6.91868,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-10","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-06-04 14:47:05","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-114","AGE":40.59786,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-04-20 03:27:50","TRTEDTM":"2022-04-20 15:27:50","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.32093,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-114","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-04-20 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-114","AGE":40.59786,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-04-20 03:27:50","TRTEDTM":"2022-04-20 15:27:50","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.32093,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-114","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":11}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-114","AGE":40.59786,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-04-20 03:27:50","TRTEDTM":"2022-04-20 15:27:50","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.32093,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-114","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-114","AGE":40.59786,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-04-20 03:27:50","TRTEDTM":"2022-04-20 15:27:50","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.32093,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-114","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":11}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-114","AGE":40.59786,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-04-20 03:27:50","TRTEDTM":"2022-04-20 15:27:50","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.32093,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-114","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.08087,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-05-20 03:27:50","ADY":30}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-114","AGE":40.59786,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-04-20 03:27:50","TRTEDTM":"2022-04-20 15:27:50","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.32093,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-114","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.0726,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-05-17 03:27:50","ADY":27}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-114","AGE":40.59786,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-04-20 03:27:50","TRTEDTM":"2022-04-20 15:27:50","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.32093,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-114","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.16979,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-06-22 03:27:50","ADY":63}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-114","AGE":40.59786,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-04-20 03:27:50","TRTEDTM":"2022-04-20 15:27:50","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.32093,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-114","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":13.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-07-25 05:31:32","ADY":97}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-4","SUBJID":"id-114","AGE":40.59786,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-04-20 03:27:50","TRTEDTM":"2022-04-20 15:27:50","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"A","STRATA2":"S2","BMRKR1":4.32093,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-4-id-114","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":35.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-12-23 01:02:25","ADY":248}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-113","AGE":40.7266,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-08 10:15:08","TRTEDTM":"2021-12-07 22:15:08","EOSDY":731,"EOSDT":"2021-12-07","STRATA1":"A","STRATA2":"S2","BMRKR1":3.22132,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-113","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-12-07 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-113","AGE":40.7266,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-08 10:15:08","TRTEDTM":"2021-12-07 22:15:08","EOSDY":731,"EOSDT":"2021-12-07","STRATA1":"A","STRATA2":"S2","BMRKR1":3.22132,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-113","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-113","AGE":40.7266,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-08 10:15:08","TRTEDTM":"2021-12-07 22:15:08","EOSDY":731,"EOSDT":"2021-12-07","STRATA1":"A","STRATA2":"S2","BMRKR1":3.22132,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-113","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-113","AGE":40.7266,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-08 10:15:08","TRTEDTM":"2021-12-07 22:15:08","EOSDY":731,"EOSDT":"2021-12-07","STRATA1":"A","STRATA2":"S2","BMRKR1":3.22132,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-113","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-113","AGE":40.7266,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-08 10:15:08","TRTEDTM":"2021-12-07 22:15:08","EOSDY":731,"EOSDT":"2021-12-07","STRATA1":"A","STRATA2":"S2","BMRKR1":3.22132,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-113","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.0113,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-13 10:15:08","ADY":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-113","AGE":40.7266,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-08 10:15:08","TRTEDTM":"2021-12-07 22:15:08","EOSDY":731,"EOSDT":"2021-12-07","STRATA1":"A","STRATA2":"S2","BMRKR1":3.22132,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-113","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.79104,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-22 10:15:08","ADY":289}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-113","AGE":40.7266,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-08 10:15:08","TRTEDTM":"2021-12-07 22:15:08","EOSDY":731,"EOSDT":"2021-12-07","STRATA1":"A","STRATA2":"S2","BMRKR1":3.22132,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-113","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.10173,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-01-15 10:15:08","ADY":38}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-113","AGE":40.7266,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-08 10:15:08","TRTEDTM":"2021-12-07 22:15:08","EOSDY":731,"EOSDT":"2021-12-07","STRATA1":"A","STRATA2":"S2","BMRKR1":3.22132,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-113","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":89.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-08-22 08:22:26","ADY":624}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-113","AGE":40.7266,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-08 10:15:08","TRTEDTM":"2021-12-07 22:15:08","EOSDY":731,"EOSDT":"2021-12-07","STRATA1":"A","STRATA2":"S2","BMRKR1":3.22132,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-113","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":83.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-07-12 08:01:41","ADY":583}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-163","AGE":34.46448,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-04 19:11:17","TRTEDTM":"2021-08-04 07:11:17","EOSDY":731,"EOSDT":"2021-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.76879,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-163","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-08-04 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-163","AGE":34.46448,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-04 19:11:17","TRTEDTM":"2021-08-04 07:11:17","EOSDY":731,"EOSDT":"2021-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.76879,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-163","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-163","AGE":34.46448,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-04 19:11:17","TRTEDTM":"2021-08-04 07:11:17","EOSDY":731,"EOSDT":"2021-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.76879,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-163","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-163","AGE":34.46448,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-04 19:11:17","TRTEDTM":"2021-08-04 07:11:17","EOSDY":731,"EOSDT":"2021-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.76879,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-163","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-163","AGE":34.46448,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-04 19:11:17","TRTEDTM":"2021-08-04 07:11:17","EOSDY":731,"EOSDT":"2021-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.76879,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-163","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-08-05 19:11:17","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-163","AGE":34.46448,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-04 19:11:17","TRTEDTM":"2021-08-04 07:11:17","EOSDY":731,"EOSDT":"2021-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.76879,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-163","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.16564,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-10-04 19:11:17","ADY":61}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-163","AGE":34.46448,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-04 19:11:17","TRTEDTM":"2021-08-04 07:11:17","EOSDY":731,"EOSDT":"2021-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.76879,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-163","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.43344,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-01-10 19:11:17","ADY":159}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-163","AGE":34.46448,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-04 19:11:17","TRTEDTM":"2021-08-04 07:11:17","EOSDY":731,"EOSDT":"2021-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.76879,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-163","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":60.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-10-01 16:43:51","ADY":425}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-163","AGE":34.46448,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-08-04 19:11:17","TRTEDTM":"2021-08-04 07:11:17","EOSDY":731,"EOSDT":"2021-08-04","STRATA1":"C","STRATA2":"S2","BMRKR1":12.76879,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-163","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":37.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-04-21 20:30:25","ADY":262}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-166","AGE":39.85728,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-20 04:24:16","TRTEDTM":"2021-12-19 16:24:16","EOSDY":731,"EOSDT":"2021-12-19","STRATA1":"A","STRATA2":"S1","BMRKR1":6.39221,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-166","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-12-19 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-166","AGE":39.85728,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-20 04:24:16","TRTEDTM":"2021-12-19 16:24:16","EOSDY":731,"EOSDT":"2021-12-19","STRATA1":"A","STRATA2":"S1","BMRKR1":6.39221,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-166","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-166","AGE":39.85728,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-20 04:24:16","TRTEDTM":"2021-12-19 16:24:16","EOSDY":731,"EOSDT":"2021-12-19","STRATA1":"A","STRATA2":"S1","BMRKR1":6.39221,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-166","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-166","AGE":39.85728,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-20 04:24:16","TRTEDTM":"2021-12-19 16:24:16","EOSDY":731,"EOSDT":"2021-12-19","STRATA1":"A","STRATA2":"S1","BMRKR1":6.39221,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-166","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-166","AGE":39.85728,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-20 04:24:16","TRTEDTM":"2021-12-19 16:24:16","EOSDY":731,"EOSDT":"2021-12-19","STRATA1":"A","STRATA2":"S1","BMRKR1":6.39221,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-166","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-12-20 04:24:16","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-166","AGE":39.85728,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-20 04:24:16","TRTEDTM":"2021-12-19 16:24:16","EOSDY":731,"EOSDT":"2021-12-19","STRATA1":"A","STRATA2":"S1","BMRKR1":6.39221,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-166","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.49441,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-06-18 04:24:16","ADY":181}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-166","AGE":39.85728,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-20 04:24:16","TRTEDTM":"2021-12-19 16:24:16","EOSDY":731,"EOSDT":"2021-12-19","STRATA1":"A","STRATA2":"S1","BMRKR1":6.39221,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-166","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.7667,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-26 04:24:16","ADY":281}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-166","AGE":39.85728,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-20 04:24:16","TRTEDTM":"2021-12-19 16:24:16","EOSDY":731,"EOSDT":"2021-12-19","STRATA1":"A","STRATA2":"S1","BMRKR1":6.39221,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-166","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":35.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-21 00:14:58","ADY":246}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-166","AGE":39.85728,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-20 04:24:16","TRTEDTM":"2021-12-19 16:24:16","EOSDY":731,"EOSDT":"2021-12-19","STRATA1":"A","STRATA2":"S1","BMRKR1":6.39221,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-166","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":35.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-25 19:33:37","ADY":250}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-30","AGE":22.35815,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-03 10:24:48","TRTEDTM":"2021-09-02 22:24:48","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"B","STRATA2":"S1","BMRKR1":5.6506,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-30","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-09-02 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-30","AGE":22.35815,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-03 10:24:48","TRTEDTM":"2021-09-02 22:24:48","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"B","STRATA2":"S1","BMRKR1":5.6506,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-30","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-30","AGE":22.35815,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-03 10:24:48","TRTEDTM":"2021-09-02 22:24:48","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"B","STRATA2":"S1","BMRKR1":5.6506,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-30","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-30","AGE":22.35815,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-03 10:24:48","TRTEDTM":"2021-09-02 22:24:48","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"B","STRATA2":"S1","BMRKR1":5.6506,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-30","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-30","AGE":22.35815,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-03 10:24:48","TRTEDTM":"2021-09-02 22:24:48","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"B","STRATA2":"S1","BMRKR1":5.6506,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-30","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-09-03 10:24:48","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-30","AGE":22.35815,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-03 10:24:48","TRTEDTM":"2021-09-02 22:24:48","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"B","STRATA2":"S1","BMRKR1":5.6506,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-30","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-09-03 10:24:48","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-30","AGE":22.35815,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-03 10:24:48","TRTEDTM":"2021-09-02 22:24:48","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"B","STRATA2":"S1","BMRKR1":5.6506,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-30","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.07481,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-10-01 10:24:48","ADY":28}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-30","AGE":22.35815,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-03 10:24:48","TRTEDTM":"2021-09-02 22:24:48","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"B","STRATA2":"S1","BMRKR1":5.6506,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-30","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-09-03 10:24:48","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-5","SUBJID":"id-30","AGE":22.35815,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-03 10:24:48","TRTEDTM":"2021-09-02 22:24:48","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"B","STRATA2":"S1","BMRKR1":5.6506,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-5-id-30","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":38.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-05-28 09:23:58","ADY":269}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-6","SUBJID":"id-83","AGE":29.86678,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-14 23:13:37","TRTEDTM":"2022-03-15 11:13:37","EOSDY":731,"EOSDT":"2022-03-15","STRATA1":"A","STRATA2":"S1","BMRKR1":5.48983,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-6-id-83","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-03-15 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-6","SUBJID":"id-83","AGE":29.86678,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-14 23:13:37","TRTEDTM":"2022-03-15 11:13:37","EOSDY":731,"EOSDT":"2022-03-15","STRATA1":"A","STRATA2":"S1","BMRKR1":5.48983,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-6-id-83","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-6","SUBJID":"id-83","AGE":29.86678,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-14 23:13:37","TRTEDTM":"2022-03-15 11:13:37","EOSDY":731,"EOSDT":"2022-03-15","STRATA1":"A","STRATA2":"S1","BMRKR1":5.48983,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-6-id-83","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-6","SUBJID":"id-83","AGE":29.86678,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-14 23:13:37","TRTEDTM":"2022-03-15 11:13:37","EOSDY":731,"EOSDT":"2022-03-15","STRATA1":"A","STRATA2":"S1","BMRKR1":5.48983,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-6-id-83","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-6","SUBJID":"id-83","AGE":29.86678,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-14 23:13:37","TRTEDTM":"2022-03-15 11:13:37","EOSDY":731,"EOSDT":"2022-03-15","STRATA1":"A","STRATA2":"S1","BMRKR1":5.48983,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-6-id-83","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.09407,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-18 23:13:37","ADY":35}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-6","SUBJID":"id-83","AGE":29.86678,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-14 23:13:37","TRTEDTM":"2022-03-15 11:13:37","EOSDY":731,"EOSDT":"2022-03-15","STRATA1":"A","STRATA2":"S1","BMRKR1":5.48983,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-6-id-83","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":1.57175,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-10-10 23:13:37","ADY":575}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-6","SUBJID":"id-83","AGE":29.86678,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-14 23:13:37","TRTEDTM":"2022-03-15 11:13:37","EOSDY":731,"EOSDT":"2022-03-15","STRATA1":"A","STRATA2":"S1","BMRKR1":5.48983,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-6-id-83","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.40284,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-09 23:13:37","ADY":148}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-6","SUBJID":"id-83","AGE":29.86678,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-14 23:13:37","TRTEDTM":"2022-03-15 11:13:37","EOSDY":731,"EOSDT":"2022-03-15","STRATA1":"A","STRATA2":"S1","BMRKR1":5.48983,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-6-id-83","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":43.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-01-12 06:46:17","ADY":305}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-6","SUBJID":"id-83","AGE":29.86678,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-03-14 23:13:37","TRTEDTM":"2022-03-15 11:13:37","EOSDY":731,"EOSDT":"2022-03-15","STRATA1":"A","STRATA2":"S1","BMRKR1":5.48983,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-6-id-83","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":54.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-04-01 07:28:38","ADY":384}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-193","AGE":44.37654,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 23:57:00","TRTEDTM":"2022-04-08 11:57:00","EOSDY":731,"EOSDT":"2022-04-08","STRATA1":"A","STRATA2":"S1","BMRKR1":3.07326,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-193","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-04-08 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-193","AGE":44.37654,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 23:57:00","TRTEDTM":"2022-04-08 11:57:00","EOSDY":731,"EOSDT":"2022-04-08","STRATA1":"A","STRATA2":"S1","BMRKR1":3.07326,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-193","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-193","AGE":44.37654,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 23:57:00","TRTEDTM":"2022-04-08 11:57:00","EOSDY":731,"EOSDT":"2022-04-08","STRATA1":"A","STRATA2":"S1","BMRKR1":3.07326,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-193","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-193","AGE":44.37654,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 23:57:00","TRTEDTM":"2022-04-08 11:57:00","EOSDY":731,"EOSDT":"2022-04-08","STRATA1":"A","STRATA2":"S1","BMRKR1":3.07326,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-193","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-193","AGE":44.37654,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 23:57:00","TRTEDTM":"2022-04-08 11:57:00","EOSDY":731,"EOSDT":"2022-04-08","STRATA1":"A","STRATA2":"S1","BMRKR1":3.07326,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-193","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2022-04-09 23:57:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-193","AGE":44.37654,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 23:57:00","TRTEDTM":"2022-04-08 11:57:00","EOSDY":731,"EOSDT":"2022-04-08","STRATA1":"A","STRATA2":"S1","BMRKR1":3.07326,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-193","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.14932,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-06-01 23:57:00","ADY":55}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-193","AGE":44.37654,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 23:57:00","TRTEDTM":"2022-04-08 11:57:00","EOSDY":731,"EOSDT":"2022-04-08","STRATA1":"A","STRATA2":"S1","BMRKR1":3.07326,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-193","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2022-04-09 23:57:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-193","AGE":44.37654,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 23:57:00","TRTEDTM":"2022-04-08 11:57:00","EOSDY":731,"EOSDT":"2022-04-08","STRATA1":"A","STRATA2":"S1","BMRKR1":3.07326,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-193","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":7.14286,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2020-05-26 00:41:32","ADY":50}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-193","AGE":44.37654,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 23:57:00","TRTEDTM":"2022-04-08 11:57:00","EOSDY":731,"EOSDT":"2022-04-08","STRATA1":"A","STRATA2":"S1","BMRKR1":3.07326,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-193","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":98.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-02-26 09:00:57","ADY":691}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-25","AGE":26.93282,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-29 13:52:08","TRTEDTM":"2021-12-29 01:52:08","EOSDY":731,"EOSDT":"2021-12-29","STRATA1":"B","STRATA2":"S2","BMRKR1":6.02635,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-25","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-12-29 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-25","AGE":26.93282,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-29 13:52:08","TRTEDTM":"2021-12-29 01:52:08","EOSDY":731,"EOSDT":"2021-12-29","STRATA1":"B","STRATA2":"S2","BMRKR1":6.02635,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-25","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-25","AGE":26.93282,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-29 13:52:08","TRTEDTM":"2021-12-29 01:52:08","EOSDY":731,"EOSDT":"2021-12-29","STRATA1":"B","STRATA2":"S2","BMRKR1":6.02635,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-25","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-25","AGE":26.93282,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-29 13:52:08","TRTEDTM":"2021-12-29 01:52:08","EOSDY":731,"EOSDT":"2021-12-29","STRATA1":"B","STRATA2":"S2","BMRKR1":6.02635,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-25","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-25","AGE":26.93282,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-29 13:52:08","TRTEDTM":"2021-12-29 01:52:08","EOSDY":731,"EOSDT":"2021-12-29","STRATA1":"B","STRATA2":"S2","BMRKR1":6.02635,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-25","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.35924,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-05-09 13:52:08","ADY":132}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-25","AGE":26.93282,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-29 13:52:08","TRTEDTM":"2021-12-29 01:52:08","EOSDY":731,"EOSDT":"2021-12-29","STRATA1":"B","STRATA2":"S2","BMRKR1":6.02635,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-25","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.03653,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-01-12 13:52:08","ADY":14}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-25","AGE":26.93282,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-29 13:52:08","TRTEDTM":"2021-12-29 01:52:08","EOSDY":731,"EOSDT":"2021-12-29","STRATA1":"B","STRATA2":"S2","BMRKR1":6.02635,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-25","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.13924,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-02-18 13:52:08","ADY":51}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-25","AGE":26.93282,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-29 13:52:08","TRTEDTM":"2021-12-29 01:52:08","EOSDY":731,"EOSDT":"2021-12-29","STRATA1":"B","STRATA2":"S2","BMRKR1":6.02635,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-25","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":46.71429,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2020-11-19 06:35:16","ADY":327}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-7","SUBJID":"id-25","AGE":26.93282,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-29 13:52:08","TRTEDTM":"2021-12-29 01:52:08","EOSDY":731,"EOSDT":"2021-12-29","STRATA1":"B","STRATA2":"S2","BMRKR1":6.02635,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-7-id-25","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":64.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-03-23 22:37:56","ADY":451}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-155","AGE":34.15878,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-21 00:16:27","TRTEDTM":"2021-03-20 12:16:27","EOSDY":731,"EOSDT":"2021-03-20","STRATA1":"C","STRATA2":"S1","BMRKR1":4.20701,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-155","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-03-20 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-155","AGE":34.15878,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-21 00:16:27","TRTEDTM":"2021-03-20 12:16:27","EOSDY":731,"EOSDT":"2021-03-20","STRATA1":"C","STRATA2":"S1","BMRKR1":4.20701,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-155","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-155","AGE":34.15878,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-21 00:16:27","TRTEDTM":"2021-03-20 12:16:27","EOSDY":731,"EOSDT":"2021-03-20","STRATA1":"C","STRATA2":"S1","BMRKR1":4.20701,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-155","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-155","AGE":34.15878,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-21 00:16:27","TRTEDTM":"2021-03-20 12:16:27","EOSDY":731,"EOSDT":"2021-03-20","STRATA1":"C","STRATA2":"S1","BMRKR1":4.20701,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-155","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-155","AGE":34.15878,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-21 00:16:27","TRTEDTM":"2021-03-20 12:16:27","EOSDY":731,"EOSDT":"2021-03-20","STRATA1":"C","STRATA2":"S1","BMRKR1":4.20701,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-155","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-03-21 00:16:27","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-155","AGE":34.15878,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-21 00:16:27","TRTEDTM":"2021-03-20 12:16:27","EOSDY":731,"EOSDT":"2021-03-20","STRATA1":"C","STRATA2":"S1","BMRKR1":4.20701,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-155","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.36397,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-01 00:16:27","ADY":133}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-155","AGE":34.15878,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-21 00:16:27","TRTEDTM":"2021-03-20 12:16:27","EOSDY":731,"EOSDT":"2021-03-20","STRATA1":"C","STRATA2":"S1","BMRKR1":4.20701,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-155","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-03-21 00:16:27","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-155","AGE":34.15878,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-21 00:16:27","TRTEDTM":"2021-03-20 12:16:27","EOSDY":731,"EOSDT":"2021-03-20","STRATA1":"C","STRATA2":"S1","BMRKR1":4.20701,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-155","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":64,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2020-06-10 23:49:35","ADY":448}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-155","AGE":34.15878,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-03-21 00:16:27","TRTEDTM":"2021-03-20 12:16:27","EOSDY":731,"EOSDT":"2021-03-20","STRATA1":"C","STRATA2":"S1","BMRKR1":4.20701,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-155","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":91,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-12-16 17:54:59","ADY":637}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-184","AGE":23.33768,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-29 01:49:13","TRTEDTM":"2022-06-29 13:49:13","EOSDY":731,"EOSDT":"2022-06-29","STRATA1":"B","STRATA2":"S1","BMRKR1":2.39452,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-184","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-06-29 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-184","AGE":23.33768,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-29 01:49:13","TRTEDTM":"2022-06-29 13:49:13","EOSDY":731,"EOSDT":"2022-06-29","STRATA1":"B","STRATA2":"S1","BMRKR1":2.39452,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-184","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-184","AGE":23.33768,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-29 01:49:13","TRTEDTM":"2022-06-29 13:49:13","EOSDY":731,"EOSDT":"2022-06-29","STRATA1":"B","STRATA2":"S1","BMRKR1":2.39452,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-184","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-184","AGE":23.33768,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-29 01:49:13","TRTEDTM":"2022-06-29 13:49:13","EOSDY":731,"EOSDT":"2022-06-29","STRATA1":"B","STRATA2":"S1","BMRKR1":2.39452,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-184","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-184","AGE":23.33768,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-29 01:49:13","TRTEDTM":"2022-06-29 13:49:13","EOSDY":731,"EOSDT":"2022-06-29","STRATA1":"B","STRATA2":"S1","BMRKR1":2.39452,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-184","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.20376,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-12 01:49:13","ADY":75}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-184","AGE":23.33768,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-29 01:49:13","TRTEDTM":"2022-06-29 13:49:13","EOSDY":731,"EOSDT":"2022-06-29","STRATA1":"B","STRATA2":"S1","BMRKR1":2.39452,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-184","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.36915,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-11-11 01:49:13","ADY":135}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-184","AGE":23.33768,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-29 01:49:13","TRTEDTM":"2022-06-29 13:49:13","EOSDY":731,"EOSDT":"2022-06-29","STRATA1":"B","STRATA2":"S1","BMRKR1":2.39452,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-184","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.09611,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-04 01:49:13","ADY":36}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-184","AGE":23.33768,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-29 01:49:13","TRTEDTM":"2022-06-29 13:49:13","EOSDY":731,"EOSDT":"2022-06-29","STRATA1":"B","STRATA2":"S1","BMRKR1":2.39452,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-184","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":27.14286,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-01-04 18:20:13","ADY":190}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-8","SUBJID":"id-184","AGE":23.33768,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-29 01:49:13","TRTEDTM":"2022-06-29 13:49:13","EOSDY":731,"EOSDT":"2022-06-29","STRATA1":"B","STRATA2":"S1","BMRKR1":2.39452,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-8-id-184","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":65.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-10-01 10:40:19","ADY":460}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-106","AGE":34.73932,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-14 23:49:06","TRTEDTM":"2022-10-15 11:49:06","EOSDY":731,"EOSDT":"2022-10-15","STRATA1":"B","STRATA2":"S1","BMRKR1":5.62284,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-106","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-10-15 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-106","AGE":34.73932,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-14 23:49:06","TRTEDTM":"2022-10-15 11:49:06","EOSDY":731,"EOSDT":"2022-10-15","STRATA1":"B","STRATA2":"S1","BMRKR1":5.62284,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-106","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":13}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-106","AGE":34.73932,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-14 23:49:06","TRTEDTM":"2022-10-15 11:49:06","EOSDY":731,"EOSDT":"2022-10-15","STRATA1":"B","STRATA2":"S1","BMRKR1":5.62284,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-106","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-106","AGE":34.73932,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-14 23:49:06","TRTEDTM":"2022-10-15 11:49:06","EOSDY":731,"EOSDT":"2022-10-15","STRATA1":"B","STRATA2":"S1","BMRKR1":5.62284,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-106","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":10}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-106","AGE":34.73932,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-14 23:49:06","TRTEDTM":"2022-10-15 11:49:06","EOSDY":731,"EOSDT":"2022-10-15","STRATA1":"B","STRATA2":"S1","BMRKR1":5.62284,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-106","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.40962,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-03-13 23:49:06","ADY":150}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-106","AGE":34.73932,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-14 23:49:06","TRTEDTM":"2022-10-15 11:49:06","EOSDY":731,"EOSDT":"2022-10-15","STRATA1":"B","STRATA2":"S1","BMRKR1":5.62284,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-106","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.5911,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-05-18 23:49:06","ADY":216}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-106","AGE":34.73932,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-14 23:49:06","TRTEDTM":"2022-10-15 11:49:06","EOSDY":731,"EOSDT":"2022-10-15","STRATA1":"B","STRATA2":"S1","BMRKR1":5.62284,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-106","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.20916,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-12-30 23:49:06","ADY":77}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-106","AGE":34.73932,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-14 23:49:06","TRTEDTM":"2022-10-15 11:49:06","EOSDY":731,"EOSDT":"2022-10-15","STRATA1":"B","STRATA2":"S1","BMRKR1":5.62284,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-106","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":99.85714,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2022-09-12 10:21:43","ADY":699}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-106","AGE":34.73932,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-10-14 23:49:06","TRTEDTM":"2022-10-15 11:49:06","EOSDY":731,"EOSDT":"2022-10-15","STRATA1":"B","STRATA2":"S1","BMRKR1":5.62284,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-106","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-10-14 23:49:06","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-124","AGE":36.12815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-05-23 04:08:27","TRTEDTM":"2022-05-23 16:08:27","EOSDY":731,"EOSDT":"2022-05-23","STRATA1":"A","STRATA2":"S1","BMRKR1":11.12422,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-124","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-05-23 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-124","AGE":36.12815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-05-23 04:08:27","TRTEDTM":"2022-05-23 16:08:27","EOSDY":731,"EOSDT":"2022-05-23","STRATA1":"A","STRATA2":"S1","BMRKR1":11.12422,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-124","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-124","AGE":36.12815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-05-23 04:08:27","TRTEDTM":"2022-05-23 16:08:27","EOSDY":731,"EOSDT":"2022-05-23","STRATA1":"A","STRATA2":"S1","BMRKR1":11.12422,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-124","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-124","AGE":36.12815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-05-23 04:08:27","TRTEDTM":"2022-05-23 16:08:27","EOSDY":731,"EOSDT":"2022-05-23","STRATA1":"A","STRATA2":"S1","BMRKR1":11.12422,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-124","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-124","AGE":36.12815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-05-23 04:08:27","TRTEDTM":"2022-05-23 16:08:27","EOSDY":731,"EOSDT":"2022-05-23","STRATA1":"A","STRATA2":"S1","BMRKR1":11.12422,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-124","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-05-24 04:08:27","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-124","AGE":36.12815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-05-23 04:08:27","TRTEDTM":"2022-05-23 16:08:27","EOSDY":731,"EOSDT":"2022-05-23","STRATA1":"A","STRATA2":"S1","BMRKR1":11.12422,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-124","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.09443,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-06-27 04:08:27","ADY":35}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-124","AGE":36.12815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-05-23 04:08:27","TRTEDTM":"2022-05-23 16:08:27","EOSDY":731,"EOSDT":"2022-05-23","STRATA1":"A","STRATA2":"S1","BMRKR1":11.12422,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-124","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.06243,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-06-15 04:08:27","ADY":23}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-124","AGE":36.12815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-05-23 04:08:27","TRTEDTM":"2022-05-23 16:08:27","EOSDY":731,"EOSDT":"2022-05-23","STRATA1":"A","STRATA2":"S1","BMRKR1":11.12422,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-124","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":71.28571,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-10-03 15:10:50","ADY":499}
{"STUDYID":"AB12345","COUNTRY":"CHN","SITEID":"CHN-9","SUBJID":"id-124","AGE":36.12815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-05-23 04:08:27","TRTEDTM":"2022-05-23 16:08:27","EOSDY":731,"EOSDT":"2022-05-23","STRATA1":"A","STRATA2":"S1","BMRKR1":11.12422,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-CHN-9-id-124","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":2.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-06-08 01:09:21","ADY":17}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-11","SUBJID":"id-111","AGE":39.08581,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-12 02:49:28","TRTEDTM":"2022-12-12 14:49:28","EOSDY":731,"EOSDT":"2022-12-12","STRATA1":"A","STRATA2":"S1","BMRKR1":2.68891,"BMRKR2":"MEDIUM","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-11-id-111","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-12-12 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-11","SUBJID":"id-111","AGE":39.08581,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-12 02:49:28","TRTEDTM":"2022-12-12 14:49:28","EOSDY":731,"EOSDT":"2022-12-12","STRATA1":"A","STRATA2":"S1","BMRKR1":2.68891,"BMRKR2":"MEDIUM","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-11-id-111","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-11","SUBJID":"id-111","AGE":39.08581,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-12 02:49:28","TRTEDTM":"2022-12-12 14:49:28","EOSDY":731,"EOSDT":"2022-12-12","STRATA1":"A","STRATA2":"S1","BMRKR1":2.68891,"BMRKR2":"MEDIUM","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-11-id-111","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":12}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-11","SUBJID":"id-111","AGE":39.08581,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-12 02:49:28","TRTEDTM":"2022-12-12 14:49:28","EOSDY":731,"EOSDT":"2022-12-12","STRATA1":"A","STRATA2":"S1","BMRKR1":2.68891,"BMRKR2":"MEDIUM","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-11-id-111","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-11","SUBJID":"id-111","AGE":39.08581,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-12 02:49:28","TRTEDTM":"2022-12-12 14:49:28","EOSDY":731,"EOSDT":"2022-12-12","STRATA1":"A","STRATA2":"S1","BMRKR1":2.68891,"BMRKR2":"MEDIUM","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-11-id-111","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.08256,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-12 02:49:28","ADY":31}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-11","SUBJID":"id-111","AGE":39.08581,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-12 02:49:28","TRTEDTM":"2022-12-12 14:49:28","EOSDY":731,"EOSDT":"2022-12-12","STRATA1":"A","STRATA2":"S1","BMRKR1":2.68891,"BMRKR2":"MEDIUM","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-11-id-111","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.01413,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-12-18 02:49:28","ADY":6}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-11","SUBJID":"id-111","AGE":39.08581,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-12 02:49:28","TRTEDTM":"2022-12-12 14:49:28","EOSDY":731,"EOSDT":"2022-12-12","STRATA1":"A","STRATA2":"S1","BMRKR1":2.68891,"BMRKR2":"MEDIUM","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-11-id-111","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.00426,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-12-14 02:49:28","ADY":2}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-11","SUBJID":"id-111","AGE":39.08581,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-12 02:49:28","TRTEDTM":"2022-12-12 14:49:28","EOSDY":731,"EOSDT":"2022-12-12","STRATA1":"A","STRATA2":"S1","BMRKR1":2.68891,"BMRKR2":"MEDIUM","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-11-id-111","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-12-12 08:40:27","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-11","SUBJID":"id-111","AGE":39.08581,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-12-12 02:49:28","TRTEDTM":"2022-12-12 14:49:28","EOSDY":731,"EOSDT":"2022-12-12","STRATA1":"A","STRATA2":"S1","BMRKR1":2.68891,"BMRKR2":"MEDIUM","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-11-id-111","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":0,"AVAL":95.57143,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2022-10-11 00:04:29","ADY":669}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-3","SUBJID":"id-80","AGE":41.51608,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-01-15 10:48:14","TRTEDTM":"2022-01-14 22:48:14","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"C","STRATA2":"S2","BMRKR1":8.96424,"BMRKR2":"LOW","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-3-id-80","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-01-14 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-3","SUBJID":"id-80","AGE":41.51608,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-01-15 10:48:14","TRTEDTM":"2022-01-14 22:48:14","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"C","STRATA2":"S2","BMRKR1":8.96424,"BMRKR2":"LOW","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-3-id-80","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-3","SUBJID":"id-80","AGE":41.51608,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-01-15 10:48:14","TRTEDTM":"2022-01-14 22:48:14","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"C","STRATA2":"S2","BMRKR1":8.96424,"BMRKR2":"LOW","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-3-id-80","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-3","SUBJID":"id-80","AGE":41.51608,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-01-15 10:48:14","TRTEDTM":"2022-01-14 22:48:14","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"C","STRATA2":"S2","BMRKR1":8.96424,"BMRKR2":"LOW","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-3-id-80","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-3","SUBJID":"id-80","AGE":41.51608,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-01-15 10:48:14","TRTEDTM":"2022-01-14 22:48:14","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"C","STRATA2":"S2","BMRKR1":8.96424,"BMRKR2":"LOW","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-3-id-80","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-01-15 10:48:14","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-3","SUBJID":"id-80","AGE":41.51608,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-01-15 10:48:14","TRTEDTM":"2022-01-14 22:48:14","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"C","STRATA2":"S2","BMRKR1":8.96424,"BMRKR2":"LOW","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-3-id-80","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.2816,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-27 10:48:14","ADY":103}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-3","SUBJID":"id-80","AGE":41.51608,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-01-15 10:48:14","TRTEDTM":"2022-01-14 22:48:14","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"C","STRATA2":"S2","BMRKR1":8.96424,"BMRKR2":"LOW","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-3-id-80","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.282,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-28 10:48:14","ADY":104}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-3","SUBJID":"id-80","AGE":41.51608,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-01-15 10:48:14","TRTEDTM":"2022-01-14 22:48:14","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"C","STRATA2":"S2","BMRKR1":8.96424,"BMRKR2":"LOW","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-3-id-80","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":81.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-08-07 13:50:41","ADY":571}
{"STUDYID":"AB12345","COUNTRY":"GBR","SITEID":"GBR-3","SUBJID":"id-80","AGE":41.51608,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-01-15 10:48:14","TRTEDTM":"2022-01-14 22:48:14","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"C","STRATA2":"S2","BMRKR1":8.96424,"BMRKR2":"LOW","REGION1":"Europe","SAFFL":"Y","USUBJID":"AB12345-GBR-3-id-80","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":0,"AVAL":44.57143,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2020-11-21 05:45:17","ADY":312}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-1","SUBJID":"id-21","AGE":45.68162,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-10-25 20:53:58","TRTEDTM":"2022-10-26 08:53:58","EOSDY":731,"EOSDT":"2022-10-26","STRATA1":"C","STRATA2":"S1","BMRKR1":7.0899,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-1-id-21","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-10-26 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-1","SUBJID":"id-21","AGE":45.68162,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-10-25 20:53:58","TRTEDTM":"2022-10-26 08:53:58","EOSDY":731,"EOSDT":"2022-10-26","STRATA1":"C","STRATA2":"S1","BMRKR1":7.0899,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-1-id-21","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-1","SUBJID":"id-21","AGE":45.68162,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-10-25 20:53:58","TRTEDTM":"2022-10-26 08:53:58","EOSDY":731,"EOSDT":"2022-10-26","STRATA1":"C","STRATA2":"S1","BMRKR1":7.0899,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-1-id-21","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-1","SUBJID":"id-21","AGE":45.68162,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-10-25 20:53:58","TRTEDTM":"2022-10-26 08:53:58","EOSDY":731,"EOSDT":"2022-10-26","STRATA1":"C","STRATA2":"S1","BMRKR1":7.0899,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-1-id-21","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-1","SUBJID":"id-21","AGE":45.68162,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-10-25 20:53:58","TRTEDTM":"2022-10-26 08:53:58","EOSDY":731,"EOSDT":"2022-10-26","STRATA1":"C","STRATA2":"S1","BMRKR1":7.0899,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-1-id-21","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.01533,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-31 20:53:58","ADY":6}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-1","SUBJID":"id-21","AGE":45.68162,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-10-25 20:53:58","TRTEDTM":"2022-10-26 08:53:58","EOSDY":731,"EOSDT":"2022-10-26","STRATA1":"C","STRATA2":"S1","BMRKR1":7.0899,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-1-id-21","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.37312,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-03-11 20:53:58","ADY":137}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-1","SUBJID":"id-21","AGE":45.68162,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-10-25 20:53:58","TRTEDTM":"2022-10-26 08:53:58","EOSDY":731,"EOSDT":"2022-10-26","STRATA1":"C","STRATA2":"S1","BMRKR1":7.0899,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-1-id-21","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.03232,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-11-06 20:53:58","ADY":12}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-1","SUBJID":"id-21","AGE":45.68162,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-10-25 20:53:58","TRTEDTM":"2022-10-26 08:53:58","EOSDY":731,"EOSDT":"2022-10-26","STRATA1":"C","STRATA2":"S1","BMRKR1":7.0899,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-1-id-21","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":55.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-11-14 05:31:29","ADY":386}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-1","SUBJID":"id-21","AGE":45.68162,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-10-25 20:53:58","TRTEDTM":"2022-10-26 08:53:58","EOSDY":731,"EOSDT":"2022-10-26","STRATA1":"C","STRATA2":"S1","BMRKR1":7.0899,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-1-id-21","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":0,"AVAL":31.14286,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-05-30 10:05:08","ADY":218}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-109","AGE":25.48788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-27 12:45:05","TRTEDTM":"2021-03-27 00:45:05","EOSDY":731,"EOSDT":"2021-03-27","STRATA1":"A","STRATA2":"S2","BMRKR1":1.44944,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-109","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-03-27 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-109","AGE":25.48788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-27 12:45:05","TRTEDTM":"2021-03-27 00:45:05","EOSDY":731,"EOSDT":"2021-03-27","STRATA1":"A","STRATA2":"S2","BMRKR1":1.44944,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-109","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-109","AGE":25.48788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-27 12:45:05","TRTEDTM":"2021-03-27 00:45:05","EOSDY":731,"EOSDT":"2021-03-27","STRATA1":"A","STRATA2":"S2","BMRKR1":1.44944,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-109","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-109","AGE":25.48788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-27 12:45:05","TRTEDTM":"2021-03-27 00:45:05","EOSDY":731,"EOSDT":"2021-03-27","STRATA1":"A","STRATA2":"S2","BMRKR1":1.44944,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-109","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-109","AGE":25.48788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-27 12:45:05","TRTEDTM":"2021-03-27 00:45:05","EOSDY":731,"EOSDT":"2021-03-27","STRATA1":"A","STRATA2":"S2","BMRKR1":1.44944,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-109","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-03-28 12:45:05","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-109","AGE":25.48788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-27 12:45:05","TRTEDTM":"2021-03-27 00:45:05","EOSDY":731,"EOSDT":"2021-03-27","STRATA1":"A","STRATA2":"S2","BMRKR1":1.44944,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-109","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-03-28 12:45:05","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-109","AGE":25.48788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-27 12:45:05","TRTEDTM":"2021-03-27 00:45:05","EOSDY":731,"EOSDT":"2021-03-27","STRATA1":"A","STRATA2":"S2","BMRKR1":1.44944,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-109","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.42297,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-29 12:45:05","ADY":155}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-109","AGE":25.48788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-27 12:45:05","TRTEDTM":"2021-03-27 00:45:05","EOSDY":731,"EOSDT":"2021-03-27","STRATA1":"A","STRATA2":"S2","BMRKR1":1.44944,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-109","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-03-27 12:45:05","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-109","AGE":25.48788,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-27 12:45:05","TRTEDTM":"2021-03-27 00:45:05","EOSDY":731,"EOSDT":"2021-03-27","STRATA1":"A","STRATA2":"S2","BMRKR1":1.44944,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-109","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":0,"AVAL":58.71429,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2020-05-10 20:46:13","ADY":411}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-135","AGE":24.08815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-06-09 01:40:54","TRTEDTM":"2022-06-09 13:40:54","EOSDY":731,"EOSDT":"2022-06-09","STRATA1":"A","STRATA2":"S2","BMRKR1":4.27932,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-135","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-06-09 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-135","AGE":24.08815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-06-09 01:40:54","TRTEDTM":"2022-06-09 13:40:54","EOSDY":731,"EOSDT":"2022-06-09","STRATA1":"A","STRATA2":"S2","BMRKR1":4.27932,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-135","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-135","AGE":24.08815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-06-09 01:40:54","TRTEDTM":"2022-06-09 13:40:54","EOSDY":731,"EOSDT":"2022-06-09","STRATA1":"A","STRATA2":"S2","BMRKR1":4.27932,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-135","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-135","AGE":24.08815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-06-09 01:40:54","TRTEDTM":"2022-06-09 13:40:54","EOSDY":731,"EOSDT":"2022-06-09","STRATA1":"A","STRATA2":"S2","BMRKR1":4.27932,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-135","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-135","AGE":24.08815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-06-09 01:40:54","TRTEDTM":"2022-06-09 13:40:54","EOSDY":731,"EOSDT":"2022-06-09","STRATA1":"A","STRATA2":"S2","BMRKR1":4.27932,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-135","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.16095,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-07 01:40:54","ADY":59}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-135","AGE":24.08815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-06-09 01:40:54","TRTEDTM":"2022-06-09 13:40:54","EOSDY":731,"EOSDT":"2022-06-09","STRATA1":"A","STRATA2":"S2","BMRKR1":4.27932,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-135","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.6636,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-02-07 01:40:54","ADY":243}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-135","AGE":24.08815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-06-09 01:40:54","TRTEDTM":"2022-06-09 13:40:54","EOSDY":731,"EOSDT":"2022-06-09","STRATA1":"A","STRATA2":"S2","BMRKR1":4.27932,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-135","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.22263,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-30 01:40:54","ADY":82}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-135","AGE":24.08815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-06-09 01:40:54","TRTEDTM":"2022-06-09 13:40:54","EOSDY":731,"EOSDT":"2022-06-09","STRATA1":"A","STRATA2":"S2","BMRKR1":4.27932,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-135","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":78.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-12-12 10:09:35","ADY":552}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-135","AGE":24.08815,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-06-09 01:40:54","TRTEDTM":"2022-06-09 13:40:54","EOSDY":731,"EOSDT":"2022-06-09","STRATA1":"A","STRATA2":"S2","BMRKR1":4.27932,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-135","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":0,"AVAL":52.71429,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-06-12 19:05:28","ADY":369}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-189","AGE":57.47833,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-06-12 05:09:20","TRTEDTM":"2021-06-11 17:09:20","EOSDY":731,"EOSDT":"2021-06-11","STRATA1":"B","STRATA2":"S2","BMRKR1":8.69213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-189","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-06-11 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-189","AGE":57.47833,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-06-12 05:09:20","TRTEDTM":"2021-06-11 17:09:20","EOSDY":731,"EOSDT":"2021-06-11","STRATA1":"B","STRATA2":"S2","BMRKR1":8.69213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-189","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-189","AGE":57.47833,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-06-12 05:09:20","TRTEDTM":"2021-06-11 17:09:20","EOSDY":731,"EOSDT":"2021-06-11","STRATA1":"B","STRATA2":"S2","BMRKR1":8.69213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-189","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-189","AGE":57.47833,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-06-12 05:09:20","TRTEDTM":"2021-06-11 17:09:20","EOSDY":731,"EOSDT":"2021-06-11","STRATA1":"B","STRATA2":"S2","BMRKR1":8.69213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-189","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-189","AGE":57.47833,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-06-12 05:09:20","TRTEDTM":"2021-06-11 17:09:20","EOSDY":731,"EOSDT":"2021-06-11","STRATA1":"B","STRATA2":"S2","BMRKR1":8.69213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-189","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.17775,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-16 05:09:20","ADY":65}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-189","AGE":57.47833,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-06-12 05:09:20","TRTEDTM":"2021-06-11 17:09:20","EOSDY":731,"EOSDT":"2021-06-11","STRATA1":"B","STRATA2":"S2","BMRKR1":8.69213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-189","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-06-12 05:09:20","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-189","AGE":57.47833,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-06-12 05:09:20","TRTEDTM":"2021-06-11 17:09:20","EOSDY":731,"EOSDT":"2021-06-11","STRATA1":"B","STRATA2":"S2","BMRKR1":8.69213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-189","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.08008,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-12 05:09:20","ADY":30}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-189","AGE":57.47833,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-06-12 05:09:20","TRTEDTM":"2021-06-11 17:09:20","EOSDY":731,"EOSDT":"2021-06-11","STRATA1":"B","STRATA2":"S2","BMRKR1":8.69213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-189","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":62.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-19 22:38:12","ADY":435}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-11","SUBJID":"id-189","AGE":57.47833,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-06-12 05:09:20","TRTEDTM":"2021-06-11 17:09:20","EOSDY":731,"EOSDT":"2021-06-11","STRATA1":"B","STRATA2":"S2","BMRKR1":8.69213,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-11-id-189","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":0,"AVAL":33.42857,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2020-01-31 15:23:46","ADY":234}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-194","AGE":30.3347,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-06 15:32:22","TRTEDTM":"2021-05-06 03:32:22","EOSDY":731,"EOSDT":"2021-05-06","STRATA1":"A","STRATA2":"S2","BMRKR1":5.0991,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-194","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-05-06 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-194","AGE":30.3347,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-06 15:32:22","TRTEDTM":"2021-05-06 03:32:22","EOSDY":731,"EOSDT":"2021-05-06","STRATA1":"A","STRATA2":"S2","BMRKR1":5.0991,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-194","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-194","AGE":30.3347,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-06 15:32:22","TRTEDTM":"2021-05-06 03:32:22","EOSDY":731,"EOSDT":"2021-05-06","STRATA1":"A","STRATA2":"S2","BMRKR1":5.0991,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-194","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-194","AGE":30.3347,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-06 15:32:22","TRTEDTM":"2021-05-06 03:32:22","EOSDY":731,"EOSDT":"2021-05-06","STRATA1":"A","STRATA2":"S2","BMRKR1":5.0991,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-194","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-194","AGE":30.3347,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-06 15:32:22","TRTEDTM":"2021-05-06 03:32:22","EOSDY":731,"EOSDT":"2021-05-06","STRATA1":"A","STRATA2":"S2","BMRKR1":5.0991,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-194","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-05-07 15:32:22","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-194","AGE":30.3347,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-06 15:32:22","TRTEDTM":"2021-05-06 03:32:22","EOSDY":731,"EOSDT":"2021-05-06","STRATA1":"A","STRATA2":"S2","BMRKR1":5.0991,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-194","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.13843,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-06-26 15:32:22","ADY":51}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-194","AGE":30.3347,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-06 15:32:22","TRTEDTM":"2021-05-06 03:32:22","EOSDY":731,"EOSDT":"2021-05-06","STRATA1":"A","STRATA2":"S2","BMRKR1":5.0991,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-194","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.09601,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-06-11 15:32:22","ADY":36}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-194","AGE":30.3347,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-06 15:32:22","TRTEDTM":"2021-05-06 03:32:22","EOSDY":731,"EOSDT":"2021-05-06","STRATA1":"A","STRATA2":"S2","BMRKR1":5.0991,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-194","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":77.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-10-28 09:21:18","ADY":542}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-194","AGE":30.3347,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-06 15:32:22","TRTEDTM":"2021-05-06 03:32:22","EOSDY":731,"EOSDT":"2021-05-06","STRATA1":"A","STRATA2":"S2","BMRKR1":5.0991,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-194","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":0,"AVAL":21.71429,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2019-10-04 11:39:12","ADY":152}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-61","AGE":40.92515,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-19 00:30:31","TRTEDTM":"2022-09-19 12:30:31","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S1","BMRKR1":18.49236,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-61","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-09-19 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-61","AGE":40.92515,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-19 00:30:31","TRTEDTM":"2022-09-19 12:30:31","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S1","BMRKR1":18.49236,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-61","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-61","AGE":40.92515,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-19 00:30:31","TRTEDTM":"2022-09-19 12:30:31","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S1","BMRKR1":18.49236,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-61","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-61","AGE":40.92515,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-19 00:30:31","TRTEDTM":"2022-09-19 12:30:31","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S1","BMRKR1":18.49236,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-61","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-61","AGE":40.92515,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-19 00:30:31","TRTEDTM":"2022-09-19 12:30:31","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S1","BMRKR1":18.49236,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-61","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.03997,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-04 00:30:31","ADY":15}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-61","AGE":40.92515,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-19 00:30:31","TRTEDTM":"2022-09-19 12:30:31","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S1","BMRKR1":18.49236,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-61","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-09-20 00:30:31","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-61","AGE":40.92515,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-19 00:30:31","TRTEDTM":"2022-09-19 12:30:31","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S1","BMRKR1":18.49236,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-61","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.73623,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-06-15 00:30:31","ADY":269}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-61","AGE":40.92515,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-19 00:30:31","TRTEDTM":"2022-09-19 12:30:31","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S1","BMRKR1":18.49236,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-61","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":45,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-07-30 21:37:18","ADY":315}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-61","AGE":40.92515,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-09-19 00:30:31","TRTEDTM":"2022-09-19 12:30:31","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S1","BMRKR1":18.49236,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-61","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":0,"AVAL":39.14286,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-06-19 07:22:05","ADY":274}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-7","AGE":40.35558,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-02 22:57:04","TRTEDTM":"2021-09-02 10:57:04","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"C","STRATA2":"S1","BMRKR1":1.09934,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-7","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-09-02 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-7","AGE":40.35558,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-02 22:57:04","TRTEDTM":"2021-09-02 10:57:04","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"C","STRATA2":"S1","BMRKR1":1.09934,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-7","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-7","AGE":40.35558,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-02 22:57:04","TRTEDTM":"2021-09-02 10:57:04","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"C","STRATA2":"S1","BMRKR1":1.09934,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-7","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-7","AGE":40.35558,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-02 22:57:04","TRTEDTM":"2021-09-02 10:57:04","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"C","STRATA2":"S1","BMRKR1":1.09934,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-7","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-7","AGE":40.35558,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-02 22:57:04","TRTEDTM":"2021-09-02 10:57:04","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"C","STRATA2":"S1","BMRKR1":1.09934,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-7","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.03618,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-16 22:57:04","ADY":14}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-7","AGE":40.35558,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-02 22:57:04","TRTEDTM":"2021-09-02 10:57:04","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"C","STRATA2":"S1","BMRKR1":1.09934,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-7","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.04178,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-18 22:57:04","ADY":16}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-7","AGE":40.35558,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-02 22:57:04","TRTEDTM":"2021-09-02 10:57:04","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"C","STRATA2":"S1","BMRKR1":1.09934,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-7","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.0723,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-29 22:57:04","ADY":27}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-7","AGE":40.35558,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-02 22:57:04","TRTEDTM":"2021-09-02 10:57:04","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"C","STRATA2":"S1","BMRKR1":1.09934,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-7","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":54.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-09-15 11:18:23","ADY":380}
{"STUDYID":"AB12345","COUNTRY":"JPN","SITEID":"JPN-2","SUBJID":"id-7","AGE":40.35558,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-09-02 22:57:04","TRTEDTM":"2021-09-02 10:57:04","EOSDY":731,"EOSDT":"2021-09-02","STRATA1":"C","STRATA2":"S1","BMRKR1":1.09934,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-JPN-2-id-7","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":0,"AVAL":62.28571,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2020-11-10 05:50:20","ADY":436}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-198","AGE":38.46446,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-01 01:05:44","TRTEDTM":"2021-11-30 13:05:44","EOSDY":731,"EOSDT":"2021-11-30","STRATA1":"B","STRATA2":"S1","BMRKR1":5.59627,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-198","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-11-30 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-198","AGE":38.46446,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-01 01:05:44","TRTEDTM":"2021-11-30 13:05:44","EOSDY":731,"EOSDT":"2021-11-30","STRATA1":"B","STRATA2":"S1","BMRKR1":5.59627,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-198","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-198","AGE":38.46446,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-01 01:05:44","TRTEDTM":"2021-11-30 13:05:44","EOSDY":731,"EOSDT":"2021-11-30","STRATA1":"B","STRATA2":"S1","BMRKR1":5.59627,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-198","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-198","AGE":38.46446,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-01 01:05:44","TRTEDTM":"2021-11-30 13:05:44","EOSDY":731,"EOSDT":"2021-11-30","STRATA1":"B","STRATA2":"S1","BMRKR1":5.59627,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-198","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-198","AGE":38.46446,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-01 01:05:44","TRTEDTM":"2021-11-30 13:05:44","EOSDY":731,"EOSDT":"2021-11-30","STRATA1":"B","STRATA2":"S1","BMRKR1":5.59627,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-198","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-12-01 01:05:44","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-198","AGE":38.46446,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-01 01:05:44","TRTEDTM":"2021-11-30 13:05:44","EOSDY":731,"EOSDT":"2021-11-30","STRATA1":"B","STRATA2":"S1","BMRKR1":5.59627,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-198","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.00297,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-03 01:05:44","ADY":2}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-198","AGE":38.46446,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-01 01:05:44","TRTEDTM":"2021-11-30 13:05:44","EOSDY":731,"EOSDT":"2021-11-30","STRATA1":"B","STRATA2":"S1","BMRKR1":5.59627,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-198","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.12061,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-01-15 01:05:44","ADY":45}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-198","AGE":38.46446,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-01 01:05:44","TRTEDTM":"2021-11-30 13:05:44","EOSDY":731,"EOSDT":"2021-11-30","STRATA1":"B","STRATA2":"S1","BMRKR1":5.59627,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-198","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":54.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-12-16 12:44:46","ADY":382}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-198","AGE":38.46446,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-12-01 01:05:44","TRTEDTM":"2021-11-30 13:05:44","EOSDY":731,"EOSDT":"2021-11-30","STRATA1":"B","STRATA2":"S1","BMRKR1":5.59627,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-198","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":38.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-24 00:01:48","ADY":268}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-35","AGE":32.77212,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-23 19:21:38","TRTEDTM":"2021-04-23 07:21:38","EOSDY":731,"EOSDT":"2021-04-23","STRATA1":"C","STRATA2":"S2","BMRKR1":5.65605,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-35","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-04-23 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-35","AGE":32.77212,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-23 19:21:38","TRTEDTM":"2021-04-23 07:21:38","EOSDY":731,"EOSDT":"2021-04-23","STRATA1":"C","STRATA2":"S2","BMRKR1":5.65605,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-35","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-35","AGE":32.77212,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-23 19:21:38","TRTEDTM":"2021-04-23 07:21:38","EOSDY":731,"EOSDT":"2021-04-23","STRATA1":"C","STRATA2":"S2","BMRKR1":5.65605,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-35","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-35","AGE":32.77212,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-23 19:21:38","TRTEDTM":"2021-04-23 07:21:38","EOSDY":731,"EOSDT":"2021-04-23","STRATA1":"C","STRATA2":"S2","BMRKR1":5.65605,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-35","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-35","AGE":32.77212,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-23 19:21:38","TRTEDTM":"2021-04-23 07:21:38","EOSDY":731,"EOSDT":"2021-04-23","STRATA1":"C","STRATA2":"S2","BMRKR1":5.65605,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-35","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-04-24 19:21:38","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-35","AGE":32.77212,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-23 19:21:38","TRTEDTM":"2021-04-23 07:21:38","EOSDY":731,"EOSDT":"2021-04-23","STRATA1":"C","STRATA2":"S2","BMRKR1":5.65605,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-35","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.12452,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-06-08 19:21:38","ADY":46}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-35","AGE":32.77212,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-23 19:21:38","TRTEDTM":"2021-04-23 07:21:38","EOSDY":731,"EOSDT":"2021-04-23","STRATA1":"C","STRATA2":"S2","BMRKR1":5.65605,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-35","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.14222,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-06-14 19:21:38","ADY":52}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-35","AGE":32.77212,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-23 19:21:38","TRTEDTM":"2021-04-23 07:21:38","EOSDY":731,"EOSDT":"2021-04-23","STRATA1":"C","STRATA2":"S2","BMRKR1":5.65605,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-35","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":61.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-06-28 07:51:04","ADY":433}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-35","AGE":32.77212,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-23 19:21:38","TRTEDTM":"2021-04-23 07:21:38","EOSDY":731,"EOSDT":"2021-04-23","STRATA1":"C","STRATA2":"S2","BMRKR1":5.65605,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-35","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":9.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-06-27 10:48:42","ADY":66}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-41","AGE":32.81808,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-08-22 17:03:42","TRTEDTM":"2022-08-23 05:03:42","EOSDY":731,"EOSDT":"2022-08-23","STRATA1":"B","STRATA2":"S2","BMRKR1":8.32347,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-41","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-08-23 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-41","AGE":32.81808,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-08-22 17:03:42","TRTEDTM":"2022-08-23 05:03:42","EOSDY":731,"EOSDT":"2022-08-23","STRATA1":"B","STRATA2":"S2","BMRKR1":8.32347,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-41","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-41","AGE":32.81808,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-08-22 17:03:42","TRTEDTM":"2022-08-23 05:03:42","EOSDY":731,"EOSDT":"2022-08-23","STRATA1":"B","STRATA2":"S2","BMRKR1":8.32347,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-41","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-41","AGE":32.81808,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-08-22 17:03:42","TRTEDTM":"2022-08-23 05:03:42","EOSDY":731,"EOSDT":"2022-08-23","STRATA1":"B","STRATA2":"S2","BMRKR1":8.32347,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-41","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-41","AGE":32.81808,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-08-22 17:03:42","TRTEDTM":"2022-08-23 05:03:42","EOSDY":731,"EOSDT":"2022-08-23","STRATA1":"B","STRATA2":"S2","BMRKR1":8.32347,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-41","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.15642,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-19 17:03:42","ADY":58}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-41","AGE":32.81808,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-08-22 17:03:42","TRTEDTM":"2022-08-23 05:03:42","EOSDY":731,"EOSDT":"2022-08-23","STRATA1":"B","STRATA2":"S2","BMRKR1":8.32347,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-41","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2022-08-24 17:03:42","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-41","AGE":32.81808,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-08-22 17:03:42","TRTEDTM":"2022-08-23 05:03:42","EOSDY":731,"EOSDT":"2022-08-23","STRATA1":"B","STRATA2":"S2","BMRKR1":8.32347,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-41","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.2579,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-11-25 17:03:42","ADY":95}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-41","AGE":32.81808,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-08-22 17:03:42","TRTEDTM":"2022-08-23 05:03:42","EOSDY":731,"EOSDT":"2022-08-23","STRATA1":"B","STRATA2":"S2","BMRKR1":8.32347,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-41","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-08-22 17:03:42","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-1","SUBJID":"id-41","AGE":32.81808,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-08-22 17:03:42","TRTEDTM":"2022-08-23 05:03:42","EOSDY":731,"EOSDT":"2022-08-23","STRATA1":"B","STRATA2":"S2","BMRKR1":8.32347,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-1-id-41","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":59.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-10-11 10:58:39","ADY":416}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-200","AGE":36.07651,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-05-07 15:48:45","TRTEDTM":"2021-05-07 03:48:45","EOSDY":731,"EOSDT":"2021-05-07","STRATA1":"B","STRATA2":"S2","BMRKR1":6.0576,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-200","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-05-07 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-200","AGE":36.07651,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-05-07 15:48:45","TRTEDTM":"2021-05-07 03:48:45","EOSDY":731,"EOSDT":"2021-05-07","STRATA1":"B","STRATA2":"S2","BMRKR1":6.0576,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-200","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-200","AGE":36.07651,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-05-07 15:48:45","TRTEDTM":"2021-05-07 03:48:45","EOSDY":731,"EOSDT":"2021-05-07","STRATA1":"B","STRATA2":"S2","BMRKR1":6.0576,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-200","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-200","AGE":36.07651,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-05-07 15:48:45","TRTEDTM":"2021-05-07 03:48:45","EOSDY":731,"EOSDT":"2021-05-07","STRATA1":"B","STRATA2":"S2","BMRKR1":6.0576,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-200","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":10}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-200","AGE":36.07651,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-05-07 15:48:45","TRTEDTM":"2021-05-07 03:48:45","EOSDY":731,"EOSDT":"2021-05-07","STRATA1":"B","STRATA2":"S2","BMRKR1":6.0576,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-200","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-05-08 15:48:45","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-200","AGE":36.07651,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-05-07 15:48:45","TRTEDTM":"2021-05-07 03:48:45","EOSDY":731,"EOSDT":"2021-05-07","STRATA1":"B","STRATA2":"S2","BMRKR1":6.0576,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-200","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-05-08 15:48:45","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-200","AGE":36.07651,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-05-07 15:48:45","TRTEDTM":"2021-05-07 03:48:45","EOSDY":731,"EOSDT":"2021-05-07","STRATA1":"B","STRATA2":"S2","BMRKR1":6.0576,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-200","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.24436,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-05 15:48:45","ADY":90}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-200","AGE":36.07651,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-05-07 15:48:45","TRTEDTM":"2021-05-07 03:48:45","EOSDY":731,"EOSDT":"2021-05-07","STRATA1":"B","STRATA2":"S2","BMRKR1":6.0576,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-200","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":52.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-05-08 06:37:42","ADY":368}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-200","AGE":36.07651,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-05-07 15:48:45","TRTEDTM":"2021-05-07 03:48:45","EOSDY":731,"EOSDT":"2021-05-07","STRATA1":"B","STRATA2":"S2","BMRKR1":6.0576,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-200","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":68.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-26 18:57:15","ADY":478}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-46","AGE":28.24294,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-28 03:14:41","TRTEDTM":"2021-11-27 15:14:41","EOSDY":731,"EOSDT":"2021-11-27","STRATA1":"B","STRATA2":"S1","BMRKR1":4.83231,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-46","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-11-27 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-46","AGE":28.24294,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-28 03:14:41","TRTEDTM":"2021-11-27 15:14:41","EOSDY":731,"EOSDT":"2021-11-27","STRATA1":"B","STRATA2":"S1","BMRKR1":4.83231,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-46","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-46","AGE":28.24294,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-28 03:14:41","TRTEDTM":"2021-11-27 15:14:41","EOSDY":731,"EOSDT":"2021-11-27","STRATA1":"B","STRATA2":"S1","BMRKR1":4.83231,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-46","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-46","AGE":28.24294,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-28 03:14:41","TRTEDTM":"2021-11-27 15:14:41","EOSDY":731,"EOSDT":"2021-11-27","STRATA1":"B","STRATA2":"S1","BMRKR1":4.83231,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-46","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-46","AGE":28.24294,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-28 03:14:41","TRTEDTM":"2021-11-27 15:14:41","EOSDY":731,"EOSDT":"2021-11-27","STRATA1":"B","STRATA2":"S1","BMRKR1":4.83231,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-46","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.28995,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-03-13 03:14:41","ADY":106}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-46","AGE":28.24294,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-28 03:14:41","TRTEDTM":"2021-11-27 15:14:41","EOSDY":731,"EOSDT":"2021-11-27","STRATA1":"B","STRATA2":"S1","BMRKR1":4.83231,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-46","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-11-28 03:14:41","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-46","AGE":28.24294,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-28 03:14:41","TRTEDTM":"2021-11-27 15:14:41","EOSDY":731,"EOSDT":"2021-11-27","STRATA1":"B","STRATA2":"S1","BMRKR1":4.83231,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-46","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.39577,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-21 03:14:41","ADY":145}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-46","AGE":28.24294,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-28 03:14:41","TRTEDTM":"2021-11-27 15:14:41","EOSDY":731,"EOSDT":"2021-11-27","STRATA1":"B","STRATA2":"S1","BMRKR1":4.83231,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-46","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":7,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-01-15 10:18:52","ADY":49}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-46","AGE":28.24294,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-28 03:14:41","TRTEDTM":"2021-11-27 15:14:41","EOSDY":731,"EOSDT":"2021-11-27","STRATA1":"B","STRATA2":"S1","BMRKR1":4.83231,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-46","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":54.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-12-10 17:26:01","ADY":379}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-72","AGE":37.41622,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-22 00:38:26","TRTEDTM":"2022-02-21 12:38:26","EOSDY":731,"EOSDT":"2022-02-21","STRATA1":"B","STRATA2":"S2","BMRKR1":8.01119,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-72","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-02-21 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-72","AGE":37.41622,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-22 00:38:26","TRTEDTM":"2022-02-21 12:38:26","EOSDY":731,"EOSDT":"2022-02-21","STRATA1":"B","STRATA2":"S2","BMRKR1":8.01119,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-72","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-72","AGE":37.41622,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-22 00:38:26","TRTEDTM":"2022-02-21 12:38:26","EOSDY":731,"EOSDT":"2022-02-21","STRATA1":"B","STRATA2":"S2","BMRKR1":8.01119,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-72","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-72","AGE":37.41622,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-22 00:38:26","TRTEDTM":"2022-02-21 12:38:26","EOSDY":731,"EOSDT":"2022-02-21","STRATA1":"B","STRATA2":"S2","BMRKR1":8.01119,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-72","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":8}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-72","AGE":37.41622,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-22 00:38:26","TRTEDTM":"2022-02-21 12:38:26","EOSDY":731,"EOSDT":"2022-02-21","STRATA1":"B","STRATA2":"S2","BMRKR1":8.01119,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-72","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.29009,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-06-07 00:38:26","ADY":106}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-72","AGE":37.41622,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-22 00:38:26","TRTEDTM":"2022-02-21 12:38:26","EOSDY":731,"EOSDT":"2022-02-21","STRATA1":"B","STRATA2":"S2","BMRKR1":8.01119,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-72","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.25157,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-05-24 00:38:26","ADY":92}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-72","AGE":37.41622,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-22 00:38:26","TRTEDTM":"2022-02-21 12:38:26","EOSDY":731,"EOSDT":"2022-02-21","STRATA1":"B","STRATA2":"S2","BMRKR1":8.01119,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-72","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.12844,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-09 00:38:26","ADY":47}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-72","AGE":37.41622,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-22 00:38:26","TRTEDTM":"2022-02-21 12:38:26","EOSDY":731,"EOSDT":"2022-02-21","STRATA1":"B","STRATA2":"S2","BMRKR1":8.01119,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-72","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":54.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-03-06 18:22:39","ADY":379}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-72","AGE":37.41622,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-02-22 00:38:26","TRTEDTM":"2022-02-21 12:38:26","EOSDY":731,"EOSDT":"2022-02-21","STRATA1":"B","STRATA2":"S2","BMRKR1":8.01119,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-72","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-02-22 00:38:26","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-99","AGE":31.54057,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 03:41:30","TRTEDTM":"2022-04-07 15:41:30","EOSDY":731,"EOSDT":"2022-04-07","STRATA1":"B","STRATA2":"S2","BMRKR1":9.48026,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-99","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-04-07 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-99","AGE":31.54057,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 03:41:30","TRTEDTM":"2022-04-07 15:41:30","EOSDY":731,"EOSDT":"2022-04-07","STRATA1":"B","STRATA2":"S2","BMRKR1":9.48026,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-99","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-99","AGE":31.54057,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 03:41:30","TRTEDTM":"2022-04-07 15:41:30","EOSDY":731,"EOSDT":"2022-04-07","STRATA1":"B","STRATA2":"S2","BMRKR1":9.48026,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-99","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-99","AGE":31.54057,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 03:41:30","TRTEDTM":"2022-04-07 15:41:30","EOSDY":731,"EOSDT":"2022-04-07","STRATA1":"B","STRATA2":"S2","BMRKR1":9.48026,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-99","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-99","AGE":31.54057,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 03:41:30","TRTEDTM":"2022-04-07 15:41:30","EOSDY":731,"EOSDT":"2022-04-07","STRATA1":"B","STRATA2":"S2","BMRKR1":9.48026,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-99","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2022-04-08 03:41:30","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-99","AGE":31.54057,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 03:41:30","TRTEDTM":"2022-04-07 15:41:30","EOSDY":731,"EOSDT":"2022-04-07","STRATA1":"B","STRATA2":"S2","BMRKR1":9.48026,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-99","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.00919,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-11 03:41:30","ADY":4}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-99","AGE":31.54057,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 03:41:30","TRTEDTM":"2022-04-07 15:41:30","EOSDY":731,"EOSDT":"2022-04-07","STRATA1":"B","STRATA2":"S2","BMRKR1":9.48026,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-99","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-04-08 03:41:30","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-99","AGE":31.54057,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 03:41:30","TRTEDTM":"2022-04-07 15:41:30","EOSDY":731,"EOSDT":"2022-04-07","STRATA1":"B","STRATA2":"S2","BMRKR1":9.48026,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-99","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-04-07 03:41:30","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-11","SUBJID":"id-99","AGE":31.54057,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-07 03:41:30","TRTEDTM":"2022-04-07 15:41:30","EOSDY":731,"EOSDT":"2022-04-07","STRATA1":"B","STRATA2":"S2","BMRKR1":9.48026,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-11-id-99","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":50,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-03-22 11:03:01","ADY":350}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-37","AGE":33.23578,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-02 17:49:22","TRTEDTM":"2021-06-02 05:49:22","EOSDY":731,"EOSDT":"2021-06-02","STRATA1":"A","STRATA2":"S2","BMRKR1":7.37719,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-37","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-06-02 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-37","AGE":33.23578,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-02 17:49:22","TRTEDTM":"2021-06-02 05:49:22","EOSDY":731,"EOSDT":"2021-06-02","STRATA1":"A","STRATA2":"S2","BMRKR1":7.37719,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-37","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-37","AGE":33.23578,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-02 17:49:22","TRTEDTM":"2021-06-02 05:49:22","EOSDY":731,"EOSDT":"2021-06-02","STRATA1":"A","STRATA2":"S2","BMRKR1":7.37719,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-37","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-37","AGE":33.23578,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-02 17:49:22","TRTEDTM":"2021-06-02 05:49:22","EOSDY":731,"EOSDT":"2021-06-02","STRATA1":"A","STRATA2":"S2","BMRKR1":7.37719,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-37","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-37","AGE":33.23578,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-02 17:49:22","TRTEDTM":"2021-06-02 05:49:22","EOSDY":731,"EOSDT":"2021-06-02","STRATA1":"A","STRATA2":"S2","BMRKR1":7.37719,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-37","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.12343,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-18 17:49:22","ADY":46}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-37","AGE":33.23578,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-02 17:49:22","TRTEDTM":"2021-06-02 05:49:22","EOSDY":731,"EOSDT":"2021-06-02","STRATA1":"A","STRATA2":"S2","BMRKR1":7.37719,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-37","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.0045,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-06-04 17:49:22","ADY":2}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-37","AGE":33.23578,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-02 17:49:22","TRTEDTM":"2021-06-02 05:49:22","EOSDY":731,"EOSDT":"2021-06-02","STRATA1":"A","STRATA2":"S2","BMRKR1":7.37719,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-37","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.01688,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-06-09 17:49:22","ADY":7}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-37","AGE":33.23578,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-02 17:49:22","TRTEDTM":"2021-06-02 05:49:22","EOSDY":731,"EOSDT":"2021-06-02","STRATA1":"A","STRATA2":"S2","BMRKR1":7.37719,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-37","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":6.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-07-16 08:47:48","ADY":45}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-37","AGE":33.23578,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-02 17:49:22","TRTEDTM":"2021-06-02 05:49:22","EOSDY":731,"EOSDT":"2021-06-02","STRATA1":"A","STRATA2":"S2","BMRKR1":7.37719,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-37","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":61.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-03 03:12:02","ADY":429}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-96","AGE":48.32019,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-17 18:01:12","TRTEDTM":"2022-12-18 06:01:12","EOSDY":731,"EOSDT":"2022-12-18","STRATA1":"A","STRATA2":"S1","BMRKR1":11.33434,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-96","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-12-18 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-96","AGE":48.32019,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-17 18:01:12","TRTEDTM":"2022-12-18 06:01:12","EOSDY":731,"EOSDT":"2022-12-18","STRATA1":"A","STRATA2":"S1","BMRKR1":11.33434,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-96","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-96","AGE":48.32019,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-17 18:01:12","TRTEDTM":"2022-12-18 06:01:12","EOSDY":731,"EOSDT":"2022-12-18","STRATA1":"A","STRATA2":"S1","BMRKR1":11.33434,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-96","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-96","AGE":48.32019,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-17 18:01:12","TRTEDTM":"2022-12-18 06:01:12","EOSDY":731,"EOSDT":"2022-12-18","STRATA1":"A","STRATA2":"S1","BMRKR1":11.33434,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-96","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-96","AGE":48.32019,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-17 18:01:12","TRTEDTM":"2022-12-18 06:01:12","EOSDY":731,"EOSDT":"2022-12-18","STRATA1":"A","STRATA2":"S1","BMRKR1":11.33434,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-96","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.2635,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-03-24 18:01:12","ADY":97}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-96","AGE":48.32019,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-17 18:01:12","TRTEDTM":"2022-12-18 06:01:12","EOSDY":731,"EOSDT":"2022-12-18","STRATA1":"A","STRATA2":"S1","BMRKR1":11.33434,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-96","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.15193,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-02-11 18:01:12","ADY":56}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-96","AGE":48.32019,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-17 18:01:12","TRTEDTM":"2022-12-18 06:01:12","EOSDY":731,"EOSDT":"2022-12-18","STRATA1":"A","STRATA2":"S1","BMRKR1":11.33434,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-96","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.83037,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-10-17 18:01:12","ADY":304}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-96","AGE":48.32019,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-17 18:01:12","TRTEDTM":"2022-12-18 06:01:12","EOSDY":731,"EOSDT":"2022-12-18","STRATA1":"A","STRATA2":"S1","BMRKR1":11.33434,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-96","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":9.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-02-23 16:26:47","ADY":69}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-13","SUBJID":"id-96","AGE":48.32019,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-12-17 18:01:12","TRTEDTM":"2022-12-18 06:01:12","EOSDY":731,"EOSDT":"2022-12-18","STRATA1":"A","STRATA2":"S1","BMRKR1":11.33434,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-13-id-96","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":63.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-03-08 18:56:42","ADY":447}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-16","SUBJID":"id-43","AGE":43.56145,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-19 04:27:06","TRTEDTM":"2022-09-19 16:27:06","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S2","BMRKR1":10.22066,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-16-id-43","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-09-19 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-16","SUBJID":"id-43","AGE":43.56145,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-19 04:27:06","TRTEDTM":"2022-09-19 16:27:06","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S2","BMRKR1":10.22066,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-16-id-43","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":12}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-16","SUBJID":"id-43","AGE":43.56145,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-19 04:27:06","TRTEDTM":"2022-09-19 16:27:06","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S2","BMRKR1":10.22066,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-16-id-43","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-16","SUBJID":"id-43","AGE":43.56145,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-19 04:27:06","TRTEDTM":"2022-09-19 16:27:06","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S2","BMRKR1":10.22066,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-16-id-43","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-16","SUBJID":"id-43","AGE":43.56145,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-19 04:27:06","TRTEDTM":"2022-09-19 16:27:06","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S2","BMRKR1":10.22066,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-16-id-43","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.48466,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-03-16 04:27:06","ADY":178}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-16","SUBJID":"id-43","AGE":43.56145,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-19 04:27:06","TRTEDTM":"2022-09-19 16:27:06","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S2","BMRKR1":10.22066,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-16-id-43","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.07739,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-18 04:27:06","ADY":29}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-16","SUBJID":"id-43","AGE":43.56145,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-19 04:27:06","TRTEDTM":"2022-09-19 16:27:06","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S2","BMRKR1":10.22066,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-16-id-43","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.33218,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-19 04:27:06","ADY":122}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-16","SUBJID":"id-43","AGE":43.56145,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-19 04:27:06","TRTEDTM":"2022-09-19 16:27:06","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S2","BMRKR1":10.22066,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-16-id-43","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":98.71429,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2022-08-10 01:40:55","ADY":691}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-16","SUBJID":"id-43","AGE":43.56145,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-09-19 04:27:06","TRTEDTM":"2022-09-19 16:27:06","EOSDY":731,"EOSDT":"2022-09-19","STRATA1":"C","STRATA2":"S2","BMRKR1":10.22066,"BMRKR2":"MEDIUM","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-16-id-43","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":22.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-02-22 16:35:12","ADY":157}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-2","SUBJID":"id-172","AGE":35.15832,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-17 00:53:10","TRTEDTM":"2022-08-17 12:53:10","EOSDY":731,"EOSDT":"2022-08-17","STRATA1":"C","STRATA2":"S2","BMRKR1":19.13252,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-2-id-172","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-08-17 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-2","SUBJID":"id-172","AGE":35.15832,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-17 00:53:10","TRTEDTM":"2022-08-17 12:53:10","EOSDY":731,"EOSDT":"2022-08-17","STRATA1":"C","STRATA2":"S2","BMRKR1":19.13252,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-2-id-172","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-2","SUBJID":"id-172","AGE":35.15832,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-17 00:53:10","TRTEDTM":"2022-08-17 12:53:10","EOSDY":731,"EOSDT":"2022-08-17","STRATA1":"C","STRATA2":"S2","BMRKR1":19.13252,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-2-id-172","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-2","SUBJID":"id-172","AGE":35.15832,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-17 00:53:10","TRTEDTM":"2022-08-17 12:53:10","EOSDY":731,"EOSDT":"2022-08-17","STRATA1":"C","STRATA2":"S2","BMRKR1":19.13252,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-2-id-172","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-2","SUBJID":"id-172","AGE":35.15832,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-17 00:53:10","TRTEDTM":"2022-08-17 12:53:10","EOSDY":731,"EOSDT":"2022-08-17","STRATA1":"C","STRATA2":"S2","BMRKR1":19.13252,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-2-id-172","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.39787,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-10 00:53:10","ADY":146}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-2","SUBJID":"id-172","AGE":35.15832,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-17 00:53:10","TRTEDTM":"2022-08-17 12:53:10","EOSDY":731,"EOSDT":"2022-08-17","STRATA1":"C","STRATA2":"S2","BMRKR1":19.13252,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-2-id-172","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-08-18 00:53:10","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-2","SUBJID":"id-172","AGE":35.15832,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-17 00:53:10","TRTEDTM":"2022-08-17 12:53:10","EOSDY":731,"EOSDT":"2022-08-17","STRATA1":"C","STRATA2":"S2","BMRKR1":19.13252,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-2-id-172","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.09665,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-22 00:53:10","ADY":36}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-2","SUBJID":"id-172","AGE":35.15832,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-17 00:53:10","TRTEDTM":"2022-08-17 12:53:10","EOSDY":731,"EOSDT":"2022-08-17","STRATA1":"C","STRATA2":"S2","BMRKR1":19.13252,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-2-id-172","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":17.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-12-17 03:30:58","ADY":123}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-2","SUBJID":"id-172","AGE":35.15832,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-08-17 00:53:10","TRTEDTM":"2022-08-17 12:53:10","EOSDY":731,"EOSDT":"2022-08-17","STRATA1":"C","STRATA2":"S2","BMRKR1":19.13252,"BMRKR2":"LOW","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-2-id-172","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":44.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-06-21 05:02:05","ADY":309}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-7","SUBJID":"id-173","AGE":30.21161,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-14 17:09:25","TRTEDTM":"2021-04-14 05:09:25","EOSDY":731,"EOSDT":"2021-04-14","STRATA1":"A","STRATA2":"S1","BMRKR1":9.04661,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-7-id-173","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-04-14 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-7","SUBJID":"id-173","AGE":30.21161,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-14 17:09:25","TRTEDTM":"2021-04-14 05:09:25","EOSDY":731,"EOSDT":"2021-04-14","STRATA1":"A","STRATA2":"S1","BMRKR1":9.04661,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-7-id-173","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-7","SUBJID":"id-173","AGE":30.21161,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-14 17:09:25","TRTEDTM":"2021-04-14 05:09:25","EOSDY":731,"EOSDT":"2021-04-14","STRATA1":"A","STRATA2":"S1","BMRKR1":9.04661,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-7-id-173","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-7","SUBJID":"id-173","AGE":30.21161,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-14 17:09:25","TRTEDTM":"2021-04-14 05:09:25","EOSDY":731,"EOSDT":"2021-04-14","STRATA1":"A","STRATA2":"S1","BMRKR1":9.04661,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-7-id-173","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-7","SUBJID":"id-173","AGE":30.21161,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-14 17:09:25","TRTEDTM":"2021-04-14 05:09:25","EOSDY":731,"EOSDT":"2021-04-14","STRATA1":"A","STRATA2":"S1","BMRKR1":9.04661,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-7-id-173","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-04-15 17:09:25","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-7","SUBJID":"id-173","AGE":30.21161,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-14 17:09:25","TRTEDTM":"2021-04-14 05:09:25","EOSDY":731,"EOSDT":"2021-04-14","STRATA1":"A","STRATA2":"S1","BMRKR1":9.04661,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-7-id-173","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.40281,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-09 17:09:25","ADY":148}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-7","SUBJID":"id-173","AGE":30.21161,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-14 17:09:25","TRTEDTM":"2021-04-14 05:09:25","EOSDY":731,"EOSDT":"2021-04-14","STRATA1":"A","STRATA2":"S1","BMRKR1":9.04661,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-7-id-173","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.06791,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-09 17:09:25","ADY":25}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-7","SUBJID":"id-173","AGE":30.21161,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-14 17:09:25","TRTEDTM":"2021-04-14 05:09:25","EOSDY":731,"EOSDT":"2021-04-14","STRATA1":"A","STRATA2":"S1","BMRKR1":9.04661,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-7-id-173","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":3,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2019-05-04 12:54:13","ADY":21}
{"STUDYID":"AB12345","COUNTRY":"NGA","SITEID":"NGA-7","SUBJID":"id-173","AGE":30.21161,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-04-14 17:09:25","TRTEDTM":"2021-04-14 05:09:25","EOSDY":731,"EOSDT":"2021-04-14","STRATA1":"A","STRATA2":"S1","BMRKR1":9.04661,"BMRKR2":"HIGH","REGION1":"Africa","SAFFL":"Y","USUBJID":"AB12345-NGA-7-id-173","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":29.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-11-03 11:43:28","ADY":204}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-164","AGE":37.81597,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"MULTIPLE","TRTSDTM":"2019-10-31 03:54:49","TRTEDTM":"2021-10-30 15:54:49","EOSDY":731,"EOSDT":"2021-10-30","STRATA1":"B","STRATA2":"S2","BMRKR1":4.46296,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-164","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-10-30 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-164","AGE":37.81597,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"MULTIPLE","TRTSDTM":"2019-10-31 03:54:49","TRTEDTM":"2021-10-30 15:54:49","EOSDY":731,"EOSDT":"2021-10-30","STRATA1":"B","STRATA2":"S2","BMRKR1":4.46296,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-164","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-164","AGE":37.81597,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"MULTIPLE","TRTSDTM":"2019-10-31 03:54:49","TRTEDTM":"2021-10-30 15:54:49","EOSDY":731,"EOSDT":"2021-10-30","STRATA1":"B","STRATA2":"S2","BMRKR1":4.46296,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-164","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-164","AGE":37.81597,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"MULTIPLE","TRTSDTM":"2019-10-31 03:54:49","TRTEDTM":"2021-10-30 15:54:49","EOSDY":731,"EOSDT":"2021-10-30","STRATA1":"B","STRATA2":"S2","BMRKR1":4.46296,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-164","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-164","AGE":37.81597,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"MULTIPLE","TRTSDTM":"2019-10-31 03:54:49","TRTEDTM":"2021-10-30 15:54:49","EOSDY":731,"EOSDT":"2021-10-30","STRATA1":"B","STRATA2":"S2","BMRKR1":4.46296,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-164","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-10-31 03:54:49","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-164","AGE":37.81597,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"MULTIPLE","TRTSDTM":"2019-10-31 03:54:49","TRTEDTM":"2021-10-30 15:54:49","EOSDY":731,"EOSDT":"2021-10-30","STRATA1":"B","STRATA2":"S2","BMRKR1":4.46296,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-164","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.05722,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-21 03:54:49","ADY":21}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-164","AGE":37.81597,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"MULTIPLE","TRTSDTM":"2019-10-31 03:54:49","TRTEDTM":"2021-10-30 15:54:49","EOSDY":731,"EOSDT":"2021-10-30","STRATA1":"B","STRATA2":"S2","BMRKR1":4.46296,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-164","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.50126,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-05-02 03:54:49","ADY":184}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-164","AGE":37.81597,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"MULTIPLE","TRTSDTM":"2019-10-31 03:54:49","TRTEDTM":"2021-10-30 15:54:49","EOSDY":731,"EOSDT":"2021-10-30","STRATA1":"B","STRATA2":"S2","BMRKR1":4.46296,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-164","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":42,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-19 16:35:31","ADY":294}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-164","AGE":37.81597,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"MULTIPLE","TRTSDTM":"2019-10-31 03:54:49","TRTEDTM":"2021-10-30 15:54:49","EOSDY":731,"EOSDT":"2021-10-30","STRATA1":"B","STRATA2":"S2","BMRKR1":4.46296,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-164","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":60.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-12-28 13:44:27","ADY":425}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-20","AGE":30.37366,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-19 15:29:14","TRTEDTM":"2022-04-20 03:29:14","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"C","STRATA2":"S1","BMRKR1":16.15027,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-20","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-04-20 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-20","AGE":30.37366,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-19 15:29:14","TRTEDTM":"2022-04-20 03:29:14","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"C","STRATA2":"S1","BMRKR1":16.15027,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-20","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-20","AGE":30.37366,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-19 15:29:14","TRTEDTM":"2022-04-20 03:29:14","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"C","STRATA2":"S1","BMRKR1":16.15027,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-20","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-20","AGE":30.37366,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-19 15:29:14","TRTEDTM":"2022-04-20 03:29:14","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"C","STRATA2":"S1","BMRKR1":16.15027,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-20","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-20","AGE":30.37366,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-19 15:29:14","TRTEDTM":"2022-04-20 03:29:14","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"C","STRATA2":"S1","BMRKR1":16.15027,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-20","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.06496,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-05-13 15:29:14","ADY":24}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-20","AGE":30.37366,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-19 15:29:14","TRTEDTM":"2022-04-20 03:29:14","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"C","STRATA2":"S1","BMRKR1":16.15027,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-20","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.06608,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-05-14 15:29:14","ADY":25}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-20","AGE":30.37366,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-19 15:29:14","TRTEDTM":"2022-04-20 03:29:14","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"C","STRATA2":"S1","BMRKR1":16.15027,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-20","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.38865,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-08 15:29:14","ADY":142}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-20","AGE":30.37366,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-19 15:29:14","TRTEDTM":"2022-04-20 03:29:14","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"C","STRATA2":"S1","BMRKR1":16.15027,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-20","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":2.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-05-08 10:07:29","ADY":20}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-20","AGE":30.37366,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-04-19 15:29:14","TRTEDTM":"2022-04-20 03:29:14","EOSDY":731,"EOSDT":"2022-04-20","STRATA1":"C","STRATA2":"S1","BMRKR1":16.15027,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-20","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":17.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-21 09:15:37","ADY":125}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-39","AGE":28.31864,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-07-25 13:00:07","TRTEDTM":"2021-07-25 01:00:07","EOSDY":731,"EOSDT":"2021-07-25","STRATA1":"B","STRATA2":"S1","BMRKR1":10.51884,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-39","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-07-25 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-39","AGE":28.31864,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-07-25 13:00:07","TRTEDTM":"2021-07-25 01:00:07","EOSDY":731,"EOSDT":"2021-07-25","STRATA1":"B","STRATA2":"S1","BMRKR1":10.51884,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-39","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-39","AGE":28.31864,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-07-25 13:00:07","TRTEDTM":"2021-07-25 01:00:07","EOSDY":731,"EOSDT":"2021-07-25","STRATA1":"B","STRATA2":"S1","BMRKR1":10.51884,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-39","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-39","AGE":28.31864,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-07-25 13:00:07","TRTEDTM":"2021-07-25 01:00:07","EOSDY":731,"EOSDT":"2021-07-25","STRATA1":"B","STRATA2":"S1","BMRKR1":10.51884,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-39","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-39","AGE":28.31864,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-07-25 13:00:07","TRTEDTM":"2021-07-25 01:00:07","EOSDY":731,"EOSDT":"2021-07-25","STRATA1":"B","STRATA2":"S1","BMRKR1":10.51884,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-39","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.13198,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-12 13:00:07","ADY":49}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-39","AGE":28.31864,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-07-25 13:00:07","TRTEDTM":"2021-07-25 01:00:07","EOSDY":731,"EOSDT":"2021-07-25","STRATA1":"B","STRATA2":"S1","BMRKR1":10.51884,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-39","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.03827,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-08 13:00:07","ADY":14}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-39","AGE":28.31864,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-07-25 13:00:07","TRTEDTM":"2021-07-25 01:00:07","EOSDY":731,"EOSDT":"2021-07-25","STRATA1":"B","STRATA2":"S1","BMRKR1":10.51884,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-39","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-07-26 13:00:07","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-39","AGE":28.31864,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-07-25 13:00:07","TRTEDTM":"2021-07-25 01:00:07","EOSDY":731,"EOSDT":"2021-07-25","STRATA1":"B","STRATA2":"S1","BMRKR1":10.51884,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-39","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":61.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-09-26 21:05:55","ADY":430}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-39","AGE":28.31864,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-07-25 13:00:07","TRTEDTM":"2021-07-25 01:00:07","EOSDY":731,"EOSDT":"2021-07-25","STRATA1":"B","STRATA2":"S1","BMRKR1":10.51884,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-39","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":29.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-02-13 18:47:16","ADY":204}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-49","AGE":43.85054,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-25 08:39:54","TRTEDTM":"2021-04-24 20:39:54","EOSDY":731,"EOSDT":"2021-04-24","STRATA1":"C","STRATA2":"S1","BMRKR1":6.19281,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-49","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-04-24 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-49","AGE":43.85054,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-25 08:39:54","TRTEDTM":"2021-04-24 20:39:54","EOSDY":731,"EOSDT":"2021-04-24","STRATA1":"C","STRATA2":"S1","BMRKR1":6.19281,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-49","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-49","AGE":43.85054,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-25 08:39:54","TRTEDTM":"2021-04-24 20:39:54","EOSDY":731,"EOSDT":"2021-04-24","STRATA1":"C","STRATA2":"S1","BMRKR1":6.19281,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-49","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-49","AGE":43.85054,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-25 08:39:54","TRTEDTM":"2021-04-24 20:39:54","EOSDY":731,"EOSDT":"2021-04-24","STRATA1":"C","STRATA2":"S1","BMRKR1":6.19281,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-49","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-49","AGE":43.85054,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-25 08:39:54","TRTEDTM":"2021-04-24 20:39:54","EOSDY":731,"EOSDT":"2021-04-24","STRATA1":"C","STRATA2":"S1","BMRKR1":6.19281,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-49","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.25904,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-29 08:39:54","ADY":95}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-49","AGE":43.85054,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-25 08:39:54","TRTEDTM":"2021-04-24 20:39:54","EOSDY":731,"EOSDT":"2021-04-24","STRATA1":"C","STRATA2":"S1","BMRKR1":6.19281,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-49","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.06876,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-21 08:39:54","ADY":26}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-49","AGE":43.85054,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-25 08:39:54","TRTEDTM":"2021-04-24 20:39:54","EOSDY":731,"EOSDT":"2021-04-24","STRATA1":"C","STRATA2":"S1","BMRKR1":6.19281,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-49","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.4446,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-10-05 08:39:54","ADY":163}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-49","AGE":43.85054,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-25 08:39:54","TRTEDTM":"2021-04-24 20:39:54","EOSDY":731,"EOSDT":"2021-04-24","STRATA1":"C","STRATA2":"S1","BMRKR1":6.19281,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-49","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":67.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-11 18:31:12","ADY":475}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-49","AGE":43.85054,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-25 08:39:54","TRTEDTM":"2021-04-24 20:39:54","EOSDY":731,"EOSDT":"2021-04-24","STRATA1":"C","STRATA2":"S1","BMRKR1":6.19281,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-49","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":50.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-04-14 11:46:13","ADY":356}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-79","AGE":33.8459,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-12-10 13:47:47","TRTEDTM":"2022-12-11 01:47:47","EOSDY":731,"EOSDT":"2022-12-11","STRATA1":"A","STRATA2":"S2","BMRKR1":8.10779,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-79","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-12-11 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-79","AGE":33.8459,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-12-10 13:47:47","TRTEDTM":"2022-12-11 01:47:47","EOSDY":731,"EOSDT":"2022-12-11","STRATA1":"A","STRATA2":"S2","BMRKR1":8.10779,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-79","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-79","AGE":33.8459,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-12-10 13:47:47","TRTEDTM":"2022-12-11 01:47:47","EOSDY":731,"EOSDT":"2022-12-11","STRATA1":"A","STRATA2":"S2","BMRKR1":8.10779,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-79","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-79","AGE":33.8459,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-12-10 13:47:47","TRTEDTM":"2022-12-11 01:47:47","EOSDY":731,"EOSDT":"2022-12-11","STRATA1":"A","STRATA2":"S2","BMRKR1":8.10779,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-79","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":8}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-79","AGE":33.8459,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-12-10 13:47:47","TRTEDTM":"2022-12-11 01:47:47","EOSDY":731,"EOSDT":"2022-12-11","STRATA1":"A","STRATA2":"S2","BMRKR1":8.10779,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-79","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2022-12-12 13:47:47","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-79","AGE":33.8459,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-12-10 13:47:47","TRTEDTM":"2022-12-11 01:47:47","EOSDY":731,"EOSDT":"2022-12-11","STRATA1":"A","STRATA2":"S2","BMRKR1":8.10779,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-79","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.24324,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-03-09 13:47:47","ADY":89}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-79","AGE":33.8459,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-12-10 13:47:47","TRTEDTM":"2022-12-11 01:47:47","EOSDY":731,"EOSDT":"2022-12-11","STRATA1":"A","STRATA2":"S2","BMRKR1":8.10779,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-79","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.07003,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-05 13:47:47","ADY":26}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-79","AGE":33.8459,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-12-10 13:47:47","TRTEDTM":"2022-12-11 01:47:47","EOSDY":731,"EOSDT":"2022-12-11","STRATA1":"A","STRATA2":"S2","BMRKR1":8.10779,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-79","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":59.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-01-29 22:22:49","ADY":416}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-79","AGE":33.8459,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-12-10 13:47:47","TRTEDTM":"2022-12-11 01:47:47","EOSDY":731,"EOSDT":"2022-12-11","STRATA1":"A","STRATA2":"S2","BMRKR1":8.10779,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-79","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":39.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-09-12 20:34:35","ADY":277}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-87","AGE":26.00468,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-12-04 02:33:35","TRTEDTM":"2021-12-03 14:33:35","EOSDY":731,"EOSDT":"2021-12-03","STRATA1":"C","STRATA2":"S1","BMRKR1":7.60794,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-87","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-12-03 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-87","AGE":26.00468,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-12-04 02:33:35","TRTEDTM":"2021-12-03 14:33:35","EOSDY":731,"EOSDT":"2021-12-03","STRATA1":"C","STRATA2":"S1","BMRKR1":7.60794,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-87","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-87","AGE":26.00468,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-12-04 02:33:35","TRTEDTM":"2021-12-03 14:33:35","EOSDY":731,"EOSDT":"2021-12-03","STRATA1":"C","STRATA2":"S1","BMRKR1":7.60794,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-87","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-87","AGE":26.00468,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-12-04 02:33:35","TRTEDTM":"2021-12-03 14:33:35","EOSDY":731,"EOSDT":"2021-12-03","STRATA1":"C","STRATA2":"S1","BMRKR1":7.60794,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-87","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-87","AGE":26.00468,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-12-04 02:33:35","TRTEDTM":"2021-12-03 14:33:35","EOSDY":731,"EOSDT":"2021-12-03","STRATA1":"C","STRATA2":"S1","BMRKR1":7.60794,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-87","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-12-04 02:33:35","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-87","AGE":26.00468,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-12-04 02:33:35","TRTEDTM":"2021-12-03 14:33:35","EOSDY":731,"EOSDT":"2021-12-03","STRATA1":"C","STRATA2":"S1","BMRKR1":7.60794,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-87","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.25165,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-03-05 02:33:35","ADY":92}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-87","AGE":26.00468,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-12-04 02:33:35","TRTEDTM":"2021-12-03 14:33:35","EOSDY":731,"EOSDT":"2021-12-03","STRATA1":"C","STRATA2":"S1","BMRKR1":7.60794,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-87","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.04311,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-20 02:33:35","ADY":16}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-87","AGE":26.00468,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-12-04 02:33:35","TRTEDTM":"2021-12-03 14:33:35","EOSDY":731,"EOSDT":"2021-12-03","STRATA1":"C","STRATA2":"S1","BMRKR1":7.60794,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-87","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":3,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-12-24 00:57:36","ADY":21}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-1","SUBJID":"id-87","AGE":26.00468,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-12-04 02:33:35","TRTEDTM":"2021-12-03 14:33:35","EOSDY":731,"EOSDT":"2021-12-03","STRATA1":"C","STRATA2":"S1","BMRKR1":7.60794,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-1-id-87","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":31.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-07-12 21:30:52","ADY":222}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-112","AGE":26.81625,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-26 14:00:58","TRTEDTM":"2022-04-27 02:00:58","EOSDY":731,"EOSDT":"2022-04-27","STRATA1":"C","STRATA2":"S1","BMRKR1":3.18424,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-112","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-04-27 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-112","AGE":26.81625,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-26 14:00:58","TRTEDTM":"2022-04-27 02:00:58","EOSDY":731,"EOSDT":"2022-04-27","STRATA1":"C","STRATA2":"S1","BMRKR1":3.18424,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-112","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-112","AGE":26.81625,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-26 14:00:58","TRTEDTM":"2022-04-27 02:00:58","EOSDY":731,"EOSDT":"2022-04-27","STRATA1":"C","STRATA2":"S1","BMRKR1":3.18424,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-112","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-112","AGE":26.81625,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-26 14:00:58","TRTEDTM":"2022-04-27 02:00:58","EOSDY":731,"EOSDT":"2022-04-27","STRATA1":"C","STRATA2":"S1","BMRKR1":3.18424,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-112","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-112","AGE":26.81625,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-26 14:00:58","TRTEDTM":"2022-04-27 02:00:58","EOSDY":731,"EOSDT":"2022-04-27","STRATA1":"C","STRATA2":"S1","BMRKR1":3.18424,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-112","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.23799,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-07-22 14:00:58","ADY":87}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-112","AGE":26.81625,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-26 14:00:58","TRTEDTM":"2022-04-27 02:00:58","EOSDY":731,"EOSDT":"2022-04-27","STRATA1":"C","STRATA2":"S1","BMRKR1":3.18424,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-112","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-04-28 14:00:58","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-112","AGE":26.81625,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-26 14:00:58","TRTEDTM":"2022-04-27 02:00:58","EOSDY":731,"EOSDT":"2022-04-27","STRATA1":"C","STRATA2":"S1","BMRKR1":3.18424,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-112","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.44065,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-04 14:00:58","ADY":161}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-112","AGE":26.81625,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-26 14:00:58","TRTEDTM":"2022-04-27 02:00:58","EOSDY":731,"EOSDT":"2022-04-27","STRATA1":"C","STRATA2":"S1","BMRKR1":3.18424,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-112","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":59.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-06-18 07:28:18","ADY":419}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-112","AGE":26.81625,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-04-26 14:00:58","TRTEDTM":"2022-04-27 02:00:58","EOSDY":731,"EOSDT":"2022-04-27","STRATA1":"C","STRATA2":"S1","BMRKR1":3.18424,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-112","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":57,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-05-29 03:55:27","ADY":399}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-117","AGE":43.48289,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-04-18 01:06:00","TRTEDTM":"2022-04-18 13:06:00","EOSDY":731,"EOSDT":"2022-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":7.47485,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-117","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-04-18 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-117","AGE":43.48289,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-04-18 01:06:00","TRTEDTM":"2022-04-18 13:06:00","EOSDY":731,"EOSDT":"2022-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":7.47485,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-117","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-117","AGE":43.48289,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-04-18 01:06:00","TRTEDTM":"2022-04-18 13:06:00","EOSDY":731,"EOSDT":"2022-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":7.47485,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-117","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-117","AGE":43.48289,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-04-18 01:06:00","TRTEDTM":"2022-04-18 13:06:00","EOSDY":731,"EOSDT":"2022-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":7.47485,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-117","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-117","AGE":43.48289,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-04-18 01:06:00","TRTEDTM":"2022-04-18 13:06:00","EOSDY":731,"EOSDT":"2022-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":7.47485,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-117","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.20771,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-07-03 01:06:00","ADY":76}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-117","AGE":43.48289,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-04-18 01:06:00","TRTEDTM":"2022-04-18 13:06:00","EOSDY":731,"EOSDT":"2022-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":7.47485,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-117","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.41271,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-16 01:06:00","ADY":151}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-117","AGE":43.48289,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-04-18 01:06:00","TRTEDTM":"2022-04-18 13:06:00","EOSDY":731,"EOSDT":"2022-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":7.47485,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-117","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.18078,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-06-24 01:06:00","ADY":67}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-117","AGE":43.48289,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-04-18 01:06:00","TRTEDTM":"2022-04-18 13:06:00","EOSDY":731,"EOSDT":"2022-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":7.47485,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-117","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":14.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-07-26 23:12:46","ADY":100}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-117","AGE":43.48289,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-04-18 01:06:00","TRTEDTM":"2022-04-18 13:06:00","EOSDY":731,"EOSDT":"2022-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":7.47485,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-117","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":86.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-12-16 13:45:24","ADY":608}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-148","AGE":31.81097,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-28 16:27:57","TRTEDTM":"2021-04-28 04:27:57","EOSDY":731,"EOSDT":"2021-04-28","STRATA1":"A","STRATA2":"S2","BMRKR1":7.77185,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-148","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-04-28 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-148","AGE":31.81097,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-28 16:27:57","TRTEDTM":"2021-04-28 04:27:57","EOSDY":731,"EOSDT":"2021-04-28","STRATA1":"A","STRATA2":"S2","BMRKR1":7.77185,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-148","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-148","AGE":31.81097,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-28 16:27:57","TRTEDTM":"2021-04-28 04:27:57","EOSDY":731,"EOSDT":"2021-04-28","STRATA1":"A","STRATA2":"S2","BMRKR1":7.77185,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-148","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-148","AGE":31.81097,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-28 16:27:57","TRTEDTM":"2021-04-28 04:27:57","EOSDY":731,"EOSDT":"2021-04-28","STRATA1":"A","STRATA2":"S2","BMRKR1":7.77185,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-148","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-148","AGE":31.81097,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-28 16:27:57","TRTEDTM":"2021-04-28 04:27:57","EOSDY":731,"EOSDT":"2021-04-28","STRATA1":"A","STRATA2":"S2","BMRKR1":7.77185,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-148","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.25847,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-01 16:27:57","ADY":95}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-148","AGE":31.81097,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-28 16:27:57","TRTEDTM":"2021-04-28 04:27:57","EOSDY":731,"EOSDT":"2021-04-28","STRATA1":"A","STRATA2":"S2","BMRKR1":7.77185,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-148","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-04-29 16:27:57","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-148","AGE":31.81097,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-28 16:27:57","TRTEDTM":"2021-04-28 04:27:57","EOSDY":731,"EOSDT":"2021-04-28","STRATA1":"A","STRATA2":"S2","BMRKR1":7.77185,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-148","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.08879,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-31 16:27:57","ADY":33}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-148","AGE":31.81097,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-28 16:27:57","TRTEDTM":"2021-04-28 04:27:57","EOSDY":731,"EOSDT":"2021-04-28","STRATA1":"A","STRATA2":"S2","BMRKR1":7.77185,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-148","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":96.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-02-28 17:08:17","ADY":673}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-148","AGE":31.81097,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-28 16:27:57","TRTEDTM":"2021-04-28 04:27:57","EOSDY":731,"EOSDT":"2021-04-28","STRATA1":"A","STRATA2":"S2","BMRKR1":7.77185,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-148","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":70.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-31 05:01:39","ADY":492}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-191","AGE":37.58691,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-10-24 09:04:39","TRTEDTM":"2022-10-24 21:04:39","EOSDY":731,"EOSDT":"2022-10-24","STRATA1":"C","STRATA2":"S1","BMRKR1":4.09533,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-191","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-10-24 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-191","AGE":37.58691,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-10-24 09:04:39","TRTEDTM":"2022-10-24 21:04:39","EOSDY":731,"EOSDT":"2022-10-24","STRATA1":"C","STRATA2":"S1","BMRKR1":4.09533,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-191","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-191","AGE":37.58691,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-10-24 09:04:39","TRTEDTM":"2022-10-24 21:04:39","EOSDY":731,"EOSDT":"2022-10-24","STRATA1":"C","STRATA2":"S1","BMRKR1":4.09533,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-191","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":9}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-191","AGE":37.58691,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-10-24 09:04:39","TRTEDTM":"2022-10-24 21:04:39","EOSDY":731,"EOSDT":"2022-10-24","STRATA1":"C","STRATA2":"S1","BMRKR1":4.09533,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-191","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-191","AGE":37.58691,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-10-24 09:04:39","TRTEDTM":"2022-10-24 21:04:39","EOSDY":731,"EOSDT":"2022-10-24","STRATA1":"C","STRATA2":"S1","BMRKR1":4.09533,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-191","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.01784,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-31 09:04:39","ADY":7}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-191","AGE":37.58691,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-10-24 09:04:39","TRTEDTM":"2022-10-24 21:04:39","EOSDY":731,"EOSDT":"2022-10-24","STRATA1":"C","STRATA2":"S1","BMRKR1":4.09533,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-191","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.05755,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-11-15 09:04:39","ADY":22}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-191","AGE":37.58691,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-10-24 09:04:39","TRTEDTM":"2022-10-24 21:04:39","EOSDY":731,"EOSDT":"2022-10-24","STRATA1":"C","STRATA2":"S1","BMRKR1":4.09533,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-191","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.43321,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-04-01 09:04:39","ADY":159}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-191","AGE":37.58691,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-10-24 09:04:39","TRTEDTM":"2022-10-24 21:04:39","EOSDY":731,"EOSDT":"2022-10-24","STRATA1":"C","STRATA2":"S1","BMRKR1":4.09533,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-191","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":49.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-10-04 06:39:39","ADY":346}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-191","AGE":37.58691,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-10-24 09:04:39","TRTEDTM":"2022-10-24 21:04:39","EOSDY":731,"EOSDT":"2022-10-24","STRATA1":"C","STRATA2":"S1","BMRKR1":4.09533,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-191","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":50.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-10-14 22:15:14","ADY":356}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-85","AGE":37.00443,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-01 11:23:14","TRTEDTM":"2021-06-30 23:23:14","EOSDY":731,"EOSDT":"2021-06-30","STRATA1":"A","STRATA2":"S1","BMRKR1":4.75279,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-85","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-06-30 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-85","AGE":37.00443,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-01 11:23:14","TRTEDTM":"2021-06-30 23:23:14","EOSDY":731,"EOSDT":"2021-06-30","STRATA1":"A","STRATA2":"S1","BMRKR1":4.75279,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-85","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-85","AGE":37.00443,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-01 11:23:14","TRTEDTM":"2021-06-30 23:23:14","EOSDY":731,"EOSDT":"2021-06-30","STRATA1":"A","STRATA2":"S1","BMRKR1":4.75279,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-85","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-85","AGE":37.00443,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-01 11:23:14","TRTEDTM":"2021-06-30 23:23:14","EOSDY":731,"EOSDT":"2021-06-30","STRATA1":"A","STRATA2":"S1","BMRKR1":4.75279,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-85","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-85","AGE":37.00443,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-01 11:23:14","TRTEDTM":"2021-06-30 23:23:14","EOSDY":731,"EOSDT":"2021-06-30","STRATA1":"A","STRATA2":"S1","BMRKR1":4.75279,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-85","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-07-01 11:23:14","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-85","AGE":37.00443,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-01 11:23:14","TRTEDTM":"2021-06-30 23:23:14","EOSDY":731,"EOSDT":"2021-06-30","STRATA1":"A","STRATA2":"S1","BMRKR1":4.75279,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-85","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-07-01 11:23:14","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-85","AGE":37.00443,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-01 11:23:14","TRTEDTM":"2021-06-30 23:23:14","EOSDY":731,"EOSDT":"2021-06-30","STRATA1":"A","STRATA2":"S1","BMRKR1":4.75279,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-85","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.42988,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-06 11:23:14","ADY":158}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-85","AGE":37.00443,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-01 11:23:14","TRTEDTM":"2021-06-30 23:23:14","EOSDY":731,"EOSDT":"2021-06-30","STRATA1":"A","STRATA2":"S1","BMRKR1":4.75279,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-85","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":76.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-12-19 16:38:20","ADY":538}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-11","SUBJID":"id-85","AGE":37.00443,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-07-01 11:23:14","TRTEDTM":"2021-06-30 23:23:14","EOSDY":731,"EOSDT":"2021-06-30","STRATA1":"A","STRATA2":"S1","BMRKR1":4.75279,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-11-id-85","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":64.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-09-26 03:49:13","ADY":454}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-145","AGE":44.34622,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-02-14 21:49:44","TRTEDTM":"2023-02-15 09:49:44","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"A","STRATA2":"S1","BMRKR1":2.02768,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-145","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2023-02-15 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-145","AGE":44.34622,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-02-14 21:49:44","TRTEDTM":"2023-02-15 09:49:44","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"A","STRATA2":"S1","BMRKR1":2.02768,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-145","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-145","AGE":44.34622,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-02-14 21:49:44","TRTEDTM":"2023-02-15 09:49:44","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"A","STRATA2":"S1","BMRKR1":2.02768,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-145","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-145","AGE":44.34622,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-02-14 21:49:44","TRTEDTM":"2023-02-15 09:49:44","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"A","STRATA2":"S1","BMRKR1":2.02768,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-145","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-145","AGE":44.34622,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-02-14 21:49:44","TRTEDTM":"2023-02-15 09:49:44","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"A","STRATA2":"S1","BMRKR1":2.02768,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-145","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.14485,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-04-08 21:49:44","ADY":53}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-145","AGE":44.34622,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-02-14 21:49:44","TRTEDTM":"2023-02-15 09:49:44","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"A","STRATA2":"S1","BMRKR1":2.02768,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-145","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.37699,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-07-02 21:49:44","ADY":138}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-145","AGE":44.34622,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-02-14 21:49:44","TRTEDTM":"2023-02-15 09:49:44","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"A","STRATA2":"S1","BMRKR1":2.02768,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-145","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.32759,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-06-14 21:49:44","ADY":120}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-145","AGE":44.34622,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-02-14 21:49:44","TRTEDTM":"2023-02-15 09:49:44","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"A","STRATA2":"S1","BMRKR1":2.02768,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-145","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":84.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-09-25 07:27:48","ADY":589}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-145","AGE":44.34622,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2021-02-14 21:49:44","TRTEDTM":"2023-02-15 09:49:44","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"A","STRATA2":"S1","BMRKR1":2.02768,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-145","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":19.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-06-27 23:18:09","ADY":134}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-169","AGE":41.72071,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-04 10:31:08","TRTEDTM":"2022-04-04 22:31:08","EOSDY":731,"EOSDT":"2022-04-04","STRATA1":"A","STRATA2":"S2","BMRKR1":4.45384,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-169","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-04-04 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-169","AGE":41.72071,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-04 10:31:08","TRTEDTM":"2022-04-04 22:31:08","EOSDY":731,"EOSDT":"2022-04-04","STRATA1":"A","STRATA2":"S2","BMRKR1":4.45384,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-169","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-169","AGE":41.72071,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-04 10:31:08","TRTEDTM":"2022-04-04 22:31:08","EOSDY":731,"EOSDT":"2022-04-04","STRATA1":"A","STRATA2":"S2","BMRKR1":4.45384,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-169","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":10}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-169","AGE":41.72071,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-04 10:31:08","TRTEDTM":"2022-04-04 22:31:08","EOSDY":731,"EOSDT":"2022-04-04","STRATA1":"A","STRATA2":"S2","BMRKR1":4.45384,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-169","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-169","AGE":41.72071,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-04 10:31:08","TRTEDTM":"2022-04-04 22:31:08","EOSDY":731,"EOSDT":"2022-04-04","STRATA1":"A","STRATA2":"S2","BMRKR1":4.45384,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-169","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.31984,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-07-30 10:31:08","ADY":117}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-169","AGE":41.72071,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-04 10:31:08","TRTEDTM":"2022-04-04 22:31:08","EOSDY":731,"EOSDT":"2022-04-04","STRATA1":"A","STRATA2":"S2","BMRKR1":4.45384,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-169","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.3192,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-07-30 10:31:08","ADY":117}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-169","AGE":41.72071,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-04 10:31:08","TRTEDTM":"2022-04-04 22:31:08","EOSDY":731,"EOSDT":"2022-04-04","STRATA1":"A","STRATA2":"S2","BMRKR1":4.45384,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-169","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.2743,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-07-14 10:31:08","ADY":101}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-169","AGE":41.72071,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-04 10:31:08","TRTEDTM":"2022-04-04 22:31:08","EOSDY":731,"EOSDT":"2022-04-04","STRATA1":"A","STRATA2":"S2","BMRKR1":4.45384,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-169","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":8.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-05-30 20:13:39","ADY":57}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-13","SUBJID":"id-169","AGE":41.72071,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-04-04 10:31:08","TRTEDTM":"2022-04-04 22:31:08","EOSDY":731,"EOSDT":"2022-04-04","STRATA1":"A","STRATA2":"S2","BMRKR1":4.45384,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-13-id-169","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":69.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-08-04 14:18:26","ADY":488}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-14","SUBJID":"id-17","AGE":44.68747,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-03-05 04:10:01","TRTEDTM":"2021-03-04 16:10:01","EOSDY":731,"EOSDT":"2021-03-04","STRATA1":"B","STRATA2":"S1","BMRKR1":17.84549,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-14-id-17","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-03-04 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-14","SUBJID":"id-17","AGE":44.68747,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-03-05 04:10:01","TRTEDTM":"2021-03-04 16:10:01","EOSDY":731,"EOSDT":"2021-03-04","STRATA1":"B","STRATA2":"S1","BMRKR1":17.84549,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-14-id-17","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-14","SUBJID":"id-17","AGE":44.68747,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-03-05 04:10:01","TRTEDTM":"2021-03-04 16:10:01","EOSDY":731,"EOSDT":"2021-03-04","STRATA1":"B","STRATA2":"S1","BMRKR1":17.84549,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-14-id-17","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-14","SUBJID":"id-17","AGE":44.68747,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-03-05 04:10:01","TRTEDTM":"2021-03-04 16:10:01","EOSDY":731,"EOSDT":"2021-03-04","STRATA1":"B","STRATA2":"S1","BMRKR1":17.84549,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-14-id-17","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-14","SUBJID":"id-17","AGE":44.68747,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-03-05 04:10:01","TRTEDTM":"2021-03-04 16:10:01","EOSDY":731,"EOSDT":"2021-03-04","STRATA1":"B","STRATA2":"S1","BMRKR1":17.84549,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-14-id-17","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.00455,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-03-07 04:10:01","ADY":2}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-14","SUBJID":"id-17","AGE":44.68747,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-03-05 04:10:01","TRTEDTM":"2021-03-04 16:10:01","EOSDY":731,"EOSDT":"2021-03-04","STRATA1":"B","STRATA2":"S1","BMRKR1":17.84549,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-14-id-17","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.35867,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-15 04:10:01","ADY":132}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-14","SUBJID":"id-17","AGE":44.68747,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-03-05 04:10:01","TRTEDTM":"2021-03-04 16:10:01","EOSDY":731,"EOSDT":"2021-03-04","STRATA1":"B","STRATA2":"S1","BMRKR1":17.84549,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-14-id-17","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.52867,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-15 04:10:01","ADY":194}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-14","SUBJID":"id-17","AGE":44.68747,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-03-05 04:10:01","TRTEDTM":"2021-03-04 16:10:01","EOSDY":731,"EOSDT":"2021-03-04","STRATA1":"B","STRATA2":"S1","BMRKR1":17.84549,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-14-id-17","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":89.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-11-18 08:40:02","ADY":625}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-14","SUBJID":"id-17","AGE":44.68747,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-03-05 04:10:01","TRTEDTM":"2021-03-04 16:10:01","EOSDY":731,"EOSDT":"2021-03-04","STRATA1":"B","STRATA2":"S1","BMRKR1":17.84549,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-14-id-17","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":72.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-07-25 01:26:26","ADY":509}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-15","AGE":27.91905,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-16 21:34:21","TRTEDTM":"2022-06-17 09:34:21","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"B","STRATA2":"S2","BMRKR1":5.83253,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-15","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-06-17 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-15","AGE":27.91905,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-16 21:34:21","TRTEDTM":"2022-06-17 09:34:21","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"B","STRATA2":"S2","BMRKR1":5.83253,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-15","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-15","AGE":27.91905,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-16 21:34:21","TRTEDTM":"2022-06-17 09:34:21","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"B","STRATA2":"S2","BMRKR1":5.83253,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-15","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-15","AGE":27.91905,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-16 21:34:21","TRTEDTM":"2022-06-17 09:34:21","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"B","STRATA2":"S2","BMRKR1":5.83253,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-15","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-15","AGE":27.91905,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-16 21:34:21","TRTEDTM":"2022-06-17 09:34:21","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"B","STRATA2":"S2","BMRKR1":5.83253,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-15","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.51929,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-12-23 21:34:21","ADY":190}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-15","AGE":27.91905,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-16 21:34:21","TRTEDTM":"2022-06-17 09:34:21","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"B","STRATA2":"S2","BMRKR1":5.83253,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-15","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.58939,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-18 21:34:21","ADY":216}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-15","AGE":27.91905,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-16 21:34:21","TRTEDTM":"2022-06-17 09:34:21","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"B","STRATA2":"S2","BMRKR1":5.83253,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-15","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.75735,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-03-20 21:34:21","ADY":277}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-15","AGE":27.91905,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-16 21:34:21","TRTEDTM":"2022-06-17 09:34:21","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"B","STRATA2":"S2","BMRKR1":5.83253,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-15","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":34.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-02-09 08:45:52","ADY":239}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-15","AGE":27.91905,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-16 21:34:21","TRTEDTM":"2022-06-17 09:34:21","EOSDY":731,"EOSDT":"2022-06-17","STRATA1":"B","STRATA2":"S2","BMRKR1":5.83253,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-15","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":87.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-02-15 03:53:58","ADY":610}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-187","AGE":49.59901,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-11-28 12:41:35","TRTEDTM":"2021-11-28 00:41:35","EOSDY":731,"EOSDT":"2021-11-28","STRATA1":"B","STRATA2":"S2","BMRKR1":7.3923,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-187","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-11-28 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-187","AGE":49.59901,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-11-28 12:41:35","TRTEDTM":"2021-11-28 00:41:35","EOSDY":731,"EOSDT":"2021-11-28","STRATA1":"B","STRATA2":"S2","BMRKR1":7.3923,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-187","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-187","AGE":49.59901,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-11-28 12:41:35","TRTEDTM":"2021-11-28 00:41:35","EOSDY":731,"EOSDT":"2021-11-28","STRATA1":"B","STRATA2":"S2","BMRKR1":7.3923,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-187","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-187","AGE":49.59901,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-11-28 12:41:35","TRTEDTM":"2021-11-28 00:41:35","EOSDY":731,"EOSDT":"2021-11-28","STRATA1":"B","STRATA2":"S2","BMRKR1":7.3923,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-187","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-187","AGE":49.59901,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-11-28 12:41:35","TRTEDTM":"2021-11-28 00:41:35","EOSDY":731,"EOSDT":"2021-11-28","STRATA1":"B","STRATA2":"S2","BMRKR1":7.3923,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-187","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-11-29 12:41:35","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-187","AGE":49.59901,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-11-28 12:41:35","TRTEDTM":"2021-11-28 00:41:35","EOSDY":731,"EOSDT":"2021-11-28","STRATA1":"B","STRATA2":"S2","BMRKR1":7.3923,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-187","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.08889,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-31 12:41:35","ADY":33}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-187","AGE":49.59901,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-11-28 12:41:35","TRTEDTM":"2021-11-28 00:41:35","EOSDY":731,"EOSDT":"2021-11-28","STRATA1":"B","STRATA2":"S2","BMRKR1":7.3923,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-187","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.06457,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-22 12:41:35","ADY":24}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-187","AGE":49.59901,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-11-28 12:41:35","TRTEDTM":"2021-11-28 00:41:35","EOSDY":731,"EOSDT":"2021-11-28","STRATA1":"B","STRATA2":"S2","BMRKR1":7.3923,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-187","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":85.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-07-20 15:39:53","ADY":601}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-15","SUBJID":"id-187","AGE":49.59901,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-11-28 12:41:35","TRTEDTM":"2021-11-28 00:41:35","EOSDY":731,"EOSDT":"2021-11-28","STRATA1":"B","STRATA2":"S2","BMRKR1":7.3923,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-15-id-187","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":29.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-06-18 12:59:29","ADY":204}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-82","AGE":40.50974,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-17 13:10:38","TRTEDTM":"2021-12-17 01:10:38","EOSDY":731,"EOSDT":"2021-12-17","STRATA1":"C","STRATA2":"S2","BMRKR1":4.45782,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-82","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-12-17 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-82","AGE":40.50974,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-17 13:10:38","TRTEDTM":"2021-12-17 01:10:38","EOSDY":731,"EOSDT":"2021-12-17","STRATA1":"C","STRATA2":"S2","BMRKR1":4.45782,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-82","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-82","AGE":40.50974,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-17 13:10:38","TRTEDTM":"2021-12-17 01:10:38","EOSDY":731,"EOSDT":"2021-12-17","STRATA1":"C","STRATA2":"S2","BMRKR1":4.45782,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-82","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-82","AGE":40.50974,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-17 13:10:38","TRTEDTM":"2021-12-17 01:10:38","EOSDY":731,"EOSDT":"2021-12-17","STRATA1":"C","STRATA2":"S2","BMRKR1":4.45782,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-82","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":8}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-82","AGE":40.50974,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-17 13:10:38","TRTEDTM":"2021-12-17 01:10:38","EOSDY":731,"EOSDT":"2021-12-17","STRATA1":"C","STRATA2":"S2","BMRKR1":4.45782,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-82","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-12-18 13:10:38","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-82","AGE":40.50974,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-17 13:10:38","TRTEDTM":"2021-12-17 01:10:38","EOSDY":731,"EOSDT":"2021-12-17","STRATA1":"C","STRATA2":"S2","BMRKR1":4.45782,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-82","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-12-18 13:10:38","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-82","AGE":40.50974,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-17 13:10:38","TRTEDTM":"2021-12-17 01:10:38","EOSDY":731,"EOSDT":"2021-12-17","STRATA1":"C","STRATA2":"S2","BMRKR1":4.45782,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-82","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.08367,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-01-17 13:10:38","ADY":31}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-82","AGE":40.50974,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-17 13:10:38","TRTEDTM":"2021-12-17 01:10:38","EOSDY":731,"EOSDT":"2021-12-17","STRATA1":"C","STRATA2":"S2","BMRKR1":4.45782,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-82","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":63.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-03-06 06:58:02","ADY":446}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-82","AGE":40.50974,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-12-17 13:10:38","TRTEDTM":"2021-12-17 01:10:38","EOSDY":731,"EOSDT":"2021-12-17","STRATA1":"C","STRATA2":"S2","BMRKR1":4.45782,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-82","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":84.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-08-01 16:24:34","ADY":594}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-95","AGE":31.07386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-10-12 20:37:19","TRTEDTM":"2022-10-13 08:37:19","EOSDY":731,"EOSDT":"2022-10-13","STRATA1":"C","STRATA2":"S2","BMRKR1":5.44348,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-95","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-10-13 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-95","AGE":31.07386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-10-12 20:37:19","TRTEDTM":"2022-10-13 08:37:19","EOSDY":731,"EOSDT":"2022-10-13","STRATA1":"C","STRATA2":"S2","BMRKR1":5.44348,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-95","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-95","AGE":31.07386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-10-12 20:37:19","TRTEDTM":"2022-10-13 08:37:19","EOSDY":731,"EOSDT":"2022-10-13","STRATA1":"C","STRATA2":"S2","BMRKR1":5.44348,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-95","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-95","AGE":31.07386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-10-12 20:37:19","TRTEDTM":"2022-10-13 08:37:19","EOSDY":731,"EOSDT":"2022-10-13","STRATA1":"C","STRATA2":"S2","BMRKR1":5.44348,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-95","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-95","AGE":31.07386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-10-12 20:37:19","TRTEDTM":"2022-10-13 08:37:19","EOSDY":731,"EOSDT":"2022-10-13","STRATA1":"C","STRATA2":"S2","BMRKR1":5.44348,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-95","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.03405,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-25 20:37:19","ADY":13}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-95","AGE":31.07386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-10-12 20:37:19","TRTEDTM":"2022-10-13 08:37:19","EOSDY":731,"EOSDT":"2022-10-13","STRATA1":"C","STRATA2":"S2","BMRKR1":5.44348,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-95","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.01066,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-16 20:37:19","ADY":4}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-95","AGE":31.07386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-10-12 20:37:19","TRTEDTM":"2022-10-13 08:37:19","EOSDY":731,"EOSDT":"2022-10-13","STRATA1":"C","STRATA2":"S2","BMRKR1":5.44348,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-95","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.0067,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-15 20:37:19","ADY":3}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-95","AGE":31.07386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-10-12 20:37:19","TRTEDTM":"2022-10-13 08:37:19","EOSDY":731,"EOSDT":"2022-10-13","STRATA1":"C","STRATA2":"S2","BMRKR1":5.44348,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-95","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":80.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-04-28 23:40:02","ADY":564}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-2","SUBJID":"id-95","AGE":31.07386,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-10-12 20:37:19","TRTEDTM":"2022-10-13 08:37:19","EOSDY":731,"EOSDT":"2022-10-13","STRATA1":"C","STRATA2":"S2","BMRKR1":5.44348,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-2-id-95","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":59,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-11-28 16:48:57","ADY":413}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-3","SUBJID":"id-68","AGE":44.41352,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-26 14:29:42","TRTEDTM":"2021-09-26 02:29:42","EOSDY":731,"EOSDT":"2021-09-26","STRATA1":"A","STRATA2":"S1","BMRKR1":2.57506,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-3-id-68","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-09-26 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-3","SUBJID":"id-68","AGE":44.41352,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-26 14:29:42","TRTEDTM":"2021-09-26 02:29:42","EOSDY":731,"EOSDT":"2021-09-26","STRATA1":"A","STRATA2":"S1","BMRKR1":2.57506,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-3-id-68","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-3","SUBJID":"id-68","AGE":44.41352,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-26 14:29:42","TRTEDTM":"2021-09-26 02:29:42","EOSDY":731,"EOSDT":"2021-09-26","STRATA1":"A","STRATA2":"S1","BMRKR1":2.57506,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-3-id-68","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-3","SUBJID":"id-68","AGE":44.41352,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-26 14:29:42","TRTEDTM":"2021-09-26 02:29:42","EOSDY":731,"EOSDT":"2021-09-26","STRATA1":"A","STRATA2":"S1","BMRKR1":2.57506,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-3-id-68","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-3","SUBJID":"id-68","AGE":44.41352,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-26 14:29:42","TRTEDTM":"2021-09-26 02:29:42","EOSDY":731,"EOSDT":"2021-09-26","STRATA1":"A","STRATA2":"S1","BMRKR1":2.57506,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-3-id-68","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-09-27 14:29:42","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-3","SUBJID":"id-68","AGE":44.41352,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-26 14:29:42","TRTEDTM":"2021-09-26 02:29:42","EOSDY":731,"EOSDT":"2021-09-26","STRATA1":"A","STRATA2":"S1","BMRKR1":2.57506,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-3-id-68","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-09-27 14:29:42","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-3","SUBJID":"id-68","AGE":44.41352,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-26 14:29:42","TRTEDTM":"2021-09-26 02:29:42","EOSDY":731,"EOSDT":"2021-09-26","STRATA1":"A","STRATA2":"S1","BMRKR1":2.57506,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-3-id-68","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.34319,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-01-30 14:29:42","ADY":126}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-3","SUBJID":"id-68","AGE":44.41352,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-26 14:29:42","TRTEDTM":"2021-09-26 02:29:42","EOSDY":731,"EOSDT":"2021-09-26","STRATA1":"A","STRATA2":"S1","BMRKR1":2.57506,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-3-id-68","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":38.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-06-20 10:27:42","ADY":269}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-3","SUBJID":"id-68","AGE":44.41352,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-09-26 14:29:42","TRTEDTM":"2021-09-26 02:29:42","EOSDY":731,"EOSDT":"2021-09-26","STRATA1":"A","STRATA2":"S1","BMRKR1":2.57506,"BMRKR2":"LOW","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-3-id-68","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":35.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-05-28 13:05:21","ADY":246}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-125","AGE":30.00557,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-12 19:30:20","TRTEDTM":"2021-06-12 07:30:20","EOSDY":731,"EOSDT":"2021-06-12","STRATA1":"B","STRATA2":"S2","BMRKR1":11.22204,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-125","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-06-12 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-125","AGE":30.00557,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-12 19:30:20","TRTEDTM":"2021-06-12 07:30:20","EOSDY":731,"EOSDT":"2021-06-12","STRATA1":"B","STRATA2":"S2","BMRKR1":11.22204,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-125","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-125","AGE":30.00557,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-12 19:30:20","TRTEDTM":"2021-06-12 07:30:20","EOSDY":731,"EOSDT":"2021-06-12","STRATA1":"B","STRATA2":"S2","BMRKR1":11.22204,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-125","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-125","AGE":30.00557,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-12 19:30:20","TRTEDTM":"2021-06-12 07:30:20","EOSDY":731,"EOSDT":"2021-06-12","STRATA1":"B","STRATA2":"S2","BMRKR1":11.22204,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-125","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-125","AGE":30.00557,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-12 19:30:20","TRTEDTM":"2021-06-12 07:30:20","EOSDY":731,"EOSDT":"2021-06-12","STRATA1":"B","STRATA2":"S2","BMRKR1":11.22204,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-125","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.48616,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-07 19:30:20","ADY":178}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-125","AGE":30.00557,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-12 19:30:20","TRTEDTM":"2021-06-12 07:30:20","EOSDY":731,"EOSDT":"2021-06-12","STRATA1":"B","STRATA2":"S2","BMRKR1":11.22204,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-125","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.38699,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-01 19:30:20","ADY":142}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-125","AGE":30.00557,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-12 19:30:20","TRTEDTM":"2021-06-12 07:30:20","EOSDY":731,"EOSDT":"2021-06-12","STRATA1":"B","STRATA2":"S2","BMRKR1":11.22204,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-125","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.09573,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-17 19:30:20","ADY":35}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-125","AGE":30.00557,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-12 19:30:20","TRTEDTM":"2021-06-12 07:30:20","EOSDY":731,"EOSDT":"2021-06-12","STRATA1":"B","STRATA2":"S2","BMRKR1":11.22204,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-125","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":63.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-29 20:39:37","ADY":445}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-125","AGE":30.00557,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-06-12 19:30:20","TRTEDTM":"2021-06-12 07:30:20","EOSDY":731,"EOSDT":"2021-06-12","STRATA1":"B","STRATA2":"S2","BMRKR1":11.22204,"BMRKR2":"MEDIUM","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-125","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":94,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-03-30 19:28:53","ADY":658}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-188","AGE":27.97494,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-10 14:38:23","TRTEDTM":"2022-06-11 02:38:23","EOSDY":731,"EOSDT":"2022-06-11","STRATA1":"B","STRATA2":"S1","BMRKR1":6.14057,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-188","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-06-11 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-188","AGE":27.97494,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-10 14:38:23","TRTEDTM":"2022-06-11 02:38:23","EOSDY":731,"EOSDT":"2022-06-11","STRATA1":"B","STRATA2":"S1","BMRKR1":6.14057,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-188","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-188","AGE":27.97494,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-10 14:38:23","TRTEDTM":"2022-06-11 02:38:23","EOSDY":731,"EOSDT":"2022-06-11","STRATA1":"B","STRATA2":"S1","BMRKR1":6.14057,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-188","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-188","AGE":27.97494,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-10 14:38:23","TRTEDTM":"2022-06-11 02:38:23","EOSDY":731,"EOSDT":"2022-06-11","STRATA1":"B","STRATA2":"S1","BMRKR1":6.14057,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-188","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-188","AGE":27.97494,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-10 14:38:23","TRTEDTM":"2022-06-11 02:38:23","EOSDY":731,"EOSDT":"2022-06-11","STRATA1":"B","STRATA2":"S1","BMRKR1":6.14057,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-188","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.17021,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-12 14:38:23","ADY":63}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-188","AGE":27.97494,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-10 14:38:23","TRTEDTM":"2022-06-11 02:38:23","EOSDY":731,"EOSDT":"2022-06-11","STRATA1":"B","STRATA2":"S1","BMRKR1":6.14057,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-188","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.05063,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-06-29 14:38:23","ADY":19}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-188","AGE":27.97494,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-10 14:38:23","TRTEDTM":"2022-06-11 02:38:23","EOSDY":731,"EOSDT":"2022-06-11","STRATA1":"B","STRATA2":"S1","BMRKR1":6.14057,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-188","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2022-06-12 14:38:23","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-188","AGE":27.97494,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-10 14:38:23","TRTEDTM":"2022-06-11 02:38:23","EOSDY":731,"EOSDT":"2022-06-11","STRATA1":"B","STRATA2":"S1","BMRKR1":6.14057,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-188","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":77.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-12-03 15:59:47","ADY":542}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-5","SUBJID":"id-188","AGE":27.97494,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-10 14:38:23","TRTEDTM":"2022-06-11 02:38:23","EOSDY":731,"EOSDT":"2022-06-11","STRATA1":"B","STRATA2":"S1","BMRKR1":6.14057,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-5-id-188","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":23.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-11-19 21:34:45","ADY":163}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-6","SUBJID":"id-178","AGE":30.10786,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-18 20:50:40","TRTEDTM":"2021-03-18 08:50:40","EOSDY":731,"EOSDT":"2021-03-18","STRATA1":"C","STRATA2":"S2","BMRKR1":7.82358,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-6-id-178","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-03-18 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-6","SUBJID":"id-178","AGE":30.10786,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-18 20:50:40","TRTEDTM":"2021-03-18 08:50:40","EOSDY":731,"EOSDT":"2021-03-18","STRATA1":"C","STRATA2":"S2","BMRKR1":7.82358,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-6-id-178","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-6","SUBJID":"id-178","AGE":30.10786,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-18 20:50:40","TRTEDTM":"2021-03-18 08:50:40","EOSDY":731,"EOSDT":"2021-03-18","STRATA1":"C","STRATA2":"S2","BMRKR1":7.82358,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-6-id-178","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-6","SUBJID":"id-178","AGE":30.10786,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-18 20:50:40","TRTEDTM":"2021-03-18 08:50:40","EOSDY":731,"EOSDT":"2021-03-18","STRATA1":"C","STRATA2":"S2","BMRKR1":7.82358,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-6-id-178","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-6","SUBJID":"id-178","AGE":30.10786,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-18 20:50:40","TRTEDTM":"2021-03-18 08:50:40","EOSDY":731,"EOSDT":"2021-03-18","STRATA1":"C","STRATA2":"S2","BMRKR1":7.82358,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-6-id-178","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.15316,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-13 20:50:40","ADY":56}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-6","SUBJID":"id-178","AGE":30.10786,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-18 20:50:40","TRTEDTM":"2021-03-18 08:50:40","EOSDY":731,"EOSDT":"2021-03-18","STRATA1":"C","STRATA2":"S2","BMRKR1":7.82358,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-6-id-178","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.00748,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-03-21 20:50:40","ADY":3}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-6","SUBJID":"id-178","AGE":30.10786,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-18 20:50:40","TRTEDTM":"2021-03-18 08:50:40","EOSDY":731,"EOSDT":"2021-03-18","STRATA1":"C","STRATA2":"S2","BMRKR1":7.82358,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-6-id-178","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.60087,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-10-24 20:50:40","ADY":220}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-6","SUBJID":"id-178","AGE":30.10786,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-18 20:50:40","TRTEDTM":"2021-03-18 08:50:40","EOSDY":731,"EOSDT":"2021-03-18","STRATA1":"C","STRATA2":"S2","BMRKR1":7.82358,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-6-id-178","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":96.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-01-20 18:23:43","ADY":675}
{"STUDYID":"AB12345","COUNTRY":"PAK","SITEID":"PAK-6","SUBJID":"id-178","AGE":30.10786,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-03-18 20:50:40","TRTEDTM":"2021-03-18 08:50:40","EOSDY":731,"EOSDT":"2021-03-18","STRATA1":"C","STRATA2":"S2","BMRKR1":7.82358,"BMRKR2":"HIGH","REGION1":"Asia","SAFFL":"Y","USUBJID":"AB12345-PAK-6-id-178","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":61.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-05-18 05:05:47","ADY":428}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-162","AGE":40.54049,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-27 08:10:40","TRTEDTM":"2023-01-27 20:10:40","EOSDY":731,"EOSDT":"2023-01-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.78899,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-162","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2023-01-27 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-162","AGE":40.54049,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-27 08:10:40","TRTEDTM":"2023-01-27 20:10:40","EOSDY":731,"EOSDT":"2023-01-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.78899,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-162","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-162","AGE":40.54049,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-27 08:10:40","TRTEDTM":"2023-01-27 20:10:40","EOSDY":731,"EOSDT":"2023-01-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.78899,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-162","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-162","AGE":40.54049,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-27 08:10:40","TRTEDTM":"2023-01-27 20:10:40","EOSDY":731,"EOSDT":"2023-01-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.78899,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-162","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-162","AGE":40.54049,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-27 08:10:40","TRTEDTM":"2023-01-27 20:10:40","EOSDY":731,"EOSDT":"2023-01-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.78899,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-162","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2023-01-28 08:10:40","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-162","AGE":40.54049,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-27 08:10:40","TRTEDTM":"2023-01-27 20:10:40","EOSDY":731,"EOSDT":"2023-01-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.78899,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-162","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.12684,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-03-15 08:10:40","ADY":47}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-162","AGE":40.54049,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-27 08:10:40","TRTEDTM":"2023-01-27 20:10:40","EOSDY":731,"EOSDT":"2023-01-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.78899,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-162","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.93094,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2022-01-03 08:10:40","ADY":341}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-162","AGE":40.54049,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-27 08:10:40","TRTEDTM":"2023-01-27 20:10:40","EOSDY":731,"EOSDT":"2023-01-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.78899,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-162","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":15.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-05-13 17:10:00","ADY":107}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-162","AGE":40.54049,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2021-01-27 08:10:40","TRTEDTM":"2023-01-27 20:10:40","EOSDY":731,"EOSDT":"2023-01-27","STRATA1":"A","STRATA2":"S1","BMRKR1":4.78899,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-162","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":27.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-08-04 10:20:18","ADY":190}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-176","AGE":23.01276,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-06-27 03:54:19","TRTEDTM":"2022-06-27 15:54:19","EOSDY":731,"EOSDT":"2022-06-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.80068,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-176","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-06-27 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-176","AGE":23.01276,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-06-27 03:54:19","TRTEDTM":"2022-06-27 15:54:19","EOSDY":731,"EOSDT":"2022-06-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.80068,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-176","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-176","AGE":23.01276,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-06-27 03:54:19","TRTEDTM":"2022-06-27 15:54:19","EOSDY":731,"EOSDT":"2022-06-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.80068,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-176","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":9}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-176","AGE":23.01276,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-06-27 03:54:19","TRTEDTM":"2022-06-27 15:54:19","EOSDY":731,"EOSDT":"2022-06-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.80068,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-176","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-176","AGE":23.01276,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-06-27 03:54:19","TRTEDTM":"2022-06-27 15:54:19","EOSDY":731,"EOSDT":"2022-06-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.80068,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-176","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-06-28 03:54:19","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-176","AGE":23.01276,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-06-27 03:54:19","TRTEDTM":"2022-06-27 15:54:19","EOSDY":731,"EOSDT":"2022-06-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.80068,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-176","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.1692,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-28 03:54:19","ADY":62}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-176","AGE":23.01276,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-06-27 03:54:19","TRTEDTM":"2022-06-27 15:54:19","EOSDY":731,"EOSDT":"2022-06-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.80068,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-176","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.01094,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-07-01 03:54:19","ADY":4}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-176","AGE":23.01276,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-06-27 03:54:19","TRTEDTM":"2022-06-27 15:54:19","EOSDY":731,"EOSDT":"2022-06-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.80068,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-176","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":73.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-11-21 18:49:48","ADY":513}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-176","AGE":23.01276,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2020-06-27 03:54:19","TRTEDTM":"2022-06-27 15:54:19","EOSDY":731,"EOSDT":"2022-06-27","STRATA1":"C","STRATA2":"S1","BMRKR1":4.80068,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-176","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":94.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-04-20 22:16:05","ADY":663}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-180","AGE":36.77384,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-11 02:35:25","TRTEDTM":"2021-04-10 14:35:25","EOSDY":731,"EOSDT":"2021-04-10","STRATA1":"B","STRATA2":"S1","BMRKR1":6.11566,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-180","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-04-10 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-180","AGE":36.77384,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-11 02:35:25","TRTEDTM":"2021-04-10 14:35:25","EOSDY":731,"EOSDT":"2021-04-10","STRATA1":"B","STRATA2":"S1","BMRKR1":6.11566,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-180","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":9}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-180","AGE":36.77384,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-11 02:35:25","TRTEDTM":"2021-04-10 14:35:25","EOSDY":731,"EOSDT":"2021-04-10","STRATA1":"B","STRATA2":"S1","BMRKR1":6.11566,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-180","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-180","AGE":36.77384,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-11 02:35:25","TRTEDTM":"2021-04-10 14:35:25","EOSDY":731,"EOSDT":"2021-04-10","STRATA1":"B","STRATA2":"S1","BMRKR1":6.11566,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-180","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-180","AGE":36.77384,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-11 02:35:25","TRTEDTM":"2021-04-10 14:35:25","EOSDY":731,"EOSDT":"2021-04-10","STRATA1":"B","STRATA2":"S1","BMRKR1":6.11566,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-180","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.54909,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-10-29 02:35:25","ADY":201}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-180","AGE":36.77384,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-11 02:35:25","TRTEDTM":"2021-04-10 14:35:25","EOSDY":731,"EOSDT":"2021-04-10","STRATA1":"B","STRATA2":"S1","BMRKR1":6.11566,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-180","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.4347,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-17 02:35:25","ADY":159}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-180","AGE":36.77384,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-11 02:35:25","TRTEDTM":"2021-04-10 14:35:25","EOSDY":731,"EOSDT":"2021-04-10","STRATA1":"B","STRATA2":"S1","BMRKR1":6.11566,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-180","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.05384,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-01 02:35:25","ADY":20}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-180","AGE":36.77384,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-11 02:35:25","TRTEDTM":"2021-04-10 14:35:25","EOSDY":731,"EOSDT":"2021-04-10","STRATA1":"B","STRATA2":"S1","BMRKR1":6.11566,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-180","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-04-11 02:35:25","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-180","AGE":36.77384,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-11 02:35:25","TRTEDTM":"2021-04-10 14:35:25","EOSDY":731,"EOSDT":"2021-04-10","STRATA1":"B","STRATA2":"S1","BMRKR1":6.11566,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-180","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":0,"AVAL":32.42857,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2019-11-23 22:27:52","ADY":227}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-29","AGE":32.91151,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-06 01:19:27","TRTEDTM":"2021-06-05 13:19:27","EOSDY":731,"EOSDT":"2021-06-05","STRATA1":"B","STRATA2":"S2","BMRKR1":8.04575,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-29","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-06-05 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-29","AGE":32.91151,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-06 01:19:27","TRTEDTM":"2021-06-05 13:19:27","EOSDY":731,"EOSDT":"2021-06-05","STRATA1":"B","STRATA2":"S2","BMRKR1":8.04575,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-29","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-29","AGE":32.91151,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-06 01:19:27","TRTEDTM":"2021-06-05 13:19:27","EOSDY":731,"EOSDT":"2021-06-05","STRATA1":"B","STRATA2":"S2","BMRKR1":8.04575,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-29","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-29","AGE":32.91151,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-06 01:19:27","TRTEDTM":"2021-06-05 13:19:27","EOSDY":731,"EOSDT":"2021-06-05","STRATA1":"B","STRATA2":"S2","BMRKR1":8.04575,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-29","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-29","AGE":32.91151,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-06 01:19:27","TRTEDTM":"2021-06-05 13:19:27","EOSDY":731,"EOSDT":"2021-06-05","STRATA1":"B","STRATA2":"S2","BMRKR1":8.04575,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-29","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-06-06 01:19:27","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-29","AGE":32.91151,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-06 01:19:27","TRTEDTM":"2021-06-05 13:19:27","EOSDY":731,"EOSDT":"2021-06-05","STRATA1":"B","STRATA2":"S2","BMRKR1":8.04575,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-29","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.77675,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-03-16 01:19:27","ADY":284}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-29","AGE":32.91151,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-06 01:19:27","TRTEDTM":"2021-06-05 13:19:27","EOSDY":731,"EOSDT":"2021-06-05","STRATA1":"B","STRATA2":"S2","BMRKR1":8.04575,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-29","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.07146,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-03 01:19:27","ADY":27}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-29","AGE":32.91151,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-06 01:19:27","TRTEDTM":"2021-06-05 13:19:27","EOSDY":731,"EOSDT":"2021-06-05","STRATA1":"B","STRATA2":"S2","BMRKR1":8.04575,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-29","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":63.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-08-20 11:00:46","ADY":442}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-29","AGE":32.91151,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-06 01:19:27","TRTEDTM":"2021-06-05 13:19:27","EOSDY":731,"EOSDT":"2021-06-05","STRATA1":"B","STRATA2":"S2","BMRKR1":8.04575,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-29","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":96,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-04-07 12:32:02","ADY":672}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-4","AGE":30.54711,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-21 09:25:36","TRTEDTM":"2021-11-20 21:25:36","EOSDY":731,"EOSDT":"2021-11-20","STRATA1":"C","STRATA2":"S2","BMRKR1":2.71006,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-4","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-11-20 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-4","AGE":30.54711,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-21 09:25:36","TRTEDTM":"2021-11-20 21:25:36","EOSDY":731,"EOSDT":"2021-11-20","STRATA1":"C","STRATA2":"S2","BMRKR1":2.71006,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-4","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-4","AGE":30.54711,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-21 09:25:36","TRTEDTM":"2021-11-20 21:25:36","EOSDY":731,"EOSDT":"2021-11-20","STRATA1":"C","STRATA2":"S2","BMRKR1":2.71006,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-4","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-4","AGE":30.54711,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-21 09:25:36","TRTEDTM":"2021-11-20 21:25:36","EOSDY":731,"EOSDT":"2021-11-20","STRATA1":"C","STRATA2":"S2","BMRKR1":2.71006,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-4","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-4","AGE":30.54711,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-21 09:25:36","TRTEDTM":"2021-11-20 21:25:36","EOSDY":731,"EOSDT":"2021-11-20","STRATA1":"C","STRATA2":"S2","BMRKR1":2.71006,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-4","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-11-21 09:25:36","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-4","AGE":30.54711,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-21 09:25:36","TRTEDTM":"2021-11-20 21:25:36","EOSDY":731,"EOSDT":"2021-11-20","STRATA1":"C","STRATA2":"S2","BMRKR1":2.71006,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-4","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.64054,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-07-12 09:25:36","ADY":234}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-4","AGE":30.54711,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-21 09:25:36","TRTEDTM":"2021-11-20 21:25:36","EOSDY":731,"EOSDT":"2021-11-20","STRATA1":"C","STRATA2":"S2","BMRKR1":2.71006,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-4","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-11-21 09:25:36","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-4","AGE":30.54711,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-21 09:25:36","TRTEDTM":"2021-11-20 21:25:36","EOSDY":731,"EOSDT":"2021-11-20","STRATA1":"C","STRATA2":"S2","BMRKR1":2.71006,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-4","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":20.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-04-09 05:25:26","ADY":141}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-4","AGE":30.54711,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-11-21 09:25:36","TRTEDTM":"2021-11-20 21:25:36","EOSDY":731,"EOSDT":"2021-11-20","STRATA1":"C","STRATA2":"S2","BMRKR1":2.71006,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-4","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":0,"AVAL":74.71429,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-04-26 06:39:42","ADY":523}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-77","AGE":30.33684,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-07 00:59:50","TRTEDTM":"2021-09-06 12:59:50","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S1","BMRKR1":10.10953,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-77","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-09-06 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-77","AGE":30.33684,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-07 00:59:50","TRTEDTM":"2021-09-06 12:59:50","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S1","BMRKR1":10.10953,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-77","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-77","AGE":30.33684,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-07 00:59:50","TRTEDTM":"2021-09-06 12:59:50","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S1","BMRKR1":10.10953,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-77","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-77","AGE":30.33684,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-07 00:59:50","TRTEDTM":"2021-09-06 12:59:50","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S1","BMRKR1":10.10953,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-77","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-77","AGE":30.33684,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-07 00:59:50","TRTEDTM":"2021-09-06 12:59:50","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S1","BMRKR1":10.10953,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-77","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-09-07 00:59:50","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-77","AGE":30.33684,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-07 00:59:50","TRTEDTM":"2021-09-06 12:59:50","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S1","BMRKR1":10.10953,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-77","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-09-07 00:59:50","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-77","AGE":30.33684,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-07 00:59:50","TRTEDTM":"2021-09-06 12:59:50","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S1","BMRKR1":10.10953,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-77","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-09-07 00:59:50","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-77","AGE":30.33684,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-07 00:59:50","TRTEDTM":"2021-09-06 12:59:50","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S1","BMRKR1":10.10953,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-77","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":22.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-02-13 03:59:03","ADY":160}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-77","AGE":30.33684,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2019-09-07 00:59:50","TRTEDTM":"2021-09-06 12:59:50","EOSDY":731,"EOSDT":"2021-09-06","STRATA1":"A","STRATA2":"S1","BMRKR1":10.10953,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-77","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":7.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-10-29 17:09:11","ADY":53}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-94","AGE":24.26501,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-03-29 03:19:08","TRTEDTM":"2021-03-28 15:19:08","EOSDY":731,"EOSDT":"2021-03-28","STRATA1":"C","STRATA2":"S2","BMRKR1":3.75756,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-94","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-03-28 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-94","AGE":24.26501,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-03-29 03:19:08","TRTEDTM":"2021-03-28 15:19:08","EOSDY":731,"EOSDT":"2021-03-28","STRATA1":"C","STRATA2":"S2","BMRKR1":3.75756,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-94","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":9}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-94","AGE":24.26501,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-03-29 03:19:08","TRTEDTM":"2021-03-28 15:19:08","EOSDY":731,"EOSDT":"2021-03-28","STRATA1":"C","STRATA2":"S2","BMRKR1":3.75756,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-94","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-94","AGE":24.26501,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-03-29 03:19:08","TRTEDTM":"2021-03-28 15:19:08","EOSDY":731,"EOSDT":"2021-03-28","STRATA1":"C","STRATA2":"S2","BMRKR1":3.75756,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-94","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-94","AGE":24.26501,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-03-29 03:19:08","TRTEDTM":"2021-03-28 15:19:08","EOSDY":731,"EOSDT":"2021-03-28","STRATA1":"C","STRATA2":"S2","BMRKR1":3.75756,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-94","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.21232,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-06-15 03:19:08","ADY":78}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-94","AGE":24.26501,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-03-29 03:19:08","TRTEDTM":"2021-03-28 15:19:08","EOSDY":731,"EOSDT":"2021-03-28","STRATA1":"C","STRATA2":"S2","BMRKR1":3.75756,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-94","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-03-29 03:19:08","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-94","AGE":24.26501,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-03-29 03:19:08","TRTEDTM":"2021-03-28 15:19:08","EOSDY":731,"EOSDT":"2021-03-28","STRATA1":"C","STRATA2":"S2","BMRKR1":3.75756,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-94","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.01917,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-04-06 03:19:08","ADY":8}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-94","AGE":24.26501,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-03-29 03:19:08","TRTEDTM":"2021-03-28 15:19:08","EOSDY":731,"EOSDT":"2021-03-28","STRATA1":"C","STRATA2":"S2","BMRKR1":3.75756,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-94","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":40,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-01-02 09:29:36","ADY":280}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-1","SUBJID":"id-94","AGE":24.26501,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"WHITE","TRTSDTM":"2019-03-29 03:19:08","TRTEDTM":"2021-03-28 15:19:08","EOSDY":731,"EOSDT":"2021-03-28","STRATA1":"C","STRATA2":"S2","BMRKR1":3.75756,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-1-id-94","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":26.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-10-01 22:26:46","ADY":187}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-185","AGE":27.96692,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-03 00:52:41","TRTEDTM":"2021-04-02 12:52:41","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S1","BMRKR1":2.4228,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-185","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-04-02 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-185","AGE":27.96692,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-03 00:52:41","TRTEDTM":"2021-04-02 12:52:41","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S1","BMRKR1":2.4228,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-185","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":9}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-185","AGE":27.96692,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-03 00:52:41","TRTEDTM":"2021-04-02 12:52:41","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S1","BMRKR1":2.4228,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-185","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-185","AGE":27.96692,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-03 00:52:41","TRTEDTM":"2021-04-02 12:52:41","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S1","BMRKR1":2.4228,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-185","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-185","AGE":27.96692,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-03 00:52:41","TRTEDTM":"2021-04-02 12:52:41","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S1","BMRKR1":2.4228,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-185","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.23166,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-06-27 00:52:41","ADY":85}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-185","AGE":27.96692,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-03 00:52:41","TRTEDTM":"2021-04-02 12:52:41","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S1","BMRKR1":2.4228,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-185","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":1.53298,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-10-14 00:52:41","ADY":560}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-185","AGE":27.96692,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-03 00:52:41","TRTEDTM":"2021-04-02 12:52:41","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S1","BMRKR1":2.4228,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-185","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.1128,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-15 00:52:41","ADY":42}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-185","AGE":27.96692,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-03 00:52:41","TRTEDTM":"2021-04-02 12:52:41","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S1","BMRKR1":2.4228,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-185","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":96.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-02-03 21:05:07","ADY":673}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-185","AGE":27.96692,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-03 00:52:41","TRTEDTM":"2021-04-02 12:52:41","EOSDY":731,"EOSDT":"2021-04-02","STRATA1":"B","STRATA2":"S1","BMRKR1":2.4228,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-185","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":11.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-06-22 11:45:09","ADY":81}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-70","AGE":25.49208,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-27 22:58:59","TRTEDTM":"2022-09-28 10:58:59","EOSDY":731,"EOSDT":"2022-09-28","STRATA1":"B","STRATA2":"S2","BMRKR1":4.34526,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-70","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-09-28 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-70","AGE":25.49208,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-27 22:58:59","TRTEDTM":"2022-09-28 10:58:59","EOSDY":731,"EOSDT":"2022-09-28","STRATA1":"B","STRATA2":"S2","BMRKR1":4.34526,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-70","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-70","AGE":25.49208,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-27 22:58:59","TRTEDTM":"2022-09-28 10:58:59","EOSDY":731,"EOSDT":"2022-09-28","STRATA1":"B","STRATA2":"S2","BMRKR1":4.34526,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-70","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-70","AGE":25.49208,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-27 22:58:59","TRTEDTM":"2022-09-28 10:58:59","EOSDY":731,"EOSDT":"2022-09-28","STRATA1":"B","STRATA2":"S2","BMRKR1":4.34526,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-70","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-70","AGE":25.49208,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-27 22:58:59","TRTEDTM":"2022-09-28 10:58:59","EOSDY":731,"EOSDT":"2022-09-28","STRATA1":"B","STRATA2":"S2","BMRKR1":4.34526,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-70","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-09-29 22:58:59","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-70","AGE":25.49208,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-27 22:58:59","TRTEDTM":"2022-09-28 10:58:59","EOSDY":731,"EOSDT":"2022-09-28","STRATA1":"B","STRATA2":"S2","BMRKR1":4.34526,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-70","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.3951,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-02-19 22:58:59","ADY":145}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-70","AGE":25.49208,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-27 22:58:59","TRTEDTM":"2022-09-28 10:58:59","EOSDY":731,"EOSDT":"2022-09-28","STRATA1":"B","STRATA2":"S2","BMRKR1":4.34526,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-70","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-09-29 22:58:59","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-70","AGE":25.49208,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-27 22:58:59","TRTEDTM":"2022-09-28 10:58:59","EOSDY":731,"EOSDT":"2022-09-28","STRATA1":"B","STRATA2":"S2","BMRKR1":4.34526,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-70","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-10-01 16:18:57","ADY":5}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-70","AGE":25.49208,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-09-27 22:58:59","TRTEDTM":"2022-09-28 10:58:59","EOSDY":731,"EOSDT":"2022-09-28","STRATA1":"B","STRATA2":"S2","BMRKR1":4.34526,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-70","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":23,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-03-06 13:29:12","ADY":161}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-76","AGE":38.6657,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-27 20:46:28","TRTEDTM":"2021-09-27 08:46:28","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"A","STRATA2":"S2","BMRKR1":10.59949,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-76","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-09-27 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-76","AGE":38.6657,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-27 20:46:28","TRTEDTM":"2021-09-27 08:46:28","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"A","STRATA2":"S2","BMRKR1":10.59949,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-76","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-76","AGE":38.6657,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-27 20:46:28","TRTEDTM":"2021-09-27 08:46:28","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"A","STRATA2":"S2","BMRKR1":10.59949,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-76","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-76","AGE":38.6657,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-27 20:46:28","TRTEDTM":"2021-09-27 08:46:28","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"A","STRATA2":"S2","BMRKR1":10.59949,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-76","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-76","AGE":38.6657,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-27 20:46:28","TRTEDTM":"2021-09-27 08:46:28","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"A","STRATA2":"S2","BMRKR1":10.59949,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-76","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-09-28 20:46:28","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-76","AGE":38.6657,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-27 20:46:28","TRTEDTM":"2021-09-27 08:46:28","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"A","STRATA2":"S2","BMRKR1":10.59949,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-76","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.27281,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-01-05 20:46:28","ADY":100}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-76","AGE":38.6657,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-27 20:46:28","TRTEDTM":"2021-09-27 08:46:28","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"A","STRATA2":"S2","BMRKR1":10.59949,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-76","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.59808,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-05-03 20:46:28","ADY":219}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-76","AGE":38.6657,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-27 20:46:28","TRTEDTM":"2021-09-27 08:46:28","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"A","STRATA2":"S2","BMRKR1":10.59949,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-76","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":41.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-07-14 15:30:35","ADY":292}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-11","SUBJID":"id-76","AGE":38.6657,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-27 20:46:28","TRTEDTM":"2021-09-27 08:46:28","EOSDY":731,"EOSDT":"2021-09-27","STRATA1":"A","STRATA2":"S2","BMRKR1":10.59949,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-11-id-76","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":32,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-05-07 21:03:35","ADY":224}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-12","SUBJID":"id-165","AGE":34.68285,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-06-13 10:32:29","TRTEDTM":"2022-06-13 22:32:29","EOSDY":731,"EOSDT":"2022-06-13","STRATA1":"B","STRATA2":"S2","BMRKR1":3.75684,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-12-id-165","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-06-13 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-12","SUBJID":"id-165","AGE":34.68285,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-06-13 10:32:29","TRTEDTM":"2022-06-13 22:32:29","EOSDY":731,"EOSDT":"2022-06-13","STRATA1":"B","STRATA2":"S2","BMRKR1":3.75684,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-12-id-165","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-12","SUBJID":"id-165","AGE":34.68285,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-06-13 10:32:29","TRTEDTM":"2022-06-13 22:32:29","EOSDY":731,"EOSDT":"2022-06-13","STRATA1":"B","STRATA2":"S2","BMRKR1":3.75684,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-12-id-165","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-12","SUBJID":"id-165","AGE":34.68285,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-06-13 10:32:29","TRTEDTM":"2022-06-13 22:32:29","EOSDY":731,"EOSDT":"2022-06-13","STRATA1":"B","STRATA2":"S2","BMRKR1":3.75684,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-12-id-165","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":8}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-12","SUBJID":"id-165","AGE":34.68285,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-06-13 10:32:29","TRTEDTM":"2022-06-13 22:32:29","EOSDY":731,"EOSDT":"2022-06-13","STRATA1":"B","STRATA2":"S2","BMRKR1":3.75684,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-12-id-165","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.07965,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-07-13 10:32:29","ADY":30}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-12","SUBJID":"id-165","AGE":34.68285,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-06-13 10:32:29","TRTEDTM":"2022-06-13 22:32:29","EOSDY":731,"EOSDT":"2022-06-13","STRATA1":"B","STRATA2":"S2","BMRKR1":3.75684,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-12-id-165","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-06-14 10:32:29","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-12","SUBJID":"id-165","AGE":34.68285,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-06-13 10:32:29","TRTEDTM":"2022-06-13 22:32:29","EOSDY":731,"EOSDT":"2022-06-13","STRATA1":"B","STRATA2":"S2","BMRKR1":3.75684,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-12-id-165","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.00401,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-06-15 10:32:29","ADY":2}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-12","SUBJID":"id-165","AGE":34.68285,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-06-13 10:32:29","TRTEDTM":"2022-06-13 22:32:29","EOSDY":731,"EOSDT":"2022-06-13","STRATA1":"B","STRATA2":"S2","BMRKR1":3.75684,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-12-id-165","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":71.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-10-25 08:35:23","ADY":500}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-12","SUBJID":"id-165","AGE":34.68285,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-06-13 10:32:29","TRTEDTM":"2022-06-13 22:32:29","EOSDY":731,"EOSDT":"2022-06-13","STRATA1":"B","STRATA2":"S2","BMRKR1":3.75684,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-12-id-165","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-06-13 10:32:29","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-14","SUBJID":"id-183","AGE":36.84741,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-10-01 04:33:25","TRTEDTM":"2021-09-30 16:33:25","EOSDY":731,"EOSDT":"2021-09-30","STRATA1":"A","STRATA2":"S2","BMRKR1":6.69659,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-14-id-183","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-09-30 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-14","SUBJID":"id-183","AGE":36.84741,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-10-01 04:33:25","TRTEDTM":"2021-09-30 16:33:25","EOSDY":731,"EOSDT":"2021-09-30","STRATA1":"A","STRATA2":"S2","BMRKR1":6.69659,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-14-id-183","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":8}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-14","SUBJID":"id-183","AGE":36.84741,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-10-01 04:33:25","TRTEDTM":"2021-09-30 16:33:25","EOSDY":731,"EOSDT":"2021-09-30","STRATA1":"A","STRATA2":"S2","BMRKR1":6.69659,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-14-id-183","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-14","SUBJID":"id-183","AGE":36.84741,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-10-01 04:33:25","TRTEDTM":"2021-09-30 16:33:25","EOSDY":731,"EOSDT":"2021-09-30","STRATA1":"A","STRATA2":"S2","BMRKR1":6.69659,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-14-id-183","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":10}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-14","SUBJID":"id-183","AGE":36.84741,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-10-01 04:33:25","TRTEDTM":"2021-09-30 16:33:25","EOSDY":731,"EOSDT":"2021-09-30","STRATA1":"A","STRATA2":"S2","BMRKR1":6.69659,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-14-id-183","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.21498,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-19 04:33:25","ADY":79}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-14","SUBJID":"id-183","AGE":36.84741,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-10-01 04:33:25","TRTEDTM":"2021-09-30 16:33:25","EOSDY":731,"EOSDT":"2021-09-30","STRATA1":"A","STRATA2":"S2","BMRKR1":6.69659,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-14-id-183","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.02354,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-10-10 04:33:25","ADY":9}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-14","SUBJID":"id-183","AGE":36.84741,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-10-01 04:33:25","TRTEDTM":"2021-09-30 16:33:25","EOSDY":731,"EOSDT":"2021-09-30","STRATA1":"A","STRATA2":"S2","BMRKR1":6.69659,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-14-id-183","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.0012,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-10-02 04:33:25","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-14","SUBJID":"id-183","AGE":36.84741,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-10-01 04:33:25","TRTEDTM":"2021-09-30 16:33:25","EOSDY":731,"EOSDT":"2021-09-30","STRATA1":"A","STRATA2":"S2","BMRKR1":6.69659,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-14-id-183","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":33.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-05-21 23:51:57","ADY":234}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-14","SUBJID":"id-183","AGE":36.84741,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-10-01 04:33:25","TRTEDTM":"2021-09-30 16:33:25","EOSDY":731,"EOSDT":"2021-09-30","STRATA1":"A","STRATA2":"S2","BMRKR1":6.69659,"BMRKR2":"LOW","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-14-id-183","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":85.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-05-22 13:14:09","ADY":600}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-2","SUBJID":"id-6","AGE":47.65321,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-10-23 00:24:55","TRTEDTM":"2021-10-22 12:24:55","EOSDY":731,"EOSDT":"2021-10-22","STRATA1":"A","STRATA2":"S1","BMRKR1":10.90049,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-2-id-6","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-10-22 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-2","SUBJID":"id-6","AGE":47.65321,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-10-23 00:24:55","TRTEDTM":"2021-10-22 12:24:55","EOSDY":731,"EOSDT":"2021-10-22","STRATA1":"A","STRATA2":"S1","BMRKR1":10.90049,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-2-id-6","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-2","SUBJID":"id-6","AGE":47.65321,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-10-23 00:24:55","TRTEDTM":"2021-10-22 12:24:55","EOSDY":731,"EOSDT":"2021-10-22","STRATA1":"A","STRATA2":"S1","BMRKR1":10.90049,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-2-id-6","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-2","SUBJID":"id-6","AGE":47.65321,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-10-23 00:24:55","TRTEDTM":"2021-10-22 12:24:55","EOSDY":731,"EOSDT":"2021-10-22","STRATA1":"A","STRATA2":"S1","BMRKR1":10.90049,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-2-id-6","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-2","SUBJID":"id-6","AGE":47.65321,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-10-23 00:24:55","TRTEDTM":"2021-10-22 12:24:55","EOSDY":731,"EOSDT":"2021-10-22","STRATA1":"A","STRATA2":"S1","BMRKR1":10.90049,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-2-id-6","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.19071,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-01-01 00:24:55","ADY":70}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-2","SUBJID":"id-6","AGE":47.65321,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-10-23 00:24:55","TRTEDTM":"2021-10-22 12:24:55","EOSDY":731,"EOSDT":"2021-10-22","STRATA1":"A","STRATA2":"S1","BMRKR1":10.90049,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-2-id-6","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.13746,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-13 00:24:55","ADY":51}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-2","SUBJID":"id-6","AGE":47.65321,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-10-23 00:24:55","TRTEDTM":"2021-10-22 12:24:55","EOSDY":731,"EOSDT":"2021-10-22","STRATA1":"A","STRATA2":"S1","BMRKR1":10.90049,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-2-id-6","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-10-23 00:24:55","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-2","SUBJID":"id-6","AGE":47.65321,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-10-23 00:24:55","TRTEDTM":"2021-10-22 12:24:55","EOSDY":731,"EOSDT":"2021-10-22","STRATA1":"A","STRATA2":"S1","BMRKR1":10.90049,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-2-id-6","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-10-23 00:24:55","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-2","SUBJID":"id-6","AGE":47.65321,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-10-23 00:24:55","TRTEDTM":"2021-10-22 12:24:55","EOSDY":731,"EOSDT":"2021-10-22","STRATA1":"A","STRATA2":"S1","BMRKR1":10.90049,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-2-id-6","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":93.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-08-09 02:31:51","ADY":657}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-4","SUBJID":"id-150","AGE":25.27567,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-09 04:52:27","TRTEDTM":"2021-11-08 16:52:27","EOSDY":731,"EOSDT":"2021-11-08","STRATA1":"B","STRATA2":"S2","BMRKR1":14.18094,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-4-id-150","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-11-08 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-4","SUBJID":"id-150","AGE":25.27567,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-09 04:52:27","TRTEDTM":"2021-11-08 16:52:27","EOSDY":731,"EOSDT":"2021-11-08","STRATA1":"B","STRATA2":"S2","BMRKR1":14.18094,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-4-id-150","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-4","SUBJID":"id-150","AGE":25.27567,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-09 04:52:27","TRTEDTM":"2021-11-08 16:52:27","EOSDY":731,"EOSDT":"2021-11-08","STRATA1":"B","STRATA2":"S2","BMRKR1":14.18094,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-4-id-150","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-4","SUBJID":"id-150","AGE":25.27567,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-09 04:52:27","TRTEDTM":"2021-11-08 16:52:27","EOSDY":731,"EOSDT":"2021-11-08","STRATA1":"B","STRATA2":"S2","BMRKR1":14.18094,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-4-id-150","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-4","SUBJID":"id-150","AGE":25.27567,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-09 04:52:27","TRTEDTM":"2021-11-08 16:52:27","EOSDY":731,"EOSDT":"2021-11-08","STRATA1":"B","STRATA2":"S2","BMRKR1":14.18094,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-4-id-150","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-11-09 04:52:27","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-4","SUBJID":"id-150","AGE":25.27567,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-09 04:52:27","TRTEDTM":"2021-11-08 16:52:27","EOSDY":731,"EOSDT":"2021-11-08","STRATA1":"B","STRATA2":"S2","BMRKR1":14.18094,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-4-id-150","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-11-09 04:52:27","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-4","SUBJID":"id-150","AGE":25.27567,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-09 04:52:27","TRTEDTM":"2021-11-08 16:52:27","EOSDY":731,"EOSDT":"2021-11-08","STRATA1":"B","STRATA2":"S2","BMRKR1":14.18094,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-4-id-150","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.29789,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-02-26 04:52:27","ADY":109}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-4","SUBJID":"id-150","AGE":25.27567,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-09 04:52:27","TRTEDTM":"2021-11-08 16:52:27","EOSDY":731,"EOSDT":"2021-11-08","STRATA1":"B","STRATA2":"S2","BMRKR1":14.18094,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-4-id-150","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":92.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-08-19 09:09:22","ADY":650}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-4","SUBJID":"id-150","AGE":25.27567,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-11-09 04:52:27","TRTEDTM":"2021-11-08 16:52:27","EOSDY":731,"EOSDT":"2021-11-08","STRATA1":"B","STRATA2":"S2","BMRKR1":14.18094,"BMRKR2":"MEDIUM","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-4-id-150","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":79.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-05-19 12:21:24","ADY":558}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-7","SUBJID":"id-52","AGE":28.2361,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-16 02:05:26","TRTEDTM":"2021-08-15 14:05:26","EOSDY":731,"EOSDT":"2021-08-15","STRATA1":"A","STRATA2":"S1","BMRKR1":4.79945,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-7-id-52","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-08-15 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-7","SUBJID":"id-52","AGE":28.2361,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-16 02:05:26","TRTEDTM":"2021-08-15 14:05:26","EOSDY":731,"EOSDT":"2021-08-15","STRATA1":"A","STRATA2":"S1","BMRKR1":4.79945,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-7-id-52","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-7","SUBJID":"id-52","AGE":28.2361,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-16 02:05:26","TRTEDTM":"2021-08-15 14:05:26","EOSDY":731,"EOSDT":"2021-08-15","STRATA1":"A","STRATA2":"S1","BMRKR1":4.79945,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-7-id-52","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-7","SUBJID":"id-52","AGE":28.2361,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-16 02:05:26","TRTEDTM":"2021-08-15 14:05:26","EOSDY":731,"EOSDT":"2021-08-15","STRATA1":"A","STRATA2":"S1","BMRKR1":4.79945,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-7-id-52","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-7","SUBJID":"id-52","AGE":28.2361,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-16 02:05:26","TRTEDTM":"2021-08-15 14:05:26","EOSDY":731,"EOSDT":"2021-08-15","STRATA1":"A","STRATA2":"S1","BMRKR1":4.79945,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-7-id-52","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-08-16 02:05:26","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-7","SUBJID":"id-52","AGE":28.2361,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-16 02:05:26","TRTEDTM":"2021-08-15 14:05:26","EOSDY":731,"EOSDT":"2021-08-15","STRATA1":"A","STRATA2":"S1","BMRKR1":4.79945,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-7-id-52","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-08-16 02:05:26","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-7","SUBJID":"id-52","AGE":28.2361,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-16 02:05:26","TRTEDTM":"2021-08-15 14:05:26","EOSDY":731,"EOSDT":"2021-08-15","STRATA1":"A","STRATA2":"S1","BMRKR1":4.79945,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-7-id-52","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.07511,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-13 02:05:26","ADY":28}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-7","SUBJID":"id-52","AGE":28.2361,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-16 02:05:26","TRTEDTM":"2021-08-15 14:05:26","EOSDY":731,"EOSDT":"2021-08-15","STRATA1":"A","STRATA2":"S1","BMRKR1":4.79945,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-7-id-52","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":85.42857,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-04-04 13:37:55","ADY":598}
{"STUDYID":"AB12345","COUNTRY":"RUS","SITEID":"RUS-7","SUBJID":"id-52","AGE":28.2361,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-08-16 02:05:26","TRTEDTM":"2021-08-15 14:05:26","EOSDY":731,"EOSDT":"2021-08-15","STRATA1":"A","STRATA2":"S1","BMRKR1":4.79945,"BMRKR2":"HIGH","REGION1":"Eurasia","SAFFL":"Y","USUBJID":"AB12345-RUS-7-id-52","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":74.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-01-18 05:19:28","ADY":522}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-110","AGE":32.22158,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-29 11:44:05","TRTEDTM":"2022-11-29 23:44:05","EOSDY":731,"EOSDT":"2022-11-29","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00995,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-110","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-11-29 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-110","AGE":32.22158,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-29 11:44:05","TRTEDTM":"2022-11-29 23:44:05","EOSDY":731,"EOSDT":"2022-11-29","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00995,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-110","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-110","AGE":32.22158,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-29 11:44:05","TRTEDTM":"2022-11-29 23:44:05","EOSDY":731,"EOSDT":"2022-11-29","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00995,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-110","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-110","AGE":32.22158,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-29 11:44:05","TRTEDTM":"2022-11-29 23:44:05","EOSDY":731,"EOSDT":"2022-11-29","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00995,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-110","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-110","AGE":32.22158,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-29 11:44:05","TRTEDTM":"2022-11-29 23:44:05","EOSDY":731,"EOSDT":"2022-11-29","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00995,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-110","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.26134,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-03-05 11:44:05","ADY":96}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-110","AGE":32.22158,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-29 11:44:05","TRTEDTM":"2022-11-29 23:44:05","EOSDY":731,"EOSDT":"2022-11-29","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00995,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-110","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.23388,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-02-23 11:44:05","ADY":86}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-110","AGE":32.22158,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-29 11:44:05","TRTEDTM":"2022-11-29 23:44:05","EOSDY":731,"EOSDT":"2022-11-29","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00995,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-110","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.04625,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-12-16 11:44:05","ADY":17}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-110","AGE":32.22158,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-29 11:44:05","TRTEDTM":"2022-11-29 23:44:05","EOSDY":731,"EOSDT":"2022-11-29","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00995,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-110","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":44.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-10-06 16:16:45","ADY":312}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-110","AGE":32.22158,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-11-29 11:44:05","TRTEDTM":"2022-11-29 23:44:05","EOSDY":731,"EOSDT":"2022-11-29","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00995,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-110","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":37.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-08-15 07:01:25","ADY":260}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-136","AGE":23.32915,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-28 20:03:31","TRTEDTM":"2022-03-29 08:03:31","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.8676,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-136","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-03-29 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-136","AGE":23.32915,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-28 20:03:31","TRTEDTM":"2022-03-29 08:03:31","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.8676,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-136","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-136","AGE":23.32915,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-28 20:03:31","TRTEDTM":"2022-03-29 08:03:31","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.8676,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-136","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-136","AGE":23.32915,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-28 20:03:31","TRTEDTM":"2022-03-29 08:03:31","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.8676,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-136","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-136","AGE":23.32915,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-28 20:03:31","TRTEDTM":"2022-03-29 08:03:31","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.8676,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-136","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-03-30 20:03:31","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-136","AGE":23.32915,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-28 20:03:31","TRTEDTM":"2022-03-29 08:03:31","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.8676,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-136","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.03874,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-04-12 20:03:31","ADY":15}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-136","AGE":23.32915,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-28 20:03:31","TRTEDTM":"2022-03-29 08:03:31","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.8676,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-136","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.22165,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-06-17 20:03:31","ADY":81}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-136","AGE":23.32915,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-28 20:03:31","TRTEDTM":"2022-03-29 08:03:31","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.8676,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-136","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":61.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-06-01 12:14:01","ADY":431}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-136","AGE":23.32915,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2020-03-28 20:03:31","TRTEDTM":"2022-03-29 08:03:31","EOSDY":731,"EOSDT":"2022-03-29","STRATA1":"B","STRATA2":"S2","BMRKR1":2.8676,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-136","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-04-01 04:24:03","ADY":5}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-137","AGE":29.67216,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-12 02:03:20","TRTEDTM":"2021-09-11 14:03:20","EOSDY":731,"EOSDT":"2021-09-11","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57034,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-137","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-09-11 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-137","AGE":29.67216,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-12 02:03:20","TRTEDTM":"2021-09-11 14:03:20","EOSDY":731,"EOSDT":"2021-09-11","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57034,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-137","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-137","AGE":29.67216,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-12 02:03:20","TRTEDTM":"2021-09-11 14:03:20","EOSDY":731,"EOSDT":"2021-09-11","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57034,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-137","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-137","AGE":29.67216,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-12 02:03:20","TRTEDTM":"2021-09-11 14:03:20","EOSDY":731,"EOSDT":"2021-09-11","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57034,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-137","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-137","AGE":29.67216,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-12 02:03:20","TRTEDTM":"2021-09-11 14:03:20","EOSDY":731,"EOSDT":"2021-09-11","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57034,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-137","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.15587,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-08 02:03:20","ADY":57}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-137","AGE":29.67216,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-12 02:03:20","TRTEDTM":"2021-09-11 14:03:20","EOSDY":731,"EOSDT":"2021-09-11","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57034,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-137","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.35164,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-01-19 02:03:20","ADY":129}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-137","AGE":29.67216,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-12 02:03:20","TRTEDTM":"2021-09-11 14:03:20","EOSDY":731,"EOSDT":"2021-09-11","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57034,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-137","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.12984,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-10-30 02:03:20","ADY":48}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-137","AGE":29.67216,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-12 02:03:20","TRTEDTM":"2021-09-11 14:03:20","EOSDY":731,"EOSDT":"2021-09-11","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57034,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-137","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":73.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-02-09 12:59:38","ADY":517}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-137","AGE":29.67216,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-12 02:03:20","TRTEDTM":"2021-09-11 14:03:20","EOSDY":731,"EOSDT":"2021-09-11","STRATA1":"B","STRATA2":"S1","BMRKR1":11.57034,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-137","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":35.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-05-18 10:06:21","ADY":250}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-151","AGE":39.52294,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-12 14:11:30","TRTEDTM":"2021-04-12 02:11:30","EOSDY":731,"EOSDT":"2021-04-12","STRATA1":"A","STRATA2":"S2","BMRKR1":6.05645,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-151","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-04-12 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-151","AGE":39.52294,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-12 14:11:30","TRTEDTM":"2021-04-12 02:11:30","EOSDY":731,"EOSDT":"2021-04-12","STRATA1":"A","STRATA2":"S2","BMRKR1":6.05645,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-151","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-151","AGE":39.52294,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-12 14:11:30","TRTEDTM":"2021-04-12 02:11:30","EOSDY":731,"EOSDT":"2021-04-12","STRATA1":"A","STRATA2":"S2","BMRKR1":6.05645,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-151","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-151","AGE":39.52294,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-12 14:11:30","TRTEDTM":"2021-04-12 02:11:30","EOSDY":731,"EOSDT":"2021-04-12","STRATA1":"A","STRATA2":"S2","BMRKR1":6.05645,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-151","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":8}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-151","AGE":39.52294,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-12 14:11:30","TRTEDTM":"2021-04-12 02:11:30","EOSDY":731,"EOSDT":"2021-04-12","STRATA1":"A","STRATA2":"S2","BMRKR1":6.05645,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-151","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.0121,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-04-17 14:11:30","ADY":5}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-151","AGE":39.52294,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-12 14:11:30","TRTEDTM":"2021-04-12 02:11:30","EOSDY":731,"EOSDT":"2021-04-12","STRATA1":"A","STRATA2":"S2","BMRKR1":6.05645,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-151","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period","ADTM":"2021-04-13 14:11:30","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-151","AGE":39.52294,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-12 14:11:30","TRTEDTM":"2021-04-12 02:11:30","EOSDY":731,"EOSDT":"2021-04-12","STRATA1":"A","STRATA2":"S2","BMRKR1":6.05645,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-151","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.54964,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-10-30 14:11:30","ADY":201}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-151","AGE":39.52294,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-12 14:11:30","TRTEDTM":"2021-04-12 02:11:30","EOSDY":731,"EOSDT":"2021-04-12","STRATA1":"A","STRATA2":"S2","BMRKR1":6.05645,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-151","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":51.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-04-07 14:48:25","ADY":362}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-151","AGE":39.52294,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2019-04-12 14:11:30","TRTEDTM":"2021-04-12 02:11:30","EOSDY":731,"EOSDT":"2021-04-12","STRATA1":"A","STRATA2":"S2","BMRKR1":6.05645,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-151","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":55.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-05-06 07:10:29","ADY":391}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-196","AGE":47.81285,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-07 10:59:40","TRTEDTM":"2021-06-06 22:59:40","EOSDY":731,"EOSDT":"2021-06-06","STRATA1":"B","STRATA2":"S1","BMRKR1":6.55756,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-196","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-06-06 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-196","AGE":47.81285,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-07 10:59:40","TRTEDTM":"2021-06-06 22:59:40","EOSDY":731,"EOSDT":"2021-06-06","STRATA1":"B","STRATA2":"S1","BMRKR1":6.55756,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-196","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":10}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-196","AGE":47.81285,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-07 10:59:40","TRTEDTM":"2021-06-06 22:59:40","EOSDY":731,"EOSDT":"2021-06-06","STRATA1":"B","STRATA2":"S1","BMRKR1":6.55756,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-196","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-196","AGE":47.81285,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-07 10:59:40","TRTEDTM":"2021-06-06 22:59:40","EOSDY":731,"EOSDT":"2021-06-06","STRATA1":"B","STRATA2":"S1","BMRKR1":6.55756,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-196","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-196","AGE":47.81285,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-07 10:59:40","TRTEDTM":"2021-06-06 22:59:40","EOSDY":731,"EOSDT":"2021-06-06","STRATA1":"B","STRATA2":"S1","BMRKR1":6.55756,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-196","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.10174,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-15 10:59:40","ADY":38}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-196","AGE":47.81285,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-07 10:59:40","TRTEDTM":"2021-06-06 22:59:40","EOSDY":731,"EOSDT":"2021-06-06","STRATA1":"B","STRATA2":"S1","BMRKR1":6.55756,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-196","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-06-07 10:59:40","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-196","AGE":47.81285,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-07 10:59:40","TRTEDTM":"2021-06-06 22:59:40","EOSDY":731,"EOSDT":"2021-06-06","STRATA1":"B","STRATA2":"S1","BMRKR1":6.55756,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-196","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.23609,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-02 10:59:40","ADY":87}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-196","AGE":47.81285,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-07 10:59:40","TRTEDTM":"2021-06-06 22:59:40","EOSDY":731,"EOSDT":"2021-06-06","STRATA1":"B","STRATA2":"S1","BMRKR1":6.55756,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-196","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":5.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-07-12 10:09:43","ADY":36}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-196","AGE":47.81285,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-06-07 10:59:40","TRTEDTM":"2021-06-06 22:59:40","EOSDY":731,"EOSDT":"2021-06-06","STRATA1":"B","STRATA2":"S1","BMRKR1":6.55756,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-196","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":20.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-10-26 08:13:05","ADY":142}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-45","AGE":37.48063,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-31 14:06:55","TRTEDTM":"2021-03-31 02:06:55","EOSDY":731,"EOSDT":"2021-03-31","STRATA1":"A","STRATA2":"S2","BMRKR1":5.5664,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-45","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-03-31 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-45","AGE":37.48063,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-31 14:06:55","TRTEDTM":"2021-03-31 02:06:55","EOSDY":731,"EOSDT":"2021-03-31","STRATA1":"A","STRATA2":"S2","BMRKR1":5.5664,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-45","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-45","AGE":37.48063,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-31 14:06:55","TRTEDTM":"2021-03-31 02:06:55","EOSDY":731,"EOSDT":"2021-03-31","STRATA1":"A","STRATA2":"S2","BMRKR1":5.5664,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-45","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-45","AGE":37.48063,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-31 14:06:55","TRTEDTM":"2021-03-31 02:06:55","EOSDY":731,"EOSDT":"2021-03-31","STRATA1":"A","STRATA2":"S2","BMRKR1":5.5664,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-45","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-45","AGE":37.48063,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-31 14:06:55","TRTEDTM":"2021-03-31 02:06:55","EOSDY":731,"EOSDT":"2021-03-31","STRATA1":"A","STRATA2":"S2","BMRKR1":5.5664,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-45","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.12763,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-17 14:06:55","ADY":47}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-45","AGE":37.48063,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-31 14:06:55","TRTEDTM":"2021-03-31 02:06:55","EOSDY":731,"EOSDT":"2021-03-31","STRATA1":"A","STRATA2":"S2","BMRKR1":5.5664,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-45","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.13518,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-20 14:06:55","ADY":50}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-45","AGE":37.48063,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-31 14:06:55","TRTEDTM":"2021-03-31 02:06:55","EOSDY":731,"EOSDT":"2021-03-31","STRATA1":"A","STRATA2":"S2","BMRKR1":5.5664,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-45","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.02698,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-04-10 14:06:55","ADY":10}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-45","AGE":37.48063,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-31 14:06:55","TRTEDTM":"2021-03-31 02:06:55","EOSDY":731,"EOSDT":"2021-03-31","STRATA1":"A","STRATA2":"S2","BMRKR1":5.5664,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-45","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":11.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-06-21 01:55:11","ADY":83}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-45","AGE":37.48063,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-03-31 14:06:55","TRTEDTM":"2021-03-31 02:06:55","EOSDY":731,"EOSDT":"2021-03-31","STRATA1":"A","STRATA2":"S2","BMRKR1":5.5664,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-45","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":55.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-04-22 23:01:46","ADY":389}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-58","AGE":36.22667,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-01-14 23:01:21","TRTEDTM":"2022-01-14 11:01:21","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"B","STRATA2":"S1","BMRKR1":15.38105,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-58","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-01-14 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-58","AGE":36.22667,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-01-14 23:01:21","TRTEDTM":"2022-01-14 11:01:21","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"B","STRATA2":"S1","BMRKR1":15.38105,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-58","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-58","AGE":36.22667,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-01-14 23:01:21","TRTEDTM":"2022-01-14 11:01:21","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"B","STRATA2":"S1","BMRKR1":15.38105,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-58","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-58","AGE":36.22667,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-01-14 23:01:21","TRTEDTM":"2022-01-14 11:01:21","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"B","STRATA2":"S1","BMRKR1":15.38105,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-58","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-58","AGE":36.22667,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-01-14 23:01:21","TRTEDTM":"2022-01-14 11:01:21","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"B","STRATA2":"S1","BMRKR1":15.38105,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-58","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.07815,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-02-12 23:01:21","ADY":29}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-58","AGE":36.22667,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-01-14 23:01:21","TRTEDTM":"2022-01-14 11:01:21","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"B","STRATA2":"S1","BMRKR1":15.38105,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-58","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.1744,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-03-18 23:01:21","ADY":64}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-58","AGE":36.22667,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-01-14 23:01:21","TRTEDTM":"2022-01-14 11:01:21","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"B","STRATA2":"S1","BMRKR1":15.38105,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-58","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.13694,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-03-05 23:01:21","ADY":51}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-58","AGE":36.22667,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-01-14 23:01:21","TRTEDTM":"2022-01-14 11:01:21","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"B","STRATA2":"S1","BMRKR1":15.38105,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-58","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":91.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-10-12 06:55:00","ADY":638}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-1","SUBJID":"id-58","AGE":36.22667,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2020-01-14 23:01:21","TRTEDTM":"2022-01-14 11:01:21","EOSDY":731,"EOSDT":"2022-01-14","STRATA1":"B","STRATA2":"S1","BMRKR1":15.38105,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-1-id-58","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-01-14 23:01:21","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-138","AGE":25.74479,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-19 07:53:52","TRTEDTM":"2021-04-18 19:53:52","EOSDY":731,"EOSDT":"2021-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":6.7161,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-138","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-04-18 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-138","AGE":25.74479,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-19 07:53:52","TRTEDTM":"2021-04-18 19:53:52","EOSDY":731,"EOSDT":"2021-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":6.7161,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-138","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-138","AGE":25.74479,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-19 07:53:52","TRTEDTM":"2021-04-18 19:53:52","EOSDY":731,"EOSDT":"2021-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":6.7161,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-138","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":9}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-138","AGE":25.74479,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-19 07:53:52","TRTEDTM":"2021-04-18 19:53:52","EOSDY":731,"EOSDT":"2021-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":6.7161,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-138","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":8}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-138","AGE":25.74479,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-19 07:53:52","TRTEDTM":"2021-04-18 19:53:52","EOSDY":731,"EOSDT":"2021-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":6.7161,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-138","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-04-19 07:53:52","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-138","AGE":25.74479,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-19 07:53:52","TRTEDTM":"2021-04-18 19:53:52","EOSDY":731,"EOSDT":"2021-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":6.7161,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-138","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.66636,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-12-19 07:53:52","ADY":244}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-138","AGE":25.74479,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-19 07:53:52","TRTEDTM":"2021-04-18 19:53:52","EOSDY":731,"EOSDT":"2021-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":6.7161,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-138","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.18441,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-06-26 07:53:52","ADY":68}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-138","AGE":25.74479,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-19 07:53:52","TRTEDTM":"2021-04-18 19:53:52","EOSDY":731,"EOSDT":"2021-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":6.7161,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-138","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":80.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-11-04 19:56:26","ADY":566}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-138","AGE":25.74479,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-04-19 07:53:52","TRTEDTM":"2021-04-18 19:53:52","EOSDY":731,"EOSDT":"2021-04-18","STRATA1":"A","STRATA2":"S2","BMRKR1":6.7161,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-138","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":53.28571,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-04-25 23:44:05","ADY":373}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-142","AGE":28.64347,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-04-19 11:51:55","TRTEDTM":"2022-04-19 23:51:55","EOSDY":731,"EOSDT":"2022-04-19","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00698,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-142","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-04-19 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-142","AGE":28.64347,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-04-19 11:51:55","TRTEDTM":"2022-04-19 23:51:55","EOSDY":731,"EOSDT":"2022-04-19","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00698,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-142","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-142","AGE":28.64347,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-04-19 11:51:55","TRTEDTM":"2022-04-19 23:51:55","EOSDY":731,"EOSDT":"2022-04-19","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00698,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-142","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-142","AGE":28.64347,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-04-19 11:51:55","TRTEDTM":"2022-04-19 23:51:55","EOSDY":731,"EOSDT":"2022-04-19","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00698,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-142","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":6}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-142","AGE":28.64347,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-04-19 11:51:55","TRTEDTM":"2022-04-19 23:51:55","EOSDY":731,"EOSDT":"2022-04-19","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00698,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-142","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.06714,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-05-14 11:51:55","ADY":25}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-142","AGE":28.64347,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-04-19 11:51:55","TRTEDTM":"2022-04-19 23:51:55","EOSDY":731,"EOSDT":"2022-04-19","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00698,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-142","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.40075,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-13 11:51:55","ADY":147}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-142","AGE":28.64347,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-04-19 11:51:55","TRTEDTM":"2022-04-19 23:51:55","EOSDY":731,"EOSDT":"2022-04-19","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00698,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-142","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.30142,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-08 11:51:55","ADY":111}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-142","AGE":28.64347,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-04-19 11:51:55","TRTEDTM":"2022-04-19 23:51:55","EOSDY":731,"EOSDT":"2022-04-19","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00698,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-142","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":37.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-01-08 04:38:06","ADY":265}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-142","AGE":28.64347,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","TRTSDTM":"2020-04-19 11:51:55","TRTEDTM":"2022-04-19 23:51:55","EOSDY":731,"EOSDT":"2022-04-19","STRATA1":"A","STRATA2":"S2","BMRKR1":5.00698,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-142","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-04-19 11:51:55","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-152","AGE":37.54864,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-01 07:47:04","TRTEDTM":"2022-06-01 19:47:04","EOSDY":731,"EOSDT":"2022-06-01","STRATA1":"B","STRATA2":"S1","BMRKR1":3.15891,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-152","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-06-01 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-152","AGE":37.54864,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-01 07:47:04","TRTEDTM":"2022-06-01 19:47:04","EOSDY":731,"EOSDT":"2022-06-01","STRATA1":"B","STRATA2":"S1","BMRKR1":3.15891,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-152","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":7}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-152","AGE":37.54864,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-01 07:47:04","TRTEDTM":"2022-06-01 19:47:04","EOSDY":731,"EOSDT":"2022-06-01","STRATA1":"B","STRATA2":"S1","BMRKR1":3.15891,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-152","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-152","AGE":37.54864,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-01 07:47:04","TRTEDTM":"2022-06-01 19:47:04","EOSDY":731,"EOSDT":"2022-06-01","STRATA1":"B","STRATA2":"S1","BMRKR1":3.15891,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-152","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-152","AGE":37.54864,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-01 07:47:04","TRTEDTM":"2022-06-01 19:47:04","EOSDY":731,"EOSDT":"2022-06-01","STRATA1":"B","STRATA2":"S1","BMRKR1":3.15891,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-152","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.22341,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-22 07:47:04","ADY":82}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-152","AGE":37.54864,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-01 07:47:04","TRTEDTM":"2022-06-01 19:47:04","EOSDY":731,"EOSDT":"2022-06-01","STRATA1":"B","STRATA2":"S1","BMRKR1":3.15891,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-152","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.76635,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-03-08 07:47:04","ADY":280}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-152","AGE":37.54864,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-01 07:47:04","TRTEDTM":"2022-06-01 19:47:04","EOSDY":731,"EOSDT":"2022-06-01","STRATA1":"B","STRATA2":"S1","BMRKR1":3.15891,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-152","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-06-02 07:47:04","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-152","AGE":37.54864,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-01 07:47:04","TRTEDTM":"2022-06-01 19:47:04","EOSDY":731,"EOSDT":"2022-06-01","STRATA1":"B","STRATA2":"S1","BMRKR1":3.15891,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-152","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-06-01 07:47:04","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-152","AGE":37.54864,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2020-06-01 07:47:04","TRTEDTM":"2022-06-01 19:47:04","EOSDY":731,"EOSDT":"2022-06-01","STRATA1":"B","STRATA2":"S1","BMRKR1":3.15891,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-152","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":19.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-10-15 16:54:08","ADY":137}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-179","AGE":25.43722,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-04-07 06:49:52","TRTEDTM":"2021-04-06 18:49:52","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":6.27634,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-179","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-04-06 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-179","AGE":25.43722,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-04-07 06:49:52","TRTEDTM":"2021-04-06 18:49:52","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":6.27634,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-179","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-179","AGE":25.43722,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-04-07 06:49:52","TRTEDTM":"2021-04-06 18:49:52","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":6.27634,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-179","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":8}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-179","AGE":25.43722,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-04-07 06:49:52","TRTEDTM":"2021-04-06 18:49:52","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":6.27634,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-179","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":9}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-179","AGE":25.43722,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-04-07 06:49:52","TRTEDTM":"2021-04-06 18:49:52","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":6.27634,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-179","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.05692,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-04-28 06:49:52","ADY":21}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-179","AGE":25.43722,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-04-07 06:49:52","TRTEDTM":"2021-04-06 18:49:52","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":6.27634,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-179","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.0086,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-04-11 06:49:52","ADY":4}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-179","AGE":25.43722,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-04-07 06:49:52","TRTEDTM":"2021-04-06 18:49:52","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":6.27634,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-179","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.07115,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-05-03 06:49:52","ADY":26}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-179","AGE":25.43722,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-04-07 06:49:52","TRTEDTM":"2021-04-06 18:49:52","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":6.27634,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-179","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":45.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-02-16 11:58:11","ADY":316}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-179","AGE":25.43722,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"BLACK OR AFRICAN AMERICAN","TRTSDTM":"2019-04-07 06:49:52","TRTEDTM":"2021-04-06 18:49:52","EOSDY":731,"EOSDT":"2021-04-06","STRATA1":"C","STRATA2":"S1","BMRKR1":6.27634,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-179","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":42.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-01-30 23:33:27","ADY":299}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-32","AGE":38.98264,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-03 15:11:49","TRTEDTM":"2022-06-04 03:11:49","EOSDY":731,"EOSDT":"2022-06-04","STRATA1":"B","STRATA2":"S1","BMRKR1":4.94158,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-32","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-06-04 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-32","AGE":38.98264,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-03 15:11:49","TRTEDTM":"2022-06-04 03:11:49","EOSDY":731,"EOSDT":"2022-06-04","STRATA1":"B","STRATA2":"S1","BMRKR1":4.94158,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-32","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-32","AGE":38.98264,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-03 15:11:49","TRTEDTM":"2022-06-04 03:11:49","EOSDY":731,"EOSDT":"2022-06-04","STRATA1":"B","STRATA2":"S1","BMRKR1":4.94158,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-32","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-32","AGE":38.98264,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-03 15:11:49","TRTEDTM":"2022-06-04 03:11:49","EOSDY":731,"EOSDT":"2022-06-04","STRATA1":"B","STRATA2":"S1","BMRKR1":4.94158,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-32","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":10}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-32","AGE":38.98264,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-03 15:11:49","TRTEDTM":"2022-06-04 03:11:49","EOSDY":731,"EOSDT":"2022-06-04","STRATA1":"B","STRATA2":"S1","BMRKR1":4.94158,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-32","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-06-05 15:11:49","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-32","AGE":38.98264,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-03 15:11:49","TRTEDTM":"2022-06-04 03:11:49","EOSDY":731,"EOSDT":"2022-06-04","STRATA1":"B","STRATA2":"S1","BMRKR1":4.94158,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-32","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.89366,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-04-26 15:11:49","ADY":327}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-32","AGE":38.98264,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-03 15:11:49","TRTEDTM":"2022-06-04 03:11:49","EOSDY":731,"EOSDT":"2022-06-04","STRATA1":"B","STRATA2":"S1","BMRKR1":4.94158,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-32","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.01552,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-06-09 15:11:49","ADY":6}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-32","AGE":38.98264,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-03 15:11:49","TRTEDTM":"2022-06-04 03:11:49","EOSDY":731,"EOSDT":"2022-06-04","STRATA1":"B","STRATA2":"S1","BMRKR1":4.94158,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-32","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":86,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-01-25 13:51:47","ADY":602}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-32","AGE":38.98264,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"WHITE","TRTSDTM":"2020-06-03 15:11:49","TRTEDTM":"2022-06-04 03:11:49","EOSDY":731,"EOSDT":"2022-06-04","STRATA1":"B","STRATA2":"S1","BMRKR1":4.94158,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-32","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":2.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-06-17 14:07:01","ADY":15}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-44","AGE":31.31375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-07-11 04:47:17","TRTEDTM":"2022-07-11 16:47:17","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"B","STRATA2":"S1","BMRKR1":5.36534,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-44","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-07-11 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-44","AGE":31.31375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-07-11 04:47:17","TRTEDTM":"2022-07-11 16:47:17","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"B","STRATA2":"S1","BMRKR1":5.36534,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-44","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":9}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-44","AGE":31.31375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-07-11 04:47:17","TRTEDTM":"2022-07-11 16:47:17","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"B","STRATA2":"S1","BMRKR1":5.36534,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-44","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-44","AGE":31.31375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-07-11 04:47:17","TRTEDTM":"2022-07-11 16:47:17","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"B","STRATA2":"S1","BMRKR1":5.36534,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-44","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-44","AGE":31.31375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-07-11 04:47:17","TRTEDTM":"2022-07-11 16:47:17","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"B","STRATA2":"S1","BMRKR1":5.36534,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-44","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.51536,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-16 04:47:17","ADY":189}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-44","AGE":31.31375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-07-11 04:47:17","TRTEDTM":"2022-07-11 16:47:17","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"B","STRATA2":"S1","BMRKR1":5.36534,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-44","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-07-12 04:47:17","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-44","AGE":31.31375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-07-11 04:47:17","TRTEDTM":"2022-07-11 16:47:17","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"B","STRATA2":"S1","BMRKR1":5.36534,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-44","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2022-07-12 04:47:17","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-44","AGE":31.31375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-07-11 04:47:17","TRTEDTM":"2022-07-11 16:47:17","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"B","STRATA2":"S1","BMRKR1":5.36534,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-44","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":46.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-06-01 22:27:01","ADY":326}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-11","SUBJID":"id-44","AGE":31.31375,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-07-11 04:47:17","TRTEDTM":"2022-07-11 16:47:17","EOSDY":731,"EOSDT":"2022-07-11","STRATA1":"B","STRATA2":"S1","BMRKR1":5.36534,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-11-id-44","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":9.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-09-14 11:34:05","ADY":66}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-15","SUBJID":"id-127","AGE":25.0329,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-31 05:21:02","TRTEDTM":"2021-05-30 17:21:02","EOSDY":731,"EOSDT":"2021-05-30","STRATA1":"A","STRATA2":"S2","BMRKR1":4.8175,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-15-id-127","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-05-30 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-15","SUBJID":"id-127","AGE":25.0329,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-31 05:21:02","TRTEDTM":"2021-05-30 17:21:02","EOSDY":731,"EOSDT":"2021-05-30","STRATA1":"A","STRATA2":"S2","BMRKR1":4.8175,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-15-id-127","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-15","SUBJID":"id-127","AGE":25.0329,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-31 05:21:02","TRTEDTM":"2021-05-30 17:21:02","EOSDY":731,"EOSDT":"2021-05-30","STRATA1":"A","STRATA2":"S2","BMRKR1":4.8175,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-15-id-127","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-15","SUBJID":"id-127","AGE":25.0329,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-31 05:21:02","TRTEDTM":"2021-05-30 17:21:02","EOSDY":731,"EOSDT":"2021-05-30","STRATA1":"A","STRATA2":"S2","BMRKR1":4.8175,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-15-id-127","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-15","SUBJID":"id-127","AGE":25.0329,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-31 05:21:02","TRTEDTM":"2021-05-30 17:21:02","EOSDY":731,"EOSDT":"2021-05-30","STRATA1":"A","STRATA2":"S2","BMRKR1":4.8175,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-15-id-127","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-05-31 05:21:02","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-15","SUBJID":"id-127","AGE":25.0329,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-31 05:21:02","TRTEDTM":"2021-05-30 17:21:02","EOSDY":731,"EOSDT":"2021-05-30","STRATA1":"A","STRATA2":"S2","BMRKR1":4.8175,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-15-id-127","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Clinical Cut Off","ADTM":"2021-05-31 05:21:02","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-15","SUBJID":"id-127","AGE":25.0329,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-31 05:21:02","TRTEDTM":"2021-05-30 17:21:02","EOSDY":731,"EOSDT":"2021-05-30","STRATA1":"A","STRATA2":"S2","BMRKR1":4.8175,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-15-id-127","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.17343,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-03 05:21:02","ADY":64}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-15","SUBJID":"id-127","AGE":25.0329,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-31 05:21:02","TRTEDTM":"2021-05-30 17:21:02","EOSDY":731,"EOSDT":"2021-05-30","STRATA1":"A","STRATA2":"S2","BMRKR1":4.8175,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-15-id-127","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":88,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-02-04 09:50:37","ADY":616}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-15","SUBJID":"id-127","AGE":25.0329,"SEX":"M","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"ASIAN","TRTSDTM":"2019-05-31 05:21:02","TRTEDTM":"2021-05-30 17:21:02","EOSDY":731,"EOSDT":"2021-05-30","STRATA1":"A","STRATA2":"S2","BMRKR1":4.8175,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-15-id-127","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":14.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-09-08 08:22:26","ADY":101}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-140","AGE":44.59449,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-05-19 04:58:43","TRTEDTM":"2021-05-18 16:58:43","EOSDY":731,"EOSDT":"2021-05-18","STRATA1":"B","STRATA2":"S2","BMRKR1":6.58673,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-140","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-05-18 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-140","AGE":44.59449,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-05-19 04:58:43","TRTEDTM":"2021-05-18 16:58:43","EOSDY":731,"EOSDT":"2021-05-18","STRATA1":"B","STRATA2":"S2","BMRKR1":6.58673,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-140","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-140","AGE":44.59449,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-05-19 04:58:43","TRTEDTM":"2021-05-18 16:58:43","EOSDY":731,"EOSDT":"2021-05-18","STRATA1":"B","STRATA2":"S2","BMRKR1":6.58673,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-140","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":12}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-140","AGE":44.59449,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-05-19 04:58:43","TRTEDTM":"2021-05-18 16:58:43","EOSDY":731,"EOSDT":"2021-05-18","STRATA1":"B","STRATA2":"S2","BMRKR1":6.58673,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-140","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":8}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-140","AGE":44.59449,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-05-19 04:58:43","TRTEDTM":"2021-05-18 16:58:43","EOSDY":731,"EOSDT":"2021-05-18","STRATA1":"B","STRATA2":"S2","BMRKR1":6.58673,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-140","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-05-19 04:58:43","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-140","AGE":44.59449,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-05-19 04:58:43","TRTEDTM":"2021-05-18 16:58:43","EOSDY":731,"EOSDT":"2021-05-18","STRATA1":"B","STRATA2":"S2","BMRKR1":6.58673,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-140","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.11747,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-01 04:58:43","ADY":43}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-140","AGE":44.59449,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-05-19 04:58:43","TRTEDTM":"2021-05-18 16:58:43","EOSDY":731,"EOSDT":"2021-05-18","STRATA1":"B","STRATA2":"S2","BMRKR1":6.58673,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-140","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.11602,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-07-01 04:58:43","ADY":43}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-140","AGE":44.59449,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-05-19 04:58:43","TRTEDTM":"2021-05-18 16:58:43","EOSDY":731,"EOSDT":"2021-05-18","STRATA1":"B","STRATA2":"S2","BMRKR1":6.58673,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-140","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":94.71429,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-03-11 22:07:30","ADY":663}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-140","AGE":44.59449,"SEX":"M","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-05-19 04:58:43","TRTEDTM":"2021-05-18 16:58:43","EOSDY":731,"EOSDT":"2021-05-18","STRATA1":"B","STRATA2":"S2","BMRKR1":6.58673,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-140","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":98.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-04-06 14:26:45","ADY":689}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-190","AGE":32.31865,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-26 06:02:27","TRTEDTM":"2022-11-26 18:02:27","EOSDY":731,"EOSDT":"2022-11-26","STRATA1":"C","STRATA2":"S1","BMRKR1":2.45044,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-190","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00137,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-11-26 00:00:00","ADY":731}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-190","AGE":32.31865,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-26 06:02:27","TRTEDTM":"2022-11-26 18:02:27","EOSDY":731,"EOSDT":"2022-11-26","STRATA1":"C","STRATA2":"S1","BMRKR1":2.45044,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-190","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-190","AGE":32.31865,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-26 06:02:27","TRTEDTM":"2022-11-26 18:02:27","EOSDY":731,"EOSDT":"2022-11-26","STRATA1":"C","STRATA2":"S1","BMRKR1":2.45044,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-190","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-190","AGE":32.31865,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-26 06:02:27","TRTEDTM":"2022-11-26 18:02:27","EOSDY":731,"EOSDT":"2022-11-26","STRATA1":"C","STRATA2":"S1","BMRKR1":2.45044,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-190","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":8}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-190","AGE":32.31865,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-26 06:02:27","TRTEDTM":"2022-11-26 18:02:27","EOSDY":731,"EOSDT":"2022-11-26","STRATA1":"C","STRATA2":"S1","BMRKR1":2.45044,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-190","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.32033,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-03-24 06:02:27","ADY":118}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-190","AGE":32.31865,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-26 06:02:27","TRTEDTM":"2022-11-26 18:02:27","EOSDY":731,"EOSDT":"2022-11-26","STRATA1":"C","STRATA2":"S1","BMRKR1":2.45044,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-190","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.06485,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-12-20 06:02:27","ADY":24}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-190","AGE":32.31865,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-26 06:02:27","TRTEDTM":"2022-11-26 18:02:27","EOSDY":731,"EOSDT":"2022-11-26","STRATA1":"C","STRATA2":"S1","BMRKR1":2.45044,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-190","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.03062,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-12-08 06:02:27","ADY":12}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-190","AGE":32.31865,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-26 06:02:27","TRTEDTM":"2022-11-26 18:02:27","EOSDY":731,"EOSDT":"2022-11-26","STRATA1":"C","STRATA2":"S1","BMRKR1":2.45044,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-190","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":53.42857,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-12-04 05:05:32","ADY":374}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-18","SUBJID":"id-190","AGE":32.31865,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2020-11-26 06:02:27","TRTEDTM":"2022-11-26 18:02:27","EOSDY":731,"EOSDT":"2022-11-26","STRATA1":"C","STRATA2":"S1","BMRKR1":2.45044,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-18-id-190","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":28.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-06-10 17:49:27","ADY":197}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-19","SUBJID":"id-131","AGE":32.46819,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-16 14:09:52","TRTEDTM":"2021-04-16 02:09:52","EOSDY":731,"EOSDT":"2021-04-16","STRATA1":"C","STRATA2":"S1","BMRKR1":10.19046,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-19-id-131","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-04-16 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-19","SUBJID":"id-131","AGE":32.46819,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-16 14:09:52","TRTEDTM":"2021-04-16 02:09:52","EOSDY":731,"EOSDT":"2021-04-16","STRATA1":"C","STRATA2":"S1","BMRKR1":10.19046,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-19-id-131","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-19","SUBJID":"id-131","AGE":32.46819,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-16 14:09:52","TRTEDTM":"2021-04-16 02:09:52","EOSDY":731,"EOSDT":"2021-04-16","STRATA1":"C","STRATA2":"S1","BMRKR1":10.19046,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-19-id-131","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-19","SUBJID":"id-131","AGE":32.46819,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-16 14:09:52","TRTEDTM":"2021-04-16 02:09:52","EOSDY":731,"EOSDT":"2021-04-16","STRATA1":"C","STRATA2":"S1","BMRKR1":10.19046,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-19-id-131","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-19","SUBJID":"id-131","AGE":32.46819,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-16 14:09:52","TRTEDTM":"2021-04-16 02:09:52","EOSDY":731,"EOSDT":"2021-04-16","STRATA1":"C","STRATA2":"S1","BMRKR1":10.19046,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-19-id-131","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.3555,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-24 14:09:52","ADY":130}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-19","SUBJID":"id-131","AGE":32.46819,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-16 14:09:52","TRTEDTM":"2021-04-16 02:09:52","EOSDY":731,"EOSDT":"2021-04-16","STRATA1":"C","STRATA2":"S1","BMRKR1":10.19046,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-19-id-131","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-04-17 14:09:52","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-19","SUBJID":"id-131","AGE":32.46819,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-16 14:09:52","TRTEDTM":"2021-04-16 02:09:52","EOSDY":731,"EOSDT":"2021-04-16","STRATA1":"C","STRATA2":"S1","BMRKR1":10.19046,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-19-id-131","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2021-04-17 14:09:52","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-19","SUBJID":"id-131","AGE":32.46819,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-16 14:09:52","TRTEDTM":"2021-04-16 02:09:52","EOSDY":731,"EOSDT":"2021-04-16","STRATA1":"C","STRATA2":"S1","BMRKR1":10.19046,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-19-id-131","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":74.85714,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2020-09-20 02:38:40","ADY":524}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-19","SUBJID":"id-131","AGE":32.46819,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-04-16 14:09:52","TRTEDTM":"2021-04-16 02:09:52","EOSDY":731,"EOSDT":"2021-04-16","STRATA1":"C","STRATA2":"S1","BMRKR1":10.19046,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-19-id-131","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":31.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2019-11-22 02:17:21","ADY":221}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-2","SUBJID":"id-3","AGE":35.39604,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-07-31 23:17:04","TRTEDTM":"2022-08-01 11:17:04","EOSDY":731,"EOSDT":"2022-08-01","STRATA1":"B","STRATA2":"S1","BMRKR1":5.46242,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-2-id-3","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2022-08-01 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-2","SUBJID":"id-3","AGE":35.39604,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-07-31 23:17:04","TRTEDTM":"2022-08-01 11:17:04","EOSDY":731,"EOSDT":"2022-08-01","STRATA1":"B","STRATA2":"S1","BMRKR1":5.46242,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-2-id-3","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-2","SUBJID":"id-3","AGE":35.39604,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-07-31 23:17:04","TRTEDTM":"2022-08-01 11:17:04","EOSDY":731,"EOSDT":"2022-08-01","STRATA1":"B","STRATA2":"S1","BMRKR1":5.46242,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-2-id-3","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-2","SUBJID":"id-3","AGE":35.39604,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-07-31 23:17:04","TRTEDTM":"2022-08-01 11:17:04","EOSDY":731,"EOSDT":"2022-08-01","STRATA1":"B","STRATA2":"S1","BMRKR1":5.46242,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-2-id-3","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-2","SUBJID":"id-3","AGE":35.39604,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-07-31 23:17:04","TRTEDTM":"2022-08-01 11:17:04","EOSDY":731,"EOSDT":"2022-08-01","STRATA1":"B","STRATA2":"S1","BMRKR1":5.46242,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-2-id-3","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.44829,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-01-11 23:17:04","ADY":164}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-2","SUBJID":"id-3","AGE":35.39604,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-07-31 23:17:04","TRTEDTM":"2022-08-01 11:17:04","EOSDY":731,"EOSDT":"2022-08-01","STRATA1":"B","STRATA2":"S1","BMRKR1":5.46242,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-2-id-3","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2022-08-02 23:17:04","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-2","SUBJID":"id-3","AGE":35.39604,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-07-31 23:17:04","TRTEDTM":"2022-08-01 11:17:04","EOSDY":731,"EOSDT":"2022-08-01","STRATA1":"B","STRATA2":"S1","BMRKR1":5.46242,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-2-id-3","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.04302,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-08-16 23:17:04","ADY":16}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-2","SUBJID":"id-3","AGE":35.39604,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-07-31 23:17:04","TRTEDTM":"2022-08-01 11:17:04","EOSDY":731,"EOSDT":"2022-08-01","STRATA1":"B","STRATA2":"S1","BMRKR1":5.46242,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-2-id-3","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":44.85714,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2021-06-09 13:57:16","ADY":314}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-2","SUBJID":"id-3","AGE":35.39604,"SEX":"F","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2020-07-31 23:17:04","TRTEDTM":"2022-08-01 11:17:04","EOSDY":731,"EOSDT":"2022-08-01","STRATA1":"B","STRATA2":"S1","BMRKR1":5.46242,"BMRKR2":"LOW","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-2-id-3","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2020-07-31 23:17:04","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-3","SUBJID":"id-130","AGE":37.47094,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-07-31 12:55:02","TRTEDTM":"2021-07-31 00:55:02","EOSDY":731,"EOSDT":"2021-07-31","STRATA1":"B","STRATA2":"S2","BMRKR1":2.44787,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-3-id-130","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-07-31 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-3","SUBJID":"id-130","AGE":37.47094,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-07-31 12:55:02","TRTEDTM":"2021-07-31 00:55:02","EOSDY":731,"EOSDT":"2021-07-31","STRATA1":"B","STRATA2":"S2","BMRKR1":2.44787,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-3-id-130","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-3","SUBJID":"id-130","AGE":37.47094,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-07-31 12:55:02","TRTEDTM":"2021-07-31 00:55:02","EOSDY":731,"EOSDT":"2021-07-31","STRATA1":"B","STRATA2":"S2","BMRKR1":2.44787,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-3-id-130","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-3","SUBJID":"id-130","AGE":37.47094,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-07-31 12:55:02","TRTEDTM":"2021-07-31 00:55:02","EOSDY":731,"EOSDT":"2021-07-31","STRATA1":"B","STRATA2":"S2","BMRKR1":2.44787,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-3-id-130","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-3","SUBJID":"id-130","AGE":37.47094,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-07-31 12:55:02","TRTEDTM":"2021-07-31 00:55:02","EOSDY":731,"EOSDT":"2021-07-31","STRATA1":"B","STRATA2":"S2","BMRKR1":2.44787,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-3-id-130","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.08099,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-08-30 12:55:02","ADY":30}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-3","SUBJID":"id-130","AGE":37.47094,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-07-31 12:55:02","TRTEDTM":"2021-07-31 00:55:02","EOSDY":731,"EOSDT":"2021-07-31","STRATA1":"B","STRATA2":"S2","BMRKR1":2.44787,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-3-id-130","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.51416,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-02-04 12:55:02","ADY":188}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-3","SUBJID":"id-130","AGE":37.47094,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-07-31 12:55:02","TRTEDTM":"2021-07-31 00:55:02","EOSDY":731,"EOSDT":"2021-07-31","STRATA1":"B","STRATA2":"S2","BMRKR1":2.44787,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-3-id-130","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.09536,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-09-04 12:55:02","ADY":35}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-3","SUBJID":"id-130","AGE":37.47094,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-07-31 12:55:02","TRTEDTM":"2021-07-31 00:55:02","EOSDY":731,"EOSDT":"2021-07-31","STRATA1":"B","STRATA2":"S2","BMRKR1":2.44787,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-3-id-130","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":36.71429,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-04-12 16:46:00","ADY":257}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-3","SUBJID":"id-130","AGE":37.47094,"SEX":"F","ARMCD":"ARM C","ARM":"C: Combination","ACTARMCD":"ARM C","ACTARM":"C: Combination","RACE":"ASIAN","TRTSDTM":"2019-07-31 12:55:02","TRTEDTM":"2021-07-31 00:55:02","EOSDY":731,"EOSDT":"2021-07-31","STRATA1":"B","STRATA2":"S2","BMRKR1":2.44787,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-3-id-130","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":0.14286,"AVALU":"WEEKS","CNSDTDSC":"Treatment Start","ADTM":"2019-07-31 12:55:02","ADY":1}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-5","SUBJID":"id-157","AGE":28.43236,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-23 14:13:05","TRTEDTM":"2021-09-23 02:13:05","EOSDY":731,"EOSDT":"2021-09-23","STRATA1":"A","STRATA2":"S2","BMRKR1":6.3456,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-5-id-157","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2021-09-23 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-5","SUBJID":"id-157","AGE":28.43236,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-23 14:13:05","TRTEDTM":"2021-09-23 02:13:05","EOSDY":731,"EOSDT":"2021-09-23","STRATA1":"A","STRATA2":"S2","BMRKR1":6.3456,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-5-id-157","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":1}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-5","SUBJID":"id-157","AGE":28.43236,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-23 14:13:05","TRTEDTM":"2021-09-23 02:13:05","EOSDY":731,"EOSDT":"2021-09-23","STRATA1":"A","STRATA2":"S2","BMRKR1":6.3456,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-5-id-157","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":5}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-5","SUBJID":"id-157","AGE":28.43236,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-23 14:13:05","TRTEDTM":"2021-09-23 02:13:05","EOSDY":731,"EOSDT":"2021-09-23","STRATA1":"A","STRATA2":"S2","BMRKR1":6.3456,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-5-id-157","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":2}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-5","SUBJID":"id-157","AGE":28.43236,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-23 14:13:05","TRTEDTM":"2021-09-23 02:13:05","EOSDY":731,"EOSDT":"2021-09-23","STRATA1":"A","STRATA2":"S2","BMRKR1":6.3456,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-5-id-157","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":0,"AVAL":0.17309,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2019-11-26 14:13:05","ADY":64}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-5","SUBJID":"id-157","AGE":28.43236,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-23 14:13:05","TRTEDTM":"2021-09-23 02:13:05","EOSDY":731,"EOSDT":"2021-09-23","STRATA1":"A","STRATA2":"S2","BMRKR1":6.3456,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-5-id-157","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.84192,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-07-27 14:13:05","ADY":308}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-5","SUBJID":"id-157","AGE":28.43236,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-23 14:13:05","TRTEDTM":"2021-09-23 02:13:05","EOSDY":731,"EOSDT":"2021-09-23","STRATA1":"A","STRATA2":"S2","BMRKR1":6.3456,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-5-id-157","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.99859,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2020-09-22 14:13:05","ADY":365}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-5","SUBJID":"id-157","AGE":28.43236,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-23 14:13:05","TRTEDTM":"2021-09-23 02:13:05","EOSDY":731,"EOSDT":"2021-09-23","STRATA1":"A","STRATA2":"S2","BMRKR1":6.3456,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-5-id-157","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":1,"AVAL":54.57143,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-10-08 08:54:33","ADY":382}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-5","SUBJID":"id-157","AGE":28.43236,"SEX":"M","ARMCD":"ARM B","ARM":"B: Placebo","ACTARMCD":"ARM B","ACTARM":"B: Placebo","RACE":"ASIAN","TRTSDTM":"2019-09-23 14:13:05","TRTEDTM":"2021-09-23 02:13:05","EOSDY":731,"EOSDT":"2021-09-23","STRATA1":"A","STRATA2":"S2","BMRKR1":6.3456,"BMRKR2":"HIGH","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-5-id-157","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":30.14286,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2020-04-20 00:38:40","ADY":211}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-7","SUBJID":"id-100","AGE":25.91081,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2021-02-14 16:27:08","TRTEDTM":"2023-02-15 04:27:08","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"B","STRATA2":"S1","BMRKR1":6.49516,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-7-id-100","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AEREPTTE","PARAM":"Time to end of AE reporting period","CNSR":0,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"Completion or Discontinuation","ADTM":"2023-02-15 00:00:00","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-7","SUBJID":"id-100","AGE":25.91081,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2021-02-14 16:27:08","TRTEDTM":"2023-02-15 04:27:08","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"B","STRATA2":"S1","BMRKR1":6.49516,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-7-id-100","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT1","PARAM":"Number of occurrences of any adverse event","AVAL":0}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-7","SUBJID":"id-100","AGE":25.91081,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2021-02-14 16:27:08","TRTEDTM":"2023-02-15 04:27:08","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"B","STRATA2":"S1","BMRKR1":6.49516,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-7-id-100","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT2","PARAM":"Number of occurrences of any serious adverse event","AVAL":4}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-7","SUBJID":"id-100","AGE":25.91081,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2021-02-14 16:27:08","TRTEDTM":"2023-02-15 04:27:08","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"B","STRATA2":"S1","BMRKR1":6.49516,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-7-id-100","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETOT3","PARAM":"Number of occurrences of a grade 3-5 adverse event","AVAL":3}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-7","SUBJID":"id-100","AGE":25.91081,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2021-02-14 16:27:08","TRTEDTM":"2023-02-15 04:27:08","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"B","STRATA2":"S1","BMRKR1":6.49516,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-7-id-100","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE1","PARAM":"Time to first occurrence of any adverse event","CNSR":1,"AVAL":2.00411,"AVALU":"YEARS","EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation","ADTM":"2023-02-16 16:27:08","ADY":732}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-7","SUBJID":"id-100","AGE":25.91081,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2021-02-14 16:27:08","TRTEDTM":"2023-02-15 04:27:08","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"B","STRATA2":"S1","BMRKR1":6.49516,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-7-id-100","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE2","PARAM":"Time to first occurrence of any serious adverse event","CNSR":0,"AVAL":0.01087,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-02-18 16:27:08","ADY":4}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-7","SUBJID":"id-100","AGE":25.91081,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2021-02-14 16:27:08","TRTEDTM":"2023-02-15 04:27:08","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"B","STRATA2":"S1","BMRKR1":6.49516,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-7-id-100","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"AETTE3","PARAM":"Time to first occurrence of a grade 3-5 adverse event","CNSR":0,"AVAL":0.17412,"AVALU":"YEARS","EVNTDESC":"Preferred Term","CNSDTDSC":"","ADTM":"2021-04-19 16:27:08","ADY":64}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-7","SUBJID":"id-100","AGE":25.91081,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2021-02-14 16:27:08","TRTEDTM":"2023-02-15 04:27:08","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"B","STRATA2":"S1","BMRKR1":6.49516,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-7-id-100","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEBL","PARAM":"Time to Hy's Law Elevation in relation to Baseline","CNSR":0,"AVAL":29.28571,"AVALU":"WEEKS","EVNTDESC":"First Post-Baseline Raised ALT or AST Elevation Result","ADTM":"2021-09-06 11:38:02","ADY":205}
{"STUDYID":"AB12345","COUNTRY":"USA","SITEID":"USA-7","SUBJID":"id-100","AGE":25.91081,"SEX":"F","ARMCD":"ARM A","ARM":"A: Drug X","ACTARMCD":"ARM A","ACTARM":"A: Drug X","RACE":"WHITE","TRTSDTM":"2021-02-14 16:27:08","TRTEDTM":"2023-02-15 04:27:08","EOSDY":731,"EOSDT":"2023-02-15","STRATA1":"B","STRATA2":"S1","BMRKR1":6.49516,"BMRKR2":"MEDIUM","REGION1":"North America","SAFFL":"Y","USUBJID":"AB12345-USA-7-id-100","EOSSTT":"COMPLETED","EOTSTT":"COMPLETED","PARAMCD":"HYSTTEUL","PARAM":"Time to Hy's Law Elevation in relation to ULN","CNSR":1,"AVAL":48.42857,"AVALU":"WEEKS","CNSDTDSC":"Last Post-Baseline ALT or AST Result","ADTM":"2022-01-18 23:32:21","ADY":339}